0001144204-14-050135.txt : 20140814 0001144204-14-050135.hdr.sgml : 20140814 20140814160147 ACCESSION NUMBER: 0001144204-14-050135 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140630 FILED AS OF DATE: 20140814 DATE AS OF CHANGE: 20140814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LabStyle Innovations Corp. CENTRAL INDEX KEY: 0001533998 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452973162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-186054 FILM NUMBER: 141042553 BUSINESS ADDRESS: STREET 1: HALAMISH 9 CITY: CAESAREA INDUSTRIAL PARK STATE: L3 ZIP: 38900 BUSINESS PHONE: (972)-(3)-6222929 MAIL ADDRESS: STREET 1: HALAMISH 9 CITY: CAESAREA INDUSTRIAL PARK STATE: L3 ZIP: 38900 10-Q 1 v385596_10q.htm QUARTERLY REPORT

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2014

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                      to                    

 

Commission File No. 333-186054

 

LabStyle Innovations Corp.
(Exact name of registrant as specified in its charter)

 

Delaware 45-2973162
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)  

 

9 Halamish Street  
Caesarea Industrial Park, Israel 38900
(Address of Principal Executive Offices) (Zip Code)

 

+972-4-7704055
(Registrant’s telephone number, including area code)
 
n/a
(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x  No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

¨   Large accelerated filer ¨    Accelerated filer
¨   Non-accelerated filer x   Smaller reporting company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ¨ No x

 

As of August 13, 2014, the registrant had 25,498,305 shares of common stock outstanding.

 

 
 

 

LabStyle Innovations Corp. and Subsidiary

 

Quarterly Report on Form 10-Q

 

TABLE OF CONTENTS

 

    Page
     
Cautionary Note Regarding Forward-Looking Statements -ii-
   
PART 1-FINANCIAL INFORMATION  
     
Item 1. Financial Statements (unaudited)  
     
  Consolidated Balance Sheets as of June 30, 2014 (unaudited) and December 31, 2013 F-1-F-2
     
  Consolidated Statements of Comprehensive Loss (unaudited) for the three and six months ended June 30, 2014 and June 30, 2013 F-3
     
  Statement of Changes in Stockholders’ Deficiency (unaudited) for the six months ended June 30, 2014 F-4
     
  Consolidated Statements of Cash Flows (unaudited) for the six months ended June 30, 2014 and June 30, 2013 F-5
     
  Notes to Condensed Consolidated Financial Statements F-6-F-17
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 1
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 8
     
Item 4. Control and Procedures 9
     
PART II-OTHER INFORMATION  
     
Item 1. Legal Proceedings 10
     
Item 1A. Risk Factors 10
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 10
     
Item 3. Defaults Upon Senior Securities 10
     
Item 4. Mine Safety Disclosures 10
     
Item 5. Other Information 10
     
Item 6. Exhibits 11
     
SIGNATURES 12

 

-i-
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain information set forth in this Quarterly Report on Form 10-Q, including in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere herein may address or relate to future events and expectations and as such constitutes “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Statements which are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial condition, prospects and opportunities and are based upon information currently available to us and our management and their interpretation of what is believed to be significant factors affecting our business, including many assumptions regarding future events. Such forward-looking statements include statements regarding, among other things:

 

·our ability to produce, market and generate sales of both the software and hardware components of our Dario™ Diabetes Management Solution;

 

·our near and longer terms financing plans;

 

·our current and anticipated needs for working capital;

 

·our ability to obtain regulatory approvals for Dario™;

 

·our ability to obtain intellectual property protection for Dario™ and related inventions;

 

·our ability to establish and maintain our brand;

 

·our ability to attract and retain key members of our management team;

 

·our ability to develop and introduce new products;

 

·the anticipated trends in our industry;

 

·our ability to expand operational capabilities;

 

·competition existing today or that will likely arise in the future; and

 

·our ability to establish a market for our common stock.

 

Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “should,” “would,” “could,” “scheduled,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “seek,” or “project” or the negative of these words or other variations on these words or comparable terminology. Actual results, performance, liquidity, financial condition and results of operations, prospects and opportunities could differ materially and perhaps substantially from those expressed in, or implied by, these forward-looking statements as a result of various risks, uncertainties and other factors. These statements may be found under the section of our Annual Report on Form 10-K for the year ended December 31, 2013 (filed on March 4, 2014) entitled “Risk Factors” as well as in our other public filings.

 

-ii-
 

 

In light of these risks and uncertainties, and especially given the pre-revenue, start-up nature of our business, there can be no assurance that the forward-looking statements contained herein will in fact occur. Readers should not place undue reliance on any forward-looking statements. Except as expressly required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances or any other reason.

 

-iii-
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands

 

   June 30,   December 31, 
   2014   2013 
   Unaudited     
         
ASSETS          
           
CURRENT ASSETS:          
Cash and cash equivalents  $1,819   $2,263 
Restricted cash   -    38 
Short-term bank deposits   166    154 
Other accounts receivable and prepaid expenses   355    475 
Inventory   22    - 
           
Total current assets   2,362    2,930 
           
LEASE DEPOSIT   49    41 
           
PROPERTY AND EQUIPMENT, NET   991    1,145 
           
Total assets  $3,402   $4,116 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

- F-1 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands (except stock and stock data)

 

   June 30,   December 31, 
   2014   2013 
   Unaudited     
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
           
CURRENT LIABILITIES:          
Trade payables  $681   $586 
Other accounts payable and accrued expenses   1,095    920 
           
Total current liabilities   1,776    1,506 
           
LIABILITY RELATED TO WARRANTS   5,379    2,696 
           
COMMITMENTS AND CONTINGENT LIABILITIES          
           
STOCKHOLDERS’ EQUITY DEFICIT:          
Common Stock of $0.0001 par value -
Authorized: 80,000,000 (unaudited) and 45,000,000 shares at June 30, 2014 and December 31, 2013; Issued and Outstanding: 23,013,889 (unaudited) and 20,071,816 shares at June 30, 2014 and December 31, 2013, respectively
   2    2 
Preferred Stock of $0.0001 par value -
Authorized: 5,000,000 shares at June 30, 2014 and December 31, 2013; Issued: None at June 30, 2014 and December 31, 2013; Outstanding: None at June 30, 2014 and December 31, 2013
   -    - 
Additional paid-in capital   22,486    19,915 
Accumulated deficit   (26,241)   (20,003)
           
Total stockholders’ deficit   (3,753)   (86)
           
Total liabilities and stockholders’ deficit  $3,402   $4,116 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

- F-2 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
U.S. dollars in thousands (except stock and stock data)

 

   Three months ended June 30   Six months ended June 30 
   2014   2013   2014   2013 
   Unaudited   Unaudited 
                 
Revenues  $-   $-   $-   $- 
Ramp up of manufacturing costs   605    -    1,026    - 
                     
Gross loss   605    -    1,026    - 
                     
Operating expenses:                    
Research and development  $1,333   $1,416   $2,440   $2,091 
Marketing and pre-production costs   373    664    659    1,161 
General and administrative   1,292    1,516    2,146    3,420 
                     
Total operating expenses   2,998    3,596    5,245    6,672 
                     
Operating loss   3,603    3,596    6,271    6,672 
                     
Financial expenses (income), net:                    
Revaluation of warrants   (396)   1,664    (538)   3,800 
Other financial expense   47    26    505    41 
                     
Total financial expenses (income), net   (349)   1,690    (33)   3,841 
                     
Net loss  $3,254   $5,286   $6,238   $10,513 
                     
Net loss per share                    
                     
Basic loss per share  $(0.14)  $(0.29)  $(0.28)  $(0.63)
Weighted average number of common stock used in computing basic net loss per share   22,985,523    18,327,387    22,152,675    16,590,423 
                     
Diluted loss per share  $(0.15)  $(0.29)  $(0.29)  $(0.63)
Weighted average number of common stock used in computing diluted net loss per share   23,202,077    18,327,387    22,260,952    16,590,423 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

- F-3 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
U.S. dollars in thousands (except stock and stock data)

 

   Common stock   Additional
paid-in
   Accumulated   Total
stockholders’
 
   Number   Amount   capital   deficit   deficit 
                     
Balance as of December 31, 2012   14,547,689   $1   $5,001   $(6,072)  $(1,070)
                          
Issuance of common stock and warrants in February and June 2013 at $1.00 per unit, net of issuance cost   1,000,022      *)   996    -    996 
 Cost related to issuance of common stock to service provider   208,334    *)   488    -    488 
Cost related to issuance of warrants to service provider in March and May 2013   -    -    523    -    523 
Issuance of common stock and warrants in April and May 2013 at $2.50 per unit, net of issuance cost   4,000,000    *)   8,986    -    8,987 
Exercise of warrants   300,771    *)   708    -    708 
Exercise of options   15,000    *)   *)   -    *)
Stock-based compensation   -    -    3,213    -    3,213 
Net loss   -    -    -    (13,931)   (13,931)
                          
Balance as of December 31, 2013   20,071,816   $2   $19,915   $(20,003)  $(86)
                          
Issuance of Common Stock and warrants in February 2014 at $0.55 per unit, net of issuance cost   2,226,956    *)   1,013    -    1,013 
Exercise of warrants   342,617    *)   352    -    352 
Exercise of options   372,500    *)   7    -    7 
Stock-based compensation   -    -    1,199    -    1,199 
Net loss   -    -    -    (6,238)   (6,238)
                          
Balance as of June 30, 2014 (unaudited)   23,013,889   $2   $22,486   $(26,241)  $(3,753)

 

*) Represent an amount lower than $1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

- F-4 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

CONSOLIDATED STATEMENT OF CASH FLOWS
U.S. dollars in thousands

 

   Six months ended
June 30
 
   2014   2013 
   Unaudited 
Cash flows from operating activities:          
Net loss  $(6,238)  $(10,513)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Stock-based compensation, warrants and restricted shares   1,199    2,862 
Issuance cost related to warrants to investors and service provider   489    - 
Depreciation   358    314 
Decrease (increase) in other accounts receivable and prepaid expenses   120    (208)
Increase in inventory   (22)   - 
Increase in trade payables   39    371 
Increase in other accounts payable and accrued expenses   175    350 
Revaluation of warrants   (538)   3,800 
Loss from disposal of fixed assets   -    3 
           
Net cash used in operating activities   (4,418)   (3,021)
           
Cash flows from investing activities:          
Investment in short-term bank deposits   (130)   (105)
Proceeds of maturities of short-term bank deposit   158    14 
Investment in lease deposits   (8)   (92)
Purchase of property and equipment   (150)   (1,146)
           
Net cash used in investing activities   (130)   (1,329)
           
Cash flows from financing activities:          
Proceeds from issuance of Common Stocks and warrants, net of issuance cost   3,754    9,951 
Proceeds from exercise of options and warrants   350    195 
           
Net cash provided by financing activities   4,104    10,146 
           
Increase (decrease) in cash and cash equivalents   (444)   5,796 
Cash and cash equivalents at beginning of period   2,263    1,230 
           
Cash and cash equivalents at end of period  $1,819   $7,026 
           
Non-cash investing and financing and activities:          
           
Receivable on account of shares  $-   $31 
           
Purchase of property and equipment  $56   $39 
           
Conversion of liability related to warrants to common stock  $9   $385 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

- F-5 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 1:-GENERAL

 

a.LabStyle Innovations Corp. (the “Company”) was incorporated in Delaware and commenced operations on August 11, 2011. The Company is a mobile health (mHealth) company developing and commercializing patent-pending technologies to provide consumers with laboratory-testing capabilities using smart phones and other mobile devices.  The Company’s initial product, Dario™, is a mobile, cloud-based, diabetes management solution which includes a pocket-sized blood glucose monitoring device that, utilizing proprietary software, integrates with smart phones and other mobile devices to offer users the ability to record, save, track, analyze, manage and share diabetes related information (the “Dario™ Smart Meter”)

 

The Company has a wholly owned subsidiary, LabStyle Innovation Ltd. (“Ltd.”), incorporated and located in Israel, which commenced operations on September 14, 2011. Its principal business activity is to hold the Company’s intellectual property and to perform research and development, manufacturing, marketing and other business activities.

 

b.During the six month period ended June 30, 2014, the Company incurred operating losses and negative cash flows from operating activities amounting to $6,271 and $4,418, respectively. The Company will be required to obtain additional capital resources in the near term to extend its commercialization, ramp up its inventory and maintain its research and development activities. The Company is addressing its liquidity needs by continuing to seek for additional funding from public and/or private sources and by commencing its initial commercial sales. There are no assurances, however, that the Company will be able to obtain an adequate level of financing or commence an adequate level of initial commercial sales required for the short and long-term development and commercialization of its product.

 

According to management estimates, the Company has sufficient liquidity resources to continue its planned activity only into October 2014. Failure of the Company to obtain additional funding would have a materially adverse effect on the Company’s results of operations, future operations and overall viability.

 

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.

 

c.On March 20, 2014, the Company filed a registration statement (the “Third Registration Statement”) with the Securities and Exchange Commission (the “SEC”) covering the public resale of up to 3,897,172 shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) (including 1,670,216 shares of Common Stock underlying warrants) previously issued to the investors from the private placement occurred on February 2014 (the “February 2014 Private Placement”) (see also Note 4a and 5b). The Third Registration Statement was declared effective on June 3, 2014.

 

- F-6 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 1:-GENERAL (Cont.)

 

d.On May 1, 2014 the Company announced the receipt of a U.S. Notice of Allowance for a key patent relating to how the DarioTM blood glucose monitor draws power from and transmits data to a smart phone via the audio jack port.

 

e.On June 17, 2014, the Company held its 2014 Annual Meeting of Stockholders in which, among other matters, Company stockholders approved an amendment to the Company’s Certificate of Incorporation (the “COI”) to increase the number of authorized shares of Common Stock from 45,000,000 to 80,000,000; to amend the Company’s 2012 Equity Incentive Plan (the “2012 Plan”) to increase the number of Common Stock authorized for issuance under the 2012 Plan by 2,500,000 shares from 5,000,000 to 7,500,000 (see also Note 4b); and to approve the amendment to the COI to effect a reverse stock split of the Common Stock at a ratio of between one-for-two and one-for-five with such ratio to be determined at the sole discretion of the Board of Directors of the Company (the “Reverse Split”) and with such Reverse Split to be effected at such time and date, if at all, as determined by the Board of Directors of the Company in its sole discretion. No decision has been taken in connection to the Reverse Split as of the filing of this consolidated financial statement.

 

f.On April 28, 2014 the Company was granted with national approval and regional reimbursement for the Dario™ in Italy.

 

g.On June 25, 2014 the Company was granted with reimbursement status for strips and lancets to be utilized together with the Dario™, effective September 1, 2014 in England, Wales, Scotland and Northern Ireland.

 

h.On July 2014, the Company received approval from Israel’s Ministry of Health to sell the Dario™ for diabetes in Israel as well as released the Dario™ App for Android smartphone users in select soft launch markets, including the United Kingdom and New Zealand.

 

- F-7 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES

 

The significant accounting policies applied in the annual financial statements of the Company as disclosed in the Company’s Annual Report on Form 10-K for the period ended December 31, 2013 are applied consistently in these financial statements except:

 

In June 2014 the FASB issued Update No. 2014-10 Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this Update remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of comprehensive loss, cash flows, and shareholder deficit, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments are effective prospectively for reporting periods beginning after December 15, 2014 early adoption is permitted. The Company chose to early adopt the update for June 30, 2014 consolidated financial statement.

 

NOTE 3:-UNAUDITED INTERIM FINANCIAL STATEMENTS

 

The accompanying unaudited interim consolidated financial statements as of June 30, 2014, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company’s consolidated financial position as of June 30, 2014, the Company’s consolidated results of operations and the Company’s consolidated cash flows for the six and three months ended June 30, 2014. Results for the six and three months periods ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.

 

- F-8 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 4:-STOCKHOLDERS’ DEFICIT

 

a.On February 18, 2014, the Company consummated the February 2014 Private Placement with institutional and other accredited investors, pursuant to which the Company issued units comprised of an aggregate of (i) 2,226,956 shares of common stock and (the “Shares”) (ii) warrants initially exercisable to purchase an aggregate of 1,670,216 shares of Common Stock (the “Warrants”).  The price per unit issued in this offering was $1.88, yielding gross proceeds of approximately $3,754 net of issuance costs.

 

The placement agent for the February 2014 Private Placement received, in addition to a cash fee, 144,885 warrants to purchase Common Stock of the Company having the same terms and conditions as the investors warrants.  

 

Pursuant to the terms of the February 2014 Private Placement, the Company may be required to issue additional shares of Common Stock (the “Adjustment Shares”) to the investors in the February 2014 Private Placement at a specified time in the event that the price per share of Common Stock in the February 2014 Private Placement is greater than the price per share of the Common Stock, calculated as 90% of the average of the ten lowest weighted average prices of the Common Stock during the twenty trading day period starting immediately following the earlier of the date on which the shares, shares of Common Stock underlying warrants and Adjustment Shares have been registered for resale with the SEC or are able to be sold without restriction under Rule 144 under the Securities Act (the “Reset Price”); provided, that, subject to the terms and conditions of the February 2014 Private Placement, the Company may be required to issue further additional shares of Common Stock at one or more additional specified times if the shares of Common Stock issued in the February 2014 Private Placement are not freely tradable for certain specified minimum periods.

 

The warrants issued in the February 2014 Private Placement are immediately exercisable at an exercise price of $2.35 per share and expire five years after the date that the shares of Common Stock underlying such warrants have been registered for resale with the SEC or are able to be sold without restriction under Rule 144 under the Securities Act. The warrants are subject to adjustment under certain circumstances, including “full ratchet” anti-dilution protection upon the issuance of any Common Stock (including the Adjustment Shares), securities convertible into Common Stock, or certain other issuances at a price below the then-existing exercise price, with certain exceptions. In addition, upon certain changes in control events, as defined in the agreement, the holders of the warrants may elect to receive, subject to certain limitations and assumptions, cash equal to the Black-Scholes value of the outstanding warrants.

Based on the aforementioned terms the warrants are accounted as liability according to the provisions of ASC 815-40.

 

- F-9 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 4:-STOCKHOLDERS’ DEFICIT (Cont.)

 

In connection with the February 2014 Private Placement, the Company also entered into a Registration Rights Agreement (the “RRA”) with the investors. Pursuant to the terms of the RRA, the Company granted to the investors certain registration rights related to the Shares, the Warrants and the Adjustment Shares issued and issuable in this private placement. The Company is required to file a registration statement for the resale of the Shares, Common Stock underlying the Warrants and Adjustment Shares within 30 days following the closing date of the Offering and to use its reasonable best efforts to cause such registration statement to be declared effective within 60 days following the closing date (or 120 days following the closing date if the SEC determines to review the registration statement). The Company may incur liquidated damages for each investor of up to nine percent of the pro-rata purchase price of the Shares if it does not meet its registration obligations under the RRA.

 

On June 3, 2014, the Company’s Third Registration Statement was declared effective and based on the Reset Price feature which occurred on July 2, 2014, subsequent to the balance sheet date, 2,484,416 Adjustment Shares have been issued and 2,984,953 warrants were issued in connection with the February 2014 Private Placement and additional 851,453 warrants were issued in connection with the 2011-2012 Private Placement (see also Notes 7a).

 

b.Stock based compensation:

 

On June 17, 2014, the Company’s majority stockholders (with the prior recommendation and approval of the Company’s Board of Directors) approved an increase in the size of the 2012 Plan from 5,000,000 shares of Common Stock to 7,500,000 shares of Common Stock.

 

Following the approval of the Company’s Board of Directors of the non-employee directors option plan during March 2013 (the “Annual Directors Plan”), on May 7, 2014 our Board of Directors approved the 2014 grant of the Annual Directors Plan with 25,000 options granted to each of the Company’s then current non-employee directors. These options have an exercise price of $1.39 and shall vest in quarterly arrears over one year ended December 31, 2014. They also have a cashless exercise feature and a ten year term. On the same date, the Board of Directors also approved a one-time grant of fully-vested 150,000 options to each of the two newest non-employee directors. These options have an exercise price of $1.39, a cashless exercise feature and a ten year term.

 

In addition, on the same date, the Board of Directors approved the grant of 380,000 options to the Company’s Scientific Advisory Board (the “SAB”). These options have an exercise price of $1.39, shall vest in 4 quarterly arrears, have a cashless exercise feature and a ten year term.

 

- F-10 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 4:-STOCKHOLDERS’ DEFICIT (Cont.)

 

The abovementioned options to non-employee directors and the SAB were not issued under the Company’s 2012 Equity Incentive Plan and shall be deemed to have been issued under an “employee benefit plan” as defined in Rule 405 promulgated under the Securities Act.

 

As of June, 30, 2014, 3,139,750 options to purchase Common Stock are available for future grants under the 2012 Plan to employees, advisors, consultants and service providers of the Company or Ltd.

 

The total compensation cost related to all of the Company’s equity-based awards, recognized during the period of three and six months ended June 30, 2014 was comprised as follows:

 

   Three months
ended June 30,
2014
   Six months
ended June 30,
2014
 
   Unaudited 
         
Cost of revenues  $18   $36 
Research and development   141    280 
Sales and marketing   -    6 
General and administrative   531    877 
           
Total stock-based compensation expenses  $690   $1,199 

 

As of June 30, 2014, the total amount of unrecognized stock-based compensation expenses was approximately $923 which will be recognized over a weighted average period of 0.56 years.

 

c.During the six months ended June 30, 2014, proceeds from warrants and options exercise amounted to $343 and $7 following the issuance of 342,617 and 372,500 Common Stock, respectively.

 

- F-11 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 5:-FAIR VALUE MEASURMENTS

 

ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”), defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions and risk of nonperformance.

 

ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:

 

Level 1 -quoted prices in active markets for identical assets or liabilities;

 

Level 2 -inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

 

Level 3 -unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

a.On March 30, 2012, the Company consummated the 2011-2012 Private Placement pursuant to which the investors purchased an aggregate of 2,461,000 shares of Common Stock and warrants to purchase 2,461,000 shares of Common Stock at the exercise price of $1.50 for total consideration of $2,461.

 

The placement agent for the 2011-2012 Private Placement and its permitted designees were granted warrants to purchase an aggregate of (i) 482,200 shares of Common Stock at the exercise price of $1.00 per share and (ii) 482,200 shares of Common Stock at the exercise price of $1.50 per share. Subsequent to the issuance of the 2011-2012 Private Placement warrants, the $1.50 exercise price for both the warrants issued to the investors and placement agent were adjusted to approximately $1.30 per share due to a certain anti-dilutive issuance and, accordingly, additional warrants to purchase an aggregate of 371,017 and 72,455 shares of Common Stock were granted to such investors and the placement agent and its designees, respectively (see also Note 7a).

 

- F-12 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 5:-FAIR VALUE MEASURMENTS (Cont.)

 

b.On February 18, 2014, the Company consummated the February 2014 Private Placement with institutional and other accredited investors, pursuant to which the Company issued units comprised of an aggregate of (i) 2,226,956 shares of common stock and (ii) warrants initially exercisable to purchase an aggregate of 1,670,216 shares of Common Stock.  The price per unit issued in this offering was $1.88, yielding proceeds of approximately $3,754 net of issuance costs (See also Notes 4a and 7a).

 

In addition, the Company granted to the placement agent for the February 2014 Private Placement the right to receive warrants to purchase an aggregate of 144,885 shares of Common Stock at an exercise price of $2.35.

 

All the aforementioned warrants contain anti-dilution protection provisions and therefore the Company accounts for such warrants as a liability according to the provisions of ASC 815-40, “Derivatives and Hedging - Contracts in Entity’s Own Equity” (“ASC 815-40”). The Company measures the warrants at fair value by using Binomial option-pricing model in each reporting period until the warrants are exercised or expired, with changes in the fair values being recognized in the Company’s statement of comprehensive loss as financial income or expense.

 

In estimating the warrants’ fair value, the Company used the following assumptions:

 

Investors warrants in 2011-2012 Private Placement:

 

   June 30,
2014
   December 31,
2013
 
         
Risk-free interest rate (1)   0.61%   0.70%
Expected volatility (2)   52.04%   52.09%
Expected life (in years) (3)   2.33    2.82 
Expected dividend yield (4)   0%   0%
           
Fair value Warrants  $0.69   $0.74 

 

Placement agent warrants 2011-2012 Private Placement:

 

   June 30,
2014
   December 31,
2013
 
         
Risk-free interest rate (1)   0.39%   0.50%
Expected volatility (2)   53.85%   50.91%
Expected life (in years) (3)   1.78    2.25 
Expected dividend yield (4)   0%   0%
           
Fair value Warrants  $0.48-0.63   $ 0.67-0.83 

 

- F-13 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 5:-FAIR VALUE MEASURMENTS (Cont.)

 

Investors and placement agent warrants in February 2014 Private Placement:

 

   June 30,
2014
   Issuance
date
 
         
Risk-free interest rate (1)   1.59%   1.63%
Expected volatility (2)   52.84%   61.49%
Expected life (in years) (3)   4.93    5.20 
Expected dividend yield (4)   0%   0%
           
Fair value Warrants  $1.65   $1.78 

 

(1)Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds.

 

(2)Expected volatility - was calculated based on actual historical stock price movements of companies in the same industry over a term that is equivalent to the expected term of the option.

 

(3)Expected life - the expected life was based on the expiration date of the warrants.

 

(4)Expected dividend yield - was based on the fact that the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future.

 

The changes in Level 3 liabilities associated with the 2011-2012 Private Placement and the February 2014 Private Placement warrants are measured at fair value on a recurring basis. The following tabular presentation reflects the components of the liability associated with such warrants as of June 30, 2014:

 

   Fair value
of liability
related to
warrants
 
     
Balance at December 31, 2013  $2,696 
Fair value of warrants issue to investors and service provider   3,230 
Change in fair value of warrants during the period   (538)
Exercise of warrants (*)   (9)
      
Balance at June 30, 2014 (unaudited)  $5,379 

 

(*)During the six month period ended June 30, 2014, the placement agent exercised 9,118 warrants for a total amount of 9,118 shares of Common Stock of the Company, respectively (See also Note 4c).

 

As of June 30, 2014, there were 5,445,065 outstanding warrants relating to the above issuances.

 

- F-14 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 6:-SELECTED STATEMENTS OF OPERATIONS DATA

 

a.General and administrative:

 

   Three months ended
June 30
   Six months ended
June 30
 
   2014   2013   2014   2013 
   Unaudited 
                 
Payroll, office and related  $263   $276   $560   $534 
Legal and professional fees   242    336    453    469 
Stock-based compensation   531    280    877    1,358 
 Issuance of Common Stock and warrants to service provider   -    618    -    1,011 
 Other   256    6    256    48 
                     
 Total General and administrative  $1,292   $1,516   $2,146   $3,420 

 

b.Financial expenses (income), net:

 

   Three months ended
June 30
   Six months ended
June 30
 
   2014   2013   2014   2013 
   Unaudited 
                 
Bank charges  $2   $10   $7   $14 
Foreign currency adjustments losses   4    16    9    27 
Issuance cost related to warrants to investors and service provider   41    -    489    - 
Revaluation of warrants   (396)   1,664    (538)   3,800 
                     
Total Financial expenses (income), net  $(349)  $1,690   $(33)  $3,841 

 

- F-15 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 6:-SELECTED STATEMENTS OF OPERATIONS DATA (Cont.)

 

c.Net loss per share:

 

The following table sets forth the computation of basic and diluted net loss per share:

 

   Three months ended
June 30
   Six months ended
June 30
 
   2014   2013   2014   2013 
   Unaudited 
                 
Numerator:                    
                     
Numerator for basic net loss per share  $3,254   $5,286   $6,238   $10,513 
                     
Effect of dilutive securities:                    
Warrants issued to investors and placement agent   (290)   -    (303)   - 
                     
Numerator for dilutive net loss per share  $3,544   $5,286   $6,541   $10,513 
                     
Denominator:                    
                     
Denominator for dilutive net loss per share - weighted average number of Common Stock   22,985,523    18,327,387    22,152,675    16,590,423 
                     
Effect of dilutive securities:                    
Warrants issued to investors and placement agent   216,554    -    108,277    - 
                     
Denominator for diluted net loss per share - adjusted weighted average number of Common Stock   23,202,077    18,327,387    22,260,952    16,590,423 

 

- F-16 -
 

 

LABSTYLE INNOVATIONS CORP. AND ITS SUBSIDIARY

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except stock and stock data)

 

NOTE 7:-SUBSEQUENT EVENTS

 

a.Following the effectiveness of the Company’s Third Registration Statement on June 3, 2014 (see also Note 1c), and in accordance with the February 2014 Private Placement agreements, on July 2, 2014 the Company issued a total of 2,484,416 shares based on a Reset Price of approximately $0.89 to the investors from the February 2014 Private Placement. In addition, the abovementioned issuance triggered the following anti-dilution adjustments:

 

1.The exercise price for the investors and placement agent warrants of the February 2014 Private Placement was adjusted to approximately $0.89 and additional 2,746,688 and 238,265 warrants became eligible for issuance upon exercise of such warrants, respectively.

 

2.The exercise price for the investors and placement agent warrants of the 2011-2012 Private Placement, with a current exercise price of $1.30 was adjusted to approximately $1.05 and additional 645,054 and 122,838 warrants were issued, respectively. The exercise price for the placement agent warrants of the 2011-2012 Private Placement, with a current exercise price of $1.00 was adjusted to approximately $0.84 and additional 83,561 warrants were issued.

 

All the aforementioned warrants contain anti-dilution protection provisions and therefore will be accounted as a liability according to the provisions of ASC 815-40.

 

b.On July 7, 2014, the Company’s Board of Directors approved the grant of 1,100,000 and 395,000 options to employees and non-employees, respectively, at an exercise price of $0.98 per share. Such options shall vest in 8 quarterly instalments over a period of 2 years commencing the above date. The options have a cashless exercise feature and a ten years term, unless otherwise approved by Compensation Committee of the Board of Directors, and shall be issued under the 2012 Plan.

 

In addition on the same date, the Board of Directors approved a one-time grant of fully-vested 150,000 options to a new non-employee director. These options have an exercise price of $0.98, have a cashless exercise feature and a ten years term. The non-employee director options were not issued under the Company’s 2012 Equity Incentive Plan and shall be deemed to have been issued under an “employee benefit plan” as defined in Rule 405 promulgated under the Securities Act.

 

- F-17 -
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following financial data in this narrative are expressed in thousands, except for stock and stock data.

 

The following discussion should be read in conjunction with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the consolidated financial statements and related notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2013.

 

This discussion contains certain forward-looking statements that involve risks and uncertainties. Our actual results and the timing of certain events could differ materially from those discussed in these forward-looking statements as a result of certain factors, including, but not limited to, those set forth herein and elsewhere in this Quarterly Report and in our other filings with the Securities and Exchange Commission. See “Cautionary Note Regarding Forward Looking Statements.”

 

Overview

 

We were formed in August 2011 as a Delaware corporation. We are a mobile health (mHealth) company developing and commercializing patent-pending technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices.

 

Our initial product is Dario™, a mobile, cloud-based, diabetes management solution which includes novel software applications combined with a stylish, “all-in-one”, pocket-sized, blood glucose monitoring device (which we call our Dario™ Smart Meter) that will compete in the estimated $12 billion dollar worldwide market for patient self-monitoring of blood glucose (which we refer to as SMBG) products. Dario™ is a comprehensive, patent-pending system that combines a cutting edge software application and cloud-based data services with a novel all-in-one Dario™ Smart Meter consisting of a lancet (to obtain a blood sample), a device-specific disposable test strip cartridge and a smartphone-driven glucose reader adaptor.

 

On September 23, 2013, we announced our receipt of CE Mark certification to market Dario™. The receipt of the CE Mark allows Dario™ to be marketed and sold in 32 countries across Europe as well as in certain other countries worldwide. On March 5, 2014, MDSS, our European Authorized Representative, completed the registration of the Dario™ Smart Meter with the German Authority as required by Article 10 of Directive 98/79/EC on in vitro diagnostic medical devices. We are currently pursing regulatory approval for Dario™ in the United States and are expecting a response from the U.S. Food and Drug Administration on our 510(k) application later in 2014.

 

In January 2014, the Dario™ test strips (manufactured for us by a third party supplier) were evaluated by an independent German research institution. The aim of this study was to collect measurement data from capillary blood with defined distribution of glucose concentrations in order to perform system accuracy evaluation according to ISO 15197:2013, the current international standard requirements for SMBG systems. The results of this study showed that the Dario™ strips are well within the limits for system accuracy defined by ISO 15197:2013 in that 100% of results fell within zones A and B of the Consensus Error Grid for all systems, which means that the system accuracy requirements of the ISO 15197:2013 have been met.

 

1
 

 

In December 2013, we began offering free downloads of the Dario™ software application in selected jurisdictions, and in March 2014, we commenced our global multi-market soft launch of the Dario™ Smart Meter in selected jurisdictions. The first shipments were sent to distributers in late March 2014.

 

In April 2014, we announced the receipt of reimbursement coverage for the use of the Dario™ Smart Meter in Italy, making 600,000 Italians eligible for reimbursement coverage. We are pursuing reimbursement coverage in other jurisdictions.

 

In June 2014, we were granted (effective September 1, 2014) reimbursement status in England, Wales, Scotland and Northern Ireland for strips and lancets to be utilized together with the Dario™ Smart Meter. We are actively pursuing reimbursement coverage in other jurisdictions.

 

In July 2014, we received approval from Israel’s Ministry of Health to sell the Dario™ Smart Meter for diabetes in Israel as well as released the Dario™ Diabetes Management App for Android smartphone users. The mobile application will have the same user interface and features as the iOS Dario™ Application and will be available in select soft launch markets, including the United Kingdom and New Zealand.

 

In addition, since 2013, we have worked to secure distribution partnerships in a number of jurisdictions, including the United Kingdom, Italy, Australia, New Zealand, the Netherlands and Canada. These partnerships, along with our own online marketing programs, will be key to our sales and distributions efforts for Dario™.

 

We are presently pursuing patent applications in multiple jurisdictions covering the specific processes related to blood glucose level measurement as well as more general methods of rapid tests of body fluids using mobile devices and cloud-based services. On May 1, 2014 we announced the receipt of a U.S. Notice of Allowance for a key patent relating to how the Dario™ blood glucose monitor draws power from and transmits data to a smart phone via the audio jack port. We believe this represents a critical intellectual property recognition and a significant initial validation of our intellectual property efforts.

 

Readers are cautioned that, according to our management’s estimates, based on our budget and the initial launch of our commercial sales we believe that we will have sufficient resources to continue our activity only into October 2014. This includes a small amount of anticipated initial inflows from sales of Dario™ through distribution partners. As such, we have a significant present need for capital. If we are unable to scale up our commercial launch of Dario™ or meet our commercial sales targets (or if we are unable to generate any revenue at all), and if we are unable to obtain additional capital resources in the near term, we may be unable to continue activities, absent a material alternations in our business plans and our business might fail.

 

2
 

 

Critical Accounting Policies

 

Our financial statements are prepared using the accrual basis of accounting in accordance with accounting principles generally accepted in the United States (or US GAAP). Our fiscal year ends December 31.

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operations discuss our financial statements, which have been prepared in accordance with US GAAP. The preparation of these financial statements requires making estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues and expenses for the reporting periods. On an ongoing basis, we evaluate such estimates and judgments. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ (perhaps significantly) from these estimates under different assumptions or conditions.

 

While all the accounting policies impact the financial statements, certain policies may be viewed to be critical. Our management believes that the accounting policies which involve more significant judgments and estimates used in the preparation of our consolidated financial statement include warrants liability, stock-based compensation, accounting for production equipment and its related useful life:

 

Warrant liability

 

The fair value of the liability for certain warrants issued to investors and our previous placement agents in connection with our financings to date was calculated using the Binomial model. We accounted for these warrants according to the provisions of ASC 815, “Derivatives and Hedging - Contracts in Entity’s Own Equity” and, based on the anti-dilution protections contained in the warrants, we classified them as liabilities, measured at fair value each reporting period until they will be exercised or expired, with changes in the fair values being recognized in our statement of comprehensive loss as financial income or expense. The anti-dilution protection of the warrants was valued by calculating a put option. The value of the warrants was calculated using the call option value in addition with the put option value, which reflects the anti-dilution protection, multiplied by the probability that a down round will occur.

 

Fair value for each reporting period was calculated based on the following assumptions: 

(1)Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds.
(2)Expected volatility - was calculated based on actual historical stock price movements of companies in the same industry over a term that is equivalent to the expected term of the option.
(3)Expected life - the expected life was based on the expiration date of the warrants.
(4)Expected dividend yield - the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future and therefore was measured as %0.

 

Exercised warrants are being measured at fair value as of their exercise date and subsequently reclassified from liability to additional paid in capital. Our net loss for the six months ended June 30, 2014 and 2013 included finance expenses (income) in the amount of ($538) and $3,800, respectively, with connection to the above-mentioned warrants.

 

3
 

 

Stock-Based Compensation

 

We account for stock-based compensation in accordance with ASC 718 “Compensation- stock compensation” which requires companies to estimate the fair value of equity-based payment awards on the date of grant using the Black-Scholes option-pricing model.

 

The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our consolidated income statements.

 

We recognize compensation expenses for the value of awards granted based on the straight line method over the requisite service period of each of the awards, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term “forfeitures” is distinct from “cancellations” or “expirations” and represents only the unvested portion of the surrendered option. Ultimately, the actual expenses recognized over the vesting period will only be for those shares that vest.

 

We selected the Black-Scholes option pricing model as the most appropriate fair value method for stock-option awards based on the market value of the underlying shares at the date of grant. This option-pricing model requires a number of assumptions, of which the most significant are the expected stock price volatility and the expected option term. Expected volatility was calculated based upon historical volatilities of similar entities in the related sector index. The expected option term represents the period that the Company’s stock options are expected to be outstanding and is determined based on the simplified method until sufficient historical exercise data will support using expected life assumptions. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.

 

Our net loss for the second quarter of 2014 includes stock-based compensation costs in the amount of $644 as compared to $487 for the same period in 2013, with respect to options granted to employees and directors of our company, or $1,038 for the first six months of 2014 as compared to $1,763 for the same period in 2013.The decrease from 2014 to 2013 is mainly due to options granted to certain non-employee directors during 2013 as well as the leave of certain employees during 2014.

 

We apply ASC 718 and ASC 505-50 “Equity-Based Payments to Non-Employees”, with respect to options and warrants issued to non-employees. ASC 718 requires the use of option valuation models to measure the fair value of the options and warrants at the measurement date.

 

In connection with options granted to non-employees for the second quarter of 2014 and 2013, and our determination of the fair value of our common shares, we have recorded stock-based compensation expense of $46 and $45, respectively, or $161 and $87 for the first six months of 2014 and 2013, respectively, which represent the fair value of non-employee options grants.

 

Production Equipment

 

Capitalization of Costs. We capitalize direct incremental costs of third party manufacturer related to our production equipment. We cease construction cost capitalization relating to our production equipment once it is ready for its intended use and held available for occupancy. All renovations and betterments that extend the economic useful lives of assets and / or improve the performance of the production equipment are capitalized.

 

4
 

 

Useful Lives of Assets. We are required to make subjective assessments as to the useful lives of our production equipment for purposes of determining the amount of depreciation to record on an annual basis with respect to our construction of the production equipment. These assessments have a direct impact on our net income (loss). Production equipment are usually depreciated on a straight-line basis over a period of up to five years, except any renovations and betterments which are depreciated over the remaining life of the production equipment.

 

Extended Transition Period for “Emerging Growth Companies.” We have elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(1) of the Jumpstart Our Business Act of 2012 (known as the JOBS Act). This election allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates. Consequently, our financial statements may not be comparable to companies that comply with public company effective dates. Because our financial statements may not be comparable to companies that comply with public company effective dates, investors may have difficulty evaluating or comparing our business, performance or prospects in comparison to other public companies, which may have a negative impact on the value and liquidity of our common stock.

 

Results of Operations

 

Three and Six months ended June 30, 2014 and 2013 (in thousands)

 

Revenues

 

We commenced our initial “soft” commercial launch of the Dario™ Smart Meter in late March 2014 with first shipments occurring during April 2014. Although we commenced sales activities during the three and six month ended June 30, 2014, in accordance with US GAAP, we did not recognize revenues from such sales and will not until (i) our distributers demonstrate consistency of payments within the terms of our distributor agreements, and (ii) we are able to reasonably estimate an appropriate provision for expected returns under our product warranty in our distribution agreements. As of the date of this report, no payments from distributors are overdue and no returns have been made under our warranty provision. No revenues were recorded during the same period in 2013.

 

Ramp up of manufacturing costs

 

During the period of three and six month ended June 30, 2014 we recorded costs related to ramp up of manufacturing costs in the amount of $605 and $1,026, respectively. No ramp up of manufacturing costs was recorded during the same periods in 2013. The increase is due to the commencement of our initial commercial sales during March 2014 with first shipments occurring during April 2014.

 

Ramp up of manufacturing costs consists mainly of depreciation costs relating to our production equipment, payroll expenses to employees involved in production activities and inventory write-offs provided to cover market prices lower than cost as well as obsolete items.

 

5
 

 

Research and Development Expenses

 

Our research and development expenses decreased to $1,333 for the second quarter of 2014 from $1,416 for the second quarter of 2013. Research and development expenses increased to $2,440 for the first six months of 2014 from $2,091 for the first six months of 2013. This increase for the six months period was mainly due to recruitment of new employees, engineering expenses as well as software development and regulatory expenses which led us to the commencement of our initial commercial sales.

 

Research and development expenses consist mainly of payroll expenses to employees involved in research and development activities, expenses related to our Dario™ software application and related Dario™ Smart Meter, software related subcontractors and engineering expenses, depreciation and maintenance fees related to equipment and software tools used in research and development, and facilities expenses associated with and allocated to research and development activities.

 

Marketing and pre-production costs

 

Our marketing and pre-production costs decreased to $373 for the second quarter of 2014 from $664 for the second quarter of 2013. Marketing and pre-production costs decreased to $659 for the first six months of 2014 from $1,161 for the first six months of 2013. This decrease is mainly due to pre-production costs which, during 2013, were allocated to marketing and pre-production costs and in 2014, since we commenced the initial commercial sales of our product we allocated production costs to ramp up of manufacturing costs.

 

Marketing and pre-production costs consist mainly of payroll expenses of sales and marketing employees, travel expenses related to such employees, trade show expenses as well as other online and offline marketing expenses. During 2013 pre-production costs were also allocated to marketing and pre-production costs and included relevant employees expenses and depreciation of our production equipment.

 

General and Administrative Expenses

 

Our general and administrative costs decreased to $1,292 for the second quarter of 2014 from $1,516 for the second quarter of 2013. General and administrative costs decreased to $2,146 for the first six months of 2014 from $3,420 for the first six months of 2013. This decrease is mainly due to option compensation expenses for option issuances to certain directors of our company as well as costs related to the issuance of common stock and warrants to a former service provider during 2013.

 

Our general and administrative expenses consist mainly of payroll expenses for management and employees, accounting and legal fees, expenses related to investor relations, as well as our office expenses.

 

Finance Expenses, net

 

Our finance expenses (income), net for the second quarter of 2014 were income of ($349) compared to expenses of $1,690 for the same period in 2013 or income of ($33) for the first six months of 2014 compared to expenses of $3,841 for the same period in 2013. These changes were mainly due to revaluation of warrants to investors and a service provider, that are recorded as liability and presented at fair value each reporting period, and issuance cost related to warrants to investors and such service provider.

 

6
 

 

Net Loss

 

Net loss for the three and six months periods ended June 30, 2014 was $3,254 and $6,238, respectively. Net loss for the three and six months periods ended June 30, 2013 was $5,286 and $10,513, respectively. Decrease from the six month period ended June 30, 2014 was mainly due to warrants expenses as well as costs related to the issuance of common stock and warrants to a former service provider during 2013, as described above, offset by increase in operational expenses towards the anticipated soft commercial launch on March 2014.

 

Plan of Operation

 

We commenced a commercial launch of the free Dario™ app in selected jurisdictions in late 2013 and commenced an initial soft launch of the full Dario™ solution (including the software and the Smart Meter) in selected jurisdictions in March 2014 with the goal of collecting customer feedback to refine our longer-term roll-out strategy. Over time, we expect to add additional features and functionality in making Dario™ the new standard of care in diabetes data management.

 

Through our Israeli subsidiary, LabStyle Innovation Ltd., our plan of operations is to continue the development of our software and hardware offerings and related technology.

 

For the remainder of 2014, and assuming we can secure sufficient funding (of which no assurances can be given), we expect to continue with the soft launch of Dario™, expanding the soft launch to other jurisdictions, and to prepare for our longer-term roll-out of Dario™. In support of these goals, we will utilize our funds for the following activities:

 

·ramp up of mass production, marketing and distribution and sales efforts related to Dario™ software, Smart Meters and test strips;

 

·continued product development and related activities (including costs associated with application development and data storage capabilities as well as any necessary design modifications to the various elements of the Dario™ solution);

 

·continued work on registration of our patents worldwide;

 

·regulatory matters (including work on the regulatory approval of Dario™ in the U.S.);

 

·professional fees associated with being a publicly reporting company; and

 

·general and administrative matters.

 

7
 

 

Liquidity and Capital Resources

 

Since our inception, we have generated significant losses and expect to continue to generate losses for the foreseeable future. There is no assurances that we will be able to obtain an adequate level of financing needed for our near term requirements or the long-term development and commercialization of our products. These conditions raise substantial doubt about our ability to continue as a “going concern”.

 

As of June 30, 2014 we had $1,819 in cash and cash equivalents. During the first six months of 2014, we raised net proceeds in an aggregate of approximately $4,104 through a private placement transaction and the exercise of outstanding options and warrants. We may receive funds from the exercise of other outstanding warrants in the future, but there is a risk that such warrants will not be exercised.

 

Net cash and cash equivalents used in operating activities was $4,418 for the six months ended June 30, 2014 compared $3,021 for the same period in 2013.

Net cash and cash equivalents used in investing activities was $130 for the six months ended June 30, 2014 compared to $1,329 for the same period in 2013. This was mainly due to investment in our production equipment.

Net cash and cash equivalents provided by financing activities was $4,104 for the six months ended June 30, 2014 compared to $10,146 for the same period in 2013. This is mainly due to funds received from private placements in 2014 and 2013 in net amounts of $3,754 and $9,951, respectively.

 

Readers are cautioned that, according to our management’s estimates, based on our budget and the initial launch of our commercial sales we believe that we will have sufficient resources to continue our activity only into October 2014. This includes a small amount of anticipated initial inflows from sales of Dario™ through distribution partners. As such, we have a significant present need for capital. If we are unable to scale up our commercial launch of Dario™ or meet our commercial sales targets (or if we are unable to generate any revenue at all), and if we are unable to obtain additional capital resources in the near term, we may be unable to continue activities, absent a material alternations in our business plans and our business might fail.

 

Off-Balance Sheet Arrangements

 

As of June 30, 2014, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company and therefore are not required to provide the information for this item for Form 10-Q.

 

8
 

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this Report, our Chief Executive Officer and Chief Financial Officer (the “Certifying Officers”), conducted evaluations of our disclosure controls and procedures. As defined under Sections 13a – 15(e) and 15d – 15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the term “disclosure controls and procedures” means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (“SEC”). Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the Certifying Officers, to allow timely decisions regarding required disclosures.

 

Based on their evaluation, the Certifying Officers concluded that, as of June 30, 2014, our disclosure controls and procedures were designed at a reasonable assurance level and were therefore effective in providing reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including the Certifying Officers, as appropriate, to allow timely decisions regarding required disclosure.

 

Changes in internal control over financial reporting.

 

There were no changes in our internal control over financial reporting that occurred during the period ended June 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Internal Controls

 

Readers are cautioned that our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will necessarily prevent all fraud and material error. An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our control have been detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any control design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

 

9
 

 

PART II- OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

None.

 

Item 1A. Risk Factors.

 

Factors that could cause our actual results to differ materially from those in this report are any of the risks described in our Annual Report on Form 10-K for the year ended December 31, 2013 filed with the SEC on March 4, 2014. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

 

The following is an update to our risk factors for our Annual Report on Form 10-K for the year ended December 31, 2013:

 

Presently, we have sufficient cash resources to fund our anticipated operations only into October 2014. We thus have a material near term need for new funding, and our inability to obtain such funding would materially and negatively impact our business, including our ability to continue sales, marketing and manufacturing efforts for Dario™. Our inability to continue our business could lead to the loss of our stockholders’ investment in our company.

 

In addition, pursuant to the terms of the our February 2014 private placement, we have been required to, and may potentially be required to, issue additional shares of common stock (which we call the Adjustment Shares) at a specified time to the investors in our February 2014 private placement. The prior issuance of 2,484,416 Adjustment Shares in July 2014 has caused material dilution to our investors. Moreover, additional Adjustment Shares must be issued in the event that the price per share of common stock in the February 2014 Private Placement is greater than the price per share of the common stock, calculated as 90% of the average of the ten (10) lowest weighted average prices of the common stock during the twenty (20) trading day period starting August 18, 2104. Since the right to receive additional Adjustment Shares would be based on our public stock price, the existence of these rights could have a negative impact on our public stock price. Moreover, the existence of these rights could materially impair our ability to obtain financing, which would have a material adverse effect on our business and viability.

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

None.

 

Item 5. Other Information.

 

None.

 

10
 

 

Item 6. Exhibits.

 

No.   Description of Exhibit
31.1   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS *   XBRL Instance Document
101.CAL *   XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH *   XBRL Taxonomy Extension Schema Document
101.DEF *   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *   XBRL Taxonomy Extension Labels Linkbase Document
101.PRE *   XBRL Taxonomy Extension Presentation Linkbase Document

 

*XBRL (eXtensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

11
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  August 14, 2014   LabStyle Innovations Corp.
     
    By: /s/ Erez Raphael
    Name: Erez Raphael
    Title:  President and Chief Executive Officer
     
    By: /s/ Gadi Levin
    Name: Gadi Levin
    Title:  Chief Financial Officer, Secretary and Treasurer

 

12

 

EX-31.1 2 v385596_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

Certification of Chief Executive Officer

Pursuant to Rule 13a-14(a)

 

I, Erez Raphael, certify that:

 

1.                I have reviewed this Quarterly Report on Form 10-Q of LabStyle Innovations Corp.;

 

2.                Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.                The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)          Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)          Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)          Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.                The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)          Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2014

 

/s/ Erez Raphael  
Erez Raphael  
President and Chief Executive Officer  

 

 

 

EX-31.2 3 v385596_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

Certification of Chief Financial Officer

Pursuant to Rule 13a-14(a)

 

I, Gadi Levin, certify that:

 

1.           I have reviewed this Quarterly Report on Form 10-Q of LabStyle Innovations Corp.;

 

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.           The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)          Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)          Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)          Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)          Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2014

 

/s/ Gadi Levin  
Gadi Levin  
Chief Financial Officer, Secretary and Treasurer  

 

 

  

EX-32.1 4 v385596_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

LABSTYLE INNOVATIONS CORP.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of LabStyle Innovations Corp. (the “Company”) on Form 10-Q for the period ending June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Erez Raphael, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)         The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)         The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Erez Raphael  
Erez Raphael  
President and Chief Executive Officer  

 

August 14, 2014

 

 

 

 

EX-32.2 5 v385596_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

LABSTYLE INNOVATIONS CORP.

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of LabStyle Innovations Corp. (the “Company”) on Form 10-Q for the period ending June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gadi Levin, Chief Financial Officer, Secretary and Treasurer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)         The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)         The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Gadi Levin  
Gadi Levin  
Chief Financial Officer, Secretary and Treasurer  

 

August 14, 2014

 

 

 

EX-101.INS 6 drio-20140630.xml XBRL INSTANCE DOCUMENT 0001533998 2013-01-01 2013-06-30 0001533998 2013-01-01 2013-12-31 0001533998 2014-01-01 2014-03-31 0001533998 2014-01-01 2014-06-30 0001533998 2013-04-01 2013-06-30 0001533998 2014-04-01 2014-06-30 0001533998 2014-06-17 0001533998 2014-06-30 0001533998 2014-08-13 0001533998 2013-12-31 0001533998 2012-12-31 0001533998 2013-06-30 0001533998 drio:PlacementAgentWarrantsMember drio:PrivatePlacementWarrants20112012Member 2014-01-01 2014-06-30 0001533998 drio:InvestorsAndPlacementAgentWarrantsMember drio:PrivatePlacementWarrants20112012Member 2014-01-01 2014-06-30 0001533998 drio:InvestorsWarrantsMember drio:PrivatePlacementWarrants20112012Member 2014-01-01 2014-06-30 0001533998 us-gaap:PrivatePlacementMember 2014-01-01 2014-06-30 0001533998 us-gaap:CommonStockMember 2014-03-01 2014-03-31 0001533998 drio:InvestorsWarrantsMember drio:PrivatePlacementWarrants20112012Member 2013-01-01 2013-12-31 0001533998 drio:PlacementAgentWarrantsMember drio:PrivatePlacementWarrants20112012Member 2013-01-01 2013-12-31 0001533998 drio:InvestorsAndPlacementAgentWarrantsMember 2014-01-01 2014-06-30 0001533998 drio:InvestorsAndPlacementAgentWarrantsMember drio:IssuanceDateMember 2014-02-01 2014-02-28 0001533998 drio:InvestorsAndPlacementAgentWarrantsMember drio:IssuanceDateMember 2014-02-28 0001533998 drio:PlacementAgentWarrantsMember drio:PrivatePlacementWarrants20112012Member us-gaap:MinimumMember 2014-06-30 0001533998 drio:PlacementAgentWarrantsMember drio:PrivatePlacementWarrants20112012Member us-gaap:MaximumMember 2014-06-30 0001533998 drio:InvestorsAndPlacementAgentWarrantsMember 2014-06-30 0001533998 drio:InvestorsWarrantsMember drio:PrivatePlacementWarrants20112012Member 2014-06-30 0001533998 drio:PlacementAgentWarrantsMember us-gaap:MinimumMember drio:PrivatePlacementWarrants20112012Member 2013-12-31 0001533998 drio:PlacementAgentWarrantsMember us-gaap:MaximumMember drio:PrivatePlacementWarrants20112012Member 2013-12-31 0001533998 drio:InvestorsWarrantsMember drio:PrivatePlacementWarrants20112012Member 2013-12-31 0001533998 us-gaap:PrivatePlacementMember 2013-12-31 0001533998 us-gaap:PrivatePlacementMember 2014-06-30 0001533998 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0001533998 us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2014-01-01 2014-06-30 0001533998 us-gaap:PrivatePlacementMember drio:PlacementAgentsMember 2012-01-01 2012-12-31 0001533998 us-gaap:PrivatePlacementMember us-gaap:InvestorMember 2012-01-01 2012-12-31 0001533998 drio:February2014PrivatePlacementMember us-gaap:InvestorMember 2014-01-01 2014-06-30 0001533998 drio:February2014PrivatePlacementMember drio:PlacementAgentsMember 2014-01-01 2014-06-30 0001533998 drio:PlacementAgentsMember 2014-06-30 0001533998 us-gaap:CostOfSalesMember 2014-01-01 2014-03-31 0001533998 us-gaap:ResearchAndDevelopmentExpenseMember 2014-01-01 2014-03-31 0001533998 us-gaap:SellingAndMarketingExpenseMember 2014-01-01 2014-03-31 0001533998 us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-03-31 0001533998 us-gaap:CostOfSalesMember 2014-01-01 2014-06-30 0001533998 us-gaap:ResearchAndDevelopmentExpenseMember 2014-01-01 2014-06-30 0001533998 us-gaap:SellingAndMarketingExpenseMember 2014-01-01 2014-06-30 0001533998 us-gaap:GeneralAndAdministrativeExpenseMember 2014-01-01 2014-06-30 0001533998 drio:ScientificAdvisoryBoardMember us-gaap:EmployeeStockOptionMember 2014-01-01 2014-06-30 0001533998 drio:AnnualDirectorPlanMember 2014-01-01 2014-06-30 0001533998 drio:NonEmployeeDirectorsMember us-gaap:SubsequentEventMember 2014-07-01 2014-07-31 0001533998 drio:NonEmployeeDirectorsMember 2014-01-01 2014-06-30 0001533998 drio:ScientificAdvisoryBoardMember 2014-01-01 2014-06-30 0001533998 drio:February2014PrivatePlacementMember drio:PlacementAgentsMember 2014-01-01 2014-06-30 0001533998 drio:February2014PrivatePlacementWarrantsMember 2014-02-18 0001533998 drio:PlacementAgentsMember drio:February2014PrivatePlacementWarrantsMember 2014-01-01 2014-06-30 0001533998 drio:February2014PrivatePlacementWarrantsMember 2014-01-01 2014-06-30 0001533998 us-gaap:CommonStockMember 2014-01-01 2014-06-30 0001533998 us-gaap:SubsequentEventMember us-gaap:EmployeeStockOptionMember 2014-07-01 2014-07-31 0001533998 drio:NonEmployeeDirectorsMember us-gaap:SubsequentEventMember 2014-07-01 2014-07-31 0001533998 us-gaap:SubsequentEventMember drio:NonEmployeeStockOptionMember 2014-07-01 2014-07-31 0001533998 us-gaap:CommonStockMember 2012-12-31 0001533998 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001533998 us-gaap:RetainedEarningsMember 2012-12-31 0001533998 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0001533998 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0001533998 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0001533998 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-06-30 0001533998 us-gaap:RetainedEarningsMember 2014-01-01 2014-06-30 0001533998 us-gaap:CommonStockMember 2013-12-31 0001533998 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001533998 us-gaap:RetainedEarningsMember 2013-12-31 0001533998 us-gaap:CommonStockMember 2014-06-30 0001533998 us-gaap:AdditionalPaidInCapitalMember 2014-06-30 0001533998 us-gaap:RetainedEarningsMember 2014-06-30 0001533998 us-gaap:CommonStockMember 2014-03-31 0001533998 drio:EquityIncentivePlan2012Member 2014-01-01 2014-06-30 0001533998 drio:EquityIncentivePlan2012Member 2014-06-30 0001533998 drio:EquityIncentivePlan2012Member 2013-12-31 0001533998 drio:February2014PrivatePlacementWarrantsMember us-gaap:SubsequentEventMember us-gaap:InvestorMember drio:ThirdRegistrationStatementMember 2014-07-01 2014-07-31 0001533998 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember drio:ThirdRegistrationStatementMember 2014-07-01 2014-07-31 0001533998 us-gaap:SubsequentEventMember drio:February2014PrivatePlacementWarrantsMember drio:InvestorsAndPlacementAgentWarrantsMember drio:ThirdRegistrationStatementMember 2014-07-01 2014-07-31 0001533998 drio:EquityIncentivePlan2012Member 2014-06-30 0001533998 drio:EquityIncentivePlan2012Member 2013-12-31 0001533998 us-gaap:SubsequentEventMember drio:February2014PrivatePlacementWarrantsMember us-gaap:InvestorMember 2014-07-01 2014-07-31 0001533998 us-gaap:SubsequentEventMember drio:February2014PrivatePlacementWarrantsMember drio:PlacementAgentsMember 2014-07-31 0001533998 drio:PlacementAgentsMember us-gaap:CommonStockMember 2014-01-01 2014-06-30 0001533998 us-gaap:PrivatePlacementMember drio:PlacementAgentWarrantsMember 2014-07-01 2014-07-31 0001533998 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember drio:PlacementAgent2Member 2014-07-01 2014-07-31 0001533998 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember drio:PlacementAgent1Member 2014-07-01 2014-07-31 0001533998 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember us-gaap:InvestorMember 2014-07-01 2014-07-31 0001533998 us-gaap:SubsequentEventMember drio:February2014PrivatePlacementWarrantsMember drio:PlacementAgentsMember 2014-07-01 2014-07-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-TRANSFORM: none; TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: bold 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" align="justify">NOTE 3:-&#160;&#160;&#160;&#160;&#160;&#160;&#160;UNAUDITED INTERIM FINANCIAL STATEMENTS</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-TRANSFORM: none; TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-TRANSFORM: none; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 55.7pt; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" align="justify">The accompanying unaudited interim consolidated financial statements as of June 30, 2014, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company&#8217;s consolidated financial position as of June 30, 2014, the Company&#8217;s consolidated results of operations and the Company&#8217;s consolidated cash flows for the six and three months ended June 30, 2014. Results for the six and three months periods ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.78in"> <div>NOTE 5:-</div> </td> <td style="TEXT-ALIGN: justify"> <div>FAIR VALUE MEASURMENTS</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;), defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions and risk of nonperformance.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument&#8217;s categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div>Level 1 -</div> </td> <td style="TEXT-ALIGN: justify"> <div>quoted prices in active markets for identical assets or liabilities;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div>Level 2 -</div> </td> <td style="TEXT-ALIGN: justify"> <div>inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">&#160;</div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.75in"> <div>Level 3 -</div> </td> <td style="TEXT-ALIGN: justify"> <div>unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 28.35pt"> <div>a.</div> </td> <td style="TEXT-ALIGN: justify"> <div>On March 30, 2012, the Company consummated the 2011-2012 Private Placement pursuant to which the investors purchased an aggregate of 2,461,000 shares of Common Stock and warrants to purchase 2,461,000 shares of Common Stock at the exercise price of $1.50 for total consideration of $2,461.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The placement agent for the 2011-2012 Private Placement and its permitted designees were granted warrants to purchase an aggregate of (i) 482,200 shares of Common Stock at the exercise price of $1.00 per share and (ii) 482,200 shares of Common Stock at the exercise price of $1.50 per share. Subsequent to the issuance of the 2011-2012 Private Placement warrants, the $1.50 exercise price for both the warrants issued to the investors and placement agent were adjusted to approximately $1.30 per share due to a certain anti-dilutive issuance and, accordingly, additional warrants to purchase an aggregate of 371,017 and 72,455 shares of Common Stock were granted to such investors and the placement agent and its designees, respectively (see also Note 7a).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 28.35pt"> <div>b.</div> </td> <td style="TEXT-ALIGN: justify"> <div>On February 18, 2014, the Company consummated the February 2014 Private Placement with institutional and other accredited investors, pursuant to which the Company issued units comprised of an aggregate of (i)&#160;2,226,956 shares of common stock and (ii) warrants initially exercisable to purchase an aggregate of 1,670,216 shares of Common Stock.&#160;&#160;The price per unit issued in this offering was $1.88, yielding proceeds of approximately $3,754 net of issuance costs (See also Notes 4a,&#160;and 7a).</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">In addition, the Company granted to the placement agent for the February 2014 Private Placement the right to receive warrants to purchase an aggregate of 144,885 shares of Common Stock at an exercise price of $2.35.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">All the aforementioned warrants contain anti-dilution protection provisions and therefore the Company accounts for such warrants as a liability according to the provisions of ASC 815-40, &#8220;Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC 815-40&#8221;). The Company measures the warrants at fair value by using Binomial option-pricing model in each reporting period until the warrants are exercised or expired, with changes in the fair values being recognized in the Company&#8217;s statement of comprehensive loss as financial income or expense.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>In estimating the warrants&#8217; fair value, the Company used the following assumptions:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Investors warrants in 2011-2012 Private Placement:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="WIDTH: 88%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 56.7pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="white-space:nowrap; TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>June 30,<br/> 2014</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>December 31,<br/> 2013</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; WIDTH: 64%"> <div>Risk-free interest rate (1)</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>0.61</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>0.70</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected volatility (2)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>52.04</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>52.09</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected life (in years) (3)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>2.33</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>2.82</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected dividend yield (4)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Fair value Warrants</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>0.69</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>0.74</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Placement agent warrants 2011-2012 Private Placement:</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="WIDTH: 88%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 56.7pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="white-space:nowrap; TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>June 30,<br/> 2014</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>December 31,<br/> 2013</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; WIDTH: 64%"> <div>Risk-free interest rate (1)</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>0.39</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>0.50</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected volatility (2)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>53.85</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>50.91</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected life (in years) (3)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>1.78</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>2.25</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected dividend yield (4)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Fair value Warrants</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>0.48-0.63</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;0.67-0.83</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Investors and placement agent warrants in February 2014 Private Placement:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="WIDTH: 88%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 56.7pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="white-space:nowrap; TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>June 30,<br/> 2014</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>Issuance<br/> date</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; WIDTH: 64%"> <div>Risk-free interest rate (1)</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>1.59</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>1.63</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected volatility (2)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>52.84</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>61.49</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected life (in years) (3)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>4.93</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>5.20</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected dividend yield (4)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Fair value Warrants</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>1.65</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>1.78</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 35.25pt"> <div>(1)</div> </td> <td style="TEXT-ALIGN: justify"> <div>Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -35.45pt; MARGIN: 0pt 0px 0pt 92.15pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 35.25pt"> <div>(2)</div> </td> <td style="TEXT-ALIGN: justify"> <div>Expected volatility - was calculated&#160;based on actual historical stock price movements of companies in the same industry over a&#160;term that is equivalent to the expected term of the option.&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -35.45pt; MARGIN: 0pt 0px 0pt 92.15pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 35.25pt"> <div>(3)</div> </td> <td style="TEXT-ALIGN: justify"> <div>Expected life - the expected life was based on the expiration date of the warrants.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -35.45pt; MARGIN: 0pt 0px 0pt 92.15pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 35.25pt"> <div>(4)</div> </td> <td style="TEXT-ALIGN: justify"> <div>Expected dividend yield - was based on the fact that the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The changes in Level 3 liabilities associated with the 2011-2012 Private Placement and the February 2014 Private Placement warrants are measured at fair value on a recurring basis. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following tabular presentation reflects the components of the liability associated with such warrants as of June 30, 2014:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="WIDTH: 82%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 85.05pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="white-space:nowrap; TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>Fair&#160;value<br/> of&#160;liability<br/> related&#160;to<br/> warrants</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt; WIDTH: 87%"> <div>Balance at December 31, 2013</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 10%"> <div>2,696</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>Fair value of warrants issue to investors and service provider</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>3,230</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>Change in fair value of warrants during the period</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>(538</div> </td> <td style="TEXT-ALIGN: left"> <div>)</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; PADDING-BOTTOM: 1pt; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>Exercise of warrants (*)</div> </td> <td style="PADDING-BOTTOM: 1pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> <div>(9</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <div>)</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>Balance at June 30, 2014 (unaudited)</div> </td> <td style="PADDING-BOTTOM: 2.5pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> <div>5,379</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 85.05pt"></td> <td style="WIDTH: 28.35pt"> <div>(*)</div> </td> <td style="TEXT-ALIGN: justify"> <div>During the six month period ended June 30, 2014, the placement agent exercised 9,118 warrants for a total amount of 9,118 shares of Common Stock of the Company, respectively (See also Note 4c).<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of June 30, 2014, there were 5,445,065 outstanding warrants relating to the above issuances.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both">NOTE 4:-</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">STOCKHOLDERS&#8217; DEFICIT</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">a.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">On February 18, 2014, the Company consummated the February 2014 Private Placement with institutional and other accredited investors, pursuant to which the Company issued units comprised of an aggregate of (i)&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,226,956</font> shares of common stock and (the &#8220;Shares&#8221;)&#160;(ii) warrants initially <font style="FONT-FAMILY:Times New Roman, Times, Serif">&#160;</font> exercisable to purchase an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,670,216</font> shares of Common Stock (the &#8220;Warrants&#8221;).&#160;&#160;The price per unit issued in this offering was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.88</font>, yielding gross proceeds of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,754</font> net of issuance costs.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The placement agent for the February 2014 Private Placement received, in addition to a cash fee, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 144,885</font> warrants to purchase Common Stock of the Company having the same terms and conditions as the investors warrants.&#160;&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Pursuant to the terms of the February 2014 Private Placement, the Company may be required to issue additional shares of Common Stock (the &#8220;Adjustment Shares&#8221;) to the investors in the February 2014 Private Placement at a specified time in the event that the price per share of Common Stock in the February 2014 Private Placement is greater than the price per share of the Common Stock, calculated as <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 90</font>% of the average of the ten lowest weighted average prices of the Common Stock during the twenty trading day period starting immediately following the earlier of the date on which the shares, shares of Common Stock underlying warrants and Adjustment Shares have been registered for resale with the SEC or are able to be sold without restriction under Rule 144 under the Securities Act (the &#8220;Reset Price&#8221;);&#160;provided, that, subject to the terms and conditions of the February 2014 Private Placement, the Company may be required to issue further additional shares of Common Stock at one or more additional specified times if the shares of Common Stock issued in the February 2014 Private Placement are not freely tradable for certain specified minimum periods.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The warrants issued in the February 2014 Private Placement are immediately exercisable at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.35</font> per share and expire five years after the date that the shares of Common Stock underlying such warrants have been registered for resale with the SEC or are able to be sold without restriction under Rule 144 under the Securities Act. The warrants are subject to adjustment under certain circumstances, including &#8220;full ratchet&#8221; anti-dilution protection upon the issuance of any Common Stock (including the Adjustment Shares), securities convertible into Common Stock, or certain other issuances at a price below the then-existing exercise price, with certain exceptions. In addition, upon certain changes in control events, as defined in the agreement, the holders of the warrants may elect to receive, subject to certain limitations and assumptions, cash equal to the Black-Scholes value of the outstanding warrants.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Based on the aforementioned terms the warrants are accounted as liability according to the provisions of ASC 815-40.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">In connection with the February 2014 Private Placement, the Company also entered into a Registration Rights Agreement (the &#8220;RRA&#8221;) with the investors. Pursuant to the terms of the RRA, the Company granted to the investors certain registration rights related to the Shares, the Warrants and the Adjustment Shares issued and issuable in this private placement. The Company is required to file a registration statement for the resale of the Shares, Common Stock underlying the Warrants and Adjustment Shares within 30 days following the closing date of the Offering and to use its reasonable best efforts to cause such registration statement to be declared effective within 60 days following the closing date (or 120 days following the closing date if the SEC determines to review the registration statement). The Company may incur liquidated damages for each investor of up to nine percent of the pro-rata purchase price of the Shares if it does not meet its registration obligations under the RRA.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">On June 3, 2014, the Company&#8217;s Third Registration Statement was declared effective and based on the Reset Price feature which occurred on July 2, 2014, subsequent to the balance sheet date, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,484,416</font> Adjustment Shares have been issued&#160;and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,984,953</font> warrants were issued in connection with the February 2014 Private Placement and additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 851,453</font> warrants were issued in connection with the 2011-2012 Private Placement (see also Notes 7a).</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 27.75pt"> <div style="CLEAR:both;CLEAR: both">b.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Stock based compensation:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">On June 17, 2014, the Company&#8217;s majority stockholders (with the prior recommendation and approval of the Company&#8217;s Board of Directors) approved&#160;an increase in the size of the 2012 Plan from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000,000</font> shares of Common Stock to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7,500,000</font> shares of Common Stock.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 2.55pt 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Following the approval of the Company&#8217;s Board of Directors of the non-employee directors option plan during March 2013 (the &#8220;Annual Directors Plan&#8221;), on May 7, 2014 our Board of Directors approved the 2014 grant of the Annual Directors Plan with <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25,000</font> options granted to each of the Company&#8217;s then current non-employee directors. These options have an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.39</font> and shall vest in quarterly arrears over one year ended December 31, 2014. They also have a cashless exercise feature and a ten year term. On the same date, the Board of Directors also approved a one-time grant of fully-vested <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 150,000</font> options to each of the two newest non-employee directors. These options have an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.39</font>, a cashless exercise feature and a ten year term.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.6pt; MARGIN: 0pt 2.55pt 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">In addition, on the same date, the Board of Directors approved the grant of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 380,000</font> options to the Company&#8217;s Scientific Advisory Board (the &#8220;SAB&#8221;). These options have an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.39</font>, shall vest in 4 quarterly arrears, have a cashless exercise feature and a ten year term.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.6pt; MARGIN: 0pt 2.55pt 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The abovementioned options to non-employee directors and the SAB were not issued under the Company&#8217;s 2012 Equity Incentive Plan and shall be deemed to have been issued under an &#8220;employee benefit plan&#8221; as defined in Rule 405 promulgated under the Securities Act.<font style="FONT-FAMILY:Times New Roman, Times, Serif">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -0.6pt; MARGIN: 0pt 2.55pt 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">As of June, 30, 2014, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,139,750</font> options to purchase Common Stock are available for future grants under the 2012 Plan to employees, advisors, consultants and service providers of the Company or Ltd.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">The total compensation cost related to all of the Company&#8217;s equity-based awards, recognized during the period of three and six&#160;months ended June 30, 2014 was comprised as follows:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 113.4pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in 0in 0in 1.17in; WIDTH: 82%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Three&#160;months<br/> ended&#160;June&#160;30,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Six&#160;months<br/> ended&#160;June&#160;30,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Unaudited</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Cost of revenues</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>18</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>141</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>280</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Sales and marketing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>531</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>877</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Total stock-based compensation expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>690</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,199</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">As of June 30, 2014, the total amount of unrecognized stock-based compensation expenses was approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">923</font> which will be recognized over a weighted average period of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.56</font> years.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">c.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">During the six months ended June 30, 2014, proceeds from warrants and options exercise amounted to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">343</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7</font> following the issuance of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 342,617</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 372,500</font> Common Stock, respectively.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">NOTE 6:-&#160;&#160;&#160;&#160;&#160;&#160;&#160;SELECTED STATEMENTS OF OPERATIONS DATA</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">a.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">General and administrative:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 1.17in; WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div style="CLEAR:both;CLEAR: both"> Three&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div style="CLEAR:both;CLEAR: both">Six&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%" colspan="11"> <div style="CLEAR:both;CLEAR: both">Unaudited</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Payroll, office and related</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">263</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">276</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">560</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">534</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Legal and professional fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">242</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">336</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">453</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">469</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Stock-based compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">531</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">280</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">877</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,358</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Issuance of Common Stock and warrants to service provider</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">618</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,011</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">256</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">256</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">48</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Total General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,292</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,516</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">2,146</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">3,420</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">b.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Financial expenses (income), net:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 1.17in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Six&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%" colspan="11"> <div>Unaudited</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Bank charges</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>2</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>7</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>14</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Foreign currency adjustments losses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>4</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>16</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Issuance cost related to warrants to investors and service provider</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>41</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>489</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Revaluation of warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(396)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,664</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(538)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,800</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Total Financial expenses (income), net</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(349)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,690</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(33)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,841</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 18pt"> <div>c.</div> </td> <td style="TEXT-ALIGN: justify"> <div>&#160;&#160;&#160;Net loss per share:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0px 0in 1.15in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table sets forth the computation of basic and diluted net loss per share:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 1.2in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Six&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%" colspan="11"> <div>Unaudited</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Numerator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Numerator for basic net loss per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,254</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>5,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>6,238</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>10,513</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Effect of dilutive securities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Warrants issued to investors and placement agent</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(290)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(303)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Numerator for dilutive net loss per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,544</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>5,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>6,541</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>10,513</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Denominator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Denominator for dilutive net loss per share - weighted average number of Common Stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>22,985,523</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>18,327,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>22,152,675</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>16,590,423</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Effect of dilutive securities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Warrants issued to investors and placement agent</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>216,554</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>108,277</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Denominator for diluted net loss per share - adjusted weighted average number of Common Stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>23,202,077</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>18,327,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>22,260,952</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>16,590,423</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both">NOTE 7:-</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">SUBSEQUENT EVENTS</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">a.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Following the effectiveness of the Company&#8217;s Third Registration Statement on June 3, 2014 (see also Note 1c), and in accordance with the February 2014 Private Placement agreements, on July 2, 2014 the Company issued a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,484,416</font> shares based on a Reset Price of&#160;approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.89</font> to the investors from the February 2014 Private Placement. In addition, the abovementioned issuance triggered the following anti-dilution adjustments:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 84.45pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 30pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-WEIGHT: normal">1.</font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-WEIGHT: normal">The exercise price for the investors and placement agent warrants of the February 2014 Private Placement was adjusted to&#160;approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.89</font> and additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,746,688</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 238,265</font> warrants became eligible for issuance upon exercise of such warrants, respectively.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 113.4pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 84.45pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 30pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-WEIGHT: normal">2.</font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-WEIGHT: normal">The exercise price for the investors and placement agent warrants of the 2011-2012 Private Placement, with a current exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.30</font> was adjusted to&#160;approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.05</font> and additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 645,054</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 122,838</font> warrants were issued, respectively. The exercise price for the placement agent warrants of the 2011-2012 Private Placement, with a current exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.00</font> was adjusted to&#160;approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.84</font> and additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 83,561</font> warrants were issued.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>&#160;</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">All the aforementioned warrants contain anti-dilution protection provisions and therefore will be accounted as a liability according to the provisions of ASC 815-40.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>&#160;</b></div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">b.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">On July 7, 2014, the Company&#8217;s Board of Directors approved the grant of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,100,000</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 395,000</font> options to employees and non-employees, respectively, at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.98</font> per share. Such options shall vest in 8 quarterly instalments over a period of 2 years commencing the above date. The options have a cashless exercise feature and a ten years term, unless otherwise approved by Compensation Committee of the Board of Directors, and shall be issued under the 2012 Plan.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">In addition on the same date, the Board of Directors approved a one-time grant of fully-vested <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 150,000</font> options to a new non-employee director. These options have an exercise price of $0.98, have a cashless exercise feature and a ten years term. The non-employee director options were not issued under the Company&#8217;s 2012 Equity Incentive Plan and shall be deemed to have been issued under an &#8220;employee benefit plan&#8221; as defined in Rule 405 promulgated under the Securities Act.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> Placement agent warrants 2011-2012 Private Placement:<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="WIDTH: 88%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 56.7pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="white-space:nowrap; TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>June 30,<br/> 2014</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>December 31,<br/> 2013</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; WIDTH: 64%"> <div>Risk-free interest rate (1)</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>0.39</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>0.50</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected volatility (2)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>53.85</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>50.91</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected life (in years) (3)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>1.78</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>2.25</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected dividend yield (4)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Fair value Warrants</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>0.48-0.63</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;0.67-0.83</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> Investors and placement agent warrants in February 2014 Private Placement: <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="WIDTH: 88%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 56.7pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="white-space:nowrap; TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>June 30,<br/> 2014</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>Issuance<br/> date</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; WIDTH: 64%"> <div>Risk-free interest rate (1)</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>1.59</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>1.63</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected volatility (2)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>52.84</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>61.49</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected life (in years) (3)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>4.93</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>5.20</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected dividend yield (4)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Fair value Warrants</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>1.65</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>1.78</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 35.25pt"> <div>(1)</div> </td> <td style="TEXT-ALIGN: justify"> <div>Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -35.45pt; MARGIN: 0pt 0px 0pt 92.15pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 35.25pt"> <div>(2)</div> </td> <td style="TEXT-ALIGN: justify"> <div>Expected volatility - was calculated&#160;based on actual historical stock price movements of companies in the same industry over a&#160;term that is equivalent to the expected term of the option.&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -35.45pt; MARGIN: 0pt 0px 0pt 92.15pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 35.25pt"> <div>(3)</div> </td> <td style="TEXT-ALIGN: justify"> <div>Expected life - the expected life was based on the expiration date of the warrants.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -35.45pt; MARGIN: 0pt 0px 0pt 92.15pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"></td> <td style="WIDTH: 35.25pt"> <div>(4)</div> </td> <td style="TEXT-ALIGN: justify"> <div>Expected dividend yield - was based on the fact that the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future.</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> In estimating the warrants&#8217; fair value, the Company used the following assumptions: <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">Investors warrants in 2011-2012 Private Placement:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="WIDTH: 88%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 56.7pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="white-space:nowrap; TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>June 30,<br/> 2014</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>December 31,<br/> 2013</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; WIDTH: 64%"> <div>Risk-free interest rate (1)</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>0.61</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 15%"> <div>0.70</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected volatility (2)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>52.04</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>52.09</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected life (in years) (3)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>2.33</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>2.82</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Expected dividend yield (4)</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>0</div> </td> <td style="TEXT-ALIGN: left"> <div>%</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>Fair value Warrants</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>0.69</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>$</div> </td> <td style="TEXT-ALIGN: right"> <div>0.74</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> The following tabular presentation reflects the components of the liability associated with such warrants as of June 30, 2014: <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="WIDTH: 82%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif; MARGIN-LEFT: 85.05pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: bottom"> <td style="white-space:nowrap; TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: center; FONT-WEIGHT: bold" colspan="2"> <div>Fair&#160;value<br/> of&#160;liability<br/> related&#160;to<br/> warrants</div> </td> <td style="white-space:nowrap; PADDING-BOTTOM: 1pt; FONT-WEIGHT: bold"> <div>&#160;</div> </td> </tr> <tr style="VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right" colspan="2"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt; WIDTH: 87%"> <div>Balance at December 31, 2013</div> </td> <td style="WIDTH: 1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; WIDTH: 10%"> <div>2,696</div> </td> <td style="TEXT-ALIGN: left; WIDTH: 1%"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>Fair value of warrants issue to investors and service provider</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>3,230</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>Change in fair value of warrants during the period</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>(538</div> </td> <td style="TEXT-ALIGN: left"> <div>)</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; PADDING-BOTTOM: 1pt; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>Exercise of warrants (*)</div> </td> <td style="PADDING-BOTTOM: 1pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 1pt solid; TEXT-ALIGN: right"> <div>(9</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 1pt"> <div>)</div> </td> </tr> <tr style="BACKGROUND-COLOR: rgb(204,238,255); VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>&#160;</div> </td> <td> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left"> <div>&#160;</div> </td> </tr> <tr style="BACKGROUND-COLOR: white; VERTICAL-ALIGN: bottom"> <td style="TEXT-ALIGN: justify; PADDING-BOTTOM: 2.5pt; TEXT-INDENT: -11.35pt; PADDING-LEFT: 11.35pt"> <div>Balance at June 30, 2014 (unaudited)</div> </td> <td style="PADDING-BOTTOM: 2.5pt"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: left"> <div>$</div> </td> <td style="BORDER-BOTTOM: black 2.5pt double; TEXT-ALIGN: right"> <div>5,379</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2.5pt"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 85.05pt"></td> <td style="WIDTH: 28.35pt"> <div>(*)</div> </td> <td style="TEXT-ALIGN: justify"> <div>During the six month period ended June 30, 2014, the placement agent exercised 9,118 warrants for a total amount of 9,118 shares of Common Stock of the Company, respectively (See also Note 4c).</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">The total compensation cost related to all of the Company&#8217;s equity-based awards, recognized during the period of three and six&#160;months ended June 30, 2014 was comprised as follows:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 113.4pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in 0in 0in 1.17in; WIDTH: 82%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Three&#160;months<br/> ended&#160;June&#160;30,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Six&#160;months<br/> ended&#160;June&#160;30,<br/> 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Unaudited</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Cost of revenues</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>18</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>36</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>141</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>280</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Sales and marketing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>531</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>877</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="57%"> <div>Total stock-based compensation expenses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>690</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,199</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">a.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">General and administrative:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 1.17in; WIDTH: 85%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div style="CLEAR:both;CLEAR: both"> Three&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div style="CLEAR:both;CLEAR: both">Six&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div style="CLEAR:both;CLEAR: both">2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%" colspan="11"> <div style="CLEAR:both;CLEAR: both">Unaudited</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Payroll, office and related</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">263</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">276</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">560</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">534</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Legal and professional fees</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">242</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">336</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">453</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">469</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Stock-based compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">531</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">280</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">877</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,358</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Issuance of Common Stock and warrants to service provider</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">618</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,011</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Other</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">256</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">6</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">256</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">48</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div style="CLEAR:both;CLEAR: both">Total General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,292</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">1,516</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">2,146</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div style="CLEAR:both;CLEAR: both">3,420</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div style="CLEAR:both;CLEAR: both">&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">b.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">Financial expenses (income), net:</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 1.17in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Six&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%" colspan="11"> <div>Unaudited</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Bank charges</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>2</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>7</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>14</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Foreign currency adjustments losses</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>4</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>16</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Issuance cost related to warrants to investors and service provider</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>41</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>489</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Revaluation of warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(396)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,664</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(538)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,800</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Total Financial expenses (income), net</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(349)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>1,690</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(33)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,841</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> -6271000 -4418000 3897172 0.0070 0.0050 0.0061 0.0039 0.0159 0.0163 0.5209 0.5091 0.5204 0.5385 0.5284 0.6149 P2Y9M25D P2Y3M P2Y3M29D P1Y9M11D P4Y11M5D P5Y2M12D 0 0 0 0 0 0 1.78 0.48 0.63 1.65 0.69 0.67 0.83 0.74 1819000 2263000 0 38000 166000 154000 2362000 2930000 49000 41000 991000 1145000 3402000 4116000 681000 586000 1095000 920000 1776000 1506000 5379000 2696000 2000 2000 0 0 22486000 19915000 -3753000 -86000 3402000 4116000 2696000 3230000 -538000 9000 5379000 2461000 2226956 482200 1.00 1.50 2461 3754 2461000 482200 1670216 144885 1.50 1.50 2.35 1.30 371017 72455 5445065 9118 18000 141000 0 531000 36000 280000 6000 877000 380000 25000 150000 1.39 1.39 1.39 923 P6M22D 144885 1.88 2.35 3754 0.9 342617 534000 560000 276000 263000 469000 453000 336000 242000 1358000 877000 280000 531000 1011000 0 618000 0 3420000 2146000 1516000 1292000 14000 7000 10000 2000 -27000 -9000 -16000 -4000 0 489000 0 41000 -3800000 538000 -1664000 396000 -3841000 33000 -1690000 349000 0.98 150000 1100000 395000 0.0001 0.0001 80000000 45000000 23013889 20071816 23013889 20071816 0.0001 0.0001 5000000 5000000 0 0 0 0 2091000 2440000 1416000 1333000 1161000 659000 664000 373000 -6672000 -3596000 -3603000 -41000 -505000 -26000 -47000 -10513000 -6238000 -5286000 -3254000 -0.63 -0.28 -0.29 -0.14 16590423 22152675 18327387 22985523 -0.63 -0.29 -0.29 -0.15 16590423 22260952 18327387 23202077 -1070000 1000 5001000 -6072000 14547689 996000 996000 0 1000022 488000 488000 0 208334 523000 0 523000 0 0 8987000 8986000 0 4000000 1013000 1013000 0 2226956 708000 708000 0 352000 352000 0 300771 0 7000 7000 0 15000 372500 3213000 0 3213000 0 1199000 0 1199000 0 -13931000 0 0 -13931000 0 0 -6238000 2000 19915000 -20003000 2000 22486000 -26241000 20071816 23013889 1.00 2.50 0.55 2862000 1199000 0 489000 314000 358000 208000 -120000 371000 39000 350000 175000 -3800000 538000 -3021000 105000 130000 14000 158000 92000 8000 1146000 150000 -1329000 -130000 9951000 3754000 195000 350000 10146000 4104000 5796000 -444000 1230000 7026000 31000 0 385000 9000 39000 56000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both">NOTE 1:-</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">GENERAL</div> </td> </tr> </table> &#160; <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"></td> <td style="WIDTH: 28.75pt">a.</td> <td style="TEXT-ALIGN: justify">LabStyle Innovations Corp. (the &#8220;Company&#8221;) was incorporated in Delaware and commenced operations on August 11, 2011. The Company is a mobile health (mHealth) company developing and commercializing patent-pending technologies to provide consumers with laboratory-testing capabilities using smart phones and other mobile devices.&#160; The Company&#8217;s initial product, Dario&#153;, is a mobile, cloud-based, diabetes management solution which includes a pocket-sized blood glucose monitoring device that, utilizing proprietary software, integrates with smart phones and other mobile devices to offer users the ability to record, save, track, analyze, manage and share diabetes related information (the &#8220;Dario&#153; Smart Meter&#8221;)</td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 92.7pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 84.45pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has a wholly owned subsidiary, LabStyle Innovation Ltd. (&#8220;Ltd.&#8221;), incorporated and located in Israel, which commenced operations on September 14, 2011. Its principal business activity is to hold the Company&#8217;s intellectual property and to perform research and development, manufacturing, marketing and other business activities.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 0pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">b.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">During the six month period ended June 30, 2014, the Company incurred operating losses and negative cash flows from operating activities amounting to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6,271</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,418</font>, respectively. The Company will be required to obtain additional capital resources in the near term to&#160;extend its commercialization,&#160;ramp up its inventory and maintain its research and development activities. The Company is addressing its liquidity needs by continuing to seek for additional funding from public and/or private sources and by commencing its initial commercial sales. There are no assurances, however, that the Company will be able to obtain an adequate level of financing or commence an adequate level of initial commercial sales required for the short and long-term development and commercialization of its product.</div> <div style="CLEAR:both;CLEAR: both">&#160;</div> <div style="CLEAR:both;CLEAR: both">According to management estimates, the Company has sufficient liquidity resources to continue its planned activity&#160;only into October 2014. Failure of the Company to obtain additional funding would have a materially adverse effect on the Company&#8217;s results of operations, future operations and overall viability.&#160;</div> <div style="CLEAR:both;CLEAR: both">&#160;</div> These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.</td> </tr> </table> &#160;&#160; <table style="MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.35pt"> <div style="CLEAR:both;CLEAR: both">c.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">On March 20, 2014, the Company filed a registration statement (the &#8220;Third Registration Statement&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;) covering the public resale of up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,897,172</font> shares of common stock, par value $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.0001</font> per share, of the Company (the &#8220;Common Stock&#8221;) (including <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,670,216</font> shares of Common Stock underlying warrants) previously issued to <font style="FONT-SIZE: 10pt">the investors from the private placement occurred on February 2014 (</font>the &#8220;February 2014 Private Placement&#8221;) (see also Note 4a and 5b). The Third Registration Statement was declared effective on June 3, 2014.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">d.</div> </td> <td style="TEXT-ALIGN: justify">On May 1, 2014 the Company announced the receipt of a U.S. Notice of Allowance for a key patent relating to how the Dario&#153; blood glucose monitor draws power from and transmits data to a smart phone via the audio jack port.&#160;</td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> e</font></font>.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">On June 17, 2014, the Company held its 2014 Annual Meeting of Stockholders in which, among other matters, Company stockholders approved an amendment&#160;to&#160;the Company&#8217;s Certificate of Incorporation (the &#8220;COI&#8221;) to increase the number of authorized shares of Common Stock&#160;from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 45,000,000</font> to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 80,000,000</font>; to amend the Company&#8217;s 2012 Equity Incentive Plan (the &#8220;2012 Plan&#8221;) to increase the number of Common Stock authorized for issuance under the 2012 Plan by <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,500,000</font> shares from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000,000</font> to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 7,500,000</font> (see also Note 4b); and to approve the amendment to the COI to effect a reverse stock split of the Common Stock at a ratio of between one-for-two and one-for-five with such ratio to be determined at the sole discretion of the Board of Directors of the&#160;Company&#160;(the &#8220;Reverse Split&#8221;) and with such Reverse Split to be effected at such time and date, if at all, as determined by the Board of Directors of the Company&#160;in its sole discretion. No decision has been taken in connection to the Reverse Split as of the filing of this consolidated financial statement.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">f.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">On April 28, 2014 the Company was granted with national approval and regional reimbursement for the Dario&#153;&#160;in Italy.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">g.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">On June 25, 2014 the Company was granted with reimbursement status for strips and lancets to be utilized together with the Dario&#153;,&#160;effective September 1, 2014 in England, Wales, Scotland and Northern Ireland.</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <table style="MARGIN-TOP: 0pt; WIDTH: 100%; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 55.7pt"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="WIDTH: 28.75pt"> <div style="CLEAR:both;CLEAR: both">h.</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">On July 2014, the Company received approval from Israel&#8217;s Ministry of Health to sell the Dario&#153; for diabetes in Israel as well as released the Dario&#153; App for Android smartphone users in select soft launch markets, including the United Kingdom and New Zealand.</div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: bold 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0in"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="TEXT-ALIGN: left; WIDTH: 56.7pt"> <div style="CLEAR:both;CLEAR: both">NOTE 2:-</div> </td> <td style="TEXT-ALIGN: justify"> <div style="CLEAR:both;CLEAR: both">SIGNIFICANT ACCOUNTING POLICIES</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif"> The significant accounting policies applied in the annual financial statements of the Company as disclosed in the Company&#8217;s Annual Report on Form 10-K for the period ended December 31, 2013 are applied consistently in these financial statements except:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 56.7pt; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>In June 2014 the FASB issued Update No. 2014-10 Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this Update remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of comprehensive loss, cash flows, and shareholder deficit, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments are effective prospectively for reporting periods beginning after December 15, 2014 early adoption is permitted. The Company chose to early adopt the update for June 30, 2014 consolidated financial statement.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 10-Q false 2014-06-30 2014 Q2 LabStyle Innovations Corp. 0001533998 --12-31 Smaller Reporting Company DRIO 25498305 355000 475000 22000 0 -26241000 -20003000 0 0 0 0 0 1026000 0 605000 0 -1026000 0 -605000 6672000 5245000 3596000 2998000 0 22000 48000 256000 6000 256000 -3000 0 0.0001 45000000 2500000 7500000 5000000 690000 2484416 851453 2984953 7500000 5000000 3139750 vest in quarterly arrears over one year ended December 31, 2014 P10Y 2484416 0.89 7000 343000 9118 1.30 0.89 1.00 0.84 1.05 1.05 2746688 238265 645054 122838 83561 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0px 0in 1.15in; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table sets forth the computation of basic and diluted net loss per share:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in 0in 0in 1.2in; WIDTH: 85%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Six&#160;months&#160;ended<br/> June&#160;30</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="43%" colspan="11"> <div>Unaudited</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Numerator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Numerator for basic net loss per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,254</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>5,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>6,238</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>10,513</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Effect of dilutive securities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Warrants issued to investors and placement agent</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(290)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>(303)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Numerator for dilutive net loss per share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>3,544</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>5,286</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>6,541</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>10,513</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Denominator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Denominator for dilutive net loss per share - weighted average number of Common Stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>22,985,523</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>18,327,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>22,152,675</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>16,590,423</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Effect of dilutive securities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Warrants issued to investors and placement agent</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>216,554</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>108,277</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="40%"> <div>Denominator for diluted net loss per share - adjusted weighted average number of Common Stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>23,202,077</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>18,327,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>22,260,952</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%"> <div>16,590,423</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0 -303000 0 -290000 -10513000 -6541000 -5286000 -3544000 0 108277 0 216554 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt">In June 2014 the FASB issued Update No. 2014-10 Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this Update remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of comprehensive loss, cash flows, and shareholder deficit, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments are effective prospectively for reporting periods beginning after December 15, 2014 early adoption is permitted. The Company chose to early adopt the update for June 30, 2014 consolidated financial statement.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds. Expected volatility - was calculated based on actual historical stock price movements of companies in the same industry over a term that is equivalent to the expected term of the option. Expected life - the expected life was based on the expiration date of the warrants. Expected dividend yield - was based on the fact that the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future. During the six month period ended June 30, 2014, the placement agent exercised 9,118 warrants for a total amount of 9,118 shares of Common Stock of the Company, respectively (See also Note 4c). Represent an amount lower than $1. EX-101.SCH 7 drio-20140630.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT link:presentationLink link:definitionLink link:calculationLink 106 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 107 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - GENERAL link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - UNAUDITED INTERIM FINANCIAL STATEMENTS link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - STOCKHOLDERS' DEFICIT link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - FAIR VALUE MEASURMENTS link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - STOCKHOLDERS' DEFICIT (Tables) link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - FAIR VALUE MEASURMENTS (Tables) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA (Tables) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - GENERAL (Details Textual) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - STOCKHOLDERS' DEFICIT (Details) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - STOCKHOLDERS' DEFICIT (Details Textual) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - FAIR VALUE MEASURMENTS (Details) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - FAIR VALUE MEASURMENTS (Details 1) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - FAIR VALUE MEASURMENTS (Details Textual) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA (Details) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA (Details 1) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA (Details 2) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - SUBSEQUENT EVENTS (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 drio-20140630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 drio-20140630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 drio-20140630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 drio-20140630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"M[M-FQ@$``/L2```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/PC`4AN]-_`]+;\W6 MM2JB87#AQZ62B#^@K@>VL+5-6Q#^O=WXB"$((9)X;EA@[7D?>O%D>WN#15U% M<["NU"HC+$E)!"K7LE23C'R,7N(NB9P72HI**\C($AP9]"\O>J.E`1>%W/%#J\@)JX1)M0(4[8VUKX<-7.Z%&Y%,Q`.*TKBK@$'H MWH3FSN\!ZWUOX6AL*2$:"NM?11TPZ**B7]I./[6>)H>'[*'4XW&9@]3YK`XG MD#AC04A7`/BZ2MIK4HM2;;@/Y+>+'6TO[,P@S?]K!Y_(P9%P7"/AN$'"<8N$ MHX.$XPX)1Q<)QST2#I9B`<%B5(9%J0R+4QD6J3(L5F58M,JP>)5A$2O#8E:. MQ:P70T]EEP("_+=VU#"G!W@Y^Q#'*&B&%IM7"AK+)Q^"ILVIMD=FS`(K"]A MV\?LZS6VB:'H.3UPIUB!IDJ2(/=DT[:ZZG\#``#__P,`4$L#!!0`!@`(```` M(0"U53`C]0```$P"```+``@"7W)E;',O+G)E;',@H@0"**```@`````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````C)+/3L,P#,;O2+Q#Y/OJ;D@(H:6[3$B[(50>P"3N'[6-HR1` M]_:$`X)*8]O1]N?//UO>[N9I5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4 MQQJ.'&%7W=YL7WBDE)MBU_NHLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9 MJ&74"T\U<%J"`=[!ZH^^CSYLK$SO+=N5# M9@NIS]NHFD++28,5\YS3$$X4UD^&'!Q0]47P```/__`P!02P,$%``&``@````A`&+@ M!5.R`0``PA$``!H`"`%X;"]?_?'KIX\_^Q[6Y7Y_K1YF^M-N'*%?+#NKVOM`XQJ'*E#IGH MM[P\GLQ'$;&0U\'`F!D-C$DXW.0`R0[.F-G!&<4.=Z[(5"%PNZ%1Q*PZ0BH-Q>K(.*TS)5"V&A!/B3-]&?(5UL4VBX-8>4'.Y$D7D";FJ`Y`;9?1]I_)#;HR/IT<>#2HX/AR;^9NFM MUO?ZIXWDQ9^7U1<```#__P,`4$L#!!0`!@`(````(0",JZP)(@,``'<)```/ M````>&PO=V]R:V)O;VLN>&ULE)9;J4L>93(.\)=]A5& M.I]',]%+9^NE2(H=)!,Q+Z#\?!&M+RDUI^QPE8;HI3X5HW^LM`PK85(>>H[!8P'%55>M]`Q&]+HK] M3L`KB%\E"/>I?J6D:F^?"+.2D)&DB(IW1I-=^E$*(RQ3I]"9)DO9701_,AIJ M9>&88KN.YPYIS_))CSU:0\NQ"?,&A/@>0NBWB*%_@\'&'&$,1*G"_K02SX>" M1L3Q/>;VF>V.$,5$%+-92^/"@>4\$8]1AWF^:_]&%`-F4\=R^3T,)%JG>X4P ME1;_[ZEJR?(&B'*-*-?-8IZ(0R;6$)UNX)G>-,_WZ)-#^]2V')]9MNT&CD^= M)S:&.=N48(R.;GO;Q`2.%?1HZ05U?#*A(]:G#OA!K2&DB3%XKIK:Y%3)#]QA MCTP\UB-0&#VZ&L]3:PG:M^B$3:UA0-B(6%XPJ:S`=XK%K+R=.!MC$F7B!:2\KSN>*F3"RKUK+UPV[6$P6/XISY M8ENL.3R[ZR5F8DVUEJ>G_-K3$*5\&-?9PD;C07B.PK"O)K9=_Z*O)^HQL?=Z MR]M/QO21$LY7/RJH)>YY$$1[R!FO)+VM\=F5A$'Z$:BM\5D0=%-7!"]:-+.6 MRN<=A'P/(+Q"];;,S<6]GU=E(^*81P55+BO53>#E/./Q#+X:RI_RM5L9INR_ MF;K_````__\#`%!+`P04``8`"````"$`CX"#T%,%``"G%0``&````'AL+W=O M'2W2.= ME5:KO3Q3,DE0`T1`F_;?KXTC/VCOHJJSLECI M;&;JFBC2E4=1@&5;5GG2P-=J9]3'2B2;UBD_&-PT72-/LD)7 M$1;5E!CE=INE(BK3MUP4C0I2B4/2P/KK?7:LS]'R=$JX/*E>WXY/:9D?(<1+ M=LB:SS:HKN7IXL>N**ODY0"\/YB=I.?8[9>K\'F65F5=;IL9A#/40J\Y^X9O M0*3U"S5N_+TV]5MOF9%0*R#3I) M!5[*\E5"?VSD(W`VKKR?6P7^K+2-V"9OA^:O\O2[R';[!N1V@)$DMMA\1J). M(:,09L8=&2DM#[``^*WEF2P-R$CRT?X]99MFO](M=^;,38L!7'L1=?.:ZUD-L#`G/$)DW M&38Z/^A]&':)SP@I&C"ZT(*$4%H6J'U;IS,+Z4186/A]P36$\`RO$:Z#@T37 M$!(DOD8,@B"B%B8Z3E""5SH$[S5P\=H"!?%:#4UL"T=LT8@MOFU#-.ROT)!@ M0F..EQHHB*U*T20"A$,K(1DIF]-Z,I.3_,2W71$7V$;#VAN71(()%X]P49![ M7(96RD79[G*Y[8JXN%_A(L'0T8;EY1,N"@))O%0@U>8A(GJ(B,<0B!ZTH^E2 M23"6:DX2'BA(EW#+(MTC1&:;D=J*AF9NVR1XC,RFW[="1$D>-08-?;SZ))A0 MZL.V/3A0$%5]UIPR&EI=ES3T"%D=4@NQLG;)8F[_8L3'_PH?"29\2&L-%*1[ M*_>).41FYTJBH9DSFR@8#\V6S7L%$24&DVBZ1BV:D"(R!!U&L>*^3UI(B.R6 MXY-U1\CN<)MLRAC977?>9PT3D^-X(CM-XBI M=RA_E\_[(FNK.T;^(\3D0)Y.3(WO82.0>!2"U9-S M>CI)-=61>J2L`J8PJGD\6;3LPL[>;<;K_H']'8N4=8S\+<^\M]_DT)Y.3(UX M1(P>+YC"*&(VL8;(2D\0$;(Z]&P2([/=URN62H[NZ8S4H$>,2"H#^5],6X_R M\/YDV:19AYW]+)7?I[H[JF-_LD]CY&YY=WG)R3V=EYKSB!=9=\`41AUH+>Z0 M!A,BN\,]4L(1LKO\N@2'\9GIL)XY5DQ.[^G,U*P?=A"/9#Q@"C/:01Y"HL=1 MXE$()BE'^G22Z@`PE,_KZUV=/IC"^.UQ_,F<,=M$/P0?4CSW?/1#RCZZQJ/P M=-[$%._>DUN>!`:9D/]7V[!%QH]C3)T?4$;Z4=ME9'C&X-SW'(?WBV@Q81>G MVZR>Q>>61YI4A#"<,X>[=$C%",->C)" M0PIXI/47\3'%W].:DU//-*U;+Y("TIR"#J-TY!8WN3DG.H8(PVYKC3"<<]?T M'5)7\MI,#H!S@[^IM;H74_='N:AV(A2'0ZVEY9N\\^*P22]/U7UT?S4C9P M0=9^W,.%J(#[(G,&X&U9-N&ULG%;) M;MLP$+T7Z#\(NM<2M7F![2"6E+9`"Q1%ES,MT381211(.D[^OD/1"TFG2=I+ M8NF]>>*;&9(SOWEL&^^!<$%9M_#1*/0]TE6LIMUVX?_\O( MPG\BPK]9OG\W/S!^+W:$2`\4.K'P=U+VLR`0U8ZT6(Q83SI`-HRW6,(CWP:B MYP370U#;!%$89D&+:>=KA1E_BP;;;&A%"E;M6]))+<))@R6L7^QH+TYJ;?46 MN1;S^WW_H6)M#Q)KVE#Y-(CZ7EO-/F\[QO&Z`=^/*,'527MXN))O:<698!LY M`KE`+_3:\S28!J"TG-<4'*BT>YQL%OXMFI53/UC.A_S\HN0@C-^>V+'#1T[K M+[0CD&PHDRK`FK%[1?U$3H=N=A&JG8$CY MFM5/!1$5)!1D1E&JE"K6P`+@K]=2U1F0$/PX_#_06NX6?IR-TG$8(Z![:R+D M'562OE?MA63M;TU"1RDM$AU%(.(H@N#5R\&!7LC@J\`2+^><'3SH%?B4Z+'J M/#0#P9,A_?FSQ;\Y!&M*Y%:I#%JP>`%5>5@F*)X'#Y#*ZLA9:<[8]\Z<++$I M^8FB$J=TB].+2PRR0\H30U4-+)U]049<7S&4^_E"G6RH(-M&-+:_MWJ&8C/R M:T:6VI3BFA+9C/*:88A81N/_,:J"H/>,6B3(*<9*.ZU:.SVH^9,AFZ-,@?-+724I3#3-0ALM+32^Y-7R M`YOM[7X4V?5ST1WVRDIS$NTG<1HJ-]$X=OV8:)(ZN2@M-)N>W5I^LG_QH\BV M'Q0Z:UIICO:3QLZ^STTTFC@5*$QT,G;V<*G1=,@4BM/)\X;@I#(+I$[&UT\0 M%60;B\;.MEEICC;F+#PWL0Q=5J:/0Q-U(DN-'4V%Z)(OJTIJ#C&.^Y=WD2*[ M9MPJ:&L40M0(O'272IG_:D9PY]-[>$;TE.FD9X%=NK>2*"9CV_U:/. M"LW@PH1[SWE?P`@TO`_.`(P@/=Z2KYAO:2>\AFQ`,AR-86-S/<3H!\GZX?I; M,PG#Q_!S![,F@:LX'`%YPY@\/:@+]SR]+O\```#__P,`4$L#!!0`!@`(```` M(0"F!?`Y%`8``-0@```9````>&PO=V]R:W-H965T8YS$)O5) M^M(VSL]_[//W.6#]&T97U7Q=Z?_\'7R9ZUK; M9<=M=JB/Q4K_6;3Z;\^__O+T7C??VGU1=!HH'-N5ON^ZT](PVGQ?5%D[J4_% M$;[9U4V5=?"Q>37:4U-DV[Y3=3`LTYP:558>=::P;.[1J'>[,B^\.G^KBF/' M1)KBD'4P_G9?GEJN5N7WR%59\^WM]"6OJQ-(O)2'LOO9B^I:E2_CUV/=9"\' MF/]B4V]_+8P'1!I^H`R]U_8VB\98V06=CU#OH M'?BST;;%+GL[='_5[U%1ONX[L-N%&=&)+;<_O:+-(:(@,[%>B,7M4`T;<3P86-Q_';&+-7>(^,I(%#PE,^N&8&"R^ MO5U>UF7/3TW]KD$.@%A[RFA&D26!#]PH%M:S=1\Y!Y91E:]49J7/=`U,:6&Y M?7]V3/O)^`Y+)!^8-6/@YYDAQ!69#6?HBJ#"WEB8B%U\3O`N@=P0\@;%A2/. M<)68-;`%14>2<.)*11Q)R@G0,""\YQC#^A-B?#L)>"@I34/)1[)F#2!^CIOM M2+'=C!E+')R'$CY*!"@1CHG16*,[F/@&XTHS2L:,1*0J0G`(LEQPB&:!#45/ M[13M)3C%&JZ=FL]%&S9CQ'8E,[T[&/\&8T[%:P5W,.$=3'0'$]]@7"E3DQN, MY8AC3M6,8!J49,$TM5F4%LQB#9<$W\@-'F^X))YLI\\1GJP!;_BX3SA&;$NJ M@]$-1EXF,6?XM1/><+GV2#B]P5P)"_&%VY807YH4SH?W<%Z^:"](GJMJY9B2 MR6O&P%#.%4V:_P8E/)3P42)`B1`E(I2(42)!B51%"*9-;YB&5S+::Z5#N3P; M8D^E8KIFC-O?W"UG2DS3%'-WPPB%K1Y*^"@1"..PK.G"E>I>B&I$*!&C1((2 MJ8H03(/GIE&FX:;17J)ICBGET9HQ"DLV*.&AA(\2`4J$*!$Q@BU`9V[!CDY< M?S$JD:!$JB($S^A.57YPQCVCO43/[*E<'1FC\@PE/)3P&;'HTYE,I$>0`.T? MBOVE=1>Q;^=,7;()U4Y0(E41@DVP:_J$3;27:!/L&L5IK!FCL@DE/)3P&<$" M:<]<::T$J$!X+4#+MCB+"!6(42)!B51%"'81>.C^A%]]-]FPF3C5]0"I',,1 M#T=\'`EP)!P0Q0TW$I";)1&_3B*(D.G,M(BTU%,1<9SY_)+OHGUT"_QX5:0O M'J1\&Y?%`5+:QW04B(>K^#@2X$@X(+S`7@+6O]>(U%_'^`420<&:V-(54J6$ MZ!K=)W_"-;:]OGYJ=$QIO[LF#%)8LL$1#T=\'`EP)!P0[IIT6XQPA1A'$AQ) ME8AH'MTQ?\(\MM$6S5O(%9-!2O-0Q",HXN-(@"/A@+"*:<^(2:1;0"00,\MQ MI:2)\:LD.)(J$=$]B*W@GOHE!J&X=)\CTF/P>H"4KC$=!>+A*OZ`L'B[CN.: M4RF>`:X2XDB$(S&.)#B2*A'1.+HCOTX[Q#BV@1?2C4C/8FMZ0`+N*ES9#`@+ M^8(0J=QZN(2/(P&.A#@2X4B,(PF.I$I$=(UNR1]PC>W@1=?D]R)$M MBTUQ.+1:7K_1`U\'W@F<6\^'T5\=>MXEM7MD"8=YX_:0+.&\;MR>T$-MVFZ< MA>!,^92]%G]DS6MY;+5#L8,AF),95-J&G4JS#UU]ZL]"7^H.3I/[/_?PWP,% M'/R9$X!W==WQ#_0"Y_]'>/X?``#__P,`4$L#!!0`!@`(````(0#*`;$=9@,` M`!X*```9````>&PO=V]R:W-H965TTBGNO(>J9",-VL_FH2^1YN"EZPYK/V?/^YOYKXG%6E*4O&&KOUG*OT/F_?O M5FG&K:*$,B:$44Z)='ULJ.K2[>0E<3\7!J;PI> MMT"Q8Q53SYK4]^IB^?G0<$%V%?C]%$U)T7'KEQ%]S0K!)=^K"=`%1NC8YT6P M"(!ILRH9>(!A]P3=K_W;:+F-(C_8K'2`?C%ZEH/_GCSR\T?!RB^LH1!MR!-F M8,?Y`T(_E[@$QL'(^EYGX)OP2KHGITI]Y^=/E!V."M*=@D?HV+)\OJ.R@(@" MS21.D:G@%0B`7Z]F6!H0$?*DGV=6JN/:3[)).@N3".#>CDIUSY#2]XJ35+S^ M;4#:HYXDOI#`\Q\D5PR3BR$\+X91.HGG:91F>/S8,C#R=33NB"*;E>!G#TH, M!,J68,%&2V#KPF`8^L"\%!<(")+<(HOF`IKQ'"XVI,(.'_3E4G"8UL2?',460@0T6QC=AV"%<11&JHZ+H2 M!*]]H.H=3\+,/B@WF.D`D]J(;8=PI8#-4`HF)D]"6NS7;8SU0:<.XO$T/&MEZXM0)0&XP4ZWG)DWFCIYN MV\T3SC+W[L^PW;URM=#.EA2-0F0P%TD+1Y#9C.`.]U=B\3?GUMU?V!JOUQ*" M;6%QYC29W&!,+:7)S)5FML>Y0['#8%T7HM'0?4R[QQ:9CY>VUI+E-1A:IV&I M9*#@?]NRZ:C#UC.(LV[=N3X*I`Y!<98X&?N+ZHO(C%8S3&HJ#G1+JTIZ!3_A MV,3,]ZMFI./TV"L%`CW'7(NJ_#H)^"Z9S2P[T*Q$'UDBO MHGN0$4YF4,["S'?SHGBKY\*.*YC+^N\1OL,H)"F<`'C/N>I>T-G^RV[S!P`` M__\#`%!+`P04``8`"````"$`&,FM5?4(``#-*@``&0```'AL+W=OFV^7R\ENMY/-6W18)ZWX%!WASDM\/JPO\//\VDY.YVB]346'?5OO M=+KMPWIW;$H'^WR/1_SRLMM$3KQY/T3'BS0Y1_OU!>J?O.U.";H=-O?8'=;G M[^^G+YOX<`*+Y]U^=_F5FC8;AXWMOQ[C\_IY#^W^J9GK#7JG/YC]8;GI8;N#%HAN;YRCE\?F-\U>:=UF^^DA[:#_[:*/I/!W M(WF+/R;GW7:^.T;0VQ`G$8'G./XNJ/Y60"!N,[6;1B`\-[;1R_I]?_DK_O"B MW>O;!<)M08M$P^SM+R=*-M"C8-/2+>&TB?=0`?B_<=B)U(`>6?],KQ^[[>7M ML6ET6U:O8VA`;SQ'R<7="7.+#_R5)RZRDB9Z9P+7$I$)H9$*X9D*S M9>I6KY^67B$T,R%;1A MEON,:`L;$6VLTQ"!:YUTM48C9*#$0:`@(0DS1@IJ7`0*&K68"3)0XB%0D)!B M?*2@9BH!Z,,\F4EK9B4,XCHOH:AU790PB$D@*<7T(#59(@,K'R)PK;S1-]62 M5\@!D9(>,(>R]#!@AOW-R4#8*.F!0*%.O8%:IQ%RL"$.`A6B,7)0Y")0$/7) MB)H@!T4>`A4B'SDHFDJ@F"0&+6EV!V=^!V=Q!R>0G&*J&!:)^Q(YV(@0@6++ MR?RZ0@Z(E&2!)^5G)(NP49(%@6*=R/PV0@XVQ$&@0C1&#HI!0(*;`J`$JD8.')(F4"N3I20@4O6X7GH]'OJEDXE!S(D/P92N:5$3)P MD#@(W)2,D8$2%X&;D@DR4.(A<%/B(P,E4P1N2F:UC'DM8U'+"&H92V1@U4,$ M;E9]A0R0**D!3Q*6&EI/O(G79(<0/C9AB9%'WNCW2'9(CM;1TE>%;DOK*/_, M\1;@QSIVFLIGIV.QES'J*AP=9$C78U6?Z#\ZS/7"2HJ7#WD M2%>KOJX^*BIIFM8QY+6-1RP@D`^.KM:R!$@N(!'GZ+5%1T;H0.;+/ MM%975R(Q8*XK5)2[*ODNOBJR%^%[\ET(:;Z3=?Q0(#W?5!,"##WBDSHGE[CY%;9D2>#Y-[ MC+PR([)T\>\QFG(C8C.K92WJTR\ MG%5JXN>WJTRF&:LX<&E2UE/F]91%/27(*#?BL\QO5S4HS%FEO;+*;]\P4?,1 M7O&4?*Q^"]($74U"W6!)*$F#=)W;:75)?HTR$S/_E.ID""IZ9!(;,X6;(]>) ME@1UDE/PQ<#+D9LB/Z>@:)HA6+8RNW_MS9`HZ)[$JJA0DT%\(RVN!VN207Y2!3OLK*'&H!&''`Z-.>1R:,(A MCT,^AZ81R:,(ACT,^AZ8[SPB;_/BGAHTL M48;B=`(/&WETCZZL:]AR(4)CSG(Y-.&0QR&?0U,.S3@TY]""0P&'EAP*.22. M3&7]!9'1A=9C#\NP5S'%P^"I=R+`[ M%MQ)ST.Q.UT\L$7NA+J]TL7*A.*&O3+*<"B\K.P0BBXK^9L&!WX0!$"6[8L.U=@ILV['"6 MX)8-VV(<=W4;3DMP'$[]?2OC#S4;SN=POJ/9<`2'XZYFPSD;CGN:#4=I.!YH M-IQUX;AKV+!C7X*;-FS.EN"6#9M\'/=T&TYZ`-[.!P$<)CRM7Z/%^ORZ.R:- M??0"H['3$D?;SO(XHOQQB4_I0:GG^`+'"-,_W^#8:`1G?N"K:[/Q$L<7_"$* MR`^B/OT+``#__P,`4$L#!!0`!@`(````(0#N>=#*4@P``'AC```9````>&PO M=V]R:W-H965T4O03YR*VES\MM5`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` MMNSXL2K?::2',G/=@7EWNW3I7_5HUI7++'^6:1[[TWZ/==8C*\._ORICZB&S M#EPM)"YBU:)>Q.8!]O]E\Q1Y)"[DU`O]-*3Y;BWJM%XSK42;[[<8<<5!4S0: M%S8-:5Q4B[IQ<1WXY?8D7%SOL,:*T]K4:3,:R.O`+]=3U(+E&+*N?>G?K.2$ M_MW^QEQWXU*7W;ANR;P._%RQ++ZR"R[8ZB^[G8AEBYB)2=06(@H-"KU%D-48 M3:*,%7%%9M.0[;&@L)M"&4_$]3A-0];C0N$U16-[_*8AZPF:HM':L&E(EJ@I ME#MBXJ8A(FF*1EO2&TQV@\F;AK2FZ!)"E;%CDU!EY5%$84?/[FHKEQ*JC086 M/'!=7(I,.NSR!J.VF#'96*UI9J1^=$P,3,PF4<9CL3JL-D,.6O8-QFDS9*O< M-G,OML>[P?@WF.`&$[:8.WHDNL'$-YCD!I/>8+(;3-YB9++?BVXCU!P[61-J MKKO62BW4&@TL>(!?69Q/OFA`I0&-!G0:,&C`I`&+!NPZ\/.`JHRG8G=TV@QY M*=W:U,=RKPY<)99)3?E-0]\$@B9IM"^L3;WNB`;B.G#5F#ORSI:T&/I*I#>8 M[`:3MQCZXA0MYJK-0N=D5T="Y[SM@%`N)712&ECPP%4GI0&5!C0:T&G`H`&3 M!BP:L&G`H0&7!CP:\&D@J`/7?8)<082UN?0L&HAI(*D#UVE)L:0MAN[^K,5< M[?[S!5M>F[IYQ55`Z"#L&O\3':1<2N@@-+#@@:L.0@,J#6@TH-.`00,F#5@T M8-.`0P,N#7@TX--`0`,A#40T$--`4@>N>P/I9.D-)JM-O:=S&BBN`L*N9Q># MPJ[O/G"5FIU,7EU?*7?D77O.#7M[NER#$;&`8@F%"H4&A0Z%`84)A06%#84# MA0N%!X4/10!%"$4$10Q%`D4*109%#D71)80R*X<8Z)V],7L[[BZW?<=)4;%$LH5"@T*'0H#"A,*"PH;"@<+N[XK=/9B/T33WE=F,*# MPHA8.)BXF'B8])@$F(281)C$F"28I)ADF.2=%)Q/(K MQ]KHF>4$EQ\?HA-/+4FOGTL4(,3IL+/2ZR)3)F0`9M&"R#V7)28J)AHF.B8&)B8F%B8V)@XF+B8>)CXF`28A M)A$F,28))BDF&28Y)D4G$2NQ'+*CE8C'OB4^TB=6(AF2GE?HNA))D2TP66*B M8J)AHF-B5*2ZSAQ/I,;EF8FS6)C8F#B8N)AXF/@5J39:EB?W])9:@+.$F$28 MQ)@DF*289)CDF!2=1*Q#5B6?J<-R,7)1J)"!V+G$46<=0K+$651,-$QT3`Q, M3$PL3&Q,'$Q<3+R*=+RS^#A+@$F(281)C$F"28I)ADE>D>J6V60ZDB5RR[\0 MR7@\F_T\$(EE6`[X7A\.NX<;RKGRM/PFC?+CJ+/\(%E6J^K(HF*B8:)C8F!B M8F)A8F/B8.)BXF'B8Q)@$F(274@Y#UT:T!D\\>7W/P>Y?O;F\SR&!),4DPR3 M').BDXC%5PZY7Q??;=-N)#Y2+YZ+DADB\PIUE,\"DR4F*B8:)CHF!B8F)A8F M-B8.)FY%+C>,Q?%!C_R:=&@?KR#`),0DPB2N"-\2>:"0MB8X18I)ADF.2=%) MQ.(K1^8_47Q\0%\L/O**S*6N4?_S.]8"DR4F*B8:)CHF!B8F)A8F-B8.)BXF M'B8^)@$F847XZ1K[0S3R3AWA%#$F"28I)ADF.29%)Q&+L!RP_T01\G%^L0C) M.?!?1B=&`#%XL*M!QB%QBHF*B8:)C8F!B8F)A8F/B8.)BXF'B8Q)@ M$F(281)CDF"28I)ADF-2=!*Q"LNA_$]4(9\!(%8AG0XC=4T3J`Z%D"QQ%A43 MK2+5._%8GDBDM;HH1J/IE`RD&'@U)B86)C8F#B8N)AXF/B8!)B$F$28Q)@DF M*289)CDF12<1JE!NFR:#1R;.BY$[HA,Z3:9"'8>Z!29+3%1,-$QT3`Q,3$PL M3&Q,'$Q<3#Q,?$P"3$),(DQB3!),THK4MX%GXS&]EYGA+#DF12<1ZY#.E^F^ M)2JWS).9D%/->84ZZX_GZ2!+G$7%1,-$Q\3`Q,3$PL3&Q,'$Q<3#Q,IR.3^39+@7!!B(I7I&&B8V)@8F)B M86)CXF#B8N)AXF,28!)B$F$28Y)@DF*289)C4G02L0[;YLG@6:-RRSR9*2F/ M>84ZZY#GJ2[5).6>U:)X!WV)LZB8:)CHF!B8F)A8F-B8.)BXF'B8^)@$F(28 M1)C$F"28I)ADF.28%)U$K$-6)9\Y'I:+D>,AO9DZ"1B M)=*I,N5H_0UGIBU39J9TRDSYI$14B9`L<1:UA2A3,B*EM:!&)<+6&#B+B8F% MB8V)@XF+B8>)CTF`28A)A$F,28))BDF&28Y)T4G$2FR;-W-#);;,FYF2CCV7 M.>H\)D*RQ%E43+2*5"?!T_+O?,5S8%T0Y[^>%8&!UV)B8F%B8^)@XF+B8>)C M$F`28A)A$F.28))BDF&28U)T$K$(Z?P9<)NT9=[,E`[9RQQ5=U\:?VNPJ'[? M49Q+3%1,-$QT3`Q,3$PL3&Q,'$Q<3#Q,?$P"3$),(DQB3!),4DPR3'),BDXB M%A^=-P.*KV6^S)2,?<_9<]?+/GQ#Q;@3V3? M;0XOF\7F[>W86^^_EQ\:4);.)C-N"D]L$>>-^..],">6=Z,)](#>XPWBP\O#6*?>_"Q M>MFXJ\/+]OW8>]L\LTT<#G^H=R!9?/S/CZ?P```/__`P!02P,$%``&``@````A`)`A)AY2 M`P``*`H``!D```!X;"]W;W)K&ULG%9=;]HP%'V? MM/\0Y1WR"00$5$U"MTJ;-$W[>#:)(5:3.+)-:?_]KF,^;--2M!=(?,\]\;G' M]O7\[J6IG6?,.*'MP@V&ONO@MJ`E:;<+]_>OAT'B.ER@MD0U;?'"?<7UP"Y$-90T2\,JV'N\81F6?U-1> MZ/MCKT&D=17#C-W"03<;4N"<%KL&MT*1,%PC`?/G%>GXD:TI;J%K$'O:=8." M-AU0K$E-Q&M/ZCI-,7O$E`@R^XPO%FX]\%LE;C>ZX].[RB^R^,E-](BZ'88),T M8$WIDX0^EG((DKV+[(?>@!_,*?$&[6KQD^Z_8K*M!+@]`D%2UZQ\S3$OH*!` M,PQ'DJF@-4P`?IV&R)4!!4$O_?^>E*):N-%X.)KX40!P9XVY>""2TG6*'1>T M^:M`P8%*D80'$L@XD`0P=#W94Q/I=>5(H.6\]0RN*`215FXCHGS#@V(=D1(@LG>?/C MP#DG,%-61X1T#22==$%%;%T1V/VV44<9,LF4$4[,[Z5O0$Q$=HD86Z7(+R&A M2;*Z1&@DAM#H?X3*)%A[FA=Q8)F1*DRL82P9V8>(_$/$ZAK"T`D3T0V];J0$ M+UPHXFFMA9/$+'&J,$F_6JWR9WHL\,W$7`]:RV.EQ[2*&DI@F]VN1()M)5-S M0JG"Q&K?F;%,CP5C,YCK08MTI<>T76`H&9M*Y.'Q\2:32::B((S,B:4*Z+$XL37IT7.F(0G.I]O-D6!3RL0J<:H@2LD@FEKA3(5'O77!V#X0 M*5G1XG_CB1Y]]".^.L[1X)-26%RYNU/Y51AU,X91+%5Y4P/!^.I ME9WKX4%D.0_-6WY?<4=)?/9>N:0ZL^I@#69;G.&ZYDY!=[+KAE#'TZBZ$*3! M#-H*=`=K/(>+0C_NG0+0J#NTQ=\1VY*6.S7>`*4_G,!.8*K5JQ=!N[Y)K*F` M%MT_5G`CP]"P_"&`-Y2*XXML2Z<[WO(?````__\#`%!+`P04``8`"````"$` M%*%_4TL$``#A#P``&0```'AL+W=O'ZJ\K@U=?WLC#>2,UR6JU--+--@U09W>?5<6W^\W?R$I@&:])JGQ:T M(FOS@S#SZ^:W+ZLKK5_9B9#&@`@56YNGICDO+8ME)U*F;$;/I`++@=9EVL#? M^FBQM4%A:V;=\JT[PR181E_4P,>CCD&8EH=BE)U8@@-2G2!M;/3OF9 M]='*[)EP95J_7LXO&2W/$&*7%WGST08UC3);_CQ6M$YW!>3]CMPTZV.W?T;A MRSRK*:.'9@;A++'0<U^0TM$X1-:[-J!?HW)U25N!/VMC3P[II6C^HM&BBW!QGQQ);[CXBP#!2%,#/L\4@9+6`!\&F4.6\-4"1];[^O^;XYK4W' MGWESVT&`&SO"FB3G(4TCN["&EO\)"'6A1!#\@=$2(O>RB"0&H3[3"03B0;[Q*&TL MD(!!<=\V+O)7UAL4).N84#!STQ@8WU61;8]P^7GK#L<(5HGMF/!O:Q2ICQ$M M2#PF]"#)&,'!L!1%"T?5XK$&'(8!D#3&@2Z"8%R)T3+<3A+1)!%/$LDC0E$` MEBIWPV,%.+PV0=ZARW"@=7,HF*`=!P=[FGDKFST<:.,2R68?.[>RM>T1RV9D M>TB3/U'LSL*YS8V2-.Q$SR?-8;WL6E%#P<#=!V$T8CM)1)-$/$DDCPA%`=CT M9`7X!CB]"7`GO?Q:`4/!N&WY7_#"'N:N+>!6-FNV2+:].+96VU@V:ZY);[NG MOY(W;,3_/V_NI.<]5Q,+!=.UO>?J;2^;[[2];/8]]]:VHNUE\[VV%_;[[:>D MS]_KI.?>XVGGL-[XVD"&@KE_9U'Q22*:).))(GE$*`HL5`5XX[LP-8^5X$YJ M`P3:8RD4B-?V/<:+P/.PUL!;&4&!@^=.H'51)",8(P_[?[H:7UAM"6%W;0_9N+CIA&HFDDGD:2AX@J!']_D@;CN?T0 MB;ZFB,-OVP@SH)'&QC6\]BJS"?3(?"8(Q]>^%IU3TA3A1 MB3-#2>HCV9*B8$9&+_RTA&',AZOB)!>B);S(P_NX=CU"2WA;A^O68(`#UCD] MDC_2^IA7S"C(`4+:LSEL0[4XHHD_#3VWK]P[VL#1JOUY@J,T@2."/0/X0&G3 M_^$W&`[GFU\```#__P,`4$L#!!0`!@`(````(0`X@I[D/@4``$D9```9```` M>&PO=V]R:W-H965T9?N>4SO+G1WZ6WDA9 M9<5E)6O*3);()2WVV>6XDO_ZT_OAR%)5)Y=]+P49?)\AG%_:&:2MMK-AYY\GJ5E416'6@$YE76T M/^:Y.E=!Z7&YSV`$-.U220XK^4E;Q)HNJX_+)D%_9^2]ZKR7JE/Q[I?9/LXN M!+(-/E$'GHOBA:+AGH:@L=IK[34._%Y*>W)(7L_U'\5[0++CJ0:[+1@1'=AB M_^F2*H6,@HRB6U0I+<[0`?@MY1F=&I"1Y&,EF_#%V;X^K63#5JR'F:$!+CV3 MJO8R*BE+Z6M5%_D_#-)N4DP$R$8$7EL137$LR[2=A^DJ]DT%7EL56]',F?V- MGCS<-."UU3`F#P/61#,,\.O>>G(R5);8QBUBJ;S`WTANS9@S\OC,:3VSZ MA*'/>,;M,X+*EA'=OO14O):A4XX.P!<#@1@(Q4`D!G9B(.X$5,CW/>F09R[I MP\NAS2VE:6[;OJY9`,3OB=3Y)&WZA&':/./V&4%EVR=Z*MX$QI_`!!.8<`(3 M36!V$YAXG.'_99@+C#C"6N$0&&%-8 MKMX$QI_`!!.8<`(336!V$YAXG.&E,>7#6VUDN'8O%MFZL)^M6;,F*THX:+$ MEA'SYA8Z4^;"9N>A`CY*!"@1HD2$$CN4B,<(SE/Z![5XS3=13VDKWE/#$JZ1 M:\:,>8H2+DIL&6$UGFK:C/[P>Z/7)8RYU0/\+J#1YX)"@/8B1(D()78H$8\1 MG*GS`5/QBR=M)9AJ"VMDS9@Q4U'"18DM2G@HX:-$@!(A2D0HL6.$TTQ0W71, M4Q,62CRFP=FJP=\.W&(=WW@;G#?4U$U^=:QOT)BC..+BR!9'/!SQ<23`D1!' M(AS9X4A\0]HCQ_FZ._/&TGI`=Q=&C&7E`_Y(%>Y!:XU![*LU13AQ-[?';%X* MUT"7:ZLKAJ"]O3T?F30>CO@X$G`=@7*PT)$0>1YQSV>*(\S^G?C\RY^F^!/? MG@\/E+>0U@6^82$K(W0M-&SAV]>T[`8[\O"W-QWJ^8/S65:B&^I97TIA9^?P"%[&MR M)+\EY3&[5-*9'$!RIM"K=,E*X>Q#75R;.NQS44,)NWE[@G]9$*@4S!2`#T51 MMQ]HL?W^3Y#'?P$``/__`P!02P,$%``&``@````A`).:SK3.!```L!(``!@` M``!X;"]W;W)K#@^8Y\!;[Z]5J7U MPINV$/769@O7MGB=BWU1'[?VWW\]W*ULJ^VR>I^5HN9;^XVW]K?=SS]M+J)Y M:D^<=Q9DJ-NM?>JZ\]IQVOS$JZQ=B#.O(7(0395U<-DGXMR^9ZOR.>FJK'EZ/M_E MHCI#BL>B++JW/JEM5?GZQ[$63?98PKQ?69#E[[G[BTGZJL@;T8I#MX!T#A*= MSCEV8@)/3'7OX%@YW)Z(>^`G\TUIX?LN>R^U-O]VS]L<%(4T"Z21BQ((P*=5%7)I@"+9:_]]*?;=:6O[T2)!B^\5:['-0/!70+M7S9>='&>0'Y MD'B-4`<8#>P!$TNIVC'$0X+H?T_302A"S[$LEYI:,_#`(@ MS)C`=7$D&$0K1A!99-HG"H$X!W7AF5&\0DQ1Q\^NE8^C`AAU0BU08)!7'^KZ] ME*D*HY:,!5IJDY3DF[L]K&G9V?*=I/?LZGA!V0Y)0JC>"V76AC%"W.H M>.CJN$F,N/X7^W-J]P&U>X88O''H+\ER3(VX%\6?$2.>/[.B4_,/J/FS=X/7 M>V;D$DJ]JQA3P9N:`4,O'V_80"N@=@1B8.$/FWJRZJY!#'H>Z0I21^;"HKU> MZ7Z8V1X"ZL0*H]KH\%"!"GX2-+F1YB"YQ5\^ZGO3)A%0,U88I*;WI**&"6C0 MI'93?_"F_8&VRT1A<%]X7C"R,D4+DZ@="YU-%]VD)LUZ=H?PT-HAMUY,1)!$ M8?#.=U[D41=,"<)U7;WM37+2KN>30W,WR%$#]A"CR/G+4-]9Z88`+.?=2%:3 MV/_J$/(UEG2(D#JQPN`+R@>-WXA_T/CQ@`!?@2O>''G*R[*U"@< M_L6#B82M$T^^(I+_4WE@T1\Y#`$X+SAG1_Y[UAR+NK5*?H"4[F()TVKPQ`$O M.G'NWTP?10V*>V_ MW[%-*3:4T5Z0I'[/R^/7)S;SF^>V\9X(%Y1U&8K\$'FD*UA)NW6&?O^Z'Z3( M$Q)W)6Y81S+T0@2Z67S^--\QOA$U(=(#ATYDJ):RGP6!*&K28N&SGG0P4C'> M8@F/?!V(GA-6\P>UAWC>-7`O)^C$2Y>O?7#B7U+ M"\X$JZ0/=H$!/9WS-)@&X+28EQ1FH&+W.*DR=!O-\BD*%G.=SQ]*=N+HWA,U MVWWEM'RD'8&P89G4`JP8VRCI0ZG^!<7!2?6]7H`?W"M)A;>-_,EVWPA=UQ)6 M.X$)J7G-RI<[(@H(%&S\8:*<"M8``'QZ+56=`8'@9WW=T5+6&8K'?C()XPCD MWHH(>4^5)?**K9"L_6M$T=[*F`SW)G#=FT1P>V5QO"^&ZZ'8'Z9)E(S_CQ"8 MZ>AT[K#$BSEG.P\Z#H!%CU7_1C-P5K'$$.[Y6"`/57.KBG0IJ`4LY=,BB>?! M$\1?["7+4\G05N1G%.E!$@#>@1$R^CBC*LH0?+XQC@[V>AI+(YGJ"41?!LYP M_NZP!0>A'<-=#DZ)':C$@3*21$.EH?FS)?FQ9)0X$@MN]!$X)7;@QO8W+XW$ MP`WC,(K3=&I+1`OK6TZ3DC>;?GWAVVDIO8<)=[3HD=*&?-ED9BDG/[26/GEQ06FCHNC_:3 MRVA*;*.-0V=1C62D7P=G+#\_9N%,/X*CQ`Y.Y.`8R7F<\V,&QYQ+9N?M\9I\ MQWQ-.^$UI(+]*?0GT)G[[`K)N$TT;&PO MO7V93]2DMRBR?__Y%=V?WA4KGXWR2S6]_ M_^+CU?K[%_=I^>)?O_^O_^6[LJP4WIV7OW]Q5U6+;[_Y MIAS?I;.DW,D7Z1Q/;O)BEE3XL[C]IEP4:3(I[]*TFDV_Z>WNOOEFEF3S%VJ< M+^<5QGUWV'VAEO/LK\OT2/^TWWOSXOOORNS[[ZKOC_/Q;D?U=KO[X&.KGT^S>:J&53HK_T?8VZOP!S/WR_0V*ZLBP8K.DED:MGIU MFER/JOLINIW/\T])A366ZB@O%CMA4]/A$8A3)%.TGZ1?U!_2^[#=J]W=W>[! MWMZ[=X?AHZ-E4>!U=9*58W3QYS0I2#AUG%3QS+:WN[WMO6[8AYG&239-"W6$ M%V_S(I[#:)9,V>`R7>1%!0[#FF:+9!ZUO"H2,J`:W<^N\VDXV*OCR^%Y^*,E M1#Z;Y7,UJO+Q+QTUNDN*M%3GRTI8&%V&K[DMO;I?Q*OM[F[_,7RC#T:<"#.> M3).HOU7@[.KE1_-,+0 MWT:/D_).84`UYC_2ORZS3\D4#!Q1Z#*%C&7C*M5-PWY&=V#"[2HM9NHZF?^B M)N#*,HN[.>=R5#(6556J(AVG&/$:TLE)0+$MDFRBTB_0>F4:36(X_X2YM4C# M55Y!VL9&^)*R3..A3P?]T4`=#R[.1\.K%;KQX?'A_"'T=7YT=_^/'\]'AP.7HE5`;!CP5I9^IX9E28J3-SV]]ZWJ[75V M8=@.#]]%@_4PA[?=SF'WC7K68!T(`T6\RCZETTB)7Q3I30K3,M':^"D$^96+ M_E:=P4=13Z54@SS/>#/DD?X$&P<3#7&F*MC.YE!-BPSB';4]NE;57\!HPGU*JPS^P.M5JA^F MFY96ANMX++Z%Y4_RZ30I2K4`9PI'18:C^;;E.B<;(55:FV?"Z4]IVE'Y:A>@ MYM.O7$O4P<;EK'JC?46K6J]94V-_1U=0F%H;GI\H*,>+R\&/@[/1\$\#=7H^ M>J)Q3[^,TT6E72HU2:KD.?9^[\D>^5ZXGY5BU+I^&2"(24_IP4C%IB(HJ/ M=!/V'DY.+R)J5C8G$;YUEE:M.V=_K]5,^.;[I,S&\N[J-C^EV>T=%7*"*#BY M3=5\*185JP5=G(I3RQ)MJ-H1LBQEDZ^E=U!MPPC'V73)`;@A_XQY3$S_FV<2 M:((?^W"*1FIXIIINCO%O5FG^IM,?Z85P$V33PQ^-0A_1SJF?/X@3$X7/GF&] M,(;U2!O6U:]X%O986]B5;=\G4PB#^`M^/!*%5;8=+9M6[?#1*K7V'7IATGG( M1M0,5HK(3B?I=;%,BGM1`>+@(33;8_\O`<;L"K\`%ZE$/"F"M!'2,Q5*2-:? MNQ$1_YUF0A&VU`EG=829JB+5?D^5UTL(B8-G95I\RK`IT)R?,K@_OV5?7SM' MMU\M\^,>0N\;X_`AN2>L%!FQ=11X?N_KUO'D[>XOBDP;'CMI8;K>SL%SF>[7 M#JF>,.:Z)0^^I,68<`/8R1(S9)NV-D_M,U\(`+>N2]-D78^BZK9A,V`):$.` M%HA9#;NUVB;0,!%+V7:>W(5:*7KGR3OEM!)Q(N&+W9V#@V$7:.UP1Y]K=\.,')ME_HP6,XNA4M[UFJFR*?J=K91FR1?1)<*G*0 M^Y._+,N*T0"A08"1!#Q@)P`3YO"T@1(ZMPR_\M\"6UIO\DECK%(=':?NQ'L` M6UJ\4[LI(7'<;M%U\`VRU9J<>`;`$H$PHG>Z*IO,\3&E`0$%-60X'!PD9'V@ MER%>^E^O:2T%'OX5>*KI%#UQJJW8ZM",Q^&0%UF#7?HM@XD]!\<\I6LO3#/) M2L#("+!@C&ZR+V"&=MCU["F<$%(TY%"]5Q)PKN90(M":0TF.\HFH]T61C]-T M`C2?\35#:\*R_&M%#^%P72SA0Y!1T#\^C]S:ZC>!T6[+[+S-1GMOT?AKS59>UJD;`#(FHZ-9FGG" M:*(Y)$<2XVQC<=;[58H33IU#"\*ND'L87/9/PY_/B]MDGOU-M&<'_#0O\VD& M;(UX$2E\H3T-_0/F<.(`EE$%$%E;G9_[U\PECZLH]/M-NC]&6AC(Q;)(U<]7 MZ9=*O9\B9H_&.CN_&JCNM]OA$I/('5J=W%9;@)'4/_[^?R!9"Z2%__'W__L: M_%]";XV1_,X!?8'-H<2.$4M"+G0&CG1'R0*>&&/*9#D(B%0^++/JZBQC=P>9 MRM0FG!&"JD3-HSP)Z,A`BC62:_8V_ M+3"=>;4-3UZ2U54ZOIOGT_R6>A*&U,@E>IN7J%Z`0?V<89AISI*C4X@[Y#*U:M'$R,\;$$".7.X\/_J+^\??_35)!43,3 MH9''#M+X2#G_XW_]OXZ_YH["GBXG.ASIJ`D2;REF0R05$!CY2H$5`7.!CI_O M,D2WV(+IZ2VL0,^13C&P"_1D MB0;U7F1I11\QODF(C-@;QD'DW'>^N!%9.. M*@'L=>@&L"(`ZYO>_PU_ZY6*E(FS5-/``A5976#B&-,24Z&4`?OS`40KR*4A MU_NL!L,&HGU&-F=ZK_+/W'=4BSBHTVJRH[8@"/P'^R>%/!&@ M;H`46G$8ED623N$-RDZMDH<1X'N=+.SN2^(=(C&$UXKM@*.Z`,]8P3<393V@SZ"[57@KE:F<3<6YI:G1W.L68`4D4XFMZ[ M[`ZJ\6YU\8J7D)(G=2_&L^!L2`IC$B*)Z:.TI=`F+/U2N/#_D_043=+Q#N8`[2&B`D4(G@K1V_H5WTR52KW,+\M>A\#8NVZ(@!R MDT@=%/0]:BC%,$_RY36V\!K9VV@^GO5R]!/K<9N3G_';."U0O7A%2X==$R^) M3PRS01-C'.L83H`WY!4M!RTWUD"2U&@%:(H*#6IPF0>BUC)C59-9O:::>%+$ M,KAX*<[1@=EX"HE!:1=L$'T$$%"'N5S!*84UTW$P&&GQ!D#M'AO$(>AB!)`EG M/=[1X$C>%4*+/L3[1M^!,-!8I#'2W=@U%/&\>]OIONV9?`N?4.C1'8`;>CEU MP9$K08*$B9^#4HBF:-D9<%+H0;`FF0I1&S`.)]/MO'F[V^G5]4'HPV^/O4&J M9GK/MC9>?0U]`S<5Q8&4=*A7T!:3)UUT^$:(2=0Z?[+*?#%-4-%$O9(CDR?5 M0YA4`_)S-&O^>F',P87M02\"1D6A)#-':1"T\WXBHGQP_5H+T;J]E,@#(3(J M63!U+0XT_IB/]B`T#T5<-HE^.2??W8.*PG2^U&,V=T0YGS6P8?NA/@4Q*XD],I/HEO3<1"%Z;0@Q!>]`7QDNZOKP> MG0^%OT`CB(F&.=E173R0N&(F3TQ]H7E\$,)[E7[HK"X)_)W0GU,5FOLS!)%Z M:@!O2LK@QY`6\B48O]8GTH2_;)BE/R'E39D\YK`ND6Z9A>N6GE:ONR58@B->O?R>B2";3>Z-9R^X-5R\[;J-I6U7GS$L;;KY^X8$E/"\7"+8U>]A MV.L4<2Q=:<1%X)U*IH3(&#\#%BG`G]`&Z)\S?9\GL`OXXQ@Y@+$@Z/K)XX/9 MO,<'JVQ9U$379,3YRQ9Q-O4$&L^Y?DQ$DT!/0V8)[XQ6':6$,/F($*$TL.@I M`D'X#-ZTL55KYV>Y__$!DD4A#!9(+83^D&+E:NG^79.65?(+_HM7X);,L6`^ M-)O6G#Y>,"2"A34"7=W!HN-%`WAA52TN3*1$;J)?H%IU:JF'B$J4AS"-40'$ MC@`K`%PPQ)V+NP+=HGF._P#]:/"E?+-(L]GU$ALC%L@ZW5:5"GV&*.N,_8_; MMHGIK-G!4^;5')@^QQ+B!!ED1F>AW2@(\Q@UXH8;-**"=57Y;8HU%YI[N'H[ MWPZ"/W%]R=Q>]&\FA)T;S&_1*S"2GQ@2X;S$.*_X@U#E#*H=_<[5D/9E'INU MN_9%P]QS(YJ^E5@VT;\B[""\*#^-7(C:_:"+WP"1W"@-Q'&E)3`&X5Z[**&* MPZNP!MT%6?XSV^)_,5UF&[3>=._U%PMYMS^?%#D*]@5B$H#-P$?H"Z/1'28N MI:8)[/(=S`J!"="F]H9(XX_`N3#"'\#.$Z0*2;.S]+/Z[T`0VT@U&OYP-D31 M.*K55?_HZ/RC%*2K"QRW.&HI16=$MF1H?*LN@`@CT"K5:IAWE-W.Q6#!:VI] M%/VD8>7Z M==_`&0=`GQ.BPW5",`FG@2>&T'J('*IZZ!\`OX@#B2'T+`Z["(2.G!:&$C2QI;7"!E."KC:K M+-(9W"C9;Q:P$VS&]D!D$P*^MC"642@6C;G217%._H<$NU"H'PBI$?\U5L'C M61`+)PV+"4^[35QX*:JD2&''9'B*!5F@WD&^[ M6@9X`UBD>&C:&<9&$;NI.FJK]QIJ[AIX59.<7O=0ISBO`G%9N\7H:N^UN$08 M'9H`0\`[0B1CF(/=Q[M09^JH0C1XS9:&;%0`?K0`:)0V%QV!\:OX.H`4:2K8T:+EA!)"]'$VN8B MY*B/QP@?U%RF]1==*9LP36XH'$Z5=:WC@-D(F*63P@16\2ZB--@?/;[5JF/9 M*.@`[PW9V:764/0G&MCW\QVPCV?]C\=#G@\-?06&HO%R4)D[:(5=!<&SV48J0$W( M[!NT`TQ,P%'8`]('Q$6;,HY5:#4K[KSHCUM=YL]M'%.\T93MEMK$@^N8@($' MID75Z4"C'R\T[&VWN5^_>39JD<#3-Q MQ2:"'T.,#*?;I8D^)B;,L!<':^4,KQU;M+T>PRE+<_QQ/XI(6@\VA/K)0"EK M/.S&<3S3'-`<8JUG5$?LQVZV/SVPBSU9&DX04:X#.YDZC.,KLMERQN2'#GM< M0UI,%'<@26.`D@E"QC48@^AP1M)^D]'*\P'*QM+_,'[*I!>T="VZ#>QB8CZ_!H^9488'5CO!M`'\U+@D<\%X M1:JW*8@R`W6Y1!<00O.G]%-G%/L`JBQ#PCQ#95Q0,9$5?_?XP&P'BT+)^RS` M0L717PAM@=O9CQ8?JEA/(@V]-O#K$Z7I9BGHX1.D"J`U3^V#/+.<]*D3_$VA M0$BFN6W%MOF*>*-.<`[)#5P?Z>R3/7UY&"=MU<6V3 M/(OPM(GXO.P;,>+YTPL"YKIL_?&5`+."@LM-%C[^'__+(]`O+!Z%G?L6+&]FY'J%V+T*T`,D$G MU0#8D'U9"RB$7[6.Y(:Z98C^UN$W&H`:MI!%`ONZB(HOB09FQDR,77]TI`Z[ M!]O[NU&(,FQDT)S)>)8:E@H'[)$8(&&J1%WZ92R71`E*U;?;59N.R[YX+VY< MYY#MJ+5.%Z[>:9H"FV@S6^/Z<>RGM8'>(COQ[#L7GL_.G!B?^>L=^:/0I26V?)>KE8^W%<460E4CLSYME1`U9$N3H:VJ3R!7Z MB+'1:9YGJ&[@\Q/'TL&[7U_U;TNX0#V+*[`Z'5J6!#*R?&UN2I`+',6;0-O. M_B$KF=_$]L[SB[53]OC`B?4Z[_#&NX.]6J'BV*RVK=JBP-[82@*GCS;H01$$ MSV<\/.AV]I\Y!#"2[C;^TZ,++37%J)PQ96C-NI52O4U>1ULYDELLXJ/=41[1 M[GEK$91L^BSY"XY/(/01$,2:TRU'#3`F)`T6%.%WBE29Q.TDK@`),("6:8V< M2*=Q9/8%EZJJ?]C81 M`4\:>N]Y2['SG"-EE@)*SN^!94[J$AR=A((5P+54.L#\(-,^4K:$JM6BK]-%SIM<`<4?7^[KNQ$ZNM7_MG/6$H@"XM=+P MK*AH,*.B_.W$$'`9S,6![M;WO5Q=&MH41W9^^="!'V"EXQ]25M*+RL M`NX$]`+,,")J>#'P6B526PO`LC89[[#B4@\J@!*\,R#+UC>UBDCX%G[67&?P MZ'#M*,@(:2C`$;6Z5HPQ"^LQ'-T33FU;P!,A(2E/-_]^FRO"QG0/]$U[EB3@ M4Y_`K`B;IX)9_"8DA;/\S)6'ONFP1N:$"Y](E04=3\.(CA)[NJ[0\8/1ZSY7 MC:2Z^D^> M#^]M=ONN"N>3LE@]?+.";HY?TQ?=(!`3MOB=G5/J^5;B/]N853`.ZSHM`J/]:]"U\(5AD M'U'LFI\]=B;+Z'TV%[-@\LNYMU4; MAY'=$*-2)V7>]>"QRM%*>_[+ZU&L(HYW1C@WPC0+NSBJT96&3?;-)(JI+`A'(/G]#:*CEG7_7BM>YYN;>_)ZU>O@W"2XF8H;\X MQ[W]7N=-]ZTTW'LKA=T!+`7Q]1NLXZ0\OU9_ZIQ\'Z@.N+/YX*;=-AEN/ MLUT%ZM-X#VZ=-EU7V+CJA4WUC`=QHE7P%Q[[@<;UNOV`L!DAD2[4HK!Z$Z,. MYAE<\RI-'TY*L^B-$2;7HO$F2"SY3H>,`K+J`VDP`>`3W!6-C9!-8RVK#MT! M'1&PAU:3NZ-IC7GT`J$]O(8:4X(;!AL!6$G\,&G"FBEXI+:T38L9S_O@F`C. M\(I"1=B&^RD6+'FXR9ZD9PB M0A#D'QU9&O&L*'S>YN9(94X<@P(S*AF8!LP=L3N."YF26SJA6NI@$S5%+06$ M36E#=)<>1H@E819M5-$]$`GY3#)PMRP)W&;81:(R1N`2[&PV1PDT(V&DLW&P MRFT3Q,%F:[3"XW-*$MP,&`&`+RA3&<5?<"89HBJT8='.W6']!6# M%!;N8SV&X!P(Y1E(V>-WGM2$BF*@QFWDPC!ZCLB]T)>39W-<4ZGG)MF+H.5R M'K<5RF@N(&WJS439D%>>P[*!8DF9D>B2Q]!QW;\];&HPHX"WZA4!>&L@%"91 MZ,[-RKSUNM'4KT&FF*SD6$R1$"L@*)^JNK)%^A:?PA#%<(G4EX!RXJ09[O=6 M'1G@4U9QJJZ*;-A?E\@8\"YXWLI`QI721LB@+AX7_!"\BJU#"E4+/Z9#Z,K= M^_"[4%OJP7KQ8&8-.CF`E)0'(8TT., M1BE2_,$H0C3V=PS#M6_:7KQI;>+FEEDN%PN@M7JF.!!4`<7%6"A=-9I,:$"Q MIRJN7_/J\V/96#?UR(`CZ/X@J(CY+@JP0*[;NM_BKWO51?#P5P)FB!YU370>DC;6(!$J M=!#\D`UL?*"MBJOG>RE]1P2[`G40J!F0L%E\LXXZW$!62,%&Z!)>&&3JN!1Z M0\)/B_^TKC.D&$JIU/XA2JEP4>PJFJU9N;E>5MX4XDIMU:_HT%P=*AWNJ%&$ M(_LN)_EK':4L`30GZGT*]H_;=@VE(+QJV]O@W4A$S7@D?;AE0G*=0M96('#] M`8[IVU`UC29P7=$O@`IS4L-+'`,#<,O#4`AWI1(8AI1:UD.HW41]#@YW=@_? M8]@U#CG\\7U4V*HMD;$+.QI^1+'Y7&& MD)S2EO480GV;6IVFM;`J#$1HXSQ1MN!(QSO0`OLMF1>^*UEBBIR)I.K,T5H* MF\+%%1+#,HI6*)Q5-9&FQ[E[64:">7O(HI-BV$9],\^J&A+BL7)T5COC6!:N MW6"E$Q=H+:PY#J#CKF;Y#:(0/RAT:H5D$?K6_6.WQ0N60@.)=8\!0_`#8@#! M13[CY60:L<#7$700-LLG\*OA``H@'YZ1`8*#V\-DJ?4` M()\U!@!9"L)$\&BA=253-JY+6$BA.I#A>1LNWP-P,*RW$4*".C,.@HZ! / M5\$=;$1#:"'^FH&J(@Z"H"`F88TOA^9@=AT8S9M<4XIT7,+9N^28%^A&LK`E_Z%/ZQ?9A\\N$?5NLX0.@\%AQC)95H4;7[O1E6C_ M$KX[L(7]G_(I2`._]YXGTE8VFV8WI`/3`4`290O"-8O"XE+*-+;8%EJW+CQ\?'(0`#<9Z,%PGP'L' M&5X+QFO@.!Y6U>">D61F2(K;8F-0 MRWV1>G%#!$ROB=;HFA_)P12@GCF0M3V\T6&.2%NP2-N)%.7(91!,\]M"!*,L M%SC(*^;$5^Y MPH@U,BDSY8(W2$NM.0DK&,N&,-6'-5D.P#(Q>S0,Y,U*;1)K/0U4#V7RP=DP M<]>6MI0T*LA7$ZXU'&2!!<3XP>HB;P!O6%TMI0:1E%.W/3X(.AT*=7[S^."& M"A^:5!A$(`\?6>X+?[=E9/.Q%AM%?[2N\ZW>YA320ZX[SIB=^BK'-FNM$* M]QF$\+1'V(@BU/XZKI?K"\PV2R*0A2?2FP/_HVWUC(5)Q9'2 M[J]D_%WH'=N3T>!T<,03R_7Y9'X.@-_.[%\-\A?"UGFB-1=S;.IDXQGH-^$9Z*];S`_Z^+'HP>97QB+5T<@QX_X89I5#VG#K MF&,.?_=2S"O>O$CN44Z."XIP;2]EF^Z-43IA9Z\1E0.*=X` M*`N;6J>&T@^;YI4LX&VG#J!@-JF4<_!UI&=T?GHU"W9&'`"A2BAL]. M$/8![#/%6V/H>N_L,2]NB%_1P]=,2$/+?+A\5,%]MRT<2)^:YQ7Q[+4^*=*R MWWZ`P704W"+>,@3%8(`UVJIEY0!16KRQ;(P9PRX,7Q\9:%>\]DZ6NZ1;0>U1?4%\WY+!_.O'60UBW#&`X'_'[::)G[LP*$M#M&>0#U%3P2C='(73O.0=WD?+J3-"74(X>J2[)]>VOA M;6NTL0K`PZ82VUALY_/S$(@[&0CU"#!O`75:E[8@^GQ'UXO4J=TO=V'/ACD' MIXC825!_YQ!Q),MO;P$03&2HVE7V`'1ZUK4ZC(3XBAMHG3&=OZ'STISYVGC9 M;/B&1<%B`"J3B7"VN""RC68@<4G0K;YB%Q-WI)'#5VYEF&3#X6_Z5ZW1DGOWUU!E3?QD0#5D/4S-<3`@ MIHST#!(EFRB'#QH>"($\RKVAKXMM,`SPJY>*O-FFI4*P])J\I1[N=0[>=.OI>*N+]O6?ASK;&C:# M.(/'R>\NOH9/8O-65C%X`#8H6`/,T:3/C=HRM?(-/%/T:UL5-Q525*_<[73- MU:+DB[UWS1IY*"Q75BJ,X]?V0GWZG`*=7*%-J#K(L[L[[PYKUXCY2IP8LL5T M4*5>T?*A5[3,\I=D:E`EP8QL.(9.>^;L+9PFM*A+C*ZQ1E.&145F1WEFB3S` M`^2-6SZ\+"J*5`36#G^`+J)VV.@<\*HH!R/%6Z"MEE[OM4YBHJ,E/'^M72$N M/2EOCO9[6&>`:+*HBI]0MF\W_&LJ]A/6Z+/&*C[J\8RR=&[\LVO.->TUU-,Z M`;>I(M?S_PQEY)$#M_X:2[5E;ZN,X!%>CMFO+ZZZ*')][[6(44??>5O2]';5TQ2DM69VY4HNHI-IJ[Z: M+#";E-EB[JPSU9F_T[K63'W0M:'(G,WA(5HLDZKV+&>YM+GWZKW_QE>H"]ERT5T=1$#6&E4U+T6U(O2$1N^)+M.J# MOE%NL`)$W%'V'&S(]*A%Q$=[S?<2PH?M1Z_$2['<';ZR*>1;]9[E\I6?D/>_ ML">?T+V`[PD3HLT%6*P&[CS66Z=1B=G)%Q(_LBX96,(6;*5NVQ71\G M`?0W:3/]*CT]<:676P+;]!^WHGV-T\>>DRKH"03RX! M1D`2-!S([QXV'!FO<[`816QBSGDXGEO_JIEQWWTR(6R^TNIZIIIBY[=SUOPS M3FQU%$`\?F8()KQ?WS#T[SOPYM%DHZYR]1X&5V.5'Y$GA(IQ7Z($3]G=ZT94 MNCH_^L./YZ?'@\N1YQL9@5TIJ`-[:GID4FX^%7T?)_2%:+7-&3AL-(\[41?B M1,\:C\&>*1N!G]#R@WR1+O(KC,]%C4W_C`H+__;G8K5M2`-P*DXK(Y"C1CYF MP7XN'Y"U[5<."1MA3N?P&]7V:W1&Z:Y\R\\+]"<\:(%:`D@_HKU-KZ[P9)^J M7MN/E*\B*)*S3J/V0IJM/OJ[JCL8*.78ICXUOZHYP$PW^GXT>ETF+*CP2EJ[ M`;4^.]-&3O,T`/ZT-QFKVLM$+QJQ$U6QHV_I@/81'._9TBFP,=:+3O6 M:.&VGZ>X9N$X1U,4($BD(\IHG2ROTA-^`+5!*^M-1)3U@]X:&#RM2O@+4E?A M[/PA?\"71W5L`W:T@!`^="%U`_!/T&.)@A<$;OBR!=4(*&+!!X9^U+!MQ5`K M58YG;$KUWE@;HYL:U@9F6M_F8%8%C>Y-L>1-\D9A_F3/C?:!).$8`;2&N<`+ M_(L,*:X6PY4S4U23>%F\.,ZM16.C"L=$S(T(?1I&D+ZA5D4_GP&\N(UVNU;&B$7\/KT);&2C+&L2KF,YHDO MC^`LZ8WC9['"X80P45Y50!;#$OKNW`W^B'A0EE:RG>_AA3UNIJA;LJ5&5$JP MNH^.]B#AMP$YDFV+=('KOFU7H]EZ.$^#X3VAWJ"K:@_2:I-/_G4((NO_A&&O M`/F*0A9Y#0=X16%FG/"5%[:$_@XO"1_*6>'D.#T'/`;?FU\1'7A0 MF$$R#8P,`V&@2WK_L'2%_4&K$QV67_%#[;@TCO''FDAE1?USR+-T\Z4>^),K M8P^;_-R+`ASW5E#5'K[ZRB:4]IQ]>]=JWW[>B\9P[[YS[QZTOONJ*^*H7+MN MM[U=.)EHMOLF_84.S(TG*T8\,`U[MAUR3+P",>S1T'&=%1[@[:-C]3)R M,$2(]`T6\!T^V]@(N=7,'26A%&TJFMLT.X+XZV#"6IB)2^+N(WB]HSM>KH@` M8+D`=-EI0]$`DAD?>YT,:YW^5$`E)'Q3U3O=!'+%Y/8<]8C4>A:@+-*KQE<) M81WTZ90VNRHE7HEZLD:-$P"=_+?ZMF3%FTF=W8YZ>N:[(I)N@C2 MK(CGL^3^V8XZQY44_+P-=C4DMEM^:B(@=[%2N_'V,#&009;CPCQ-Y'"$IR81 M-IGFIV83UMB69TY%1+Q=C)_;$S[YM0*OC\KWG@[UP]+6<)#FK`WH#-[8=L'C M9@`I]%*Z*WV#L&5O9&PO'K^OOGUU'^6(%H>U["W5X/E`5RS/]E>T]+M2_W>MG,U4)(\-;&8[O M60OUQ0K5[V]^^YOK,'IQK$]/EA4I(,(+%^I3%&VN-"TTGRS7",_]C>7!-VL_ M<(T(/@:/6K@)+&,5XDZNHXT&@PO--6Q/321SX0TF\:YN!'_KKZ!S$:?YZ;9M6&>5< MFVL@Z>;:V[JZ&X6*Z6^]:*&.\DU*\LW[U4*]4)5$Y:6_`A!_^,_6C[[[7?+G MS1_?O!G\^]OO_OFCM?K73]^4O_OI6U7+AB$RP0;U,L\'M6+AZT2REFIP<[WV M/:+(&&A"MJX^>_Y73\?OP!E`/?S9S77XB_+%<&#+$.&9ON,'2@16!OWB+9[A M6LDOEH9C/P0V_FQMN+;SDFP>X8;8,=+?N3:8"3=JR0C]CO.`:#*=9@B#T6F, M6ZA.+JADX,9ZG8R?]^C$C#5M'JL+?\Q8L1;U>@D;J^P7)0Z[C)7;BHP3/#XL M5%V''#(<#)!6:K`C#39?#F"\W@:[F/:FV5@?ZY="-6-\L6PW''"LBZ2R84#] M[>6[WN@4/UB5=FD:[BL",.#$LFA#Z-;$]Z6.KS[\I.<)3:C%H("+WCKVHY=, MM^%V`Q6=&=B;")G;1^]1M8UU8Z:>.`$4&?K>=JU0^6A]57[T7<-#D'1JC7_- M5`:,^_GP$BST[11?@H7J\-]2&*=I&IN( M`IG+4R(;EWB#\\OY?#X;7LQFL_ED/)Q,8I(?4H^VO97U;.&J3QA-90130#`? MS^87(P`RF,SBH7I%,`8`E]/I;#JBDX`U]*MRI!(,FJ!($DJ\:],8&Q"HU, MR;%*$$BR*D$@R:K"BL\T`\^E6Y4@D&15@J!OJZ;+*BRL];A34J[,A-7'V1)N M>7?7?JQXU0CKU`<_6$%_(CN,,L25:K+MYMJQUA&L2`/[\0G_1OX&_GWPHPB. MS]Q!R,AU=)`LV04.[ULK>NF7M\K'W^B70B-PV*TXX]/)!4GL:EC2W/N`#Z1N03G'B)T+!K6O#J2/?AT)#MPZDCVX-410F=?<&5,KOPM M'#S=-;"NSP:#I"O'.TZ]0`)\C\?L!T'V*?/9N,L>1AOW::LKY)=2;-R.\!57 MQWLT;=BCK&?##GNT;-B#5T?6;S+K,L+SU@6FYSU(=OAF?GX8#!@HV3'#LY,$ MT_R$W=ODJ`5WNMNO;J-XHC5(Z#A=[?`E4YF>^&W4N)G?M"Z`,L.T'.<33OS_ M6.>U!K3O;JZ?U^3<"CCA!4\^P%,W\"WTR-.W25V1?`!;5NTTJMQ),38;Y^7C MUGVP`CT^"R8>(MZ*O?CBTVU<$!6?XT,YKA4W(-5$S`^!'UEF%)^E$Q]`J,(# MIW+L56*8"N+!TV7\2<7XP!,W'UW&AP;77OV!%ZGC@W-QCR_2'_!\I-2IP034 MJ>OPB$0`;8P,`1A!!@(\?RKE`-Q3!@)8'F8(P$$+!`"GQBNZQ,&09#/P@6)( M&/]80T*.R;1DACRBEE7I%\:OT5)GTF\GFDF^!4(.*\D.1?&Y&7D5F`= M0IP"4Y%L"`!'"@1BB*&D^7=(,4B:@:DW2)J"*01F#J[/$D)C@EJ"F2$E80`\ M4J*BR-=#9L;HD08"05:&)-XPDI4B*099.;(PQ4A6BB009&5(:@E9*9)BD)4C MB2EDI4@"`1B1DB&I)62E2(I!5HXL3#&6E2()!%D9DEAB?.04J=&V:=)$)?W3 MX>"P!JKRO&[LI`ZK5DU@^&SW9/F4+!W!&/%BBJRE\9(U`\^#Q^:I\N0']B^P MRL1+UTS88`4J7NH8V2;=\C4P-O?6,ZQ%DP-#XEFOLRCS5[V@=,A&N MG/ATY>29A@0>L:=S1NN M$]\(X#2A-3OV_Y$S47OFZ>ID/.ST$'5*!4?UJVRIV\9X(R@_A98!U)T.`21\ M2J&`=LLZH0#A)CD[JU*V\,P.*#46_*\;<7SJ*BU-#R&9QLEXMS%?MXK2XT/I MK2@6BZ_)"UB`!_G$(8!I6(UWCS(()K2<(=L4*?V@*PK-4VT$GT-A'QBO4V'CZ#7]H'Y2*1%J_![A=Z6429P^9OB.]?_<=0V!I60/7"JP7I:M-J$#9W;ZG3"ON0^?_D M5DV5@)J2ZD%9_R#*2+N>K>B;(`KPN4,`T]`1[G3EQ%ZT79.[WTCNZ14E4^M# M'Y2X8Q?SG=M#QP!XJJ5Z=[*8"1J"@G]^%G*\D7J6\)#,V&E:J[:?C.HN(B19 M4;A&:=8[6*&FQ-QE[F@"56GJIJK[(%"\-4E59<44VJ6X:%]8548++5RZ@JX/ M9LF@,2ZR)]:84*@!N5WJ9A%I>J@I?E')Z+U?^+\-MGTN/.HL1GZ;%#.O3I5FL MCG.N^>J015@UOB'8@K_\/(A/;L!5;L%&78G1U^$6`/LAOCP4S^-N2AW'Y9DZ M+J3<];XS'4\'(30$,X3L;%QRA,ZAQ9F^*'\]HCM@,L#KP7+RF#`Z.?*.C*XK M>&5I-J5-`7=@Q43&QU@/< MKL''X@7BCURQ<-);Y=,-<%^)3[.)!#Z=!NEE`9 M*S3X2G!?9?"=8E^D9A8_/ES>X*O*T$QN$^`C7`MW7M"`)^O9UI!\\K,@P_&K M:N94KHG!G>HFP8/2'7=WA+H%OM^W:B^Y,KLDYG+3R M_8FX$N&^@\'QI?9P<3VY52E[H]+\4GP%'YT&#YP=_%XY4]Z:R'F>I/`0V)AO3Z]KK9.6Q.,+)DLB"&&@K*_>Q$=XZ@\B"ZV'; MRLJKH#%H2V3!75Q;RX+;F22^#P]&8V3!M)]$1 M5>;!1645=L3D1;@'E=O**NR(MQ\ALD#EMK(*.P)"(FL"@[255=@1K$!E@;NU ME97;<<)R/^7D_F*O'5E?Q?MU\."BL@H[LKXZYO15*JNP(^NKJ');7(4=02KE M'KYH*ZNP(YLG)IQY@NI8V)'E?LK)_6Y&93U^Q.GQB93"=O".<(2'57@X2J04 M5F.]?,SIY8F4PEZL?T\X_3N14E@*Y!&-)O`%OT:YC<8LNQ-.=F^-599U68?! M>88'!CR:W-PZ\,AX'Q\X']^.!EM'1"&L5KDD/5GF9V4)MQ?/!;'Q@-,HCZ"[ MYXUC>$;D!R\*WH(F%\<:?T]*L!+PA#KPWC[ MD39B\EA@Z<$;4K81`WLG:%C_PUL'MA$#>R=BV*2*]1./F/?>9IM;B,VE.'7S MB/A@>Y^M%>LY+,,C`,DCZ:.UC0(C]S\VI$:Q$A>/HRCY![.X)GE&1!S(A`6%PB?+@M M5"YB)Z-PROB[$7@8+4SH[OAHA4;%7;:@^E\]%P\HB'F/#'@&2_SH@GP]`$2M MK+6Q=:+[_,N%6KS_2_ST'W"F]%<_V%_\*!:Q4(OW'_"Q2A#%<$X.I)L/(3RJ M!_XJV\!>J+_>W5[.W]WIH[/9X'9V-AE;T[/Y]/;=V72RO'WW3I\/1H/E?X$R MU_'"J^?A9*$^1='F2M-"\\ERC?#&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T; MQ&Z''FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4* MWDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH] MATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(N MCD:"8LT`;Q)__/QY M.1`R:"'1BR^?_/;LR8NO/OW]N\*1R5D1SBB!4-?A.KL$S( MP5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N M\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$ M6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G M]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO. M.UK9>$\H8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1 M%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[. MCALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL M+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU, M,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'! M\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A M*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04 M\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WY MGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F M\=%]HCYR:`")5.R-&8>A6&.CORDNF1K'D%O^RE*IF! M2W4(=:TXRYN;RB*,HV@6EDQ4Q$98J2$QY'XO,OXLLU/)*V.#*%XP`_[Z*&I] MC59F0\*53+V>ZB^9+&L(L1.%,!]-4!*4V>K;H9**[0H8]SN=L.P:N[GHA2]% MIJ26>S."<*$5[8]Y&2Y#B+19YP)&@&4/%-\GY(FN4CHAX6;=%.A?P<^Z\SG0 M1WG^18G\-U%QJ#;,DV&[OWC!,\-SF#D2X(SLI'S%6[_!5Q$DT0V`2?3_US1/ M,68)VS3=S]>4+\VT_:&"G._9J3!_RO.O7!R.!C)-H0Q8C57^\#!CFOS(C`D";*3-K+\ST+T M$LH&B2]!X/UL?X\_'V1\"0+OER`T'DWBZ7PQ0"6TPVHJ]LP,VZR5/`>P7D%< MUPQ7/UU!Y/ME@7H@^X1P0N8P<0G1,#=OFV@=OD'ULPNQM02\M@1UB?1*X`2" M0RL"M1DN@C"*X'RAV=9^TWG[Q+@E'!&HPG`1A&%)=,8[::-:,TM,.L34 M)=(?$8X9!!ENAG!"8-3M3,S;=6J)K MMG2)M$\\,)M]Q@QAUXSZ"]PB737JK_`^\L`-&FEXU1#VW+PEOK6(XW9;X\UJ M3/O(`S=\:`[>%Q#VW/PVL(CC=LMLW?K(C7!6V])UPRU]#$^3'^]=>)/GZ#>$ M1;J.-P&K:(EIL_7%T\ER,8YNB.-(06AX`1O:L_.:<7MANGK4:YST#O/(#_?A MP1-,[:[=W4VHUY+;"]/UB[WN2>\PC_QPOQ[N9W?WKE_LM>666F;63-Z$+OIR M%N@.X)$<;MG#Y>P&[\CYK4O[#X'8[]T[S",_&,,G_)!V%U_LMR^Y(;8Y[)'-'D!*K@X\Y46A@TR>\`A&86K:;]LSY>6PU_X`I[.:'?CO M3!U$I8."[^'6:#2'1X*RYSM[863='&]VTL"YK/EXA,,[A^-"-`)X+Z6Y7N!A MI/T[L/D.``#__P,`4$L#!!0`!@`(````(0`'D3R+^@,``.\/```9````>&PO M=V]R:W-H965TD]D985 MM-[[:#;W/5)G-"_JR][_Y^^'SVO?8SRM\[2D-=G[+X3Y7PZ_?=K=:?O(KH1P M#QAJMO>OG#?;( E50IF]&&U'!RIFV5K0U>E[>.M^9S1J@&*4U$6 M_$62^EZ5;;]?:MJFIQ)T/Z-%FO7<\F)"7Q592QD]\QG0!2K1J>9-L`F`Z;#+ M"U`@RNZUY+SWOZ(M1K$?'':R0/\6Y,Y&GSUVI???VR+_4=0$J@U]$ATX4?HH MH-]S\14$!Y/H!]F!/ULO)^?T5O*_Z/T;*2Y7#NU>@B(A;)N_8,(RJ"C0S,*E M8,IH"0G`JU<5PAI0D?19OM^+G%_W?A3/EJMYA`#NG0CC#X6@]+WLQCBM_E,@ MU%$IDK`C@?>.!"UGBW"Y6G^$)>I8%J\L0&A/(5!R9'5PRM/#KJ5W#RP'";,F M%09&6R#LRZ)$#(5ZJTY0($'R5;!(+B@!@^8^':)HL0N>H"%9ASE.,;$!211D MY7L##=))<(\0K08%@PPH@"DC`H_\NKM]UB)(SSI."@,='DIK(!(G`ML0F@KX&5.% MNQLB:.]#J88,P_EFJ))2H3!KZ;!X,]=/D_$I0ALC&(^/PW7\VB0M=ZCV.'>[ M@P18SSF*8CVKH\+`CP^ZS,H[$=B&T+*/]>S%W]GM'Q'D\H_"V%0X$=B&T%3` M'6#<`Z'"[1\19/;"_#LKS$+Z!ZWU1B7C0[.+N#_\51>UW,4#@W%#=>3RD<+85#@1V(;05"`8`1]OAHPRNV$ZJ0-U M5EH8I MD!J>]NG6@:Q2%(\%@JTLNA0Q"@TI[G\Y4@-T/.*B:&*L?LJ*IRC#-TG'H%QG M#!H\'+I-!57X'^F+*,-4"R/#(U(@2YD3-P1;(7HGQ&@T.O$.4ZF!ZC"5;>K* MYY%$;!!0$HM:;(7H4L1\-*2\PU1JJCI,I4#JP6D93>Y6X^/URK"DV,O>5JDD MJ+U+;185:2\D(67)O(S>Q$Z%8.`.WZI]+Q'[GMS8A@-8MYKT0OY(VTM1,Z\D M9PB=SU90XU8M;.J"TT8^M9\HAT5+?KS"8DU@$9G/`'RFE/<78D\85O7#3P`` M`/__`P!02P,$%``&``@````A`,%'33=P$P```V(``!D```!X;"]W;W)K&ULK)U;<]M(DH7?-V+_@T+O+1'@G6%[PB+NUXV-V9EG M6:9M14NB0Z3;W?]^LU"52&0=F!(U_=*V/^0Y+-0-E85+O_O'GX\/%W_LG@_W M^Z?WE\'5Y/)B]W2W_WS_]/7]Y?_],_EM=7EQ.-X^?;Y]V#_MWE_^M3M<_N/# M?__7NY_[Y]\/WW:[XP4Y/!W>7WX['K]OKJ\/=]]VC[>'J_WWW1,=^;)_?KP] MTC^?OUX?OC_O;C]WHL>'ZW`R65P_WMX_75J'S?-K//9?OMS?[:+]W8_'W=/1 MFCSO'FZ/5/[#M_OO!W9[O'N-W>/M\^\_OO]VMW_\3A:?[A_NCW]UII<7CW>; M_.O3_OGVTP.=]Y_![/:.O;M_@/WC_=WS_K#_??E_>7'8-,N)I?7']YU%?2O^]W/P^#O%X=O^Y_I\_WGZOYI1[5- M[61:X--^_[L)S3\;1.)K4"=="_S/\\7GW9?;'P_'_]W_S';W7[\=J;GG=$;F MQ#:?_XIVASNJ4;*Y"N?&Z6[_0`6@_UX\WINN035R^^?[RY!^^/[S\=O[R^GB M:KZ<3`,*O_BT.QR3>V-Y>7'WXW#P=5J/I\M5F>8T/CJ"D)_ MOKD@`?6&SL3\Y>U%";B-S5_>7AANY$!:^0WU$G`SF[^\O3#?GCWO/]Y0?,4U<_A^ZV9]8*-<>;!9+M^/[Q^-;IH6!F7C\;F_25U M'QHX!YH2_O@P#6;OKO^@87SG8FXP)M`16XXP8];81CZ(?9#X(/5!YH/JNF$@+1!ZM]ZU?9!_'/5T!J(`V0 M=DA419L$$=="5V8)?/QV?_?[S=ZF!2/#;$IK'KL2,B:Z_BT9UC^0R)+Y<'8+ ME]ZXB_L@KH`$2`HD`Y);,BA0T<<,Z]_[^;(/XI^O@-1`&B"M)?;G5?VO_X[Z M-R:Z_BV9#OH_D,B2Y:Q;NH83?^T:]\?YW!/G,>M'5=K'F.4O>4SU\,GZX^R1 M.P\I6=''.`]O#5WVQ]FC*O,8)'Q?CE-%)XXRCG/'2^^&BD<.&HYSQ MU!OV+1_OC/7`,0G+&:WL\IMA*ULTI4O5H)6]$FS-MI#I"^N^>T2,5CV*'9I- M;)/.O&5-PA)Q21F)2Z9=IE-H/RA+@2ZE=IG-O>Y5L43*4C.2LC2>RV#IWRV! M6I9T+KIE3"IS1LNXS&?8,A:I\1?XPVAK=MI,RTBGBQC9'6&32<2,N(=Y"YZ$ MCXM+RDA<,D9N9*V\`9#S<7$I&(E+R<)=+_"T;B4HK+B1)5+!2OFI%X-0XM M[,HSF`1>)VQ9,S*83,8X'$QV[_;,?"6P>2?-IESC-PZI,1;Z5XPM1TF/C!Q: MR+9DS&AE9[^Y-V\EZ)*R1%PR1M;%\\C1HV"!>)2,?E&2"EUJEHA+P\BZS+P. MU"H3/;Y,VCELK1=6!-R=O`10T'@$5+ MEAG:7#-2P)P#EES4GGC*.<\]S?1A=P%MQ5FFVV#]B_W&P.2RI_K$/_??*15]\9IF4V+5*2SJ MLB35#*:($,6($D0IH@Q1CJA` M5"*J$-6(&D2M0KH]J&I4%S@]T]+>LK]\820C>RM(&B>8>QE!Q%$T+?=YPU): M1Q?SO%PTQ%S4(?I1;N8MH@A1C"A!E"+*$.6("D0EH@I1C:A!U"JDJ]0D0F*W&(Z9Y#JCULU`!%+DKO$\+VN41Q522(4D09HMRA02$* MB1JVA[><+R6*"U$AJA$UB%J';"%T>Y@T:C@0WM8>F-B9;-`DUK)EO444.?3K M[70)X%I(V$9V(5.)&M_)SB2`;7*VD0(6$N5LO%F[E`"VJ=A&2E-+U'AI&@E@ MFY9M<")Z,V'+ASM?/63\O.J%(8/Y4VB1MRD"FS0DP*1F)2:A/O9"H6B$?-2#P:[1%Z;=VRHC-1;6(>;%-C MSESE7[5EVRGU=<,AM><1A-X-@BU'2<>+&,DV=,S(]K*9MP9*^+"8I(S$)&-$ MTZK,!_Z^;\Y1XE4P$J^2D2O0RF\H/BXN-2-Q:1B=+%'+49V7;B\_,7W3JFR* M^:I#:FC!?BT'26>,')I)`ADSLKLQOTW7WCY/@C8I:\0FG3&+I6"Q\,9H MCC8%VI2,7&GF4^]R4*%-S1HI3>.0*\UT-?&FZ5;9Z#8[+TN?8I;N$`TL7D1M M&4EWBQR:R8(B9B2KAP2%*4>),&,DPAR%!4>)L&0DP@J%-4>)L&$DPE8)=97Z M6?K;A@$F[[32ZY(36B+(C.'?C]MRU'`<6.'LY+4S=L+9HNO3OTUGWBR2H'/* MFI/.&4>YJ_)B[?7/')T+UIQT+CF*R^S-YQ4:URPY:=QPE"WR=.5/\JURUNW_ MTF;!Z[9HI[A;X%#7"_5/TLG`E=+<63OS265S=;2W.J6'3?V[B#<<11-UWP]E M$]"NN0 MV9+JZSA<>;M?6XF26K9>)&048U2"*$64(4:5VFQ5 M5:E%,[G\;,VZC6:5F>0$$2/*F:1[PP/9$L5].4&4(LH0Y8RD$`4C70AOC)42 MQ86H$-6(&D0MHZX0NN)-]CBL^+#DE51/2,BFFBN7H(!7:8 M)8JK(D&4(LH0Y0X-.D4A4<-.X657I41Q(2I$-:(&4>N0+81J#_,XSG_>'IV+ MSD,=HJR7B[]E-&@/A]9K^U@)/K`M`6R3.+2457-[NID$L$WN$&V5,"HD MZA<[S!+`FLJA06EJB1HO32,!;-,Z9$NC6^AOR38I-_0OO0ZI%K)1@SJ)7)0> M,;##+%%\1@FB%%&&*$=4("H158AJ1`VBUJ&QRC\O;9QAVNB0JF4;11L,7%F1 MBUK*$THQHL0ARG)9F&)4ABA'88%1):(*A35&-8A:%MI/``Q?G*746,\XI]>, M7;@WM=@T;TF76[FHKKR4:.N$M*SBRHH<(B&CF)%,4PD*4XX28<9(A#D*"XX2 M8J&5,PF86K:27;AVBJPG77X11,2/II0D* M4XX2^XR1"',4%APEPI*1""L4UAPEPH:1"%LEU%4ZGGR>^9RFV9RPJ2?7X8U# M*YH6!OW9VVG;NBC5GZW72B5/<,>$[>VCJ=/0?]HE0>>4-2>=,XZRSO-PY6TR MYNAL.>G<>EN[3#!$UMD1I4 M%JE!Y:)DJS%V7BN9S1*'!L*4HT28,1)ACL*"HT18,A)AA<*:HT38,!)AJX2Z M2L_+;6>8VSKD70W\?1H7I4:/]5)7`X=D@DM0F,HO\A#.&(DP1V'!43*IEXQ$ M6*&PYB@1-HQ$V"JAKF63F?I9UZON,%'*`'W8(NK#P^G*&_I;)QSTSLBA0>>/ M&05V+S;T=TP3M$E9(_-XQFBX4Q?"/2;T*E@H7B4C5Z3IQ%M85&A3LT9L&D8G MB]0J+]UD)E,=-MD+%W";V`XS8DJ%3=,-^O?6(34*("IFH72M!(4I1TF?S!B) M,$=AP5$B+!F)L$)AS5$B;!B)L%5"5:4FAU%5^J:]A\Y%+T@=\D:$=P-XZZ*& M(X*%-.W(E1\NX!QEWU68SF?>TB!!YY0U)YTSCK+.(Q=P="Y8<]*YY"CKO)C[ M]Q4J=*Y9<]*YX2CK'$SP`JZL=0\P^>UP4/D]X'6W+,SC5MX:SJ'A8'-H.-@< M6DEWC1U:R]21H#!%88;"'(4%"DL45BBL4=B@L%5"7=7G9P^L,>\E"/T%ARE'2%ADC$>8H+#A*A"4C$58HK#E*A`TC$;9*J&N9 M%KNJ0Y^^2LQ-N#=W6:0ZKD6JXT)4[+R6TI<3AP;"E*-DSLX8B3!'8<%1(BP9 MB;!"8JQ7P]F?DGV"HKW8)^HO["H,",?&Z1&A06#?IV MY*+6\K1$S$C2H<2A@3#E*!%FC$28H[#@*!&6C$18H;#F*!$VC$38*J&N4I.1 M#B^<+U2I36"'J]&YRVEUUN"G:2Y*#8!>R-E6S%XR128H3#E*YM:,D0AS%!8< M)<*2D0@K%-8<)<*&D0A;)=2U3+.,JN5NZGG-N]MSH_0F=HN\724_37/"0>^, M'!IT_MBAM7W\)`P6]$U1[\E;-$K1*&-$2<=@P>M=TW/T*E@HLWKID"M4,%F% M\+8]&M5HU#`Z6:A6>>EF\[/K%P8'IM3S/J7F/KYU2(T$B(I9*-TK06'*4=(O M,T8BS%%8<)0(2T8BK%!8ZUSF]NJ:<@B MZMR##NCO.FR=4(T**UP/[M"XJ+7-1,)I.`DG?A=,T"IEG5AEC%Q2\XOKL"W" MH%0%Z\2J9.1*%8:+R7KNW>RO7-#`JF:=6#6,7*E^<1T>EDHU(GT\&ALQF$LC MOB[;ZFSTW.90=S6S/VF_,FT_B?NX>_ZZV^X>'@X7=_L?Y@O2M-K[\*['[O/6 MX63SD9XTHQ'G':%WO1XI M[&Q#'[`A%]_$WYE8]'J%;\YMR]`C=;=^8 M&^JHH5O7=&2T4JAL-Z-EHV=X-MO1(_0HS\8\;S/R.],U'1D[4WH89V,>`$$- M/9.S,0_.C!U9TY$Q#;VW26TYU@;THMXFIG?4T(W>O=N8U^OP"+U.MS%OS.$1 M>D-N8UZ"PR/TNAD=&6OM&RK;S6C9Z+W;S7;T"+U^2V4;ZX3T(B@=&3M3>H%V M8U[:Q++1>[14MC$W>J.3CHQI6AIE8VT0K3?Q6`NDU-!CO%AOZ(M^6*::FG*, MTP?Q-N8;84^P?_]]NNNOGW^>O]TN'C8?:$)=M)-ZL_V(_[V'T?W@89/^R-] M?)_F;_HH.?W/%G;TQ:;)%2537_;[(_^#?OBZ_]\W?/A_`0```/__`P!02P,$ M%``&``@````A`(/*!@)>`P``L@H``!@```!X;"]W;W)K[ M-T[<&+*N2'TAY'#N\?'Q-?;B[JDLG$UH"1KBLK"CX)@ZI>$5:Y6B,5;-'B>LY0F/#V6M%):1-""*/`O M#ZR6G5J9OD6N).+A6-^DO*Q!8L<*IIX;4=^W,?E%:+C,$,,'9'T'SIKL,X"0/77RV:@'XS>I*] M[XX\\-,GP;*OK**0-JP3KL".\P>D?LD0@F+_HOJ^68'OPLEH3HZ%^L%/GRG; M'Q0L]P1FA!.+L^>$RA02!1DOFJ!2R@LP`)].R;`U(!'RU#Q/+%.'I3N:>I-9 M,`J![NRH5/<,)5TG/4K%RS^:%+926B1J1>#9BH2!%XZ#*6J\4C=JZ^#9ULV] MZ'823OY7.&X+X3G@^G)$7\^Z"3$ABJP6@I\?XK M3L@11=:HLG1GK@-)2>B!QU4X"Q?^(ZQ;VG(V`QR;L>T8N$@HF_0`'_P:TQ#S M.YA&%33=#;?I@)=91&<..T97DO0`RR$LZ#LX1!7H1RO6,TL;S0DA*I/]Y,RU MH1C;?<3R#2WP#KY1!1H*PC&>PMG(=K5I2:\9-Q1CO(]8QF&?]8T/[_ZN79'< M^.MT-RTR-LVP;1$[_+$]A\24]2?ZTOB6P^DU#I%L.]1(-'UQ>($D?<0:&W9F M/QWLL>?VV)A1-([PT+@V)U2RC6GD+*>IW4Q;0S(Y]1'+*QRH5P35L&U#+=3T MNU;6!ZP^&THJ]G1+BT(Z*3_BX0G\U<+`YF1?1]B.9_@&3_PA/(KA_W*`/XJ3 MT0"^'L=K&'>@8!PGC?/S@:?0+XK7$!;<&[B"NT+S]0!W0PJG6>`!.>=<=2\X M@+EMKOX"``#__P,`4$L#!!0`!@`(````(0!JL0@ZH@4``"86```8````>&PO M=V]R:W-H965T&ULK%C;;N,V$'TOT'\0]+Z6)=\-VXM81-H% M6J`H>GE69-H68HF&I,3)WW>&%XE#R9<`?5FM#V=&AX?#0X6K[Q_YR7OG996) M8NV'@Z'O\2(5NZPXK/V__WK^-O>]JDZ*77(2!5_[G[SROV]^_FEU$>5K=>2\ M]J!"4:W]8UV?ET%0I4>>)]5`G'D!(WM1YDD-/\M#4)U+GNQD4GX*HN%P&N1) M5OBJPK)\I(;8[[.4,Y&^Y;RH59&2GY(:^%?'[%R9:GGZ2+D\*5_?SM]2D9^A MQ$MVRNI/6=3W\G3YXU"(,GDYP;P_PG&2FMKR1Z=\GJ6EJ,2^'D"Y0!'MSGD1 M+`*HM%GM,I@!RNZ5?+_VG\(EB^9^L%E)@?[)^*6R_N]51W'YIAD/\L5^*/T=GR?O)WJ/\7E5YX=CC4L]P1FA!-;[CX9 MKU)0%,H,H@E62L4)","_7IYA:X`BR8=\7K)=?5S[H^E@,AN.0@CW7GA5/V=8 MTO?2MZH6^;\J*-2E5)%(%X&G+C)O:]S(&^D\>.J\Q6`<369S^?(;B6.=",\O MLPZ4`E)0EM3)9E6*BP=="G.LS@GV?+B$PD9)1:/1]IJTH"D6><(J:W_F>Z!: M!?WPO@G'LU7P#FN8ZIAM3PR-B$T$+AB69180`-^&-$C^/Y#&*DC:O&YK@'86 MD,%9;750;>(-R$-<1LAQ(&D3;Q_XQM=,5CR,W6W M&B%23X:4<:R#@(,UK;:K"9_I5_A@,.6CD$@9#+9^W$&8C9!WP[:SM<`M'$6+ M`="_+0OF41H:F39;(FX02X-)2(5B.@@>K5"3=NL0LG@$6WYSFR$&4X8*B:*6 M80=A-D+>O:#O1J&FH\$,A/IBPV,ARDLA$6VH$=4I;H),'S(;(51#.!,?UTE& M4T(:LENJ"S$"40+HO=9"R:Z:W.TI-"9'&@,MVC5K(;MCQE0N9J)H7[5N1_FB M$UM\;S<6>I5+4T,VS0[$3*(\-2@!-%F+@#Q)AU#A#A/MS6U';T,-V4PZ$#-1 M5)UIHR$EAT9JD;O#2=NNS4E#-J<.Q$(-]:B#9FH1D.J$8[GY[I#!3*>W-623 MZ4`,#S),I`)=\>\0W=7B=X>3\F)H!K.3M[(`&*]]OH43Y_2.VRB3R`A$%PV8 MVYRD9HL0/VGO-15F.IIIR/)V5`:C8#*6;SOG-C-1$-Q&3=NSDE)&[WU<1N74 M1$9MWJ-&V3CL0(Q`E``ZJD4`-9O!M_U=Q903$RH:LA5K(%L+]S@,=115[,IY M&'W)Z&4T75@-V4;?A1B!B&+8L:YBHW#^P,Z4F0X9;?^69B:*=-G4.1J9B:*: MM2<"I8R^;"WR[T%!($G;9!V(139$"0!- MFP`J-E\\TF28Z'#1D"U9`]F2N>X?Z2AXM.X_N^+^<.5#&-^1K.O^LL#:EXHI M+=05D+JQR'EYX#$_G2HO%6]XO0/GP&;5P.KN:1N-X?))ENB,3&%$2N".+);P M*0[+Y.+A<(G?R'TC4`M.SKZ1.8S(RR^W6@35P(A[\(W+X]]=<"8CV5MOCR/GRT9'*[.YR>QE"_=X*@?*_PH%6O5*"4K!,T M;X!;NG-RX+\GY2$K*N_$][#,0WD8E>J>3_VHQ1F6'^[J1`WW<_*_1[B/Y?"G M\Q!/^[T0M?D!V@7-#>_F/P```/__`P!02P,$%``&``@````A`"/;H.:5!0`` M!!<``!@```!X;"]W;W)K>Y?.-Z M^>T]/SJOHJRRXK1RV=AW'7%*BVUVVJ_Q55Z$'E2C8NS.(%E5Y1Y4L/'D0 M=WE2/K^<1VF1G\'%4W;,ZH_&J>ODZ>+'_E24R=,1SOW.PB1M?3N[S+"V+ MJMC58W#G(='^F>?>W`-/Z^4V@Q/(L#NEV*W<[VP1!]SUULLF0/]FXJTR_G:J M0_'V6YEM_\A.`J(->9(9>"J*9PG]L95?P6*OM_JQR<"?I;,5N^3E6/]5O/TN MLOVAAG1'<")YL,7VXT%4*404W(QY)#VEQ1$(P$\GSV1I0$22]^;W6[:M#RLW MF(RCJ1\P@#M/HJH?,^G2==*7JB[R_Q#$E"MTPI63`-@K.WQU>[&'1)IS/21U MLEZ6Q9L#Q0);5>=$EAY;@,/V0+A]=\1K)X2C22??I9?&%Y"O("VO:\;F2^\5 M0IDJS`8Q4]?1&!L1MPB9`:#7<83348X!I.YRT%M*Q.$+L3(ZWN4DPI-X,!?<[OTU(-X@)#8S>N4'$MQ`6-W`RG)L$KUPX>)>F M*Q05-65'452&62EI9MG>K.MH,EA=DHKV&I9"CGIK8QKM.!E:]` M*IE3DNK8,@?1M;!);3;XW0D;*KG):]K+9:OV%B@/:L"0]"MZ<1N0>S8?6D"L`LC(-`C1O$T M57[$:(QCY42I"XSY3GULAF02#&S5"R,AT/6C&)JJSWHS@5GF*S.!D:%P)\$7 MID&@/2M:EN#W*L^RSG74K:CQ3TV#!DUT-]#Y0%H*U.;+D*[&'BN[ZAG&0BU! M-K5/C02.EWJ[7;5G10U!+;5>J2DG+;7`T"";&FPS7$FX1).K9$"GE0+=ZM:; M$)N?%&E#Z8;=>#E*NQU"4E8;!5+Z/XU(4<:6?3Z/M"K9#*68$X;W[T@<1X#- MD,X)!<(DFY-3E1_Z0#.;Z^JU^9%9,4Q-Y#_7]!(7TIFA0!C!D/F]")HSA?G7 M^X.,C($44?*M$(8Z2:I/VKG07`+"L$<1[7B$:#K7?68'\4M#@U\8&J&6+\40 M0;PV:#)*0;+Y1(.Q4TD6Q933N M/C:I3XV0X-((Z9$R1TBDDX;Q4BZ4]FAELEG)>?!I[8/GQKZVD/TW"H1/)GI[ M10X]H#&8Z9,A.WR,Q$>[7)1[$8OCL7+2XD4^-#+X%[W[%A]!-_`(VKP8>IT! MWB#/R5[\3,I]=JJRIJ>'UL_CS`:[.`-SY_ M#.!=4=3M!_E*U[U?K_\'``#__P,`4$L#!!0`!@`(````(0#H_\$3O0(``',' M```8````>&PO=V]R:W-H965T&ULG)5?;]HP%,7?)^T[6'YO MG`0"%!$J2M6MTBI-T_X\&\=)+.(XLDUIO_VN8PB$,D3'`R'AW!_GGIM<9G>O MLD(O7!NAZA1'08@1KYG*1%VD^-?/QYL)1L;2.J.5JGF*W[C!=_//GV9;I=>F MY-PB(-0FQ:6US900PTHNJ0E4PVOX)E=:4@NGNB"FT9QF;9&L2!R&(R*IJ+$G M3/4U#)7G@O$'Q3:2U]9#-*^H!?^F%(W9TR2[!B>I7F^:&Z9D`XB5J(1]:Z$8 M239]*FJEZ:J"OE^C(65[=GOR#B\%T\JHW`:`(][H^YYOR2T!TGR6">C`Q8XT MSU.\B*;+$2;S69O/;\&WYN@S,J7:?M$B^R9J#F'#F-P`5DJMG?0I@F+RK M?FP'\%VCC.=T4]D?:ON5BZ*T,.T$&G)]3;.W!VX8!`J8($X8P3E!H;\,H^BX8R\P&383G/O-?!^T/05RS.**.DT!!QW MMB'*8]OGQ[EWY\3.G1NOLWOO+QQ;B;N?:17+,XI))^DY@="N=^+$*09XE\'D M@/7>O&1X)#E$X+U=4O2L`>38VGZVE\-R17V+433J6O<>O>:21Z^8^%NAJ^ZY M@^?GX^Y MZ^2Q@>7HB.>[\7[]\O-/M>2ZX$M>508QM7&++8(NNZO=SEW$[=KLOH"=U]"" M/U-=B-J@BN=0&@9C2$K[K>E/K&K:G;%2%K9=^[&$/S<.3Q6T@E&NE-V?N+W< M_5W._P(``/__`P!02P,$%``&``@````A`$:F"]SO"```&2@``!@```!X;"]W M;W)K2^I;VE MK:-S>:8AW8T&""+T],S?GW+*58G+Z9"9>1B:Y547+U?L`OSPY7\M# M<7X;X_%.7\<_LS+X9>G?_[CX:.X M?BO?\OPV``_G\G'X=KM=-I-)N7O+3]MR7%SR,XR\%-?3]@9OKZ^3\G+-M_O* MZ'2<^)ZWF)RVA_,0/6RN?7P4+R^'71X5N_=3?KZADVM^W-X@__+M<"G)VVG7 MQ]UI>_WV?AGMBM,%7#P?CH?;S\KI<'#:;?YX/1?7[?,1YOU#S;8[\EV]<=R? M#KMK418OMS&XFV"B[IS7D_4$/#T][`\P`RW[X)J_/`Z_JDTV]8>3IX=*H/\> M\H^R\?>@?"L^TNMA_^?AG(/:L$YZ!9Z+XINF_K'7$!A/'.ND6H&_KX-]_K)] M/][^57QD^>'U[0;+/8<9Z8EM]C^CO-R!HN!F[,^UIUUQA`3@_\'IH$L#%-G^ MJ%X_#OO;V^-PNAC/E]Y4`7WPG)>WY*!=#@>[]_)6G/Z')&5

\)/,&%KNHFVMZV3P_7XF,`#R,L M97G9ZD=;;<"A+I@IE%U[P4"E:)NOVJ@R!78)5?[]:35_F'R'PMP92H`4F%E- M6=J4D"BZ#+7;B("&S`'7 M2LP&*:NJ`$;*6]8B5K,-<7S&LXV:!L)9+,E)DSSW/,%/)3]K\D<+;^ESMI8( ML"OT%T&3A0BU6UQ2I,#_K)-X%$)B4/U%",PKW=1L/ELN5J)F8VF3$/!IF)08 M%"8CH,W$D@2VMZ8D>@^8`=9=[=I(2#-EQ5$:I,RJ>:[7XED(:93RC0BH\YT) M*6.D*-B@6.WUS(Z:D!N]+3E14QJEJ!D!FEX7L*4/;.Q2G\7=/5(;"7W$;`*D MP#+Q9`0C)`9E&R%@2L>#?[ZHQUB:)`1\&B4E!D7)"&@SL92!_5TJ<__TT$9" M&5$;`5*PX5TQB1$P(TV?&=TBC1,P)LWY8* MNARE#/=WWLI*Z"#.C\!PNBJ$*91QQ(B=,LK!@T1/&&E;[U_%@4DC"AV&U7HG'*S3CC1`RA6HH,@C6G8*/G_7&:XY#\DHF"3OI*#MIE'4:V66G MV\W^RF!S:BLCSII`(F(0\VRMUTH\ ML:ECDEDF(_A1H7&Z6'+XHJ/NWC\JMCRWQ-$=&%)S1Q8)ATRA.48&P3E"ODNU M4D+(V+%*&/E\"V$*A=`E=T*G'*A6K$='[<,STGRN^GTI5EF)@E+BZ`@,J;.@='3=!5#.D3$R M!>7[B_7Z/V-5L44F//JTZ9P)`Z"PG] M-`L)$2RDZOBT)HG'(4BILQTE5#NG_L7T/8;=J' MO5BWP*>6M)ZNH(1,H5PC@Y@:6OK0']NZQHY-PLBG@5*F4*",D38CNX9TJ]E? M&FQ,;6G$?AKXS>Y5J;4X\T(SWGRVT`)+S9&$!FEVR9T`J1,@8Z2K2'3OV5\) M[%2;2CCML8\<7.[1PI^*%BDTA*82U`#;B6)W[-`31EKH*0^2<)E!VA*RB^*7 MFF._I3E6XH-`8$CF1T^X&B`_-!E"4POTBR;B&(L=>F)%\/V9;,!3QR2S3$;^ MPI_5:5N"Z!]G^M=&Q1:'D!(3"`RIZQ!B"BU@9!!<0'\*_>+*^0G4L4H8:=L- M\!AB"H7*&&DSLL41[7'W9X0)*[_2#@Q'?Q/+WWLKYQ-`S2*](A>*72AQH=2% M]*TJG2@D`>Y1";PEA;==3OGU-0_SX[$<[(IW?0-J`3]+,XJWLP*U"2M[@4=J M`]EBV(2'X&+69?N:_[6]OA[. MY>"8OT#:WEC?1KKBU2Y\[^<04``/,9```9````>&PO M=V]R:W-H965T9>ZOIB*4J5'DB?5I+B0,US9%V6>U/"S/"C5I23)KFF4GQ1M.C64 M/,G.,E,PRV?J,7)Z4;^^7E[3( M+R#QFIVR^K,1E:4\-@)S".CI\ MYI6R4D!IN]YE\`0T[5))]AOYNVK&JBXKVW63H'\R`9(=C#7;/X8GH@YF[ M3X=4*6049";:G"JEQ0DZ`/]+>49+`S*2_&@^K]FN/FYDW9C,%U-=!5QZ)57M M9512EM+WJB[R?QFDME),1&M%#.A]>QU"3S9>M(WALV\\T99S=6Y\H0M0S\US MP&>KHLTFZFSZ%8U5EPOJ0IN,V62FS1?+KV1#[7,*7SJ=IY.J,(,:OYVD3K;K MLKA*,(A`K+HD=$BJ)KU%YS3SI??^_ZP'SZG*=RK3B(&K%=3KQU975VOE`VHL M;1F+,6!(SQ@S'K$[A%84U76ZP*V-RC=Q.Z)KXK$`*R6JX8N!H`O<1'5MRLN& M0T:X<=01W8WC+G"3O351(-U]SJ&*!SG7H3H>CZXNQ;05GV)#YSMM,>0^PQI/ MV$/"F/.(,T0$$7=(B"+>$-&U6S8:;_TAHRWYO@0,@<3V):-K0F_"(2,0T0-" MN%'\`.F[PGFG_Y1WM!7UKJL5BP46?<`6`XX8<,6`)P9\,1"PP'WZEL*#AT-$ MUX2RBIY@XD?,;71S*9P)*1PO>TISJ6.!N]2)`4<,N&+`$P.^&`A8X.98*`8B M,1!W@?MBO0TN+@7P$OR)&8"V@C4WL@PK_1&+&[C@7G%D"5[71I38=C9 MW.7Y2G#:N;]L:`MA=G6YR\9"F!,]=GFD3GR4"%`B1(D()>(Q@O,'WGN)UU;"(.*,2/)LE'"800S>S93A7G8O;^L3\5WI8?J^R@1H$2($A%* MQ&,$9Q?=*XHKSQD,QO%A15N)=@FYM!@S9A=*."CAHH2'$CY*!(R8LSEBN5JH MXD@.48T()>(Q@C,--C,#T_`Q1EN)IHF[`\:LF@=5W1=AKK39Y1%/G7$!%Q7P M4,(?OT4P?CE$]2.4B,<(SB@5]A.<4^/#JL$%BW1A3V2U$"O&Y93]XZ=*NV7& MC'I"QL5E/$YF-G_4&_\))L!O%>)(A"/Q*,*;1[>2XMQHH#M$NG\7QYDNK`NL M%AHQR,81!T=<'/%PQ,>1`$?"%F&5J[%:X0LWPE7B480WD.XG10/QEYO*MJ'W MBT9=%U9N5@N-&LAT1A`'5W%QQ,,1'T<"'`E;A!FX>&P@>VB&/)P.XM$;\0;2 M_:QH(/ZB@S/9X0@4UO56"XVX8^.(@R,NCG@XXN-(@",ACD0X0L^\:7Z9QZJQ M@(7R;5O$#&1GVNR,,R?E@=CD=*JDM'BGY]5T_=U'V5FZIYEP'@`G,T+U(>LG,EG<@>'G$Z6<`JNF2']NQ'75R:D\/7HH;#]N;K$?ZX0N!T=#H! M>%\4=?>#WJ#_<\WV/P```/__`P!02P,$%``&``@````A`.8Y;Y^G`@``Q`8` M`!D```!X;"]W;W)K&ULC%7+;MLP$+P7Z#\0O$RK7+Z^]?MQ9(2ZUA;L$:W(J>/PM*KS<Z+`PMKX5B-M"=:.%+J8UB#I:F"FUG!"OZ3:H)DRBZ#!63+?4, MF3F'0Y>EY.)&\[T2K?,D1C3,@7];R\X>V10_ATXQ<[?O+KA6'5#L9"/=8T]* MB>+9UZK5ANT:R/LA3AD_+5_1*67%XXVP'`H*-$$R1R:N&S``3Z(D MG@PH"'O(:0+"LG!U3F>7P7P1S6*`DYVP[E8B)25\;YU6?STH[DUYKM[:#7-L MLS;Z0*#=@+8=P\,39T!\].09!I=OF01W2+)%EIPN*`%]"X6]W\2+Q3J\AVKP M)\RUQ\#S&3,@0G`S6`(;8TNGRW-41C`J8[G0RK4/C&62TS*SJ0QFGK[9C:,< M;H*ZCY-(EP._=^`QZ0@S'Q"31`%R?J((AB9!>L_U6[R4]J`SI"'1L30F/UO] MK\NXJ;3B7?;RN"IU)/D?Y^3JH(I^YE*FFT"@#_O@3N MFTKX2#(YQLOH=#8XDT?WYGTI!$^E?"3MKV9_]OW4\%=3"5.)3Z)I+.%ZCQ,A M@3LU1(=AM4UP_\MXFFU]D88/,$0Z5HGOS%2RM:01)5!&P0*Z9_P8\@NG.W`) MHT0[&!_]:PU_"P'7*@H`7&KMC@L0#H?_S^8?````__\#`%!+`P04``8`"``` M`"$`(?HJ4?<2``"$90``&0```'AL+W=O*/[>MAMW_^>%E,II<7V^>[ M_?WN^=O'RW__R_ZVOKPX'&^?[V\?]\_;CY=_;0^7__CTG__QX/EP_'X\OFZNIP][!]NCU,]B_;9RKYNG]]NCW2/U^_71U>7K>W]T.E MI\>KV72ZO'JZW3U?>@^;U_?XV'_]NKO;FOW=]Z?M\]$[>=T^WAZI_X>'W'NZ>X^[I]O7W[^__':W?WHA%U]VC[OC7X/3RXNGNTWW[7G_>OOED<;]9[&X MO0N^AW^`^Z?=W>O^L/]ZG)"[*]]1'//UU?45>?KTX7Y'(W!AOWC=?OUX^;G8 M]-?3RZM/'X8`_>]N^^.0_/_%X6'_HWG=W?_7[GE+T:9Y/.U<:E!$;O\D5NOFP/1[MS/B\O M[KX?CONG__-6!?OR7F;LA3Z#E^6D7$WG!37Z7B=S=D*?[*2XGLS695$NG9:IB2$2]!F:7TV*Q?1$]/K[D:?881KM\7X(+RTJ>)2U"?`6^/\LKGV9"VYO9X^^G#Z_[' M!:T%E$B'EUNWLA0;YS8DK`_4*85_EL&4NL[+9^?FXR6%CG+S0)?='Y]FQ>S# MU1]TJ=RQS0W:%-*B"A;NNG!NC0:U!E:#1H-6@TZ#/@%7%)93;.CR^3MBX]RX MV(11W020!$L%(EB$*D:#6@.K0:-!JT&G09\`$0A:`OZ.0#@WM*")))G+D=]X MFX*FY)1)I32I3B:GZ`"I@5@@#9`62`>D3XD($JUV?T>0G!NZ&&DJ3@&8%0L9 M@ALV>BM*)Y-3E(#40"R0!D@+I`/2IT1$B99S$:7\QAB6%6<]!",,XH;)XG0U M54QH7I*`J9PQIVJI45R@1!=IYQC116BWSP<2*Z:IQ?;*2/79J)>WQF7YZ<2/ZZ9&8)4#&;<4TFL2J1F01-8A:1!VB M7B`Y9J<^TC$//Y#S-IJ<98%E^JIC,TRRJ>=EG MIP72/I_I)TN'M)\>+9>G%*L*0`91C<@B:A"UB#I$O4!RS#0=8LQNGDJZ+,Z, MW553*PFC=(X\4G,4Q0S/T:EB.D=1;LO^.HTP8HZ\I*`\C=>\1[/Y"54%((.H M1F01-8A:1!VB7B`Y9K?_IV,>KJ4I7>UG)LGK!C%X1FF"GE`,?U'&2X0GB:WH M(XK7653[LL-N'T\[?*:??ML7_4R5P-"#J@!D$-6(+*(&48NH0]0+),?L-NET MS.%"&BE0"[_9BV!X1!F;QEX='"JNF.2U050CLH@:1"VB#E$OD(C/;)Q4&H%TB..2=5"K<$GZ M"S=8R0LWGF]DAYV"2)/X3#^]X$AS=08:I$)D$-6(+*(&48NH0]0+),?L),*( M,;.B2'84=V'29JBN3WV$B%9A*S*(:D0648.H1=0AZ@6281@G?F8H?AA1$V&` M%2*#J$9D$36(6D0=HEX@.6:G/-*I=VOVK]U7<+H%TB.V6F=-"W. MK((LC=(5P2,U]?%XZ!7-[&05IQY0C58648.H1=0AZ@6281BGXF:HXA@E!](* MD4%4([*(&D0MH@Y1+Y`Q=K,(SGUH'DF+58>WOJYZC1&)7K MN`$&='U"AM&20AQ/4G-UWJJC5<@&B[X:1&VLF+I79^XN6@7WO?`E(Z-5X7#^ M+(=;.<>'W=WO-WL:"<4C$[$Y?<4ZK':?YR@6&8F`>:LR#1A+RL)_6SO5WS'5 M[&;I'RUPWV/8X#FZ:1"UL>+P/?"TB#<=ACYWT2"&*>V@#-,X(3E'(68QZG&.:I&1B65))>#FH@J6*5A\+[F M$=5L-5\-F3*=+-5598,!B;6D,75D:K"Q-E8,,],%%!I3>K\/Y3]K2\91*]', MI41I<;J64&U2')P`+4E:)4/3-PF"5;Q)9QC-XZI5,UI,ASB6L\E4A)8AN M^^IXR(BR+/2O"BCF@F$D4LK[HNZ&BA:M&O35HE474/35!Y1)FW'B>([BF)%* M&WTD#E:Q4X:1ZUM,U,E*37$5 MK<(4&T0U(HNH0=0BZA#U`LDP./GX_J5WX=5F>H>5D9AZ;Y4@@U8U(HNH0=0B MZA#U`LDQCQ/&"Q3&C-*#0D!1X1M&9TY6T2HDB$5?#:(V5DR6A;G:=;MH%=SW MPI>,C);/OW2R6J"J9B0"YJW2DQ5;T<&)SS]J":NC01B,#9YCW!M$;:SXDY-5 M-`B>>^%&AFF<.EZ@.F:4GJR"5;+9,DI/5H@L5FP0M5BQ0]2+BG+,XV3L`F4L M(R5CE?ZL@E4:!N\KU1QL19K#S>=T,E?+K@T&%/JX0<]5/C786!LKAD3H`@J- MJ4-,'\I_UI:,XSBMNT"MRTB)%M6I*E@EHH41B98PM)H1;9,NCN6<'MN73ZS8 M6.G-0/INEK&U-E8,K76JM>GD6AV(^U@IWYH,Y3C-NT#-RTBEI))Q5;!*4Y(U M;T0U6W%*%I.5DI$V&,0Z#7INT:H+*)RL9FJ.^F`P>)8A&B>1%RB1&:ELTR>K M8!7GWS`2V>;=<[;IDU6LD)][?[+"EMI8,6;:6RWUL4*^)1'"EFEC;HD M*JZ8+!N&T9F3%5LY>1^7]X7.J.@K)$:#+;;1*O&ESW)=OD6]?D5?U*),HW%" MNT2AS8@>H`BCJ1`91#4BBZA!U"+J$/4"R3&/$]KN011U4X*1/&,ME,:MHE6( MC$%4([*(&D0MH@Y1+Y`,@U;5;]],=;N1#H-'R8&J8JL$&40U(HNH0=0BZA#U M`LDQCY/()4ID1NF1(:"H]0VC,V>L:!42Q**O!E$;*R9KPT)IUBY:!?>]\"4C MHX7T+YVQW,*JD\0C$3!&:<`\^OD9BSVGWUXQ2HYJ#:(V5DQCI21W%ZUBK-)> MREB-$\NTCT!0/$H/6L$J;J&&47K00F2Q8H.HQ8H=HEY4E&,>IVIINF','KF+ M,VZ.^D9_Q14I4<-$&$9"@K#0]=JSF)3ZH!7KI(VI66^PL396#.UW`87&ENI" MZX/!NTY:E*ZC1`QJW\'#V>^P@E545H91JGT9A9/6;+)6,;*QTIN1]-VD_`EA M:V/%@#K9VK*8+-2\];%2OC61DVYY':$'!W.I!QFIG-0GK6"5Y"2C-"<#\FFR MF%RK-+'!(+IIT'.+5EU`WG,Y44*C#^6#8QFA<8J95E=]U3)RZV-RU>J#5K"* MTV\8I;*F/%?(MR1".4\BT6$,(/:(D"_VK MV"I=Y1B)C/(5TZ^PT*I!7RU:=0'%&>H#RJ3-.(6\1(7,2*6-/F@%J]@IP^C, M08NM.).*R5+=>[#138AY@XVUT2I)!#ACZ<;T+90^NJ'&9/*,T]A+U-B,TH<# M$1E$-2*+J$'4(NH0]0+),6N-G3PN_/81PYVGE'H,*'F@/R)W<_`W==8UH9@4 M5ERP%C$_9%^=QGO_]TSTBS7HH$?TX'Q(M(JM$F00U8@LH@91BZA#U`LDQZS5 MJYN?Y?P=/SELM4N\?$;^QG"% MLH81A2/=7-0AIHI684\PB&I$%E&#J$74(>H%DA$:)TI6*$H8T58;!E@A,HAJ M1!91@ZA%U"'J!9)CUJ+D[:74_?Q>*1%&=-:/8_96=&8-R+"5.Y%%]5&J;P#J M:!4JVN!^\"6[/DZCK%"C,!)=]U:BZQZIKBMY5;,OLHI=3WW)KCLI\'YYM7+F M:G_P2'2=41IUCU37E?*HV;WH>NI+=ETK#[>,%&.?YE^A(&$D1N2MQ&1XY$ZJ M21ZIS;IF7V05)R/U)4>D=<692P#5Q,JC]*XE(WHE8NB!842GRX!J1%94%/U< MCQ,5@[E,&D;RKH[^R6\5K)*N,Z(S>!)U?1ZLV8I.?6Z'GBVOHW@=O@RVT0U% M0(XM)QYFR^$536]/QQK%`R-YQB[C2<<_@!VLDC,VH_36#",ZU;DQS6?ZIUA6 MU)%CTB)CV'#?-2;4&VN/U-2I`%?!*ITZ7S&]?<)6=/LDFK%/%U.HG M@FJ=$Q>C5X7!BTI9KS747&IAP163NZR&$3U*>;K:`J*!Q;5CJ?8@RU;R1DOY MLW&/DPQKE`R,TIM@`:6SZ"N*6604\]=R16\ELAM_RD1;`S*(:D0648.H M1=0AZ@628QZG1-:H1!C)<]A2G96K:!761H.H1F01-8A:1!VB7B`1!GIO]9BI M'\SEKL%H^&+!N_8OLO9O!'[:OG[;5MO'Q\/%W?Z[>TDUK?F?/IRP?X/VS6J^ M<8=%"A&4+*AD<*Y+ULN-NPPS==9K*AG.2%#GFDH&T:Y+2FK';PRZ9$DEI$DR M[2RI!W2/,U="/:"[:YF2U93&,QQ<=#NK&94,@E67S*D._1HZXVU!)?0%1*Z$ M7DKN-V3M;4'MT"\`,G5**J%'EG(E-#_T%$^F9$;1H==VY$I**AGV5=V#&<6- MWNF0J[.BDF'G@CH447H90*X.S2G]/CY34E`[]*ZN7`EYHQ=$Y4K(&[T:*5,R MHUC3"X1R)10W?_<0>DUQ\XNB+J&!9L?I4C?7!G4KVZN">D5O8,STJJ!>^35: MMUW0G-%[YK".6:TW[D"')71O8&.S)736HCJYOM%[\3]GLXE2@"&O&6GG<)[DPUO1255MH3N\U#@<[TVJR659/NVHK[1/0@< MZ0V-YR8[GHI*JFP)/6)&(\WV@.)69^O0TV4;FRVAA\PV[N$I[!O]Q&?C?KJ" M)?1+GXW['4^N9$$EN3KT(Q]*CUR)6=!X2"7GO%&&Y$OFQ<:]HR%39SZCDEQ" MTPL<**-S)?3&@(U[14#.&XTT6W)#X[G)CJ>BDBI;0C_`HI'FVC&+!97DHD._ MO=JXWQ1AWVYH/#?9\5144F5+Z.4:--)K[%Q MKXV@DJO314=_`^/E]MOVOV]?O^V>#Q>/VZ\D/Z;#=XRO_J]H^'\<^7#R97^D M/WXQG%,>Z*^=;.GM%%/WWN*O^_TQ_,,U&PO=V]R:W-H965T'X_KU]W<7OZY.5S^>O?WOWWZL=M_.WS= M;(X7I.'U<'OY]7A\6UY='1Z^;E[6A]'N;?-*+4^[_V MT\OS53(>SZ]>UMO72Z=AN3]'Q^[I:?NPR7G9+]Y7A]I_H>OV[># MU_;R<(ZZE_7^V_>W7QYV+V^DXO/V>7O\LU5Z>?'RL*R_O.[VZ\_/9/MN_P'J7[8/^]UA]W0;JYHHTW7UZW)(%UNT7^\W3[>7]9-DL MYI=7=Y]:!_UWN_EQB/[_XO!U]Z/<;Q__L7W=D+=IG>P*?-[MOEG1^M$BZGP% MO4V[`O_:7SQNGM;?GX__WOVH-MLO7X^TW#.RR!JV?/PSWQP>R*.D9I3,K*:' MW3--@/Y[\;*UH4$>6?]Q>YG0P-O'X]?;RW0^FBW&Z83$+SYO#D>SM2HO+QZ^ M'XZ[E_\YH0FK#U`Q917TUZL8/@^:<6L,_64EB\&VS%D' M_64=R6`=='&U\Z"_G0[OCQ-NO.%N])>[W8R2Z]EDUCKR1,<)A4T[H/V?;L0S M5_'*140;8/GZN+[[M-_]N*"KEM;\\+:V>\!D:17[T'(3Z8+MO5BC(+-:[JV: MV\O%Y06%T8$ND-_OTO'LT]7O%-0/++-"F8F4R+R$C6"K-M>@T,!H4&I0:5!K MT$3@BMS2^88NE[_"-U:-]8VW:N5!<%:B'.$E?)=<@T(#HT&I0:5!K4$3`>$( MNN3_"D=8->TF%`7)7%J^`3 M>W`-W%VL&MJ@*#R[H$C'U\I++'0J*I^XZIG:-?>ZVV:A*YO9.L2^0XN7@=AMC.=H4U8 M*N2\.:,T[%\%H_G4W2\DJ=JIC.@C;;)GZ<_99'NJJ\,AM73*P9E-6ZCC+%XZ MAYS/VXNO8*F4CH'(/RJA,UZ*^D=2(:&1MMJS4]LZF0W=%=P)3)>`OVA6$X?4 M6NJ\P4O%:^DZ3L,64+#4-$[1DCDLJ.M(07".W?8HC>W^8.]P)Z\PT"%:6&]S M-F$4KZ)#8A49!9L-=^R[ONSQ&<_SYW9M=PB+Z?.Y3$X+43)71V,V8:DPUYR1 MO?D('7%+<1VGB_;RFZ4+M?*&U;A+5H:D/7U/F?S;[NV]@RK>7]PA+FSFDSZL M3S8!E",J$!E$):(*48VH$4CX(M'YAEW^>=I>GJ/D^F*<[WN-ELO<:M!FV%Y94K0]\ZXV/[X(3 M/N6CV:<3M7NL6.CD?7"0\9=\CJA`9!"5B"I$-:)&(.D>G6>XA*LAG:B=<^6E M*):[:T9G,D'&NR)'5"`RB$I$%:(:42.0=)C-0`9)!DJBC(+.Y M(G4DJ>`&0`5*&40EH@I1C:@12+K!YA4#W.#2$+&A.137$1)`.:("D4%4(JH0 MU8@:@:3--D<98+-+:83-#I'-(?XA"<^23BHL/:`"I0RB$E&%J$;4""3=8+.8 M`6YP28]P@T.T*WD#LP10CJA`9!"5B"I$-:)&(&FS3K\^.+\QS4HPZSD>Z=LZXP7DYJSBJ<3!JM#1KTSMD1],E2,:W_[> M6-*/-E\\?\--.;V,Z@Z,9-TAU9F7EXKN:QG%-21&T[&[B4U&8^4B$SK%NXR2 M*G&T*G0,CG3&1*.I1*D)G?I'DZ[4Z>X'(=EEM7Y"J]0A%9*Z=.6EXI!T'45( M,G)1DHQT9!M6$_4I47.%4K5'7O.UVN,;+]!.4+K(9ID#HLV*JYW;(15MZA+( MR"C;<19'FT,BVASB]5?WIX9UR.I6"I$&(U6AHU_8FE'_2$WH<$Z4#4N.4TR. M&<5U-(_BD'(=:6[>BH*E:)?SR'@4I$K45:%4[5'0U7C4$S8V0QT0-BZA%9N] M0RIL0HG6%6=LG5>'C4,R"J#XQAW]^H[F:B,Q+!!%7XF#54$J"@0]6*T'6ZB8 M;((:6B=Y_0U+KZW5^OIS"$M%J1`4B@ZA$5"&J M$34"2??H%-:ZYR=*1?0C!D=LN(*P5.2E3CJ,-<4.`U0$3=ZM!E&)J$)4(VH$ MD@X;EO_:7W+4ED&0\@%B M4%>)J`H=PZ6:I&KKKX.45]\(7=(S-AF+/>-VD8&_K=K?-_2UPEE>^+D[8ZE9 M[#`G]7Z]@/O$#UN@FA)1%3J^4R\(`L%-/.=V@M)-PU+(*::0C.)Z@9<*F6#. M**X7(#+8L4148<<:42,Z2IMM'A>'QNF;,_H9%6*`DT.ZG+K?%Q)]5Y5QQ_BY M`D9Q)NV1OX77VZ[Q`K2&T6`JT2MQL"IT](%0>^0'4[?FC6]_;RSIQV$9Y!0S M2$8J%5>3RKQ4N#_(&44Y=,&(\@I[7 M;3RZ4<73)G3J'TVZ4F?,'X0DUGVG7/>5(:GK!5XJOC)=1Q&2C%R43$8+=7-D M6$W4IT3-%4K5'OEZ0:+6J/$">.,WTUGS:1>UXK)>P$A%FZX7>*DHVAC%T<:( MHTW7"T*'_K5O;S%+'*D*';M(.SE2$SKTCR2B;&:3UO,WOE9OX(N"D491L,2[1DFVHRP MF$U6^7[6Z/[@U#C+^^LL1%8@,HA)1A:A& MU`@D/6_SN/@"/J]R0->FS6!H'8)[X"$3%CI9.0@RP3U.=U1,*%#*("H158AJ M1(U`TCTZF?W)RH&]U%W6'SD,'C+Q4K0E=FY5QUD69(+#6'DH)A0H91"5B"I$ M-:)&(.FP89DPY40Z$V8D*P=3=>>6!:G@!JNZD0"F#J$14(:H1-0))-]AD M+KZL/MAM7.X7WT73[;/U3%PY0)0C*A`91"6B"E&-J!%(VFQSO`$VNY10V.P0 M#>$7-:,[8.N&^$:8T0>5@R#E=1G452*J0L=P$293M?770&9 MGZH6`T?N5@R#@C3&HID14A8ZQK]2-9!VDO/I&Z)*^&I91 MDE%Z`V$4EP^\5$@,W8O@8%7HZ,>O/?*#18\AMVH:+_#> M8-*1P_)(>D,&'.F0/>`B1^I#F#O2_N\-R1E%Z73!R-WI_;,5E>LN(7I'IU@=1 MCJA`9!"5B"I$-:)&(&FSSE[M^ISU@M<"$UF/HO4)J%T?=5CEOEFN3SARY5R' M99T+S#H9B?5Q4A'*4:I`9!"5B"I$-:)&(&FS3A#M^B2S$1UI'T0GIHH+1O'R M=*A='I6DY+Z'7)YPWLNIVI3G_+-QX3*D^'::4;06&:(<48'(("H158AJ1(U`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`````__\#`%!+`P04``8`"````"$`=K_A&TT&``!?&``` M&0```'AL+W=OZBOIXW]UY?DT]*V^J&X'HI+>ZTV]O>JMS]O M?_UE_=9V+_VYJ@8+%*[]QCX/PRUTG+X\5TW13]I;=84[Q[9KB@%^=B>GOW55 M<:"#FHLS==VYTQ3UU68*8?<>C?9XK,LJ:LO7IKH.3*2K+L4`\^_/]:U'M:9\ MCUQ3="^OMT]EV]Q`XKF^U,-W*FI;31GFIVO;%<\7\/N;%Q0E:M,?AGQ3EUW; MM\=A`G(.FZCI\\I9.:"T71]J\("$W>JJX\9^\L+<6]G.=DT#]'==O?72_ZW^ MW+ZE77WXK;Y6$&U8)[("SVW[0DSS`T$PV#%&)W0%_NBL0W4L7B_#G^U;5M6G M\P#+/0./B&/AX7M4]25$%&0FTQE1*ML+3`#^M9J:I`9$I/A&KV_U83AO;'\^ MF2UO,@"K"EZ,/AR@>N[D7-82M`%S0JAF*[ M[MHW"W8)Q+B_%63/>2&,Q)5D3Q1K^U]+"VM*1)Z(RL:&R<.J]9"/7[>^ZZ^= MKY!#);?9F3:>:K%'"Y(P1#;20:R#1`>I#C(=Y!)P(`@B$I!'/R$21(5$`GW8 M(1A#,]7<1@L<$ND@UD&B@U0'F0YR"2AN^S_%;:("NUA*`&^I^;EC-A[$7V3) M3`N%,!&Q,$ALD,0@J4$R@^0R42("Q>`G)`)1@4T%81?>^FZ@^KOC1H]"(DQ$ M2`P2&R0Q2&J0S""Y3)200&G30S+W)PO`]TL^U@4RC@8!)[_C9"XVR-X@$2=R M.8$#7H1.F=EG M,=UGP[DN7W8MK!44BSLQ\>'496GA#(FB5*A;WT8G$ MT$B%#6D`3(U,W$>-7-90`N%!3RI'XH['T.:AR]1:]9DCGS:R-#![$T6(6&=) M>HX8T5@2$D2C5HIH')@A&@?FB%@W+3<;Y!24_?NAE:8BFMM$%PYB?]SZW$I" M$4B4F2DV4F2CGB$U"76G2F+Q[OY/S5,MNCB3_]B:*$`4B M,+&)$A.E)LI,E".B<5?](WW&^_WC7C.]Y;J[01OC[HIHH>Z&5HQ75][;(ZWJ:X:,-*%O#]@O&>1`\:0 M#U56!&PQM@^\&'`C^I9,4>2)<9CO,4H)V/"0X955)$X^&;J2K3I3:7 M'(=0%346I!5Z?RR(M58/&-*29Z$N\IZ\NY.J,2YRA(B]OK/*R*W@Y!9QG;I& MPAA:J:F5(6+9822'K*$&A+1,4D!^K&ZRO@OV+"[TSF-(S1GM(-^CT;C:$4?! M>`[$B*9T0\U\(V?XHT:5%(>,*ADBIK)<:$N6\_O^G9PAG944HO\Y.ED?IL2" M(<@9#,_>XTA.$(:"\:2)N54PUMC$')BBU3@P0S0.S)6!:@J0[DGR[\=2@+5@ MBML,*2DP=5?Z5N%6X^I%'D,!)*VT+[2A#*+^T-RLG=?E/NOE@7I\22-W8D@]@3V;=$]NFI MJ;I3M:\NE]XJVU?RG1"FN%T+S#YB[H(07DA!0.?S$%Z<3)XN0GC-N,.7(;3@ M=_@JA([4Y/DBA+[4Y-`UA:2U,>_`Y]8G6DOTF9+/L'?L=],0/L>8.CL_A*\2 M)G\*PB?V.5=_P"+VM2W6$977IJTO'/A"S'P-/J>=V@`^[-+O.\"&_@M;; MG4"B']MVP!_D`>)/`]M_`0``__\#`%!+`P04``8`"````"$`?4OPZ#,+```. M.```&0```'AL+W=O+^%)$`I:GM5XB2V=%=:K>[N/C,T;=$44@$SG?GV>QS;L8__N12Z\S),?SX^ M\3G'=OXQX?;W']O7P?=Z?]@TN[MA#NK=NGG<[)[OAO_^L_QM/AP[+\>7NKZ."`/N\/=\.5X?%N,1H?U2[U=':Z: MMWI'+4_-?KLZTI_[Y]'A;5^O'MM.V]=1.A[/1MO59C-F\'YVV[/L?==K7_^NWMMW6S?2,77S:OF^//UNEP ML%TOU/.NV:^^O%+[3>/?VQV-66;ZJ0K M\*5IOFI3]:@1=1Y![[*MP#_W@\?Z:?7M]?BOYEW6F^>7(Y5[2A'IP!://T5] M6%-&RULTK#8#^'6PW>FI01E8_VL_WS>/QY6Z8S:ZFU^,L(?/!E_IP M+#?:Y7"P_G8X-MO_&J,VHLY):IW09X^3$QTSVY$^7JS=F+8U[8C?;IA7Z7S:3*=Z72? MZ$CKM1TJ?=J.-R?MJ;6UI\^S1C@R\Z*=9F)U7-W?[IOW`:U=JOSA;:5W@F1! MSMS\,D/M9MQ?33B::=K)@_9R-Z2H:2X=:)5\OT_FR>WH.\WLM;59]MAPB]Q9 MZ&FLW8H8%#$H8U#%0,9`!6!$2>@R0;/[%V1">]&9<#$L'?"I2:.PG87K(F)0 MQ*",014#&0,5`!8VK_'P+)GY\#H2Y'8:;=#" M&M%'4(!95R4V5*TO@]O&Z1%J8SY"0\("`!%`"B`ED`J(!*)"PJ*B&V`8E2Y` M.KVBB7GA[5#[X0$;0@&'N;WN[O+.R"T<`:0`4@*I@$@@*B0L!PEIU#`) MITO;6O-0+0J+BT@@*A"5B"I$$I%BB,>G[__!U-5%OB9M>7&1]8TLJK)%49GG M49F]55=G1`6B$E&%2")2#/%L:%D09..#:AL103G[_)!?+K:L^S*/WV<+W&UIVBF&Q25^R8N=V?EDB820`6B$E&% M2")2#/%TZ#M\D(X/RFWU0%AN@UBY`8D$4(&H1%0ADH@40SP^+2+.C\]*CC`^ M@WA);\9Q23LK7U)`A7Y.YTNC1%0ADH@40SQD+2?.#]F(#UHP;N3+)-0CYD:$ M2"`J$)6(*D02D6*(QZ=E21#?Y_=KJV_"T`V*JAWIHCSIK%S.!*("48FH0B01 M*89X-K1V";+QP0(V2H=5.Q0_MMJ`1`*H0%0BJA!)1(HA'I_6)4%\NMK97)]M M7:K!$J-P6.R=Z`E4V$WTF)K;CL$6)Q`5B$I$%2*)2#'$TI%>),9::WZ+LB@( M)DFL-;^#,?<;VQ'*H"O==?1H0*M2D05 M(HE(,<1S<9%Z2E$]610$DR,2B`I$):(*D42D&.+Q:>T2U?IS*]N((#;-.UT4 M5ML?&-EJ=U:NM"(%5"`J$56()"+%$,^&EC5!-CY8V48$L9!!%^4I((&H0%0B MJA!)1(HA'E^/>OI&JM MN7BR*%S;B`2B`E&)J$(D$2F&>'R1>`K.-DY/[`QUE$.!CD(D'*+U&]S+_?D6 M']Y%HBE#T621OE$'5XN/5[R5FUX"48&H1%0ADH@40SSD'AUE3YL^J`CJILRB ML"*`A+,**T*O:'3G%7QX%PF;#(6-15/_")TC$H@*1"6B"I%$I!CB\47"YH.< MHW[)#)K,.V62(Q(.T;[6S^^BOG2SG4 M^N)9N$C29"AI+&)9,%8!$LZ*CSQZF"Z\E1MYZ5"8!>O^I"_I.MYTU5$.]61! M:XS@5J\WQV3:'OP>7S;KK\M&@][OUC)Z@:'-^T-FA$JH`"P*,I$C$A9-Q^V[ M$#0YHN>=PAOXO)B+!9XK;Z5?J4`WTALX-\HBXX9/C(O43X;JQR*Z([FKY8B$ M0^8=(OT>1^&0WS=*A[RORB'?43KD.RJ'S'M3X0L<&4V?_[_DVDDD`PRBK=:' M#4BT5S>7R1\CF]T4]0[EBD-]&@6/&#JK/RMV#A$.\8/?,4 MSNK:O@K5W8Y-Q5VS]ULY=-*O=%;&;Q9=5KGFUB]/V$5:;():S"*]^+J$77N9 MT<:5.R._00N'_&9?6$35;=\3FT0WSM)U\5XJA[P7R;VD\V@LRG5IO?!<1"+M M@\F#RFQB4#1YXBD$@6?NI6.4&U:!&?,Y%`R)V1K[:PB&:SVQ`+A])VSDPSF#/FZK0CNBZ5 MZ^*]2(>,E_EU5#)EVXT7GB(M#`,U\<&6V+'REGYCM(AWU&QCCR^2#-^;@J@E)P8Q*9`.HX?X9R5KYZP2(^XVV_2 M<32G"VMD3'E>MRTK%T5G8#3VZB(2OFF:?R`^'Y9_/V5\*3CBF= M\IR@\K2(OKAPDR-')!`5B$I$%2*)2#'$XX[4Y=FG$:148;58Y)=&[JP\$@ZQ MO3/Q-P(^/"V\SE_!1J:%PG]B4'@8A$@@*A"5B"I$$I%BB,5'CQHLOK/3WW;D MFY5#/M>Y1WX])M-H50AGQ2OB-VL^XHM$G/Z"(MI3+6HW../9_(S"O-^^K??/ M=5Z_OAX&Z^:;_HD$;>_WMQTVO]]89NE"'^C0DH*6";6TSN.6R?5"+X2>/I,; M:FFWL;A/.EWHKR%Z^J0S:FE3#7WH.G28W==G3BVM&H(^-`(Z$NWIDXTIGO:I M*>Z3D#?Z2KZG3T+>Z-OIGI:4O-'WNGTME%'ZJK&O):.6]A85CR"E7-,75CU] M$O)FEF'<)R%O]*937Q_R1N\(];50%>A5FKX6J@*]A-+70E6@%S)Z6N@RO5*,V]6:8D]^8XH1S3BXP]5T[H9T?T4A^VT('20A\7];7,J*5O7'3,0"U] M$=(I$\V9OA9ZW*4^?:.F7T0]]%9?#[EG7$L]7?HXE;>ON@^3Q8-Y?(XG!`UV MV3M8.L1;Z%,:3`J=Y2WT25U?RXQ:^M)%ASO4TN>-#O@6I6D9=8.C7V.]K9[K M?ZSVSYO=8?!:/]%6-&X/HO;F]USFCZ/5!5^:(_T.JY4(+_2[NYK.3\;Z[=2G MICFZ/VBXH^Z7?/?_`P``__\#`%!+`P04``8`"````"$`V[_=]8\$``#=#P`` M&0```'AL+W=OYYXGTR(I$#/B)E3"RYU61U/"S.GCB5+%D)R<5 MN1?Z_M@KDJQT%<.\NH>#[_=9RF*>G@M6UHJD8GE2@WYQS$ZB82O2>^B*I'HZ MGSZGO#@!Q6.69_6K)'6=(IU_/92\2AYSV/=+,$K2AEO^Z-$765IQP??U`.@\ M);2_YYDW\X!IM=AEL`.TW:G8?NFN@WD<3%UOM9`&_Y; M5C)P&_*$&7CD_`E#O^X0@LE>;_:#S,"/RMFQ?7+.ZY_\\@_+#L<:TAW!CG!C M\]UKS$0*C@+-((R0*>4Y"("_3I%A:8`CR8M\7K)=?5RZX6P03J,@&D.\\\A$ M_9`AI^ND9U'SXK>*"C278@DU"SPURW0P"J/)-$"2&Q.'>B(\F^5!J%G^QLR1 MG@E//7,X'D03?RB7O*W;4R9(3^.D3E:+BE\<*%38I3@E6/;!'(@;,Y4,8^^? MW`5;D62-+$MWXCK@FX"2>%Z%LV#A/4,:4QVSZ<=T(K9-!.8,:6,+\$"O$0VF M?X!H9$'1S7*;!K!V0?>P;2*:*;$%$(60W0]0B"Q+%_Y:MH94TD;%!&"5"8IH MR-:$&-DV0G1#"7R`;F2!@@)SC*9P-J2J-CKHEG`38H3;"!$.+YTM_'HS:,H5 M@Z6^AG>C$6KUB"K>ZB#08&VK+6*B9_P>/1A,]2@D')GBW/:0V$;(VO`>VE[( M=WHDN^$?FF3C"TZD.C0R;G48I#4AB%H3U(NK@^!A.=66)5&+Y[+5@6YG#H.I M0H6,5:?'KK'M(;&-D+5G=&UT:@J'`23ZM@R<1V5HQ#+*(-@.NP;I06K0V-0; M$1G`$7F_0S*::M-0%+99[$,Q@:@`[,-6BNXO*&Q+':,:R'*JA>3)85S0AX#F MH%Y-3!25B@W9DGH[C=BANO(TY,N/$*E@VX196$PQJ@&[JZ4![0JC`135>T]5 MW:;;O&T"!86T44V-&5JPB6H:7-Q.!(C*Q9YJR7W#,MV!;4T:LNS9!GTLIAC5 M@*W5TB`K+()=O"%&=V1;C(;L\C)0VXV"J-/<8_R$Q%J@938SSE*]V'LMO6_( M5)T:2J9)QR;0S5M]5,JVU8=B`E$!(-,6@(9-X&OP_36&1)UVH2!28T/?-T[H M&C-1S:9B]`ZX8&*OQK`#W^^7ZM?$+P7)\U`9H>X'ZENV8-6!;5F>"R?E9_SV MAUI;+0RL+B;P\L#-1(KKC8Q@1)+W1L8P(HNI-S*!$?GUV!F!"]!:IKJ#;_!B MA-9T\7`.WY%7<)![3>UZ-%^K"U:7"'9Q=1.PAZM;F,[A:+RR<."#4MD`NRL$ MH%7EQ3-#<+DZ)0?V/:D.62FN9^E'S$R0&;EB\AEN5_/<( MUV@&9[:/E;OGO&Y^8`&9B_GJ?P```/__`P!02P,$%``&``@````A`,O,5%K( M$P``K64``!D```!X;"]W;W)K&ULK)U)\X4!4FT(@D9096J_GU[9(3#(_QE001'EU+I M2W\/D;%E>.2BM__X\^'^XH_=T^%N__CN[S=?[I[_/+N\E__S'Y; M7UX/]W<[Q]W[R[_VATN__'^O__K[8_]T^^'K[O=\P4Y/![>77Y]?OZV MO;HZW'[=/=P_!M/+BX?;;?GESOO/Z?SFEKV'OX#]P]WM MT_ZP__S\ANRN;$'QG#=7FRMR>O_VTQV=@:GVBZ?=YW>7'Z;;?AE=7KU_.U30 MO^]V/P[>_U\QN_OR]9F:>T%G9$YL^^FO9'>XI1HEFS?1PCC=[N^I`/3? MBX<[TS6H1F[^?'<9T0_??7K^^NYRMGRS6$UF4PJ_^+@[/&=WQO+RXO;[X7G_ M\'\V:.JLK,G,F="?SB1Z,X\6J_4Y)G-G0G^RR?DEH3(/IT-_.I/UF]5TLIFM M7GXV*^=!?SJ/Z9OU8C%?KL\PH?$U%(3^?'5!IM0;!A/S/Z\ORI3;V/S/ZPO# MC3R55GY%O4RYFCBX:5A@7.@*>&/]]%R\?;J#QK&MR[F M&F.F843,$6;,&MM$@U2#3(-<@T*#4H-*@UJ#1H-6@TZ#W@-75-?'"J=9YU=4 MN+$Q%`T'MTD"% MVIW15#)^;>#>:U1T%0AZ[S*LO6L;8^:38Q=7'3P^AAQK&$@*)`.2`RF`E$`J M(#60!D@+I`/2^R2H;9K/H+;-)'+FY&%L:/ZA-CU6;;1?]X<^W-01),-^@N?TV/'1(=%M,1O92`)D!1(!B0'4@`I@51` M:B`-D!9(!Z3W25"%F[.JT$2'56C):B:M#"0Y$J])5Y-CDP[+Q/08Q%-4!B0' M4@`I@51'XO]\%/Y\?0SBGV^`M$`Z(+U/@HHVR5#06>TJ_8U)SIZ_WMW^?KVG M#D^7QI%./*/5N%NC&Y>P!09C6D9Z38`H<6CA7WNCE1I\J41Q-62(@Q"Q"2;B: MVT1K,IV''3*5`*Z%S*'9_#C86U6J53W00L!2EQ4 M.&(FJF)2B6+[#%&.J$!4(JH0U8@:1"VB#E'OD*V)L/)-PN!7_LBT1%MMQWG) MY1=^+5L4U#*@Q&S+F+:07I0BRA#EB`I$):(*48VH0=0BZA#UC$;ZL\D!SJA2 MES+X56K1S%PRCGLT*S7D8[-%9:I45EX)HT`X4>EQRE$KM_FCC#,^+L8YHY/& M!4+%4BXJ&CXMQR^BD<<=1SGBFAGW/QP?C<."0 M\3FM;,+5!<2B&:W9O%96)8A-CFY:>7./]=+90NQ`]:P:;L&E, MUNQ?>%R^Z+>216K\Z(V^J8N2WI8PDMZ6.D3CQQN+$W5B M&0O%*VH6FR[.36=L7AJ,,8N",1;I*T8\=5'2(Q.'EK*?GC):V]EOH>:M M#%UREHA+P.J0]+'$H:6@U*'5<#]XF*(S%.8H+%!8HK!"88W"!H4M M"CL4]H$PJ-+HE^3S@TMX^7=(#0`U)<<JB@<\6:D\XU1UGG:#I7S@TZMZPYZ=QQE'6>S2-U`>W% M62IUNI%%1]@GZ,>"8:8SUG_NOU%C_^R:1AN2>DWH$/UQ''Z($D0IH@Q1CJA` M5"*J$-6(&D0MH@Y1'Z"PJO7FP.D9+<)=`$8R@F)!7F,OU,H[X2A:0!S'V4J6 M%V$Q37K[\HDWLMFP/_$Z1#4A+6^C/)1@5(HH0Y0C*A"5B"I$-:(&48NH0]0' M**S2\])H3N3,:)$D#1S!-O6$L7-DR'*$16(2D25(+\0:LJN)8H+ MT2!J$76(^@"%%6^R/+\OZ]GM13O89DFOV\.BH#T`)4X8[L?!#K9$<55DB')$ M!:+2(:]U!Z:Y@W&X/XHH<>CO M=[`E@&LA8QO9[.EZ22` M;7JVP1V_R.28__\18S/5X*+@DE>I@'CXK:#1$H?"$0,[V!+%9Y0ARA$5B$I$ M%:(:48.H1=0AZAT:V<&.=(;ZDQ4"IJ*#0U"E,:*$D?2B%%&&*$=4("H158AJ M1`VB%E&'J&$R8U+2=UV6'@O M+&,/L)B\.J3VWB1=&C8`8HZ2;8*$D>POI`ZYO6MU%AD+ MQ"-G)!Y%Z`$9*2O$I&(D)G5HHDZF88%XM(S$HPL](M76/2L&D[!-QG+*%VV- MSC"-="@8?M-(;<3''"4=+V$DV[TI(]O+YFH-E/%A,%6,Q*MFY`JTAH:R]>'=%VM9(BX=HY,EZCEJ9`SIQ/15J[(9YJL.!4,+]D4Y M2#ICXM!<$LB4D=WU^&VV4?LI&=KDK!&;PB%Z@L4LEJ;+I1JC)=I4:%,SJ*FZ3ZP"5DZ+39T"N,0#2Q>1,6,I-,F#LUE MV98RDM5#AL*A_@)ZLV3/CI MDCC4LDQ5L2!9;T\7:C`D'!5<+->R%`C+:9)6/QO^23E-N%I=6A0T/:!D!BA% ME"'*$16(2D05HAI1@ZA%U"'J`Q16Z7DYKIDT=95:9+9;):]:JPW&V`DIBB]O M":(4488H1U0@*A%5B&I$#:(648>H#U!8R^>EO?1(#M2R14''!90XH1>5(LH0 MY8@*1"6B"E&-J$'4(NH0]0$*JM0\4''&7#"$AW.!0W.YPL>,).U*&%%E2_>& M37R)XNZ=((2J+\3B%7K6&3HI8H M+D2#J$74(>H=LH4(V^.7I(MS3!<=HLT>+G[,R&\/*]QL[!,R^!BZTU``VV0. MK62UD$O4^+9Y(0%L4SI$NXV,*HGZFTU\"6!-XY!7FE:BQDO320#;]`[9TH0M MI)-#O9)]T6TOROE@Q%@4M)!#4B>)$X8C!C;Q)8K/*$.4(RH0E8@J1#6B!E&+ MJ$/4.S16^3J-/+UFG&.^Z%!0RRZ%E$>2$A>UDH>M4D290[3YP[6<8U2!J$1A MA5$UH@:%+49UB'H6VL]P^"^OFP3XG$LO9F"#`[V[0DM'N:BN5=89NRAONRT1 M(==?RLB?7^PO>L*E;"09FT1 MPDTICK)/V:D<\U1UGD9P9XL.K>L M.>G<<10_<[S0KZSU@778`\Y+=VFY!8/*(F^XQ"XJ&%0N2G9S4Q>UED5/AL*< MHT18,!)AB<**HT18,Q)A@\*6HT38,1)A'PC#*C5IJ#^H?G*!M5EK,'HL4E<# M>1[.WO*CO,"T13!ZCD*>S5(7M9()+D-ASE$R-Q>,1%BBL.(H$=:,1-B@L.4H M$7:,1-@'PJ"6S>HMJ&4S=;WH)MZ@##-?AZ@/>[..'OJQB_*[M0B/%[ M([TIG:%-SAJ9QPM&E/!Y$Z&ZCU.B5\5"\:H9N2+-)FIAT:!-RQJQZ1B=+%(? M>(5-9I+7EP\,\Y"-VEISB`8&5W?LD#\*,"IE)%TK0V'.46)?,!)AB<**HT18 M,Q)A@\*6HT38,1)A'PC#*OTEN>X"_O:Q6PQ5TN##)USUIQT+CC*.H]=E=H86S4I&A1,-@L"@:;16OIKJGSVLC4D3GD M"7.'/&&!PA*%%0IK%#8H;%'8H;`/A&%5GYPE"_T,A3E'25L4C$18HK#B*!'6C$38H+#E*!%VC$38!\*PEL]+IA>83#L4 M=%Q(@!.,2AE)7\X<"CJN]?+L"Q26**PX2B;[FI'\8H/"EJ-$V#$281\(PRK5 MF?.P5C)STHN_DK+`;-JA3;`S:#5;JPM7B585Z\2J9L2EFB[H`VQJ&=Z@5H8N5(M M%YO)7)]@'UB%+4B-%E[FN\#,UR$UFZO^$;NH8`!` MRIRRETR1&0ISCI*YM6`DPA*%%4>)L&8DP@:%+4>)L&,DPCX0AK5L,E)_S?_R M-,WFLGY>O+!([2JIM67LHH)NC7FQB]K8)WRBZ9*^ZZL>;D:CW"%O%!6,Z">\ M!:^ZII?H5;%09O7:(5>HZ60=P8<#T*A%HX[1R4+U@5?0;$N=79^>;X;P<+YQ MR%NQQ`[Y(P&C4D;2O3(4YAPE_;)@),(2A15'B;!F),(&A2U'B;!C),(^$(95 MJK-?,Q)FFS-?[U]B4NP0]4FO`^I=A]A%^:/"H8UWAX:1S42B632))KH+9FB5 MLTZL"D8NJ1F_#J-5Q3JQJAFY4D71'B=O_=?,6=%M#OWQZQ M_<3\=33;FM<\:7-$'YDMMN9YM[$C*SHRU!!HUG1DF)W@R(:.#$M/=80^81%7BT5/0#(_S#?/O!?D1?&\VW]$'8D=.C\QX][25]C7\L MGLYY])0C.@/[&)'Z97HRA'YZ[.22>;1-Z2XXEHKN[F_-#7P\0C?LM_7H$;H' MOS6WV5%#-[3IR%AU75/9KD?+1D_V;./1(_2`#Y5MF.74F=*C)G1D[$SI$9VM M>2P$RT9/ZE#9QMSHF1$Z,J:A%V:IKL=:C=Z0W*;T*1BHZ8 M5Q7Q"+V:N#5O'^(1>L^/CHP."BK;]6C9Z(7G;3QZA-Y[IK*-]4YZ`Y>.C)TI MO;F\-6_+8MGH!68JVY@;O4I+1\8T/8U7^FXCFM%'$[?FNXAXA+Z#N#6?.L0C M]&G#K?EZ(1ZAKQ5NS0<)\0A]^H^.C'7>Z\WV>K1H\68;CQY(-EOZ2.G8;U#' M'564FZWY=B9*JLV6/C@ZPJ?4:ZWBZC@(Z!_+^';S9=?>/'VY>SQ79?I/BX?Z9_)H-61?3/!]`_B[*C3U1-WM#>P>?]_IG_0C]] M=?R'5M[_1P````#__P,`4$L#!!0`!@`(````(0"P;]^==@(``.\%```9```` M>&PO=V]R:W-H965T$V0`,419)/S6C>0T4>P]&;Y_MWBH,V#K0`<08;&9K1R MKDT9LZ("Q6VD6VCP3:&-X@Z/IF2V-<#S[I*JV2B.9TQQV=#`D)I+.'112`%K M+78*&A=(#-3V)2XA$YQ\[!KKX16+5)L92W=8T=*B1+I7=EHP[SBA; M+KKZ_)1PL(/_Q%;Z\,G(_(ML`(N-;?(-V&K]X*%WN0_A979V>],UX*LA.11\ M5[MO^O`99%DY[/84$_)YI?GC&JS`@B)--)IZ)J%K-(!/HJ2?#"P(/V9TA,(R M=U5&Q[-H.H_'"<+)%JS;2$])B=A9I]6O`$HZ4X&KL[;FCB\71A\(MAO1MN5^ M>)(4B4^>`D/O\D\FT9TG67F6C,XI07V+A=TOQW&R8'NLAGC"W`8,/GO,,X*A MF]X2VAA:>KL\)V4/]LJ^7-[*;0@,94:]D1^BH_1?"G=Y7, M9V^GB_1#S;_WTX-?2H7(I)OB;DS"@H4I5F!*^`AU;8G0.[\\(QR_/MKO]6KD M[[^.3])5M^^L?X'[UO(2[KDI96-)#052QM$<$S5A8\/!Z19=XM9IAYO6_:WP MPPHX@7&$X$)K=SJ@,.L_U&UL(*($`2B@``$````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````G)%!3\,@&(;O)OZ'AGL+;1==2,L2-3NY MQ,09C3>$;QNQ4`)HMW\O[;HZHR>/Y'UY>+Z/:K'73?()SJO6U"C/"$K`B%8J MLZW1TWJ9SE'B`S>2-ZV!&AW`HP6[O*B$I:)U\.!:"RXH\$DD&4^%K=$N!$LQ M]F('FOLL-DP,-ZW3/,2CVV++Q3O?`BX(N<(:`I<\<-P#4SL1T8B48D+:#]<, M`"DP-*#!!(_S+,??W0!.^S\O#,E94ZMPL'&F4?><+<4QG-I[KZ9BUW595PX: MT3_'+ZO[QV'45)E^5P(0Z_?37NW7B)6D'R6DGF:S]8%H>2:%N5KA4^M\3Z;@'H4^#?Q!&"# M]\\_9U\```#__P,`4$L#!!0`!@`(````(0!+>DJ;5JJH(E0M.8BV!;`S9H^6"TU@E!MEN MU/;7KX'FJ^O-JKG9GGDS;][@,=[]Z[KL;9A4O!)#Y^JR[_28R*N"BZ>ADZ6C MBUNGIS05!2TKP8;.&U/.O?_]FS>35Q[H*Y+GE-MJO2G/)>5JI:Z!U]S5GKNH=$S[##+7R37;W[?9G7LV43H MF!C#,<>4ZY*I9#FC4MLHF\[O.;`PQ M03'!:1+\/`-R9<4<%;_+V1(#>&*%C&$,YR"RVC`:QVB$`A"G!`1!DL4IBL=D M9O0-$+1"LAAD(6JT1W$*YVA*1B@V/4`@,K5:(:T$DR0*X1R3$)I\R.XX`FA. M%B#*()E"@+-Y*[L])HQ@T+#8B="V)YF96E-DAV0/&/[*3"<)7#3]M'N=E,3> M%5N!)*6/YF)8<]CK/(7`)\NUL_IH/`F9IKQ4)#5#\H6:2;6[2LWDZ.ZAM8(/ MX)4[+>P[F^HP\-W;,Y\]VJUC;T$/(T93^ M-)4>[^U??_````__\#`%!+`0(M`!0`!@`(````(0"M M[M-FQ@$``/L2```3``````````````````````!;0V]N=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A`+55,"/U````3`(```L````````````````` M_P,``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`&+@!5.R`0``PA$``!H` M````````````````)0<``'AL+U]R96QS+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`,H!L1UF`P``'@H``!D`````````````````[!P` M`'AL+W=O&PO=V]R:W-H965T=#*4@P``'AC```9```````````` M`````+4I``!X;"]W;W)K&UL4$L!`BT`%``&``@` M```A`)`A)AY2`P``*`H``!D`````````````````/C8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`).:SK3.!``` ML!(``!@`````````````````OD,``'AL+W=O&PORYNQU$-``#3A```#0````````````````#8 M?@``>&PO&UL4$L!`BT`%``& M``@````A`('4FAZ/`P``4PP``!@`````````````````&9,``'AL+W=O&UL4$L! M`BT`%``&``@````A`,%'33=P$P```V(``!D`````````````````#YL``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&JQ"#JB!0``)A8``!@````````````````` M2K(``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`$:F"]SO"```&2@``!@`````````````````X,```'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,O,5%K($P``K64``!D` M````````````````[0T!`'AL+W=O&PO M=V]R:W-H965T&UL4$L%!@`````E`"4`]0D``/`J`0`````` ` end XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
SELECTED STATEMENTS OF OPERATIONS DATA (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Selected Statements Of Operations Data [Line Items]        
Payroll, office and related $ 263 $ 276 $ 560 $ 534
Legal and professional fees 242 336 453 469
Stock-based compensation 531 280 877 1,358
Issuance of Common Stock and warrants to service provider 0 618 0 1,011
Other 256 6 256 48
Total General and administrative $ 1,292 $ 1,516 $ 2,146 $ 3,420
ZIP 15 0001144204-14-050135-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-14-050135-xbrl.zip M4$L#!!0````(`$V`#D69R&U3=7@+``$$)0X```0Y`0``[%U[<^)(DO__(NX[U/IV M=KHC`",>-FUWSP;M1P^W?H5-S\S=Q86CD`JH:R&Q*LDV^>EUM[ MY.^__.N_?/Y+N4R^,8LYU&4&Z4W(*75IUZ'Z#Q'V)UI%JQP0_*-1;GN#D7`[G^4H%S`'C M_/'U]H+4*EIP[ZGGF/P(_R5`MB6.#(?;7_:&KCL^VM\?30P*OW&L?9RY>E"' MU?@-36[]B!KBW#A(Q78&T+):W\?;/9@T;(YW#1YU2#8^V/=O1DV?#?U8EVVU M3Y\^[KFJE>M:U,US',#RFKMC9T9[N)/1P1/E`:7C MJ$^?BI[!&QM*?S#GX^>,B`6K/=>;`!N[N@>02\AD%X4A(B-^R/I&"<>1. MQNS+GN"CL8GXE=>&#NM_V4/)+H=27'D2QA[9AX%\!7%B6RY[M"#FQS@?%/5[N&_N$M=NWIP7Z_*OWV2HA[,8I@#DVG%!S;)? M0IA5M7"<^%XX5&(Y1J+30;E>C2^*L>M2!8T=TK&-/.G8Q@XA]O6, M71]BV^+:`H9JAT5BJ._GNQ%GM,-H^.#.ZCA3+*A-;N>P9/L*1\Q2\;.7G&63;D# M]SP#^_4\/^F/0TV0,JC M^8(;!A#R-#:YSEU_$<0(F?UE+XA\',UAS=XO&(,XFL?>S_N9$R5(?!4ML]GK M4[+05LVF*:!G/XMK.WQ$R[ MC/BW1SW6[;?DRO6M)9!6NZ^U5AVEZPCA86TD$NSWP5U*7E6`7*4Z]J=\QMYG ME[Q&O>QF:(IC%4:,4&+E3HXC+-/S?"NX;A[OT^&/N9Y[NMUO$ MEU?-GD9V>')+!:.8B:\9O`&")UTX0@DJGWD77R?).PKT6]/QBV]03%=ZHY5, MS/%VSEG/\6"/\<=2`'^C5.VD?$C]_#)GE:#DVBU:M:`LX%@I:=A]7REG<)\. MI^TB2',)BLV&R::?Y!8NR"A(:BHOU+%T>\2B4_6%K5,T(<7<]-C&S5E4'"*8 M8DC!E,,F7E`;P^>6"48=?=B&F=@#,^VQ#,(\C8'W3`'*]\9>9)&"V!R(W3'3 MY-8`V'=)G1_,A;\5OA+X>HD_"EQSP.5_-,0$YK6-$;>X_*R]HLN)27]4Z]K,W"[&PT-NT) M8S+B?#U&%B>AU7ZDCM&=C/TG#NYT[F^VWC8>N+"=R5<;[B<[=+F+`>R.9?`' M;GBP-X5&X8SER`CH7&ZL-CN5VH88_C,W3T%^#N3;E@4;><269V$W(EO^`0!,WP] MZ?4$^Z>'SO1#1H(S<2N6Z:(AS5>!V0P($#>;>:O5CC-Y.J/!MG%_N`SN#S<: M?%D*]PK$[U%QSC@;*U?Q[:ZBPM&Z"H=4H5T1"NWR4&B29YD)WC2IM5Z6E7H6&Q;E2S,BW&I:/\N`%_9A5VT"],"JNS"S'B:>AU2;MWM1*"L MMIG7Y-7NVX;!44RH>4.YT;%.Z)B[U%1XB$J3YC%HM[%QRUS*+6:<4;+NRT$A*8JJ96I M*YZIRUN>8M;CF\K4%<#4Y0Q,4^^X5R8N7R9N&]\Y4#:J J&]A01B:O1F8; MW\)0UB*WUF)CW_)4UJ)PUF)CV%#6H@#68LUH2+X$5%F+_%J+^II3/E,OT9!, MZ5@Z$OR`IG:=MWK.K_6LAP]KP2EW,&7`+\]WRA/1;DS--UR+X-0:FD5:FG; MXI^;CZLIJ=^PU*_>OQ%MRT@_BY\YSNP/VRN=LNLZ9;ONUFSD!90MBF2E_(JB M_%X?#MK9MY;F[TR?IV"/VG85RGEM*`?Y.ST>/CA*@=GJ(5[E>?@O19V'D/Q] M`3=WQGL=8KR2-ZPIZ7[GTEW4]W"F/;##C>;WEZGU4-\"7JT8Y;X`)<_U!;-B MZ"_&O5YA6)8*R!=/`G(7@WZ3&L_+RQ?SY,`M)"RU34K)NW/:?`=WRC< M6R^Q*YQ4:TJJW^=1K$`F6U-2_:)4OS+BJ<17B:\*BQ:\H$.%1W=,J%5XM+BB M[UG%GPO2W"F9I$OP&;3NX!=K[P18[R;=QK>[_\S72/88U$N!,3U/1E^_9; MY^J(5,[0W^D\GG[LG/Q'T=30QW+>W>=_SSSISKNGOW1+7=OVU=WY]>W MET?$LBUV3.35SM7I&9)4;AY4#J$IF2)9_G]XSZ>^9YN&OX2?IR;^.5J$P$4< MD]]_[73/RGW\FKGZEM\_>3ZXOKVB#B#WH=J"?[S M$?I?WY['RX^L]X.[9=R9LG`=^PX2:?`"J^'\\`59O(MEX M==T](_6C\M_H:'S\;]I!]?@M?WV_:G\_A66=DLX5K*-S2[QUJK4F[/VL=6L5)OQ1A9I#Q,[L1W.5KDU0SB:2>$H M$D^[0T8HJ+O1F%H35'B>13V#@W]".&@^AX]0!0K;Y`8Z+:0/*MW2.36!W4%" M31`JB-TG_^Y9C-2K)8)*L42&](&1'F,6&3ML#&8#1Y1S.0:>>,@C=X?D>^6N M0L#A`?MDFA.\S<8X#XU5\-CA,./8!&Y2R\!Y+8,ZAIS3!?)OO!ZX1N3$7P-) M*._K!^8(/ABZ1'XME?1M)UI5O!!N]9'+:`\JLK=C0&=S4L+1)\2P81?`%EFZ MZ1G`+-.4LR9Z2;+ZMNU".R#2`8^7XW)[D\57!JS!4;];DO4R62DDO;@U)G-9 M)N)?A^%I@$E8INXY#BX#C#P8 M76(QG0D!KK:DFY(^Y0[NO8"N/I^"#0MVRA?G%O@QQV(636-;<)_%61!;:#`@ MP#-]VNTQ\XN&?20MU%VG8DCZIOWH;P?V$?PIZ.\P1D;@(0P%`7<76J<(K)#; M8.ZY/7V7.',$0I&O@+Z0MQR0Q"V#ZQ2K&D.&ADMTA]2%_9^`V!$X,("/PXQH M[@FC3C#'*8PFSRUU+:#TF4(-?^#?+NV9(,H@%\SYLE?="S6MKUJT:O6G8R+; ME$TZL3WWJ,^?F'&\1W1FFF),=0")[(>_Q]0P@M_1^$[TEQ'^M9_\TXG_Q&GP MU^?]F3Y;Z$B&#S^+4@.7N M]1YNW-+?FM??#\CEV?MN^^WV;Y;-*_`;K]12*)!DX M@'9P6VQ/A(N"U3\.N3XD/.1HR`%)43PDD.F-QKY9#RS@S`Q14=HR!QDH5N)2%_Z$),Q07`<29U3`',> MBF?:6P7A'M@._]/WL?%4%1PF,E?&!>E1`>)J^XW`LP5^@/%]8"82*&GRUP]- MX?1D\3ZXFR`"J*9F:@P@-6!QDKN^GRO'%M'@:3_5$[XF"<9*#']4<,S-$9Y% MW+U">7H^P][@[#4SG+T+B4F-K-+;^Z=GXZ%(6FOA!R3D2Z7YRA7C!K&A*1'& M90]#?E<5G$D9"`M_Q>[.(M(AP*:9U,F6C=+4$&EQ>JDWSAA.%2T#PQ\^&25L M[B\]:4C2:\4V8*[0M(!?ZM@]VY%QG-XDV2AP$<$QIOZBO)Y\!H3+6)TTH@D'H&LQ'UUXEY?J;AG>8L1YH4W'MM.@&V`H^N# MW[)#=$NI0:_5#SF&W>:Z=//`GA$EW([A>WV&:U/F[Q6S9LB#^Z(\$!ES_;*' M0=-4)WM>'\B"$\9C!P&$#'`#P7RLU#K12M5HE M?K4#7O,?"R.RN$B*TV-0.H3#AT,MT-./S;`GYNA(/C8#A].(_L`_DD:K5JHMATSH-<:Z0^PI*?O`WS9@,S%@A<1% M@J$]XD%1;&B-YG$J9("O*?S!IR9%AB-,9(N(83B)'WI(*P9H1VP MQ@0#I]SU`KE"1/N'2)`\AX6E$8$@E&8X#B$!@=;`HD(A:S,<+H.I_2RE&X,( M5&7MH/2I>9`03]T73Q'Y%%*MQOH)IO"/HX$ZD[";IPRTTL%AM533#F;H@$I6 M*5LWREVA_O+++OTURB@RQU'Z3`:F'ZE`5=>"G9EP9AI^"8NM,^87XTPIQ7KI ML-D@%N96^K'.TVT!B_MPEU0;@C1H*29)*K,L1:**B0;F)]08I.I/WH5-H?0U&>0**^],W>P0/3JBMUD_' MY.OU[>G9;?GD^N*B?7,'I.L@%'0LV!('\XNS\VYT2%XB435]&`>6N_8HZSP. MQTR7E7%T=F39CPX=!P^>O'!>GL.A[$-XUD0W[=/3SM6W*`ZAA1L721@6'J]G M[F"[PJE[`.`?2`"1]?=I)N";?)F311IN,HP+\*D](S,LI\=+/6=?WL;C14$9 MMMN;E7PN86K#ZKEE6C(0L8SPKU30W[SQ26KD67ONAJV?KAU;4#98OK9/_O'M M]OK[U6DY\:!?K=HHU>JM4JW9_/B\PN%5@(IJ%PX:/SU;\RT7/\I]+-24#XAA M-2B6S)`/VL<%>1P,KCT?^TW;E:JZ6/7@$@OQZ,WGPU:C:LO>V93*<[93&VJ%.?.ICCKE59S5?3M9&"[6:U\6K9NHJ#![?>6XM0J MAZV-DU=(3M4JM95IBR*$N%6*4UD"E>+*6$>E!291%S MDF/9=F)*91$+M%GA5Z.3FX4?^<@MPU0&4640509Q!Y-=6J6I,HBK9^K21TR5 M03W#+\[!LCKB/?N3T!I6H9.?H`&W"U,1/'GVH537V!96-`?C%,]M9`7%E^ M^4.GINZ9^.65>&?FM3_^S)OZG%$;V0_!9^>#=ZM3B\1O; M!1VAV!C_W][7-C>*).M^WXC]#UR?W3O=-R2W`*$7]TQ'N/W2ZSUNV\=V[]R] M7SHPE&QV$&@!V=;^^IM9!1(@!`@!0E)M[,S8,J(RLY[,RLS*R@**`.CPJ".H MBR'H%9S!==1X(3?X!J&KHDA`;_BJ3M9R_KB!]I_K37/T)C.S5CR!UXYBDWZ& M.A2Y>9U>8\`N^-/]>TK"O=^YL>>@709M9A:LC%Q;>QFL([#PS`R'[QYX@0J_BP>NQZ&T[+[8)+LW\EHZDT= M=N=&)?5\3=&\`[CSH[QK-D/WP`17,8>O%E==U]8,>G$"VC$JH^IK*K=V'UMB-:54236E MKQ>\G+*2L:NOT,,TYH)4:@;PKT&QGCU:_'&N:^$''!(+M3P[_.>W?*E17O!7 M?@+T@.OCHF&!*/JYS`!)S'+-/PX,9'^Y$NFK:K(+D#TAW!!GG2XX6ZK\*ISI M7KRTL_Q6J=4;]BJ@MH$;/NNA*&U["!R/Z&7>-&2('`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`37>%+?GT<&R M=,'&]4Y0-(@30?+@N3"TLH<'M?8<\.>?9+SCX8'Q?0%1E8HBPQ^0A\!B M2)W/=*%RYQ^(GT.T?C",C^%>3X9GJ"9XE6DLI*MU@AK/B?:=8JK)6*HT=;07 M6$"7Q%FJ`,56K]]I2>)*`49\[;CPYL=G0N(+U\3.?\)R$5:H"Z$"Q4R`'UIO M9>!0(^(P_\H5_E(FC^+Q8!#AKL5JT'"P9\=V7=R[T0C1*;_J!'Y[-U"Q8*9+ M)41N]95N5,X6H0%.X#0"7-WMEF4FKEY=OSAS]^.&4CAY3(AH,7#-8X8=HA$( M3?46`A_735HJ!>JN"IKJO@@C0EHE:WBWVQKX#>7GN)L;M;"A20FKA1?U=1[V M8S$]UL*S#5!8B!@7M%0+'UALD"X*C1-L0N4P.)1;W,>S&_D6F%,:.5'-65ZH`TH7>/.+=[.4 M4(7_"Y@E,D8&TF?0TR&L8OZ5GOP(JI`7:Q8E>(G>G`/"^@8+.'R&1D*U5KW: M%^+\]:W0B1A4KE+MPK`3,0E_#0A07XD#-BWXU2.68-IO>-SLC6!R&TGQ'Z$L MN$F4A_>YO3<0P4SP')4NN3J@P\\7NI[JT`R*,1Z#^\F6W%!5*:MP1]/)_G(98T$@9]R.+X)2=ZB^(51#!]^I=?Y[Y0X)B)+E6?1U.' MA0^9>@WJ9%L$Q3:VG:@AB*@AJ/`H-*W+^A9R&G/H.0R%]?]X:M)D"*0SAK.J M$<=3X3V+\@R=4"HPX6%;$@ZIT.A;\YT'W_P" MODIU\25P.**>UL+`HR;2`UD`0'`!6?LE01UYOCV@MFV^\F3;LVB9_);-U[$0 MF39\>\@8J>!]YUP@] M;.H>"U>+F*'%V)P+FK[B'WG[08%R@ M>%XC1X_5)FRT5&*(ZS1HU9KFZI:4K^'3>2K8$HH9F%7_++0;A0NU*)J&F[;, M70V=\(&/'3VT5T9=%S?P2$X?SH2!J+2[';[HUD+W%;42EF\OYTO#6EXAW56G M!U>H8:$IC'NZ]/@GCN\Q6H#%(3`VRQ[N_6DDG)O3,0_HCH74J!1>$*7I&9'( M/-1H8!A8*B=,H,,(],_!!%]Z\`,*_/GW<,B0N$H$#@H^0&T^6R!83G/B2W"> M+&*KY"*#'O&I1P9Z*5$2P1AZ3'A!@LE?SGT)!,2N\A&6F%AF`*4.!,L=C,S< M6/B%F[\L:%N<'K\-,K54*+8PA87+H')477#IZ;XVAHMD!#2S%).FXD/485G! M'O-"=**9*HH#OLMJ.`+R>MGD?0`)B5+VN6'(!; MRZ\R2=C("VU>NX`NP]&C5O1AKB)OU)%;4A#4PL@Y^E#B0!@1%<^Q^_D26\/S MP>S)OT\A/I("@L"I<\$4A;J>//E5H.X+@@RQ77)>6FIU!]U6-[[SE):88;9V M@0MDO62:AD#34)%79,MI6=`B)"VPAC+_>)'^*)7\@2*VNIL0GW9:_8,;+J5S MA;[Z<9\]\[VI(2U6T;-F146_4$7%4XT5%+)LBP2(18.EMPJ8'&(H!7,,_1 M7=#(R[_:JD/+7<[!@=MK*LO:P23BAO,8-(9,D3IFD@7J MU@-=R8*F4:M+YF^G#G7U>R'BL3R,LD?/R[^HIBE@2(SV\-_@*GN8K!#`2Z7[ M(;0Y(^X5XO:(?Z(DWL"A2SGR4U",&YIF-HGK+K@*8A]JT.D^-GTE1OS'PFVH M,20+;FAF.@$M.,8<,BJ2UJ8%`W/0X/[$K(T[*J7QPZQSV^-*R3/5[L0MFY%2EL=N?*4ZJ^R(-T?5EE0Q\T`SP'H95D@3![/Z_>##'&29M#XA!WJ$JXL3%ACRI%Z1(O%G";N@2#J MK\2S=?X`\(60&LUI?"(6&1D>]0$C>_N1/6M:?=#M*)@E'T_-9YIH7UF)4$EU M_M[K`3]!5/T)HOJR78NCK:W0V=9R%]N6*`];?67U MN\PG"&]9+9(CZ.OZ)@,+6M@:C;4E>`C*].:[F_%F7&XLL`I7?*#_DI)=(=3U:;-M M`_4-0@*W11/&SY;Q']SMC[=S8R_#6UJH/3+>%^I'6V6X24TRV.47\R.4:E"^ MX#9_/N+OCG#$W7]*S[,FLAN[&B0T"L#]!_#WOY\(6#U'FP_Y3U,3N)JH>]9N=^F! M[+U(?[:B/906-N]O?B-?49J\9S4:B+0Y?GC\Y_5%T/X@.I]Q`"T9EE5MLV+- MA?N=Q5ZJDM`B=J,>8=MDIHR.M'$\=^C_!'$!G7*X]=N=^>\OA7M@/ZTW\B.: MW[C9Q;\'G:VI!5X\@*9X\1O8Y/"S:)XY.O8('0_+2S+'1N&^ANN8?]9GI@*N MQX:NFR3&=;=*X[\]5JII1EXA)Q'_9-F,U,:HWR&]B9PF=&MO]IQR=')T-G=. M*YBTS1>_XHO^HG4P3-R(_F_/`J**.-PE/[@B$4ARV!E6EN3Q(VCH?-CSS=7[ MH*:[60RNLS!S_BMT3'9.`)S_P^9_7Q2@D2MZT3`E(@I-(Z2X*+)26&>XEVF/ M\-PRL:8D[TV-V^-R9_('%4UBN9?]);$57!7B[_L11.[(]!#9EB?H^,M[O8$:ZFW-?&YN=U-TU3> M9-:8LA/5!/;VR#Y5Z^\7N;"*(Y4CM7ZD\L!T^^MHM8'I-V(1Q[^52]6Q M&3WK`?A*#MF%*EJ*T;`)KU\`NQHR*#(/;SG>#P?O@W[_D/'>D*6]VA!YAQSR M`XDW=K[N>TOL-Z48G(.;@YN#^\`6Z6KC[T?:+()V"FXOMXG&F[O@Y^T5637! M6TL8$#9[^#:IHI382J M:^*E;]S4)[D9UN;O7>HC)2Q++_Q+DV64P,MJ3/".;3<[WK&M[LZ2H<:2WKS9 MFCK&^Q_I76=6J$]:IEM-6Z#1%M'OQIA=WEMJR^2A%+\6B=Z(]6:P_K4A4FD# M>C7ALO-Y?[^J=C(QWHG_.95J899G_I,]I#O_H+'X,B/SU MT]1M/ZOJY(1>ENA?<<4:MI]:.OV07N-\I\[PE(/[2-Z]KR9(_LN?__3G/PG" MK\'W_R>X,.#2L`!QAFI>62,,:5#3YM^BEXO#+_=D]-O174?\"?]';7VT.[V? M?8D9A]@RDM]N"UFV9H-%CEV2E[S&!7]C=#Z!B(NN MWCQ="[Z0=6N\V^.GAXOKB[/'B7'AX/'V\^`Z,/`BWE\+MW<7]Z>/5[%I%C%1X"M==_7E0LLM^A5JC7[&Z>FZ;/937"<#+LFE,CL4;'>=I4ZRD MMRE>RF[E4`7_N]ZL2US=K"N'N(3DOL?SWUEG M6W/1OC;>VY:CC*,L4UQ)[9,YQ$J!V!YVH>.K'K='FS>Y6M7./8GQ,.5BZ.'BXSZ$"\?>=.G-LTVP)]FAD:(3633K$5(ME;YK=Z:)JS6D8&M;G?E^O^%C? M@DJ](ALC'/X<_OL!__[^]1GF\.?PSRD)I;>UKC<<_AS^6X>_7*3XZ%#@WY"H M<;/X>L.H\9H\^V?L)HX](JYKV!9\,")[V!=O)PQG>6BHF?M=Z!=6P'_N2HU' M`M<#K@=5ZX&\O8M4N1YP/6B,'G25K:43N1YP/6B.'O3VK\?JWD666]V/?%C1 M()(G)!K-_>&8S^TFYK9V)QK7`ZX'C=&#+5XGSO6`ZT%C]&"+=P9R/>!ZT!@] M$%NR,F@\%@X^L-SJEN55J(-VN/,TW<6<-Q7W;,$ESBM6PDX<^]70B<,3%HWF M_G`L[#83=^W&XX!K`=>"JK6@)V[-R^!ZP/6@,7K`5X-F<\^UH)ZHLR-N+1^_ M`YK0D*ASJ]N9M][+]B+('E4F)9KDE< MD[@F\56IH5CANG2(NM3EV[B-#ZBWNHV[0UFX)MC<[4_^.EW/FIFB;*)T:NX) MQQ5G=Z#!%8"<^E%$^[R:#:NCU]0O(:C)KJ^MRM*9?]S$>*+6FXM59. M7(VX&NV+&BDBWR3C:L35:+.=YI;8Y6K$U8BKT69="5M=Z<`;2-`OC6S+"[X5 MX>"7&`N_M'YQB6.,?EDB>T'!)WP;'21OU/[)4P%PBU_#WTGF)R+GN)CC`OU^ M>O_M"N0(/\,_/CK9W^)3U&(?M(0'Y/)(4$WCV?KMZ%]3US-&LRP+5)88(U)D M,$0!!:]F_+#\$P7,[U?GCW_#[W?^FI^YSX+_GL`$X.B"1DR\[5DSK.??CCKL M]XFJZ_[O"8F6.%H]>Y*4;_%I5)3C?A@L.>&:3T7],:3!<5]9?Y"GXP*6((R, M-<:Z-"S5T@S5%,@[=C:#:?I@6)H])A];@D6\DZ*Z4X*ZQ&D54A!?PG`A:5Y3 MLTH_N+HYOT`<=PPK@N^C-)6@C\__$8_%?NC;`^6O\]3MV>WU]>G=`Y"@V::I M3ERPKK<`Y,OKV]]/A%?#->#=FP MNM6D:.ZK:OTA:"^J\TS<`M/=[)K+C='Y?T3H'Z#X!=/]N(^3XW"=\%JHDV!N`-B3RV9O!Z^?P9^W9JPX4#E0UUI6MW8F MG2.5(W4=I`X;/Y,X!!3]8B.%Y"' M+R,WK%?B>K;CTNY^3;F:O`G1;!/8VR-K5FG>I;NU:S(Y4CE2UT'JUFXVYD#E M0%W+I`ZV%LMPJ'*HJ9]B68(_F`F8 MTNXU;$IRYH,\['WDX.;@+A/<3C^]&_C76U8@3\#&)7JN+/6EEWIL8PG?#3#?%HVPYA0H#; M%]4AV[PDM;8[A4N@=?E"UM2%?S;9HR4:$N$B#%Y?"'"R#9-^PW` M+_@:2#P7/G2\%\%[P>.3X\G4FQ_,D5_]MSS=7?PZ'@U1_[M+MX:3ND!*OGLIF M7B++=;6QNEITNZ\9>]B[NI@>+NM-*1K.C=^F%(?OT!P?,.LWD=#;[$&;Y M_#;%1G'TCEZ.7IW..0)#DW5$_)L?^J;<$AL)Z>SF8:K M.GX;:;@X>CEZ.7HY>CEZ.7HY>AO*+T?O%D*>H"O&]<4EODLN>`U7S3L_>)C: M/S>]?%;ZD*/CK=Z,4&OV9\,&,K5?D%!KJDAN2L#UH"%ZH+2D08_K M`=>#`]>#7DN2!UP/N!XS*:7?#CEZ.7H;.;T\#*IYQ^MWU7%4RW,% MPW6G1!<\6S"L5^)ZMN/2JV8FIJJ1,;$\07V&?Q]RG+R3D]Y,\U9KZ8YD)L+Y$;PFW@_;X=?T,N!RRWPS@.Y(4%2O7M%VU?R M)L3'.SF=S5Q\>7:'HY>CEZ.W2>QQ]'+TGG(4_.^4+2#QKQ$KCE- M-)H0#&<>DI0G[X)N3Y]P_!T"1/FG15<)8D]20G)+Z6ZMC0;7!*X)C=&$K3;2 MX)K`-:$QFM"#-4'DFL`UX>`U8;O--)J@"@T)(?FN&<]]99VD#-NB0\N-%98' MSYUQ]'/T-Q(>'/T<_1S]'/T<_1S]!QCRU;MK>$XL>VQ86[USN0GQ_DY.:#-- M6ZV9JN9,+TAMY/3RH(?O<^V7X>(UWGMMN#AZ.7HY M>CEZ.7HY>CEZ&\HO1^\60IX-[US>VMY/UIDQH2V\$00\T07UE3CJ,SPU'3_! MW^V1<&:/Q[8E/'BV]LP/2B^ M27>PR8HF3^=^W7*X-7'P1!W'/L=^`\'!L<^QS['/L<^QS[%_8*%>O1N1S;S9 MN0F1_TY.<3-M'2\NY^CEZ.7H;1)['+TCMZ'LK>M MY);4D5H=GB'E>L'U(K1ML/6>'UPON%XT3R\DJ27U.JVA(G&]X'K!]:(Y?3^: MH!?A:/63I\)DAU\4L'YV?7%Z?P)2?HDR&."1DS3G:B:83W3[^'O$U77_=_G[W?F/^ES:L(_.HL?`QG_ M^FGJMI]5=7+R/U/5\8ACSBXA@K8T0S6OK!'"R3-LZY&\>U]-B(*__/E/?_Z3 M(/P:?.MA^N22?T^)Y5V\PK_<^8."!F*`7^[)Z+>CNX[X$_XO=<3NH]WI_90[ M].A+;+Z_G]Y_NP+@@73A'U^)F;3CF&ZQ#UK"`\Z.<%3# MS++9C)#*CH>&2'VR33T'O9\%__N!\:.OP-':KO$?TF:I"M1NBP2?>P[QM)=` MXW-A))8,"EL2?+\QFBTKO6=/\B6*?K\Z?_P;&-O><=\768KZLA_18+[01V]N M'R^$_DF1(@6?\G5'?/CQ]>'B?WYK=^.PJ)*,14R`>!>$`1:4( M%G-BT!]#&ASWE?4'48_K@_JE;9KV&PA5\%Z(0.@19`.,-7%=S''BAV?V>*): M,P:*@23V/[O"XXOAZ,(]>3;`UM!%0'CP5(^5X,,O?Y]:1)!;`AIRX8-+",#, MM84;VR."J'ULT:)]PQ)438,5#U84`GZ"]T+'NR1/#BPW,_;E.\=XA1<+=Z$* M?X?0GP!`="@3'O6'"M$;G!50`0B>:B(W9=I\&+([Z+:Z8B]J_6D&V16>5!?& M!O)4D))+/.0#F+1'"]U2)Q/'?C=@#27`P5_*)*YS/!A&R?)L*IO%J8F18X_S MB/M8N`(F0.]PDEOT&^J3_4K_!I\`DRAG.H,>N-W/Q,'S&?#4:(XL%9YLLS/M M*!"Z7M'Y2S_4WDR[6M2D)LUNX"?[RS1C+VI[@PE)P^.969Z[P$/J(Q?R>.9KA$F%#3@WM>41.0<'!*>`M. M6OG&/\L8OZGN8K/,L[=DW9"3P$:!J2_9SO>[O59O,%@>LMQQY$%+ZBG14>;3 M\40T=0QS"I;%0,7'V9P;WND$[.I\NF'FW*GV,O]N2X`%:<+6=7.V!G+K-,#@ M*LG**@LLBO)QEYM@;H)#LR0=C`D&RRNVX5_2LOEM,:]9%;2IX^!W8P/"&TJU MO.*QW(D;J/KMOWC<4>JS_[VNTNKX9S"KL_ZB)+4&\F"%]7\#K]J/9V+67$B! MV4X!J],`8(%CD3#/50%K(+>4GI@]XXU9L9.6YLZQ8E@E+,Q/"7FGIT1^*V)D MH(!5V=C'.#5-%B*##H9"Y/FT8MY;Q;Q')"0&0'NHT>S'5\.%G]C:`.]R"+X+ M]!%>_41HQF1JT8HT>$0P#?7),`UOYJ=2:":'Q?JA5X&ZGCZ<"0-1:7<[R]FE MO<$&STY6GYU\JC$[>>NG]_HLO==:F8_\:JN.CC`_-QS0).I:X3KQZB>CGE'] M2D\!BBW`4JL37[I*=P[DH;(\BCWQJ&Z#MI/QQ+1GA#";8=E6>_Y)U%UH"2HX M`U;5JWGG>!CS9.:UM:-$THP#0Z M8.O@)89-9UD29D1UT)R.X0DM2%_3Q*2@@V?`_*)@E!<5/@9?1G5?3$QLS]D? M$=6;@G&ER[S@$"I>\:$12`!U<*Q)79A:J M;KB0A++8F)9'D;N844&TM%;,V6+"5?@.:7LPR,*4C*:F.6LC=DG9P8"28%5" M^JX*%KPJK.>"[M-,@>_&H9^H\:BEK6*ZP=0KD8#YR-2#M6QO&>I)!IS"_^+? M4_1DKBP-/:=7&H]84;W1<>N'-H"BA#\1H"LR`'PA>+'4^3PG[XE89&1X&!-9 M\[^+G]&)TN$/=!_#$NZGX#YT.PKZ3N.I^:QZ$<(?YNUXA5/-2U#4G:GG6%F9 M$91PZ&!J3X*V6Y>JX?Q#-:?D$=^T5A7'SWE(>8HQ:/#&[P1/44Q=).8!UX47 MVP1!N0P!9Z;JNJ?OAOO3#TSG+PF^CZ$K0B;R'N#)T`W5F3VH)KD=T8,9^)9( M)4FO]$J2NU5A=DI\?5*FO8C:B?K3L^6$3GF+#H($YN"O\\;K9[?7UZ=W#T"Z M9INF.G%)`?^>-<+S2U1*<3:,,?2$#2U6VX!!`GB32<9'@OP$=: M(I/5'71:-&QT/K&-%3!#.RJP_9ZL.*7BJ93)ZQZNO:,H62P+"JLVWX9N?/\]$'J=%MT#UA1/JXJ'\\)J'FJJ]== MKKJ^-]P_VB.'X#84*"V&W@[Z)A_$C^OECZHY/5_1R_T3`<';E>77=X[E8054 M__7`A:IT:A=J7JVCB\>&JK9$VL4[9ML@;'RU3=5CJ?D/4I9JE3[G%4STTBL5 M^7A0])[FM?5D-R74.1Z*]4AH2TO-:OR;Q@@6%<-/&WT4/LA[J03B<7]0.WD[ M*2GI6"K-6I3L?U6[$L#OADXL79@9Q-2%#]V]5(2BZ_QAK`0U2:0WJEE=*P4#SMROS[$*6OF-Y%51GGUIZTW8O^Z7O7E[EJT6'."[C*-") M$*.,[SSRG?%=Q]@;R]M/@\BN[AJB71-0[>5HC6D3 M5DZCQJ*];RMM*#'OHMX)WVQ5N+O$H@_S:G@$/;S`@8YWB<"?\R?N\EBM5>G! M]J*1*G-C\5/:SP0/'QN63MXAY+/^@$=^'#\<"Y=$)XYJTIZKSBNV)"6J.W5F M8%0MW=WFT?HHCD&JW94X'DK'8GV[F@.TH-NEGJ$-S??'_;/B]QW'O-@!O4++"C3T'[3)H,[-@9>3:VLM@'8&%9V8X MW*+^!1[#%BD3U5B\A+9X,3R7-4SR2\L"8S]178]6:NDV8=]E6H+?F:BS?"\9 M3;&S2V$%X76#Z76#VR\3'%10)B@`<]AU,VBV%=C94!L?0'F0?(BT:A.F[O*E M`*X[';-60=NH'&QF4_^R9;"RIU8I["]*1\-EHEE=;RIEF)>+\G+1G:A`Y.6B M.S19O%%-HS;D5[2O"2T=5"[?-&-7M<,MKA):-9 M$N(EHWM=,BH=R[QD-*>D!E+-Y#5C)=!YR>C!KP2\9'2/)I.7C.Z(O'C):.R- M93:JZ97FV38(_64*J%]:<,2;TD0WEX/[-N:/7?OWM1G$_4Y+$XE^:]WCO2(. M$/=5=0WWAV4_8?4BOO#*FDP]^+-M:?`M6NRRYO4;L;WE]?>2AZ7O)3]&-H)! MLE-3=82)0UP@D!7T.&1D@D_JTDUCK'BS+1*ZN3)TZYWKVII![VFA-U9&;C[& MVUW@&\%>"]U@J6:SN=J-UG5W'*5*=AS]W5.^Y5C)V-7O8J$-6I!*UWO\:["9 M98\6?YSK5_@!A\2J5ST[_.>W?*X#WQ`KWT$XX/VC:/6'*/K5'P&2F.6:?QP8 MR/YRIOZK:F)'(+P@,;S=N\X>[Y9V1@I[@J$;49??*K5ZPUX%U#8P(%H/16GA M$S@;BU(HO)6.5F%&.NRA9X,&=ZAT,H(B?>H$!9?L^M-]Q,L'12[MT&)ZRKI>LY+HSVR$EXO@=LXP1C[\ MG[P%$0D$;3Z_ZWBNY2!JG1%7(*YXTZT\,BP'A,TR50W*??',;UD623I6-K9) M(<\YDFD1/DPM=:H#V7I1^T3)J\A>T'<+NCU],DD.(Y77RUYSK!7E&"VY7YZ% MVDB*-1Z4:T82;9>/R`4I.LKO2L3X#_M')9;7QMSN1)Z,R/G"@76-=V%L6]Z+ M[\H*Q-*)'C4:[-Q0O`UY<"FY+@Q;HCA8N#XCV\'+R6U/-05U;$_9S>SL(7KR MC2:`S^PQC"O0_':00O:/)K4$>`;+'XQ78LZ$#P\$#)GIVL*-[1&AJWW?OATM'HR_Q?TZP\OBUS^V%]GK$#NE;W9482AK.>6TGI&<9Y(0RI5:S(V- MI*+,SQ&GS`[[$?VKEV1Y9-G6?MRVYARDK%OA&9$KCQH6L^@Y>,#=/6:0M9". MPB]8O\^V$#`KIIIFS!2'#I*R3A7>K,W.4*M@[W473;5F/UO&?[!4+9X782_# MTP(TRV:\+]9[NN:X2:L-:\P!PSMT<5%=?U_273ZIV#2?2!3EXVZ53E%9G#`T M75//=)FUD-TX2C8U,8?ZOX;DJ0?1!LK!#_?])UB4DO#WN?@,:_Z/>"SV0^-G M;9G>@HFYO+[]_41X-5R#>O'^T]0$KB;JGNU;+3V0[1CZLQ4-1A8V[V_^CI@H M3=ZSPK_(?N'#XS^O+X+CR='YC`-HR;"LBC]CNW3]SL*Q51+V6C8*MK?)3!E; M.W$\=^C_!'$!G7*X]?,&_OM+X1[83]MD?$3S&S>[^/=@BYA:X,4#:(H7OQ4_ M#,O1L0OH>%A>DCDV"B<(US'_+"M4`==C0]=-$N.Z6Z7QWQXKU>SJ5\A)Q#]9 M-B.U,>J7&C21TX2RAV;/*4Q805<3A M+OG!%8E`DL/.L+(DCQ_!SNAASS=7[X.:[F8QN,["S/FOT#'9.0%P_@^;_WU1 M@$:NZ$7#E(@H-(V0XJ+(2F%AP0'N-SKDE5A3DO?(T_:XW)G\04636.ZIF22V M@IH[?[]/"2I%ZF(+0AB^9F_D/6HHE7,JF. M]L)N+X"5T[0G6."WK8G/S>UNFJ;R)K/&E/N&-JI$GI-6T6[QMJL]B9\K'J_$'P8I9#=J*:P-X>V:=J_?UVXZ>2(Y4C M%7_F@>GVU]%J`]-OQ*)W!N-*JNICPS)<#^^5?"6'[$(5+<5HV(37+X!=#1D4 MF8>W'.^'@_=!OW_(>&_(TEYMB+Q##OF!Q!L[7_>])?:;4@S.PN.-`/Q2@BRUQ6+S%X1Y`/4?KN,@O5"2-[B.WE1YOJQO-W7HOQ+F= M$,SE6\_X@E-+OV#>Q-?967"IS`;=XL2F=HLK3`9O!=>45G!J>N/)4ENVK=X! MVV8?M#B5P@XT*\O3:DS)OITILB8M]1XKHA<[?::V&_,?\NCH/I_'JH+_73]P M+ZX^<)]#7$)R[[+Y[ZP[E;EH017O3\51QE&6*:ZD%F@<8J5`;`\[2?!5C]NC MS0^JKVK)F$.:M;=9;$0[`PZS^F&6]X;%)DB)XZBY..+FBL.,FRONBG-7?%?` MLFM&9S5$(AT?17%=>>US1TAN6[AMV:IM:0+_#?;W=ED\0RX>CAXN'JY<'#U< M/#LE'JY<'#U(O^_4F6.;9DNP1R-#8S?.^E?;%L!. MLT^K5:TY#4/#^MSO:YO>]2VHU"NR,<+AS^&_'_#O[U^O,`Y_#O^]+7;" M<):'AIJYWX4S_P7\YZ[4>"1P/>!Z4+4>R-N[#(GK`=>#QNA!5]E:.I'K`=># MYNA!;__Z).U=9+G5_4*BT=P?COG<;F)N:_<:<#W@>M`8/=CBE8!< M#[@>-$8/MGCO!]<#K@>-T0.Q)2N#QF/AX`/+K6Y97KGN5+4T(M@CX

CVU+ MH+$FW<5\4[&#K^<*GBVXQ'G%2MB)8[\:.G%XPJ+1W!^.A=UFXFYKE]QR+>!: MT!@MZ(E;\S*X'G`]:(P>\-6@V=QS+:@GZNR(^W?/\-Y%G5O=SKS%BUMX9J*9 M5U7O5!:O*3=9;W7?1^''TK@N<5TJ)9;EFL0UB6L27Y4:BA6N2X>H2UV^C=OX M@'JKV[@[E(5K@LW=_N2OT_6LF2G*)DJGYIYP7'%V!QI<<;CB-`0;7'&XXNP$ M=+CB<,7ABK-3BM.08'BKN\N/MJ>:PC=B$<=OQZ3J8\,R7,]1/>.5\%Q*\;2; M#*JMV],G)*_!J*FNS]V:7.,;HER6R%Q1\ MPK?10?)&[9\\%0"W^#7R'?\7.AGX&##AZ,3Y[0CX]TFF8C@1.YV_?A;H,VU3 MG=E3[V1DO!/]\Y&@$1/O,-8,ZYE^#W^?J+KN_SY_OS/_29\S$/[16?P84/SK MIZG;?E;5RH?\4I:,O,/9^NWH7U/7,T:SHT0< M,AQ%6&;9/*I^OU^=/_X-!T,XY1WXL^"_)S"HJ!)YZ'52^G\N/X8TN"XKZP_R--Q`;L:GK4UQKHT+-72#-44"%,,5_A@4$7Y MV!(LXIT4M40E0#E.JY#BP90P7$B:UW21HA]A;YS<;QR'8@D,KE?WV#@12"`#5`$`.>!869+'XXM#R$(H8UBN M7]S%[\32V55[3\XG^M6_3ZW0XW(11[5Q,N(PR83)@_'.05(0))OO!39.&'SI MV!^;4/A>Y$[89$A+XL+0;H>04-+UT!PH18!2Y/X!;C+V$0G<9'"@<)/!G4KN M5.ZTXJ^>9#FLV:*X))`?ECK5#8\%E(<[X5R_#VJZF\7@-AV;7>9_>.#\'_K\ M'SK_'/^<_T/FG^.?\W_(_.\+_AL9SS6L"C@IFONJ6G\(VHOJ/!.WP'0WNX)U M8S0W;`(3V,M;I[WC1=@T@]SX">3X/&1\BOMW!(`#=)\`NG]W.W)\[A,^"U42 M[`U`&Q)N;!9Y984;E[9#C&=+T*:.0RQM)J@Z'M88$[PKT;1==WM12&[&=]-( ME3>O9;.W@Y?YX,];,U8-GTD.5`Y43$5N+91N M`E(;$JE4NS$RO]Y=LUU/<(BI>D3'Z]S#5[L;UBMQ/=MQ::_$IESTWH1HM@GL M[9$UJS3OTMW:I:,_*JFE/5,VQ+L$?S`.:00]BM7B+9K'1,:;=$-B4Y\T$>]CYR<'-PEPGN)F#WTYHK\H!;]W#0\Z0\J1OI?V6^;F MFX-Z_\VWW!IL[\1!$Y"^]W?6YKQI-GY?[6WT.]>VZZY_&:U\)$PM@WWAQ\/Y MD:`3S0"4N+\=M>6C+^V>U`=I=1:T)XP:)^R&>&>J^W+'SG7I7V<_7*)?6?-O MGL+0KX9G$/<,R#6L*7SF_]&V"O#0S>"AVQ4'$1XV(S!@5W<,^^3!@YFY)\^& MZQ&'Z#\L`!S[E3W]X*D>P7X=E[9S!S;)T.Z)JYHDQJ4XF9C]_3=<*.B44*B<5]4A[AAZ5S=7!Y]D0?# MOMB7?OVT$3]Q#%RJAO,/U9R24]>=CB=4&^\>E0\@5]KPDKGID8"Y9$A7+L&EV3)(S!=D99BP&-0FRL0NJ MU,T!QFX#9=@X,"J9@I0'2@,%6='"FADM*-)@N[AJXN*:&1[TQ&[E2\,C<<8[ MMZ@.CK[<2?\4\WSR02XKD4KC+-.0BD;^7KM<&KOJR1U?)-*P?K0T>QV3 M11"-"(HDBML6334KDRP!@]U_BN+W&BU%`]<:608Y*/^4OHM217(X-S#);.F[ M&*3):7XQ6(^,'%V2""H57>/,2)H[W`CY-7=Q2G.=&RBZQD$OS8ENH/PJ6N;2 M,N5;E4(3U\*TC'B5PB*.9K@$=$"+2>G4O;6:(IUN)[K-_'-"G)]TC+"8P*T2 MC_N#+$F%."Y#1`LU^FY8QG@Z#LOA7K6>";,R#;-173&G2#O'W2V*5'W?(9%* MN46:M3]1H4BK,?9=.;>&]C)SD-7SW@"P=/.#)3/?5J[`0D[];IDT);](^]L3 MZ4Z9M%YND0YJ-FG-C-J[_=P"ZV=N/J0(#&OHP(#C?Y"I5R`)B]"\,^!@9EC/ M]&5IMC!*]2"]C$\3'149J'Z31+4D_>G.9[`!;('UQK_^L, M:_06L#-Z,YB76\I*)YWB$*TYABV%TA6R5<1T2N5H36;,?#=%[HT?R" ME#+@VNM%Z$L:K!A!J^254=@P7M MW@P6-7`C+!UMW001=D/6D%G&@C`<1HE+&W0S`E<)+\/ZBV)7*4PA$W%N8?4R M[+K<[23I7-Y15TB@EV&CNZ+8RS.JIME3,#]WZHR>>'!4G:QK='H9]K@WB*(E M9#K`&F#`,N=H918.L+<.7?.PP!Z/#>:"871` M#QU!\*VMH[3]I17@W35.+,/\[<@#*!\)GS8:=85$^DLK0)Y1_4--ZP6(_0P+ M'UW?XL.L3\8JCC,L^7IDW#ED1$"']"("R3#3$<]C:9A"E*R228;178^24UTW M,/N@FG>J`7'B.8SEP8J0LTI$&1:V'9NY;&)"JQ58N0TD-5C7Q7-*5PAQ ML*Y;OBZE\U3A=Z*Z4X?E+0WOY8=E/^&UCNA$75F3J>?>$R!:@W>SL[/P*W@, ML,Q\55W#G2^0F=9F*4NZ?E9TD+5\!&MWI4Q&/)+Y"+>CP#-XM,-[8P_LBDS_ MH+*3KQ!E%>0D`K8CC+1G'5K@C[94!K MD$-H$JR^2J\Q,.*.H*-;:,W.P7]U0JO)YN9H#E5DZ2E5 M,%'EN21/SA38PE\*"6!#/$;EU\N6G]CK=R2QMT<"S('-J)1R^,QBMSO`K@#% MA;1BV6N4N@U*6\U+Y'W[]GG8#+$TV-"(G;S>L70L*R7(Z%3_U]0%$T6T7FR M7H%\YKG7=$[7=%'$3@Y/>"B*@_3\U!*12]O'IFEKJ,#4-GU5X1',MA'0<)QT MO^EOROH4[@SK>C!-,%F1-P\&;$SC.JD"*;E/DH[Q"?N^)2U1' MP[KN<_)*3)N63?IO*":!K+WX6.GKUD7P0$P3>Q-;^G?5^8-@K) M]6_$(HYJ8EF>/C8LOQGQ*]F(_XQ"`T5NQ/R'T_>;J;R85;[0:Q:_Y:N\F%$6 M(0TZS1)!R2HO9I5(-XO[*K0^J]_]H-\O00C)#Y^B>_!,"?PZ6SQRI\ZHK_*F M.OHM.W7WC?H15Q;S*[XY.3O[_[P83TQ[1@AU4-B[PE*B0SS.)NR8YX-FP+#& MR-!.]5?#M9W95QO^'O["H^&A-W@%?MJKH4]A+I8%FL,EE&-Z58%X5L_`-]O6 ML0KEQK9((!Y6D.*&@BNVMW@ZF3CV*]$O;2?(E>>2^ZEE@7#.#8=H$,OAZ8ZP M%/'W&W6\W%%"S-.>7U)6R&Y#QNJ26#\DL?Y\18=W!V`-Q!;RTT/X99--=`99 M"%/(OZ>X#+PF1#"A/P4HC\D[3\966076D@3.0H@L%7!SZ<"C'2)FKA&_$PRQ M0&807ZK/).4,<]EXSGOP6#S&SNK;E<0.S4"-2X-)+9\-_Q^CFQO;^23RL%WNVC/^D)WFB\I-2 M8IL.GOD*]86HC-S:Y,*F")86_R-\+M>V1DQHV..T]UT*-[ZLE^:=V^?<;!M' MRI%JWWPK-,0(55>0_`\8-+&QFCC(%E=B/Y-\^>+4JPFH-1O,4 M6$`<$T*.8A"Y*_6BFXVYN5@Z4*4^V0Y$;+[VI2>?Y!"O-N M1%T:LK(RV;U.5=1ULV4G9Z2=I?A1]_*I2[O^,BLE'.O?E$X=._4-^HI)2[!/ M(^*Z=#?WDL2/5.>!G9R1K^WVPH?@5PR["6UI@LM(I';]0Z.ETY8'`-46J\:[+RZUHQ'CI]GHD5<12 MVG7%&6M.L)5(1MT!PFH2SZIRDH52$8*H#7U7KCS-8*9Z+ MN+>9#5^["\L1&FA-`M)$D[$F]C<9/P>6LGJQBITR"$@10%:+52EU_/E1<-LA MQK/%6H%IX<37-]6PKFW7_4I&\,RC^KX^2++:K+:EJ,^W!C'E\Y$FZHQ5I3W< M/AMY()O5X")F_;;*1]IT9*P[[6Y9;-#^@C>VA9T_U5`%5P%5R%AZXDT-$P;= MD+@T@68UDAU$`5XRA7F@F[_@M2+BTL27L13%BI&S"*0F^YZ\JN:4QFWS_0%6 M*.<_76#-SFHSVV:U7L&JD4U".12G2#:K16W0D:<6>G/`-*N/+5C87K=^BM,D MG-4N*MP3,S^]`=;#,(\\60"]6:N7/(@IVLK!-Z4R39X9:Y,L5TMB'I!F+$4` MTF&G'BK3!)FQ)LFQKNNY:2RI]*9`$5)R-65&W2_[Y,K2R3LVH:6)BJ"S'_MW M*=65\::]*=>.#`=K5`.7)\SZZ[37K7Y-J1C;?'YRM!I:7?U:0ZEVO9/0#*6) M=&U>-2EBYV!F):0:6YX8,7MBY.&JXOS*YB54@W&G.K<.+;[0:?<\^!9]>_ZR MR7A'[62+W46+#7R&NBCEH*(4PE?TMQ7C/;AK(MRO[9]Z+[:S7H%J/\'A]Z(RI7BC5/1R"E3"K9ILD:G/V2G MTQ<'V!)H4^IR'OR/D9BG&V.V`!/.[Q>CT$?WFQC3>'CRW M307-ZR#'#752Q8K??!-25TIX1P]0RH@=5T3.\BQ5&40 MF&S`UB%NI0QSK%"E$5?(P`YRK%`9%.8V6AO8USRMC(N3F7IV?_V\W2"KM*H3 MNPHN=?PRB$W).@VR[@CJ=COU$)LCD1?ONYO0!:57+[$IDHWWPUTN3XRE1MK(3<;FU*\\^1R=5*O;FK3A)NUM=SM;T#M#?$V,$!2)V/]:8L=18SM M?(9'+$).FJRRMHI[4NPJG\+4Y,%95KF2(L7N1=N8FC399*T5LA2[:SR5F@O5 ML0!<;I`JP(MAM`(`RMM\I-TY[H7[`20-OPF-:9++NT4*-$J#"FC,@[6\O2B0 MQF&%-*;(,=[++HU&L;LFC;$=Y)LI[AS=CI:"WH(X%7-L+(GH;7?#72O6(JH* MCM)F(T<.3I)$1>KUE09PE$,'Q!RI.G$@2WUYT&\01VESE.<:#&DX4)324!=7 MMG/#G*YN*IXV&THYEMTG8#,ZTV3<*\=R;D1G'G2OL5)63F>:/-=8+45E;3I7 M@-M_.B.WF@NW>0IN\EKZ5615PU7*K$@Y*E;P/K?.4)$:PE4.G9#RK,IY+7Z] M7*7-59Z568;`L-,OCZNU+BZ68@1G1X']6"U4N;=1EW!+I!1OYY-TKJM"!E;< M&5Z4F8S04^ET*N;GGGBJ81$],.M%&):+TEYFH'EF>6(85\QT>SC2]L)>CNO;^R,-!LOK3%YR*N>E9+N6U8RI MX<(HRXYE>%'-%4`)BK[D>*VR6QE@2QW,^=R!2,1\QVRICI#%=L=V11KBG/ZL6U8T`I MR;3G;>=5FT"H==F.YG1S^'3KR".)E?5=]M.)8YB;6,BLEF"#X:"_9G`6HZD6 MILHV!QF>'4AEW9!U*U(IRPYDNW@-%T0)^I_;U5LCH-L2*SG4"^:9<+#JV2G;B&7X>LV71TGF*ZL979-%L+FV+W?"*S&W M5B6FIEHN2K516V[W&BJ$L MXU2";U4WZR4HU%HLI'@.61W^9$5J"@:K=!BRV@@V5@QEJ6+.Y%B36-]< M%9?['A;W#[9E3GIY.MIT.OV^6,KE.VG3&&KMLYT%):O+8L[]F$0^ZA%$"7A8 M\JT*[LMLR$FY]GFYQ^-6N(H1M>2_U$54RH*>U<2QGWM?ME8UJ')QS^H8N1,B M*73_K@B)Q.&SJ#)=NY3/1B[QG'C%AEE+\GQ-I,I\BZ9]G(5:9`_@50R'R4!?Y#A&U4! MIK+M^R##FZF.]I+!E-\)*9F/LL"4>;9NK6XY:QT0+,4J93@*:Y\+7(^!DM&4 MM<8/ATF!?ID,E06KK-YE."\)\#*ZL_9EGI2=^VCS>MTY"T#6SD:U2RW2<\^PK]._^,RV,C3G6:I*WWZN6;T MU%5+([>C$'WA^YJM[9U]C#<$7=G91#R>UQ(4XF=-B6RGU#;>>W2E-*1C);\T MT@IM\\NRQMJ]>*/3E/NS%&5M4"17[CW%0];@B_".>^)ZCJ'-6WZLWP`GJT$J M^(WQ8IEU"*J$G9346E8KU7GR9#-V`O.VF-OXK(9.R-PZ9Z9JC->?'#FKU6IH MW5N+DBK86#TI+0"E*0)+2/X MEY5!)B7,_EB:0P#CYX3]%\RNIME3D.8]T8CQJCZ9!+%^YY`)>)]%NQC+6>U8 MI7`!;#&BJN,K;2*R&KN*4J=CXY2 MJ4^;B:SRUF$EQ-,>R[&O8M=W37.F1+\VU"?#A/"MP.HKQYO-+BMY)X.EW,15 MSV?:S&4MRWVE;#Y7:..E:CAT.V!^M7&!:8OWMEWNKARY8CL7%:71G3(-XCH7 M;:]%=2AG>*:Z+W>._6KH1/\Z^P'.%T)[\%`AYI?-T!L0;UA0^\_]H6T5F M(BM#`"OZ4H9\`PJ7+OMA-T2ZC_:I!M&#`U)Z!9^1?E:`FXPU7XQUUD\;O01* MTY"4U3]/[A2GU+$U0G3WTK''#RI5\^^J-W4@-KL=43NPF9`SUO.8A[<6-56P MDC8+684$,1]Q,U[B4WB-5L']&S&Q'<#BBP5F)&-='TKI6%I!2,D,I,U#QC(^ MJ(9^F$XP3-[LS@13#'.)^8M)P2G(C)N[O70F5A)3.ALI$R%EW96E9)BEW%RL M6$;8[%6PT$E9UYB(LC3,L]#EI+`6?M-F,FMACZ\PY;!+/9^PF.[6[?)R>]J83DFQ1377^"41O0H[;"S@FAJ%Q>I MV=L@1QC6L2!>7DEC@M6Q1Z]J;B*F'XZ M;@9K#%WD75QL"H@RZU+.06B!SDM&F;2G23EC81X6IWR^`MB6!B"_=>Y4Q_-_ MH7&,2ZN)+HUWHI^Z+@'PL^A&%PO,P7I)]P(T5<=6VO1D=53MEO_MZN9$Z$P\^.?]LW!Y>_-X(HCX^Z,Q!O-R0]Z$ M>WNL6BWV04MX@*5K)!S][V?OLX"O&P$=P?OPZ^W+T^]7U_\\$7Z)O>&7UB\N M?O<7-DS[X>K_7;"Q%B_[A&_#W\I\<^3%=!@/S5I4".W'V[N3L!">;%//(8G/ M@O_]K[>/C[??_5?@:&W7^`]IJ_J_IJYW(EBV18+//8=XV@M^Y@#DC@2-F*8[ M4=%M^^VHPWZ?J+KN_[X@VPEH?KSXOX_MT^NK;S!Y^'YC-/LL_./B_O'J[/0Z M^(-G3T+?U9.^:Y(1_/WWJ_/'OYT(2N^X'YZ,$%#.KB].[T^>;._E,_M1P)_I MHS>WCQ>">-*F4H:O+.;2TS-&]RE?=\1O%S<7]Z?7J0-^\IS0SSC=[%=U//G\ M7V*ODXF#A5A@P?YK?LU(P(-79(9S3F8P='*LNQ7/^`YLYW)L?#!>R&^C`>2U/F,=36J-9M_(G[^*+RIKF!8&CQO M0S`"0:]A">?$5&'I(X)J81`\!J.GP5_L14!E6\+I]!FH$$2Q)8!Q$X^%1QC, M'T$P7$$5QC8LFT1X(:KIO0@?QG^C/WS$-]*'=';%/%9+S@=RT-(:_\'/)D`. MJ.>$L()*CV@OEFW:S[CGZ=G"A(5::'C=*7S1%=X,&,94GY`1VYFU/99K$C1U MLM@MG>+%X(([AI5#F+R`%7#IX#;FVP.*@3`L:CD.P3/$7"`^L?\910>O54VD M1I]J7DLX5\&)\+^HR)];85&T!%@VIGJ;%CFU!!W\"@)$"H!:]9DN+0(L1%-: MHO+V8F@O.#/F5$<:A0FL,H19,5UX,FU;%Y[-J69#V`0NB0$<(V.,=,%[48$6 M>%,@2\>>.`;Q5&<&0XP\G%T@#9:L9YQU7W:YI(*RMT&$\/(6,R^?8TO:9ZJ75S?G%VB0.H856)SY,D[_.Y30 M(N2W6T<"J,&S]=M16-47>%PRMK4Q,N@>=Y6-.0G;BA<5X?WV8IOF3+#?+`"! M.WUR#8"&,VL)"?9-N/9TL&XA9.`'80BTHC8-\09>6F#?KEQ')6;+U[%5!NZ! M3#Q:F"J(W<#&77DNZ!*\VYB`TC^A,2$ND,^R.]3N@0Y@Q3O5BV2+X<%J0S1O MRLP&W>&@%*)1(P["7T`/%+MXT\]].XGV@6K0=`3CT0.5^*L#5B$PH4Q?XV09 M:,JV!IA.E;#?1X]A#=E31UGH38X]#3"WT1U#%F6"@MMO"7,L.?7DOJB]$8",DK=8QNJRL.(F.TT*1,"#)( MS%G467LS3+!E!)Y@P3)=X9_PS)"@SL]"H1>%QZ#P/?;404<`_H[BM\!2@7<& M5LNS%ZH*L3!,F�_:R%8T?-:VOQF`,_"=,)?=&!3*&\2D-^*=5 M]C!LXI8<4%V'KU%W#U]A&L"=CD;:PET7X8D=FF*I>&39)>0/B`B=,-.C*7,^ M*5`FTR?3T)"$3_`4+`.P&@%.?6D@9?2==#4)1@W\PX4,P#,R?6K1PX9_+%M0 M77?JX$8<6*$7^PT8=%K4B8L`/)@H:O1"DX3S!'.'U)@H&_#/A%&P\R``K<$2 ME_SH*AH7@$"I4)U\L<'A8JNI]=RFDQZ9C9@;SU9K'(*NF]1%SKL4+=FZ=9V? M^`LP:^KH_F2'7&Z,$L;H!$>M";HE[G0T,C0#GUK`9Z$`\!X?0H1Q:*H6NB^! M.[`@V;9,M$_PA5O-L]&G0/-U+%RJACD%"("(PF,G*F"`Q3=["N[%"_C7&%@` MX0[(&EZOZIBW)`(!YUSST(-9Y8(`!U,3Z(51%RY/"P;P*"T++XCZ%'BI+>#N M-`!K!]H`8RT"G:L`'Z`QZJD4AJMO3)X#9DSWU5G(7"D;FLT-= MS&?;/YBG$<=BYD+5_&"4*GF0Z0,6@E0?C`CZZ06!F("SPW)([,\TXAFA.T?I MF-8,U0!3 M4S%69_[4,GN%KP!!X:%Q!C`PBE-D'I&%\[ANDF:M=$VE_A:80MU[^>T(7;L2 MG*]"F;:UG2^Y@/.EU>A\W5H"O3H(;%.2>S4R3+1M`+%GP_68B5AHRE*P_OAB M.+IP'WYXGD&/9J`P]8!??B`:5C\:_F)Z\:Z]J-8S)6!LN&Y21N#AXBSR+JIB M@0?IK]>@$K":H0:`GP'Z6FJ67&X-AOV6V)>B'AT[DHMCLATC@6X9M80)N$JO M=,>U5'^O<]SI=&).)5AQ1D8KOKHDI`7'=':`Q(@T/S"KA_(L56ABJ]?OM"2Q MMTIH88K`9.G$,:F%?O/K8CZ",T%>#7OJXK)*.PRMG-G8X,B[0)>>?K(%J-B;&V;_]6))64X\[F M226>)]AJGD#?=*FBZ\],8!L*W8C)`K_:GM(<'7[J8"T$S`\Z3,*/XX=CU!], M>\,'IR9$]AA)L5!.^(/,_)T$EF+V_7\(LNBKXBGEQ,2ZH#OJ&[CW$)@YS&30 M=!V8(G>,?K^N>BJ^5`UGT-%A9EX<6%!;^)<*IFP"X5/8C_)`7TA)DLH4?-P:EF80?].6/H;5#_<;0:3 M4S2]W\(H"O_.MK)4#^)E@&?P3C?\'76"FXITOP"^12Q]L6*CQH336ZN"SS.( MKEB41JW1U7P7(LE[/;N]BO@#8$(,OP:19=:F=/L!S=S4>[$=NO67["4M**/V MJ51L=)46N)?X3]1?*]N7'G02QZ$#T>E8&?)C<:7@=T("D<.LH2^$QT:69$X? MQ;_DE'S$%0U-`ZXNAE\]SUQ4^L7YZS$76*ITI):2-`D^',J?]9HFO9_,5MPU M?OKX.=@C\[74SY#X6HI_H.BXO<(?_1P8!JLL*<;J!MV):7BA<"@TL_1A5%/\ M\Q/QW@BQP)LF;9CHMO=FLUR8__L(X<6VS*<0+[/OP;!/N$N.65&#I@%93LBU M0>H&/_YJJ^#=PR_G!O@S-!IA?UFH<@3J^$$ZI?\"_#=JDP\*H!A.9;'*C;*CS`4>&Z2\!-,>ES>OY4$^7 MDWH\*.(.7UT.WZA>[XGV\`):$T(H3!@\8_:$^);!4OV-!690\0=0?LSNT4\= M8HR?IJ!NU+P&.T"Q>"FBXU>>:LZXU.GXK+MF&2]#?ZV5E$XU]WFZ>Y+ MW;IKSA)2"C232"/^8`VD@10K$(R$F-\-"]/P,_0R62$SJQDQS<0\(NKZO+9U M7G*(/NL;?D6E!:\8;NJ)7S^=3.@K3BW=L0V=Y1596I%5W<(K86R,<;"<%VS) MU`(7GE4#NBUAL7&#;_]A&6B9_AM^U_WD)<+T_P$;FRA^\)V%RCS9#@3"%,K^ MK-!]VA.F*_29MJG.[*EW,L)#.I]SJ0#3@/E/^ARCX1^=Q8\!D8L#0V6?]EEJ M_PO6A69]+,\_FX>W7<`HFD'<#/PNG9V>V/F\>KFV_"W>WUU=G5Q<.V5_[XO.>L1%_;A<_: M`=DN/U'7)B\[C[14=FY^:$637[DZ\0T0+FZFP4K?:=*,9QXY1JIXSV'=I=ZJS-Q5F19"!G1B`@<6 M6R"(5LWAUUV23"]YU\#S/=F+J=PS9):]US5/#E\%H5@0AEV>/GP-RD!^3##O M!]'-,?U[6^P`V!85JK"L/Q,(C#Q69_3AT9X8FC`4E8\GPH5IC`UK7E]WQ@KE MA+E+X,,;5>N>5<92#+9PR\'WME1+.`VGI/\!?AU=;*]@Y0='PUL,_6T*/@AN M'L`0C(J!V,&-J9![XAOXXP4I;K4J9Q5\2; M+4I>OJN@8H[P#6OD5>;8XL<+!P:%9>FJH^-Y0GU>>T@]:(<\S=CP@9.Y4$]G M+B:P'?!?EL,-(5\S]2NNEF_[?3T[MCD.B\.+85W0L`J^#/ M)/'+!1:3Q1SSU23`G'T0:7D1.H7H1Q/:E:?MV6TJ\O#Y--\@1LTG%I0ZY(6` M"8.I0>&V0D<.6HNS;VS7D4Z<9G@MX8/T$4\O$C,FSM#K5:STQ,*$U"F&5\D? MYW:;/NAJCC$)[SXL?S=T^"'8.Z5/^K`!T!'K&1[4&0L?NJ$A?$&,#`<0/L/S M`"M>8=FTJ\`A>G`@*\ MQ0D(BH,%RMCBA#L0SX9E44T>H7+,URDQ2/L`-;36VF;B!)XFN#'B08`5/8&@ MT8G"O:C%-RC=4Z:[2$#D,$N^?8M*+.JR`[@SH5V^T&O>9H08)^>V-D5Q/LXF M!3H.=47L=M7^GU\_Q=\5'F.^"%R:ZG.!0:2C+R/5=`D;)?*V)%98_Z(+2S]' M9*T_'&T(#XMEI]>6.U'.(J].&OL2C(!J_A-0?@F?%.B`T^VRT:/CQEZ[>F1& M8-&QE:,O_R,EC1QZ;7ALNGS/@II,R[L!05>]?M_DUD!4OI'7[!X6)'EX7`0'CKVZO#89U@9&YZCXM`;''UIMT6I+8ML M[%6O7F;]TC")L8C8^N//#SZ\C!637A)R+'SK7=8#I%QPF1@QWKXSL-L M_&2;ZQ.@=(Z^G-]?W;*Q(B]+F.=%>\8\=TT-?HIRTI`Y;G&7E.YP('>4"!12 M1H]T<(HTAE^TK%JZ8L%-H'F5F+(N`5%";:=RCU\6U2NNGI65C+YCW?XF5"\Z M\_LG)F^(MX9$L^X&B79X#@^R'@$KA9/_^LZTP>/WVH$$I^,I;2-QSISJ-622 M=2'G\N5VV<.70?!*&69T`DNXZK$(P2#]:9&^>TI&1Z\(66R0-0=/LZSY[ZA> M<_!N-N>]_-=$%1P\A?->_MNB5PU^9KO>[)_*HL3D@43^:Y[T"*5EF\03;MWCCV*&ZU<(,FPMB$B0N.L M3T*:,++LYQ)""E&2!QWY3>5&)*0)(^O>X#@T4@B9W]V2[#3E@4<_PX3V>OVH MB[(T9E&B4F34S[JN1^HJY1*5`SO]3.R4(--1!;/9(O4.[B!MZO)YW+9.3]9',V/\*& M!\GP1%G1^]8-&/O[SQZQ MSX)*BTCB[`%>5%+V_F&X*\0B#GB+%F4AP#& M\N489[,T<3X29^Q"?((_YXK&6%5[T-\`Q953?!`RH\'&2L5_PPK@$5H!Z#BT ME!%;%&(G"58HF5P/WRU!K&%V$V6XY$@NO_0I_M*+]XGA&_FDA;!D.2I'7^[$ MSC]CPBB#[MUSC''9B[\ON+ZUX-(>DW9*3G=CES4R@<"&EI3;JD*(47?)K2W( MB,FVGR?3)F&F;3",P9U**_4N^]#EL1M<7CO,2%[W5]]>GT1`&L7^%`;/%LCZ M#S/RVW)77DEN?/3E5&5P`Z`/)+8P,:CGRB`7RLTF0Q75GOV^A*IN)X?;/!3% M03@5FL9:)/@)Q$/A=SM:YW;J8L%EC#?T1,=-:O$-15Y0JZ5!40K^+PF0D=XNKJB-'"R%OCQ0_OI9^'I[ M?WYQWSZ[O;X^O7L`"C28!G7BDL_"[3\N[B^O;W\_$5X->FM8]K57_M1B$ZJD M+EI_N[CZ]C=$B31YS[IK'C>&B!,T!WC\YS709F%K"S,JS#C:/@O`R^W]B?!? M;"-MJ;W`3.H.Z;=/(&T1FD#=:N%T MPNHO+4D*PXEFSG=ACCD<-H*#W$PX\/GFZL_5GZL_=^FX2[BL7ZZ^G9?W^[O_UQCEZ M.7HY>CEZ&S*]'+T+H MY>CEZ.7HY>CEZ.7H;2B_'+U;"'GN3L_/KVZ^M:\O+O%=^L!<.K.#[W2 MFYV;7CXK?4IC-"7!;LHM22ERX(/K`=># M?=(#I24->EP/N!X#`]4#LM)1"1Q_W1A'X]MG!IA&:/)U- M*?UN2(ZLJ#AX"HUCGV._@>#@V.?8Y]CGV.?8Y]@_L%"OWBW"B]&(:!ZV5:;- ME(U7[+ZL31W#,XC+#XSMVA0WT];QLF^.7HY>CMXFL\[L%#7J!D>#9@N'?)N;2JV8FP?U+@HJW.1URG+R3D]Y,\U9K->!W)`@J=Z] MHNTK>1/BXYVCEZ.7H;.;T\Y*EY7RC:06-> M(M><)AI-"(8S#TG*DW=!MZ=/./X.`:+\TZ*K!+$G*2&YI72WUD:#:P+7A,9H MPE8;:7!-X)K0&$WHP9H@K=-3PGECTVK*W>N=R$>'\G M)[29IJW63%5SII>CEZ.7H[>A[''T=##][GVRW#Q&N^]-EP< MO1R]'+T MFHZ?X._V2#BSQV/;$AX\6_OCD(/IK5Y%V.QD45/N)*PUQ21)K>%`:2G209=2 MGV%:P77"JX5_EK1:RG#3JM[ MV!X4WZ0[V&1%DZ=SOVXYW)HX>**.8Y]COX'@X-CGV.?8Y]CGV.?8/[!0K]Z- MR&;>[-R$R'\GI[B9MHX7EW/TCEZ.7H[>1D[OOH9!&]9HUKL+ MMBNW/3CEZ&SF]/.2I>0\IL<\'T9/;?*CZOZ8N_K7A_3Z:$$!O][[$9B>+&G-Q M8KW;5G)+ZDBM#L^0A':-MAZSP^N%UPOFJ<7DM22>IW64)&X7G"]X'K1 MG+X?3="+<+3ZR5-ALL,O"E@_N[XXO3\!*;]$&8SS%^.$$K4\?-(O5-0X/,RE MHQ/GMR/@SA^=,GDB=CI__2S09]JF.K.GWLG(>"?ZYR-!(Z;I3E3-L)[I]_#W MB:KK_N_S]SOSG_0Y9>$?G<6/@21^_31UV\^J.CEYT%Z(/C7)[>A"=2QXM7M' MG`<,:;^JKJ&=6OHY"WH?\;N/Y-W[:D+P^N7/?_KSGP3AU^`UY_[QLX?YZ3-V M-.W6HJ^)O_O6>X&`6+,M#UYX3T:_'=UUQ)_P?ZDCRH]VI_=3[M"?CP1#_^WH M4M4\0__9Q=^GEL&^\>/A_$C0B68`0-W?CMKRT9?.@J\B!%7(5#?$5#?&5#>= MJ;;-(ZU;H[Y4G9MOKHYYJN7,5_2L%/Z?-T0[\K2[#&YMEWWU/,IDV3*EVRV%!_B20ZOW59,E5:GNQ-YPIIKF[<0S;,N%A6Q^(F!M M'9'$$%LTW^N&.;NZN8S8L@UHJY[-M-F3LMD4.P.IWV\XKSFT39)W?TKS*&0W MFTU)["E*MQ)>P8<^U31[:GFPPMTYM@4_LD,W[IUM&MJ,_7ON5A;`K'+T)>;6 M?S^]_W8%\06XZO"/'ZLQUST>NK38!RWA@3C&2#@J.TJXLH2_3RTB(-T"K.O" MY>G#U^!$TH^)KGI$N+&/Z=]AH17.R2LQ[0D]E?3@X=[1!8@.70;APZ,],31A M*"H?3X0+TZ#[4B!^NJU$'$\U+.$2/K,T0S6%>S*Q'10Z_/3OJ<'F$_B$N36G M&$$(JB6&7\./%]!"85FZZN@N4*4;(T.C1+7P,8<\S=CP^"!^ M;S07DS,7DVZX\%^-4O5$O#="K%6$H4CP`)E-_N`)$]X474`$9F+?>G[2]J"6\B$1@4X%1/'=B?L M9W-&<;!`V00LE0TX?R+/AF5131ZA M&QYX4VQ\L.X3U9H)&ITHP%/H&Y3N*=-=)(":,;GCOUJ;JS[8L83Y/][AC,BZ M:Q9=\W[]7^WVI6U[-S;(ZX$P.P*K6+L=+(FF8?UQ,H)'+'CD&GX1WNE'CHVL MOWC>Y.33I[>WM^/W)\<\MIWG3U*G(W_"/W_"!X_\Y[W9!)Z'P0$[1#_Z@B\/ M7@_D^$^].+B"_I>_2F+(&OXV/(0UZ@Z_``&,3 M7H_30ZSVCX`4-X%?!LNL&B"+PF@C*Z(+G%P!7*(ZDYA$7FR+=T]_O53 MA,D5O)\Z6H1RU=&.!!^_XIPIVZ?=_QV7@;E4V4?PO0SY^4]\&L',M1=RC$_* MRIGNYYUI>?5,;\BM7!^W@[S<=BOCMEL?M\.\W"J5<:O4QBVF$O)QVZN,VUY] MW(IYN>U7QFV_/FZEO-P.FK$>#8Z^7+RC1P:KRJMM@D]MHOO7%M[`S]544YN: MU!6:+TW`YQ06'0B`@"^(1M`WPO@6'$6(HS`4BGCAJN4[L]1)![\0?M:GKH>Q MSBMU06$)'/ON)KBW$"6\JJ8?N5&_-:"./N=[SLSQJV")&RR#9U`?>.2\X!$[ MY>A*`KMBISY^N[GY3?'>-N6W/A=&4G+S*U7'KU0?O_F=\Y)\MB1^ZW/:I-PN MJEB2UY;$;WUNFY3;2153_+9:HR\EM-R9Q@B#KL@B0S_#I6^^WOE_-AR6;J)I M`W\5>O-SPU6$6DK"S-;HHN9VR,6RO+8DANOSV^3Z5G-N=E%+2T=2;.J2"I6\10H=05)_3*N=VTJ62G+A$ANOS MXN3<7KI44O8MD>'ZG!LYMYLNE92`2V2XOA2_%W@06Z!QC=FV45!K'F MMK!T$46:)'->87U/R M:V-)KEDBQS7FG93\Y).,:MTA[N1,362+' M->[K]7)G)N22DFV)'-?H1_1R.Z3=DK)M21QW:]S+[.6..;HEI=L2.2['`P&R MH@[3-?P"G__Z"5]AG."_*0?_'U!+`P04````"`!-@`Y%N[ARO"8)``!8=@`` M%0`<`&1R:6\M,C`Q-#`V,S!?8V%L+GAM;%54"0`#TA7M4](5[5-U>`L``00E M#@``!#D!``#M76UOVS@2_K[`_@>M][/C.&E[VZ#9A9N77H"T#N+T]H##84%+ MXYBH+'I)RHEQN/^^0]I.+%LB*;^)=O=34X4^/ES7?ZD%O_WZXP\??JK7@T^0`"<2HJ`[#BZ))`^< MA-_$;'[0/&H>O0O4#V_JK?2Q?G+_OVO\'_6I__'UQU'H)Z M\/3T=!0A!:DI'(5L$-3KZCTQ3;YUB8``&4O$>:TOY?"LT5#CG[L\/F+\L7%R M?'S:F`VL34:>/0N:&?UT.AO;;/S[\VTG[,.`U&DB)$G"UUF*3-Z\YOOW[QOZ MMSA4T#.AY]^RD$BM*BM?0>$(];_Z;%A=/:HW3^JGS:-G$=50!T'P@;,8[J$7 M:`;.Y'@(YS5!!\-8,:Z?]3GTSFL1ITRK^?C=Z;&:_W,'8@@1H@[J%@:02-'N MM8<*-F1;*-!J@:+^]?[F18C!.")(2*'04+]KN!!I(*=K\GJ!Q%A,(V52'TFL M<.GT`:1P8-$P=P.85-1?R1DV%#* M:T`LQ>R)5F?]N#E=:'^>/O[CEI(NC:FD(%H):H2%W_HLCC"D7?V94CF>O3,F M78@U)W^X3YTIKS*1+E+.$5\W(5X&S[$]AWJ+9R4@/)S1Q1\SD"\'O>F(AD@' M`TVM3M'T9O-[G`W*ZG;*"K.+DPKDC`W56Y4W,HYD,-G!7.<)Z&-?XL]50=4* M0Y:B_]V1,>G&@`E5!';,C+/\`F]!F$6XC))XC%M;]H$O,(]VBD]X"M&<_`84 M2]#8*TQ+R)6/\,EZ""\'3_7D18#Q/<0J\CRPWPGG))%Y&%EG^(6(TQ)IE6DK M:&S&WS#E'%"I4Q64%1,(B3M4W*F:/B*\`3CI\`$ M-1VD.BNZA!X-J6D+YC)YKQ!T$<@Y7J'$C85ZT7;+2+G5O@JJ2>KE*B7#?Y2Z M1R162=H=(./H%2$'(N`2)O^:0FHI,M6XSQ>0BK\[SD84,?LX_BH`F9O6$9/' M5BCI:+)?U`EJBL]>BXP&X=I`(C2GLYH`VO`]",FI/BWH$YZ[W5Z5 MT,'AN:HB/$YH;X1(U0%-NZ?E0O9GDEPSW@$^HB&(-K^("1V87+DDG8,SC17U MX''Z?`E##B'5XAJ`SPX[6%RS8FZEL%.P@B_F$S?)K/9^#R%@[M&-=:D*M])# MW)M=/:LU*2_Y7(O:P0&[EC;R\7\[AW^]NA5]2::;9(3I*>/F8KIEWL$9@*/< M^5"_\Q3JO//64ICG$_B.P,]70+X5_,.'.+TLPB8.K]>B^AV9R]J'X;_L*&FX M)I3K^GJ[9SL7=YQ\<"B7$3X?S/=>A(5/A":JTM!.+JD8,J$K]^U>2PB0HFEP M>MO$@T/<5?"BBHT7H1&4Q8AN%6F?"'IC+%@NUSFKPN/J#`4MWF3RP5HCJ MX3`12C\SG3L;IWD`^V9<8NFPVBBVO:I;W1*!B@@!(G&-FNH0G:%\)C+E5([; M/9W".`)?CL[A6D(Y/>S3"G"KED+Q3XBC:S8G19G5H)#$X=J#LPKL!=\*5XE% M*5!+*+H6,X6 M4TMG-6SE^*B@I#`?\UY/N>:Z*^?.NHHJ"^5H>`#R9AP@4V`HIX-=]@IDLAK% M25N_5\PQ=/4,/*3BM87+A+"=QN$C;->!U_`=!+&X\I"I\^X?``^<"LMY0_?%[#RN=]E>IXYB'SM M7EEJ7BG,S4L0\!V5LO)X_)W>K!=EC'FJ\;A^?ICO^.1S;6^JJK(74AT*BHE4 M7U@26F-1\11OT#'T.A:P[G&X*:RPF1W'/,U[J,SL.\>?ZK[GRKUNJH*MYOJ? MK.R0V9=N!R>68\W,"_\&M(MPU@/8#$85R$XME3*CU-P MW%$!:D/MI2YA!#'3*V5QP[SC/)\P6[2ZG$VE212/'>LSX=]`G\@E42L:8="C MXE5@`WJVB?L$GTT6C_.SZ66)FO$!3:B02N01V`&TSMPG!*W">/Q%V">.L0`S MSI[QYH3,*)^@L<>S#.L>^](]+MU):LPM7H=X`$&.X2P'IAF_'L>@"R9DNS=E MU72LD!VW'P@L,&TW_PK;4EC"LEYMCR*&.1[@X[07,HBPRXL6T41(G)))B_ST M0#O#3F&)V66F#V#8S"M39W81RN,U39?)5W$HV\1]`M)5)K]Z-=QOGJ^@H+:; M?'^'`MV2+N/Z>@]]:99=CJ()'CB&(SA+EV\72+3+)K5;>-2,JV0&A-"OO(;B MF%,\?O]PL`CD\8Y%WX3S1)_7U>X1MG``9PJ+B;<4`>.$@0=O0.A M^LR2@KCJ]=!MV@F&5!K.;K7%U5C'6>WPINZ)X^8LH8W/K&E0/QTS64L.: M*_B'E[][JM7Y%U!+`P04````"`!-@`Y%.&[LV",Y``!VH@,`%0`<`&1R:6\M M,C`Q-#`V,S!?9&5F+GAM;%54"0`#TA7M4](5[5-U>`L``00E#@``!#D!``#M M?5MSV\B2YOM&['_P>I[=-D52EX[3,T'=/)J5)84LG]Z)C0T$!)1$3$.`&@!I MZ6SL?]\L\"*0K*P+4,5*JL_#S'';5<7\\BO4)2LO?_NWEZ?TPY0599)GOWWL M_?+EXP>617F<9(^_??QQ=_[I\..'?_O7__[?_O8_/GWZ\)5EK`@K%G^X?_UP M&E;A71%&?Y2+_A]ZO_1^V?_`_S#X-)H\?MK[TAM\^-^]WJ^]P:_#X?_Y\']' MW_[?A[/O=Q\^??CY\^/GO2]?^I\7#3_.6O[Z4B8KK7_V%VU[G__7M\OOT9@] MA9^2K*S"+'KKQ8<1]>L='1U]KO\5FI;)KV7=_S*/PJI6E5*N#V@+_E^?%LT^ M\;_ZU-O[U._]\E+&2[F@35PM?Z8YP/#S[!\_@KH^?/A;D:?LECU\J&7]M7I] M9K]]+).GYY1CK/]N7+"'WS[&19+7C'S9[W_A/_4OYV%2_#U,)^P;"\M)\<2R MJKP+[U-6?OS`1_UQ>[$4X.DU#F$`3M1G_F^?99T_@V0=99M-M?2456&2EG?L MI9J$J8982#\+$HD`SW^FI;J6O2U(=Y)G99XF,?\ZC\.43_'O8\8J'=DD?=WJ MK==-<3W7\NE/.YU!+,CZO\H>DBBI]*>@K+-3V?35J#&E9 MRB*8Z]]A^V$U5=3[FH%2]5)_O1_9IJ0*+P@I' M[RIREE!KRP+\5II' M*S^0PO*^QC(I/SV&X?-GOCQ^9FE5+OZF7C`_?>G-[1W_,O_K M8"G-J"SAG`1+]&42WBW+)H419(]0H.K/"L6_WDBOS)M7[GXN;ZR"07_?X9R0+-5O9!_]`E,Z+SNF3OU?F:!-NJ#)N8!GO'GYLT MC.J]8/0(_T^/"UF?H'^T^X0H`8I9V;?_<<`QK0U#NOV#P9?=9\L(K)BY`V_' MSK/;3LP?_M*0XQ6KV#0=__!JGY28D.,OH@$;IZ]@QM[+Z8P(3C_X+)):=, M?X1@,-AEV@R!(M1Y,\.LBXRR*N\0#(<$+G>M6-0!AK#FWZXB-QS7EN(?67Y? MLF+*SW07V?.D@G_.LPAZU:^DW#?D&$3]0\<&8_'G@H%3HYSA=<:1)=ZY`I&) M:<_TLUC"E@CJNX%LTNAT"P8N#>U$R-=6!$+BW'`$ZOF\^J!I_9E3[!%L],*) M3)_KXC',DG_4,Y=?^0M6PM):_^?UPWF2A3"QP_3-?4/V/-EMP&!XT.+&8@F6 M](VRU6``9]O/ES;T+_A"VL-_%V^8JQZ;=_![&B8E08_`Z0%,WZ#4GD[_G;"%SQ+7Q)GB9/2CY6V@7[+L,O-#>6]7DNYF%3;FK/@Z'ES\] MYQE?8U67*UF_8)]&,(3U"Y82M+U'-3OTK@FJ/(<+VP?[1((@E.H7TX:#DC^? M[2Y=M'8LV[PI]S-O1@V0]2F?)150[FD;;8-]`AU:$F8@7603R)5-^2\[4?IG23L'P"P$/'UW5Z^)! MB/!G*F`I3R=R$Q;5:\,L4AZ_-O]%94O0'B0X.GW[TC=.F-&@YK*)#R'-GQ6C.VFTCH@.V5.=%O>\63\6$6W*8\EJ M0P#E\OU2UP""?"IB:D0($#J\F4+FV9^R1]C%\Z=Y(C:4$T'KX,`C+_9=[%1( M$?Z\V3JN6,7SH=T4^32)67S\^J-D\46V%'\$2\JT]M`]R>&0EDW@[]XR?DFH M[C9P<.#T)=K7K+"@%&0"V8MZKZ^EM^PQ*2M6L/A'!C\P^\^9&$O(YWEQ,[E/ MD^B6E2'N;MMVO.#`8WB9(]_;3KI`F*=@MX$-[;JHA8]KI_L;5M3AZGJ6'*PW MW``]&G?P%,C^:BK3`LAHPP MZR]HGTMY',)NQ$TW<`&9Z8.;Q1YKW//\$W63F_"U3B/Q,RSBJPG7[?7#*(Z3 M&1J#F>'P5X-ASZ-[J;N9Y5QER,STEWV@*^!MSD>!2M_E.=:1HI!8!7MI$>H5 M^2X_9A=E.8'SUW.>P4%[7BOF^F$1/-B3GF4U^H/N/-KB71Y>M<$C7/:V%F0I M*V^RH\ED>?]Y4'(TSI(_)VQK^65E/PU'&F]&74?8L`#2;?QL<.#2$V\?.*I)D;+8,#WY8; M9)8JU-R0GEJXIO7TZDZ]#"CO$;K*(1;>N'#?;16<=D@T1.D27PDT$U")0S?*'''I/'.EY;UM5 M!;5P5/-D%XNJE6B^H;8U&).VRB?U@YDSH)RC_'F%=@NT\@1@;R.Z_-< MS,.FW-3"3;^!ZK08:+8+CBB$.NDQL"$WM5!/NTDTCUR:^W9A[Y>KAEK(J.OT MC,,OU!-N'J'U6W3A40L@W0*GM$XD[LA51@G;\PW92D&SX1<"QG_=[TID]S>` M22T0M;D?39YJNE-C74/R:-0M1)&=@%AYFL0\0O\X3+D7\?:D1];38.>E_\ITQ615:M-@2175J3I<%0F`*1&[-`[G=1,&^!JW9DTK1_ M8GU`+=ZK",D(4U`KAD.L*EY32*4]:[,Q8")BDY1K74P5AH=8%3P+'!&S,=HC MBVS5N_DAZ9XG:XHJ"6&K#0$3`0N"V68F0D`L6FHFX@F<1+FSK"XI:^T!&8$K MO$C;,EZ$((B%,O$T=W!=X/_#_;VF85I[X54G85&\PMVA/OK+%CV=_H"`B4('!F#$MJS(I1%.43^,E;%C%8`.`",LO1 M\QPF,3>0925#4T%H#Q`,*#@":5/3!ARU,G5\-F4P]NL5DZV$S68`A$`,H/$' MM`F!6F32"B3=DV'0\YDWL#4;`@S4XH-.V7->)G#.J46]RK-(R0S6!0#NTL*F M!X=:@-!-D3^SHGKE55DJ6'_Y4?69[Y/RI4W6#8#NXE*GAD0M.&@&4;GF@?`$ M/&%:+G8SX:F%`C4>T&"FU*:ME7!@#4N%[A"@@)TS+)EAHQ8:U)!>W_"$=P*0 M!*Q/9I0H:15BI!9FM+A@W(2O_'9Q5X0QTS@HXKT`)@%+E(H&9#E5P:(6EK1R M1YQ+#5,7_J:8L*8+@X1+[3%`!00L4NV8-01)+?AI$[31,@N@"%BFVC&'H;$7 M'858IQ8_O"@A=I`T0F4`S4C``M2-3"E'BYB61FP^3O"G7IH$>6 M1?(E4-(KZ.T1L(+8.)DH09(+3UJL196@-<`B8&;IS!:*C%J$T%N) MFYLPB2^RD_`YJ<)40AK2`^!1LK"T)4Z*CEJ\SBTOT9&Q^"PL,MBJ2[BL3)XF M]3'L%+0?)7(/`U7G8$`A^*\SI;I`J07?;**5'F76&X-*")A9.K.'`:,6`:,Z MH'4P8@-@6F85&[9/"5+O@2R2I^\J/LEJ_N%>GTRVR$/?Z!.[@DL]$S(X``[&8J$8A@N4?_SUA!6AF_'K)IBQ5 M;(IZ`P!VEV:QG=@=331%+#1K[28X*_^["4*_"I'..*`)I[Y.VMNJ"7$*ZO5Q M$POC\C8#:.W3'J:"@_I4EJ?$1?8\J_V_1K5AV758KAQJ@6BNL]SV^G[K&6O2@G"IB8]:1-L62*6U0SMD5UEU MH849"_&I/&?WQ00P\'_!4O3*\Q?KCP#0"/AS7#XL%[RYO M5G/]#@"2B-T4.<]UBV_OAN,`/`(&=!^SIH.ZJ,4@MIWXR+R_8:":^"*+"AB. MG;+9_SI8SXQ^'U1/P(-V%]>W%FJV%Z>I6N_L8%FD>XY5(6:N?Q?41R`0V_]Z MZE2]\NA2OQZ0=S#2!*3RZ0?9S"[^M<@GSZ#8\R2#OTO"]"V_:CA+E7YIXN?8 MVQ]1TAVFI+(1[W^FY-VT.G`:\VWBN&^-N3)CYB[GU;X'1GGBNZDDO6`]"6];0W M)&`(T_W0C*RG-3)KGH+(U>P[/YG'ZQ+HO5'H]`44!$Q.[?@Q!&G-78_$<^"0 M@/VE`VVF4*UYVK4@KSUIBW>6`P(N4X[(:D*TYON&D#1ZE`0`K;4`,"YM/ULY M\@LAN&+CPU+*!SS.KW81%]=K88,KCU^:_*.PX M^H.`$ESZ*V[5L&.*FEIB\::42C/`9F,`Y=3/1MN48\J#FLTF0&I>4A98H[%C M;8,^Y>[F[5UEX2:A--.L-@QZ^P0<%+%O14R-"`&UC.*.LA?LT\M>T/850PV4 MFF./I:CV_9U(0[!O&LR^CSOF>0M^L\88K1W./G7*?<1 M8W%Y#OKA4XQKXOI!8PDV&P#`$X@T<^G":*('>]G'NRV]O8YK;R_H'1"PL?A> M?.=JL)>6W&SU15G$VH.X!$II;'O]G<.VEU[H^@*@`G8$ER>E_0T@+B'VW-C02[.BWFX#`PS-$)L M]`W*K.LK*.)!ZEM03UU.,(GF1U0JG!9)[\'VY.W^%HGN%["E-RIM$;5$3`%MZ:16V$Q(IP?&=I.LOA]"TL_F"\*KTN MJ:JN@)>`T;LUHWKPB%74^,HR5H0I"#V*GT#9O&QHE4R9+J=:_0$Y`3MV:V(- M,!(KCC$_M[-8?*R?`Y#0JS<`8">PH6[QZFRB%M?AS+75['Y=A.436A;#3E,5 M2;205NYJ9S)0,.P16*^W0'L7]V#X:$W^\"; M`:66Z?BUEE#?7+G1"^:=-Z.C1+LJTR&"PZ\!4/W**TNQL=8LZ!T1--LA>I<_ MRK[!L69MTWA0ER:'V&@(\OFUD>%*4[QX-\2W9@5SHEX:MJON>G9@G<*2)^63 MC.^?]=TN"Q_K5>N.A4^*S$GR;H#!HP5#-G\%#&AA<9TL;A1%!8L3.&(ML^;+ M&4`[@+P>SZZ&NE>@<)WW[3M/EUTG\[Z9%-$8CL"CQX)I9`Y3=@3Y/1H&#%G0 M1.,\D5O"O\-SAMMF1,U`-H]>2*9KC4AVU[G73O*LA,V$6_#T9C?:`>3U:`XQ MU+4"Q?NN#GI$ICJHX$]M?KKCG$?GBGD>=RC\>_16+>Q[M3G'/KNRZ*.Y) M+%WV$8$04-U/34RE#)GSJIZCYR))GT*>JK9OEL=7W3/8^T+`^[D=.480[>6H MPUB:/$Y*GJ1[SY`C13\0GT#09A>&M`#:2SZ'\',=53G\FCE!RHX`@(!;2@>& M-!&ZKU&YS6SS>U\(O&1V(,T4JKW4$HSSC?; MP.1Q::]S_A:VB<5>.CB%BN7O-*NM0#2G$USO#6Q361*--@6WE\?-LDYI7".[ M*%=U/[28G>T\*$D3U;0$534RAJ5DLN_N\:'59'RW]"IJ"D+X3 M^VLJ&!7>>9JRNW%2Z"EXLR6(Z#$YF8E^,=FII1@;_0Q!3O@5A;5^I1U`<6DM MVH:%7H#'7N(O2P9W-C?A:UVI@^-Z`Y?%<(+-^$%8;?)U M\'/!7L^IY4K;\B^@&[$'.]."O0QD_YQ>#<72.#R2F6?*DZB_-/8+AW"^3%_7 M-`IUV$O!9BW6<.%YKY5'7=@>H%$PW&Z9:8DJ["5: M0P[H5WFVF&BG2<$BZ'?+GB8\V(K_Z$V>)M&K_.1N,`2`HF#CW1*_[;2SG41K MLP6E_,JMTAJN^)O-0=B=-D-*8=E+BZ;/@883N:@#"$S`3BG5II[VFW#<9RJS MJG\:QU+[1*C.EWV+^>SG:Z3B.7&M&0CIV\:IF,D"E0LQ(`JVYPTQ]S%5O]AN M-`0!?=LYS96,H$#4;,^I8;''*Y2\U@R$\VWJ-%>Q$`.B8'LN"8+SE$+7>`\0 MV:,C7$NUJ^`@#-AS*V@(H*_YI8A['KW;NFM\!0:B:6]7\+NDXF?@BRQ.IDD\ M"5.%F5_8'J"1J?_8TMPOP850YBV68D/4WY-J7%V.0&44HO2.,[#(KY^6![.3L9A4CR%Z@<0 M>4<`2R"!ET5B=>`BW%K,XA`E#.2%236*ITF9%Z^U6`IG(%FG8.CSNFR1)UVH M"$?>O%QX:!C[<\(S.4YY?@2UOPO2`Y3BTK2ZK=A4%!E"G#\?F$UAU9X&6!^` MZ-0T:!2'BE*@S5H3%,*;/^<2V[S1.J#:)E!Y&/7FM;$FMCJ9K*@]0"2P_RD^ M(2W:FG@0JKS9>NQ71MC;GE.CMI4"!S4=1BPV MP2$IKKQ9K/.;"130($#,G M@84PYLU,8XTQ6IND?>J4VZ,W@PT(^Y1G>O[>&VT!&H&'"LD'@SQ'B'$@U'BS MR8_>_5`_9F M?]".RUR/6>G32-6YJ6$Y$TWQ$2Z\F0PZ<$'K(-N>%-6!==]>',=LE;W((OY( M/>49G#*>-$T11"#K!``(),<4S73!MJ&!!*'`8C+,+)N$Z<*+@XN@2*^(M`^& M%!)?:BI>#@+1N;>K]BT/;%1LVLLVP=Y@5VOM(%@0.OR59>7BJ0.DWUH!#!HU MJ]<4*]%^4W!$_][NQJWT3VMS;D.$/`J^A2]Z)#3;`10"1CQ=$C8E1TCP=L.N/31YSH&B>FWD,BV/7YO_ MHMK*M0QJ$'];L$AI(&]W]Z:4RCOC9F,`Y3?\ORT/:C:;`!'6O-WR+;!& M[$#AD#[5P>/`FP/`HI2;#-PG.1P!"KX'%WN$3^R MY,\).V5E5"3/&O$3ND.``G;=!]0,*L*U-SO*AO1:3[*27@"3AFNH&2^:W*[C M1.K\>C.2.*&3UJZX!5Y5.^2AO?R6)V$YOF1E>?8""U4BB920M`:1"=B6E=^* M8%N4X4%4;\\E@H$Z-UBJ9/57U;411(U!D$) MI')%-:C6=A,&HF]["2WMZ)O&)F!/\7!%`B@<'O#>X#(OC.\=M;^"A1$^_X2*_!L\N,\!3'*N6,XW\I4 M889X+X"YZY97)3J$1&_V@_,P*?X>IA,VKPZP*;OR1J([1#`\<'KTU0]$5)$D MYM8,)T*T-^/!EHFF<039(N.J,\J1O5H7BU?/^6K<_P"(0.6?V MV0GV53.X"'L>G3(>Y]D'\FQ1M>6MJ,OQ:^,_E!Y41B.!.EP:![?C1M4",3(! MO+ESR$$T_JCALF,T4C`\I+%?MZ*QS8Q`5(#,"&]I(;S."%H;N]^IH=SS+1J& M>#7>IHC+E`P:%8@E_0`&@3V^U6 M*B_@=G\-SM`$P@OK,\'\A'"99.P"F()!TFDQ7\R!2R MZ.[3NE[DRNR_RQLPE]_"[RQY'/,J;5-6A(]L\61X4R3".>17(%`X@4J\VA.. M@K*0V>G-BGFV^IV)M7.5UX8`-BMX"MBK,&W^.W?UNLJK_V35+8ORQRSY!XLE M"YZSWP05$SB2&2^`CO6!3#EO]E1G<&??X#FOJ%O_%6_7\S$/A8(`&012/=&9 MG!(EB6=L[XOEHL?\W,#BTTF19(\S:69'"UBNIW#Y65H\E8Z\.H,`,@)!0H9[ MI3E`C#K+M9+O\F,V$^S',Y]>;TY9"\NTZ,,WZ@]X"(0:M2!,&QO&E3WGL^_A MTO)8@[2Y9)]10 M,,7;LS;>%'G$6%R>`XS%O?3Z87VMO&+5]4,S4`(CIN5PP=[!+ED"ND/%B+7G MW@8?,$^K!;UY$008BQY\__3@RB]I6X8C_K?Y$G_-?H'PQ[ MNVB,,,"&\6H]YV^Y*0_V!>(]0.9=NG]KH<$8\&;;:?TP=#7A>@/%S(S[DVJ< M%PHSHO7?`IWNTGKL6`_(W.IYB_JSA7,:)BGW?SK/B]J6OX4IMOZ3H.%=NM%N M1QW8A//F0-@:[ATKGD"Q]9]=S*[F^*"[7;JC.\".S1MO?H>UX/=J;/?KV,Y> MGI.Y*P]VR+'^&\%P;Y=,!8[P8W/(FZ>B])Y5_^/\.5IV)VT_6#!T6_IJNY<7 M)5",?F^YN)K&,%.VE7T!\RX9D`QQ85QZ*E_RL@O'YFLRVC/`VK\)15<'XM/_ZK#;.C\M>6BD5MCOI#!'L6X[W5 MOUM'F;07>Q:DLG?@\G@;INGF_&ZG5I&QU`0C,O5A8!`^KGZ-\JR"J7R6UB/] M]K%DCW/GA/F_ISFL@;]]K(H)\W=JF0-M+@VZU5/7^X!:O5>>,*<1.YA(08JY M]W:!:0JI3JNTT1@PT:A/H="ZF"H,CY@C;Q<$"QS1"DBR2)8JNLC;L5Y2,EW" MGK30^J'+>]I6UT@E3*3^(3$R-=*T2DNK$PD=5;)A1&(3'%)DX]W12&MY=<6G M,L^N+UZ_L@R6GW24Q:/X"70^"VR866.?ZW^H`$"%W&-CT[,K@%&)"N+ M+W8OP_N\`+GGJ?CG`DOH%'<`;+X3C76\:.K@0R)`K)D"+MEC/8ENBOR!E67] M,^=,:-V2M@=I?2<>LW'ME\/#?#9HO7(:/UL".(]/VC:_)!D^S#YIUP\1Y@[N M^7.7ST-Q8'I-DUB19]YL*`#I\3'9GMVM+7*$7F^&F.MJS(KY4BZ[(:ZT"X9? M/#JZV?P2!;`0AKR9810GJ/;GRV#OR..[O$T6M8`BO`[HO?OT=O+AITT*#<\/ M/T?(Y>7:@=&S2/TAJT`^=X>?HYH5!]5:%W_ M+>$(/7+L[L//$9$L]P[(C"8\+UCRF)U,BH)E4;-P[5?0SV5>EL?L`=K:Y`E\I9-PW12B[R,PY^]5$@L M&IH]@_Z7G;H=(PNJ+E!BCR_-*;4BKN1K0_L`0H])Y&Q^;@J(TE>8;5@X)O,96= M`;-3+SBC'4_""D*E)CYB_JE;X)3>=NB(7&696W^QOZOI"Y5;H[@#8"20BU;W M0Q,S*4/FVD'UEF=_6)2&5=3X$[4%*0DD66FG?P4H:NZHRWSC'*;R#,+?`/E:9'0;`=0".03U25A4W*$!&_7]GD0Y4U85$U7 MJ/+XM?DORJKANH.`$EQ>+]UN\H8H$:J]9:QN2JE1]7F]<=!WFS[3H-2W&0]J M-IL`D?=>;U8""ZP1.TDXI$]UXMBS9SX815'!X@1DN*@KPN6%XMZ*=@#!"1@3 ML.]!<"U5($%4;\^&L+P#CQ[51DYA8[@N4SC*Z:M<@@)1M[T*6ZN_K6>DD?4! ML0F8F%LK7P0&XR;JWEL* M2L#VV%K=*R@0=7O.8W47OLP+>2CO)^(.H(J==5F4(4+H\G;/WY15,^/89A<` M2,-A4:9_7<::D!#.O)D%+'-&ZP9BESSEGX_XIF[(T?ZY7Z8*%\FU)V!@$ M)N!Z*/\6!)N3!`OBZ&NO@'8=6L9_57'D76\'XA$X`B:>ORC-^,]+-Q"#J!U!=GMG<>GFJ@2$<>@ME6)-4N<$(VP,TIS=Y\T0, M.`%BYB2P$,:\O>=;8XS6><`^=:HS0=^;*T"CX+#RX6VC+4`C\/@F^6#$-"$X M$&J\>0G<)17W%+K(XF2:Q),P5>QEPO8`;6^7V?S4'2(8]ITZ:^C;UU0D MB;DUPXD0[5W780%B]O\5:[7> M`*`$EQ8]I\NV"4*$7G])/"6R:R4'TAL@&.X[/6=IK]XF7)FSO0X88=N;U6B+ M;--:PK=)NW(M]V8K6HEQGP$R"_=O]@&H!-P*3+Y&Y.U,#A#AT(E-2(<799]@ M>$#`>%TV`2)8O>P:AQN^67[FC-8N1DXZL.2!T:01RTWX2#ZMQ?98E?_-,X"]HE0[?1#>[$OF@;I=;OL<-][ ML03Y3!:H7(@!4;"]P):S%UA(DY+=%$G$%'$MHK8@IO<2!L:JQH$@^K88V;*6 M1H:?$,(LPK*T*/L$0Z>%;-UMM&I0"!?VRLMA(LB7?'FO8'CD]!BJM^^JE6O` M2!,8PHF]4AZN."&T%SLB1[DK>PQFF44I*R_=JPT!E,>7?NU/0GR]%D%!>/&6 MD$).8'RRGK`@? MV:E\:+?[:Z!6`E'W M3N9>6V4@<\QC4!-<)#8KN->/F5?L9_TO\N`FC?[!D$*VD5;S0!\>PJQ?=QNM MC6BV!`Z=1J:[_E8;&!`B[!EH5K:.964Y]"J+-`^&?0+9&DP4KD:#J-Z>Z6;Q M(O&,G(RU`"`=S<\X']Y7P3F#_R],DYEE`CL.4WQV^CQFKRAOX M3K-JS*HD\E01;Q%T=ZE3"V^C<=#WYYNSE$99_VZE(8CLPHG::-O3AD6LU%U# M[EK(OUI"JK,(OAKF?"5J,;X*1@B^U&V08><@7IV`,K"E[KOMTNIS=`T!]2 M*,)EQ*4),FL%ZURP:K#=R3L"5@I6\0XLBA%1JWDGDEFY\>&=`"0%0WEGVIIH M[!6^9WA:HZ`EP"03J=R=O`Y*\B-Z6K;Y+?'`[Y>^G!1OSB_"47?(GZ%TT M_'IT6&EK^!VZO`L;&WZ':(H>D=S_-/QNF(&&=%Q>!809&WZ'>!6)G34J#IW> MB6T8?H=XOD($SWLS_`X/=\;P:TH66YB%+34:,=("$0[VO&@@``,>MK[05X4^0/224AHM$*4!`UB>,T;(A/ MS+)Z#0>=L()KT]D+=^MDY>B^K(HPDE&"]@GZ^T3M<#A!"C#$#*JWK&2@CO$H MBQOU&.:B2_<323]`2L#PIB`"VVN4N(@93[^%Q1^,PP211_&4%552OH&64"CO M"%@)6.%:<:@#C)H-]2O+`&E:2_P$>N8HJV3*U#0J>@)<`@:Y5CQJ(:-F6=U` M:K+OP8Y.X-FW%5D(%KG9U",]LQHZE_*0'4%KT,'.7:!0&`@[WJP/5WF6K\HZ MGTT:ATAE7YB01!_H<>8T02$\V@L+@&M?F$[J&*UE2,**/&APAKHG3$4"EV%- M3:_29(00(%`R%+5L5I1T!+`$GP59TF@!$V/1F_&A#I`PB`<-()PX5 MV!#ZO)E-KEBE=2)9:0=0"!P7#7>T30`(%_Y2.X9%!K.F7/A,:1P^L"X`<.?. M''(L"%G>S!_KTAZ'91(9,%6W#_H'!.R,C-QK.6'N)IP;5P_ M;/C;J!@T&@=40<`4V8;9%C`1QKW90M9AGR;II))Z!2(]`!X!8Z2-[W,%$,*7 M-^,(,N7F,IMX"1J.!.H@8*2T^)7*@2*\][?F2[CB/SCF*5?*BUD8P+RPPBG\ M4I14.^E*>.@O(TA;5\(#4JZ$A^I`XX;<[\J5T&[E\0.R+H4':I="'!(QMT)+ M!:P/B#D7XOI'3AHX+&(^AM8((^II:(TYL@Z''0N.'Q"PB4@^%S%+"`YB[HBC M.$YFLMR$27R1G83/216F2I:D_>!(0,$\8LJ8!B9B'HRWK`),+%[<1)2TB3L` M-@I&#U.^9&"(>3DV[THSG-)3XGICP$3@OFMZ]A>C(.;0:&*E$%S/#XDZ=TAX M$8.PYJ4HJVJB2MQYSNZ+25B\CK+X/R89@U'Z`CHZC1<,OA!8Z_0HLP#4GM^B M&:^S66:16/6``)B`T;<[L[I(J7DRRB;J[*_/\^([*Z9)U#J#\<8XH(K=W!G- M`%)SBY1.70MD(P.!,G9OOVV!T)Z?I3QM[Z98#5'J^?AM'MSP+7R5+=IMQP.X M!'SY#-;L;D"=^UWJB%?//(N\BL8#N`2<^BSSB@.UYZK9Y?0\>BZ25,UIF[$` M)@$'/]NG9B%(>XZ:G4[,W7 MGW8!:H/>SIB-)``0+K97\4O77WOG"X`-]G:N`-C`:>E-4^?M6H'82K0I]S^= MMS%_S8'3:IU=G+=KXA04XY#>I?/V8,_I9<"2\W:M?S%Q$ECOTGD;D.V2\W8; MYMZI\_9@C\#M2_*YB%E"<%ASWD9L8?SU.%ME;[A6K M^.Y_4^33!(X1QZ\_8'&^R):I<$=1E4Q!^:R$LP/\Q03^;OZ/<);0R3=KY0>" MP8"FNY!D\[2)G%CX=,M7K@&!.[9-5K1>Q@8VK]RVHM__:U)6]4/959Y%H(YZ M,M_EMPQ.;U&2LA4,=[FFQC26`]<_#?HF8`)P/\FVHT?7AH9ZE[Q??]E?W*#A M,GW+0)PD6N8(D_K!F0P$^`B8&[;#HL!XT5)?Q(+8WTPPZ\:71OC*=0%'LD1J M53`:!S1!P+3O8^9T4!>Q8D"G[+E@4:)RO6HV`QP$G*I\TKZI#>=1]H"D8+!* MG;+9_UYDHRC*)X`>\+)DRHT4BFX)*\R*11FM+^P5#"L'97O<#M7JH!?+CL_HF?.53^JX(8YE%7V\`T!J! M^%%:

!93R$(S]0, MHYH*;X$**]F3+%"$8PHXOB%29J_4QHS/!:?X!.P)IE@UHA,(13 M;Q;+173RXE5Q><7)8L&B=)J4/,)T\E:76D%WEZ%!800L6.8SH3MF)/;0GNOG MFW?A]<)EZ/I!'@0@Z0)"$[`JV5&]X-"G1([0YH4+2WTC+?G-!?O.=?L#'`*V0&9C$8K?..E"SZY3&?@O#);/6!/ZPO.O!7P>+7&S]Z*S0K=V!!"<9+_0I>.DTG!T[V?P\DZ3/^3A<59 M%I^&%?9Y8,T!B4<30EM2Y&BLY7=H_YF<)RDK3D"BQ[R0?R0K+4%^CW>[;I^( M`(B3Q`JZ1/`0/+B$?G]]NL]3A(*5-B"S1^-)6^4+(#A)2V"X3;R]P,\,=M>3 MJJS"C(LJWS,D'8/!D4>/AHX;B!*7O;0#72[D=S"LXA+.F\!$VT$J-A&XB>77 M5?H(A(FY0.=IB'T6*VU`:(^^'FW5+H#@)G+>=++/WH#E!R=A6P#AT6NBZ_07 M0'$3I&[*Q^P\MRC5'4U4-LR-]@#&XQMV5UX0./:"N[MSP\_:^LPL6P,0CVXC M=GA9`R./PMY&63"6LJB9\;R\?GCS6()/.SQE59BDY9[9.P26U$[Y<]*7!\,A M@N'`GD>F^G?1MP>#[B"RR[5'_!;12JV"5S*JCD2A\Z3::E]ZIA3./J M--`$^<..,:\^>AR62:07IM1F1-"23Y.HA0W6B@+>1:KT(8443YUHT&!VAI)8;O33 M))U4R91]9Q&/V]?+:HYW"H9#G^8_BQ^E"J.3MR2;/)X]/(`>KK-ZLIZ%199D MCSRXH;8RU\D9C!A6#P=Z(1!OIN)-EVU=O,1RA*\N8E55)/>3:K:.S: M\6FYL[C2=X#OYFEN2S/#UHP`51"(#^O`HH5I,=,!M03@0@CSE6T#QUM"R[9+ MAO[(H"Z?_G>N%P]319!,%\[%#-/YY:=&LKI/GH1INAEL+YDS'48%-1$(/+3" MM7@:==8-M63BR.J):`L``00E#@``!#D!``#M?6MSY+B1X/>+ MN/^`&V]L=$>4>EH]ML\SMO>B])K5KEJE[59[SC&QL4&1*(D[++*&#ZG+%_?? M#P^211)O/@#(>Q_6.ZU"@LA$9B*1R,>?_M?770*>85[$6?KG;T[?O?\&P#3, MHCA]_/,W7^ZO3O[P#?A?__3?_]N?_L?)"?@1IC`/2AB!AP.X",K@/@_"7XH& M'IR^.WWW>X#_X[7G>W`" M7EY>WD5HAI+,\"[,=N#D!'\GB=-?'H("`K2PM/CS-T]EN?_AVV_Q^*\/>?(N MRQ^__?#^_7??-@._H2-_^%K$O=$OWS5C3[_]WQ]O/H=/G[[X6 MT3>(!@#\*<\2^`EN`5G`#^5A#__\31'O]@E>./G;4PZW_%4D>?XMAO\VA8]X ML_`7OL=?./T]_L)OZC_?!`\P^0;@D5\^70L1^KXW5PWT+5JEK77>P3S.HLMT MW(*'T/97_KD,\G+"VKOP-E=_GY5!,FK=74B;*[Z%X^A\A+-*7Z0TX3CZ=B#G M7G')KM:8J`PU$_SO&[2&WNK@UQ*F$8R:]6%HB5XEDQ-]3%0DGC8+>Q,F6#EG M.1=?,MG];:^#?UG_]CDS\&:?PW MHOO/L[3(DC@B_UBGT5T."YB6Y)^;[56?(`\;5-%_*LA3C_@V MS)`UL2]/>I3:YMEND0VNEYLML@M=[K$G6F=!$1>;[3H,LRHMD=TI$1/.6.LL MSUOOD'W)&,R7QU'@YWND\,`90N<7#_A12/4A;RE(;H]/KH(X_TN05/`B+L(D M*RJTN1J:50YFG7L46`P9"0\'9#SH`'BEV73V9_5G%YT%!8/67L=7Q3]$OV=A_YM5G9UMV>J M>RR;#X5V&H_;$^M_JX*\A'ER:.]:U^DVRW?D!G;<)8T3P'@FZT)MCNN0J=L9 M.E?XSAP]MO;HG!FYR4.>GK3#GK"TSOFD.X%?#"Q3QBJ^]4L'FVV@$9? MJX<"_EHAW7_YK.EM%8/8-XO$JV?._W8HH&.]THBJ;6".A+^`@#?"136S-X.#ZO M=?A#"6&-.]1K9]Q!Z^M/X"_KFR^7X./E^O.73Y@/+C*=W&0W=J;&RL9CXXO!.&#NE'OB?HR*M@0 M!_[KLX-@=1?9+HA3'5>V<@IW7FTU=A(']\,!2-B1SN`!0YINI=#Q;;2/$T[' MZ_09%FAP\5.0YP'2L1_A[@'FHJ-1.-SNN2A>]9"%VI&@&0I^IH-='X@*RO=. M0RVR3^""NR0(R1&[?D3_H\<* MGRN&:C=X'@V-K;#(3\=EW`8[])_WB,F+("0O%:J+A0ZP?0[3P8AAM2Y[K0`& MQ/_L@'ITC]#?,X;]##=LBM68Q\]!"5L=VJA/-/(4_=\'A?VH"6W9DM3%B;'# M*&#GZ&P/30R+R??!E^/3;./Z]MF(79OBO(4/>854*?Y%]&DYFYG,8-FY:X(; MXQJI@0')U&.9[\4SB\U\(_ONX)&[Z,")MRX*6&+;\B8.'N(D+F-8U$[L:)-^ M@F&5YW'ZB`;<9FG>_),$:]_$*;PNX4YFZ`SFN6+J/:\3C/@],0 MI7>.+4Y-?NN9F4;,9M&#$S[!J,+W^O-LMX?H.D_S18OR*LN90.HUQN&Q3A%- MDKKNQ69['#B);N>&;&`IP=\%52_T"=O!.ZN1B^;4C&VY!MNR$/>AN2;7OC.1OR M8+@A5GV5+K43X_YTKYHFV$B?80+#$D;''/_-=K/'E9O0YPM4*GP;MK)X?"6.Y M0ZS7I[&&,PFYS=*L6?1U&F8[6*]YA-5M-J%KR=#'7"T5W;D`G0R\J:=[^QI$ MP9`-%&(PB@?LB<`%?(9)ML<'&#K)'N%E6L)\G\>%5OT7+6CKS*V'TY"3.U"` M@($.G!=FRX@]&S*G\89-L)2[A;-T:F5)$WY&3F;7?AZ+L:Q`&PWVZU9DVX@J MLGF11#1IUWL6]@Q;[BS#\1Y]3R,>D`OA.KNQLW95;B/`8[V*`Y3L@2*OD;\! M3CE('?HGAO&!B\2!?GP^\B>V3[47&KPT-I)O$6X2!F`IQKOF(F%P%<-![H.H MM$BO8!RW`5*?L*=5<6QUQEAGCN[ZA@Q!?O/F*&(H.=QW`1DM[[52+?1&N=EO MH0JH=]R;0X-#4>ZNNY7QC\'7>%?ME#L_&&=][X?K'.Y^_;M'>I]+V2$'2,AJ MT3AH[DQUTG+CD%562I##V3<6%'@(:FH>QWES7FCM"&,[Z&^'[1*L[5J45QC! M>$<%6=EUJWC(HP-(2GI^F58IW>TQ#5K&+DM)1I3R8.*,M,HB"SO:8HX[X4S+&8)QUIABN4Q"1N70%@[+3P&;J6@OW_,K=_2&O M2K;>XHT*)J2Q5)"7ATY&9W%VZ/ZBNEX;3&+_/F:"(7-=HT,`&>.-X66^:ROU']_OLD*&0=R1]OO?<1=,_-0Q@0:X(%OY]:LW#9]LRT]00.677&W M9YR%9=N47PEO,XV<5(QM3R)O87D>%$]W>?8<1S`Z.WPI8'2=MBM<(Q7R3'*# MSC/<%ZA"?SL&%TJ$=^K$UN5\,B6&#(HF!'A&T$R)0_'>X%E!G+[MQ.P=9R8] MT.JY._&J*T#DQJTR68X^-4G`FPZA^/19RE#5T4J+X!]B_*L:_V.P6J#`V*9> MFT=##%7@G.IA2@P]OE1^@H]Q@2XK,/J21C"G_Z1?:AU;5UE^5STDU7`HYS`3(9Z,YVC`TB^4=T0D!G=''WG)T$.`.DJ/-[CJX6 M,F5RP`+=W&)/O"".5J+GC/2YK?!M&-.G((3)C\Q2$7KD77H4+3UP;E1.)G6= M'SI53_03-F91$J^K6@F&KW/%PZYY"B[3J:T:#T$ MI^BY#Z*14K=?)U1*VIGV5OB$*1SI;G^%SY:#'7;^9JF@LG"7YZZMWIE:45"8 M,]+=/HN+!/?WV?FSHX+*PGUV'"05IWI!4OUQ]H.D!NMD@J3H[Q[P@92R3)"4 MF*QN[.]JMR<>D$]Q\NSI5O)PTFSN-S"7[($ M&?7H(G`8(7NB2;R0/B&&NO+73`".,W@J@-JHMB@]MR/]%#\Y>^H(H`YO^B&" M]S#?C10\"NJ5N-78&`L9AO-7L@18M:M/XBT$;^(4'&"0BP(F?!&J+L.9B!++ M;7X(T$6,7]_2:,()UI_"*X$:8&7`LT6G:A!YQ##)/);T'B,:2)P M8JYT+7@P#^,"WN5Q:"YQ/5A/1*V/C[Z,43A``'V4+0V\G@E>_@0H:S.EBGS,9=5L2D$(=&`W@M<'?)8G*LV$"+YEV\5W>E@?2J,)#)Q@F3R;1W MS0%#JAZOAP/=,9GH@?C(3MX\\/*I*^0/MV5VFE601KN:C??$,.[X@[-^)H&, M-$[VK]N>:@N$G".GO\5LP\XZE/FIO,'V\PUY*U;QB_,W7C6]F9Q#!;$=*)H; MC89/O,'N5,N-I/52Y_BY\:EIDIC<0FTBH+4]%JECD]0&\7"@==9@5CIDB[H+ ME\J6M74W5*_W\^?+^\_NV9;/`D.6E>V_;78]K_(<5]77Y5IFO"/F9=?-Y^$5 MJ$=ZQLSJ]9]_^?3I\O8>4-[^P1?F%C`,G\>EW&+1P`N*IW4:X?^'RUP\!PFI MBE*>!WF.$P.(UT5F\^G!VS<#-?%B6`OG.^&X8_(?'=`56.-L,`I-/89NA64R MAB2U"QY!%T)G#_,XP[T?\M(Z2B`HP0-\C-,4;QJR]^EB%L7T,E5F*BZ")WXX M46!H]29CHEB8RXVY5K%9O`*I[!@_XM3+O$Z?T9](]D*MU24*4PO:0;D*'9S8 M.A4-%&A9LP/8&AAN%>5DW+"TN1$24<0SC`5&RRY2F M#;AGR3H,LPK-^@F&,";M9VG]_7T0-VU\A-E.!A-8;LY@@!E3]81TM@EJ8)"W MT.1TV%-X`.L)G"57OWH4M5*DIV!Y72+,]K231`'01'4X`;(Q,R,"@("XVA^" MA&3;%$\0EB`*2NE:.[#+909I/UAUH_2P2H9+FQ^ M7@$TP.W1J;M4]V:-#07 MZ\^7X.+R;O/Y^MX]EZMXAVU!I\,X]GC_+L<5P$K2,YKT*?VUBDF#/+F%(0>S M+@,*+(8\U`Q?D9[E=>_:!L0#J\04G4^;N\M/]W\%Z]L+WB,\ M+CT0$!T&&PJ)/G?9$Y1."1:T(A*C\Y0E$;J5TEKR&F_*^E-8%R`#[!B%?`1M M!8F4./;C`7H*9M?KL^N;Z_OKR\]$M#[?;\[_]9\W-Q>7GS[_XV^^^_Z/Z!BZ MNC[WX1@RY(Z.K+D07"'FITD M`N))F$?CI[H+#J27=AY$4./:+8.R?PF7XL! MCO7AMJ[F)N;NKLM*%FO]=QVX];K0>8;^DE>P6T5/(B$&<]CO"V"`'_^)8RA# MQ&2KX4%G`K>R-!W/]B5CW\$SJ/&4O^-8+>!ORK!,6?]QW.K24%N-^`G]:?/JUO1=D1DY'0>J(WPJ*- M/PYV6(?7+^OX;9Y]7<>__))F+RDYS6!1QCNR>6%6X(#1HLC"F/SA)2Z?6OD^ M@+S>Y#(#+_5*7#_4JT6M]S*O*V=VFS;&-/P(A[62AA&/,`WEQJ44RDDC1S$. MO):.]6@:3M\=[SAPW@R1S<>/U_?81T[]>N>;V_OKVQ\';@KW9Z(&B_':5FKQ MEY-Z&J.\YIKP+BMJ&'F5>R4UNI#4I6S+?:[5*',TCHRG'#]+H9.Z=IA[X`(T M8DM)N1#_?.6=UK7*5"]FJ,MFPL(KP!F!3+L`H:D;C3X[I3\];L_UI0BOVZJLBC1?Z!# MX0?PX;L5^GWUAS]\SWSL`_K0_SQ=_>'T]V8?6^'6.;@:6OP,$P^"YD2B(.GV M[#0/Z0[-!=&=-M*27NYH![$7O#6S(1?U*)MBK!UN,0(#'7&>*+(_X/@LJ`W4 M$VX#2/=B*F%[-C1$P?,6'^"BB-0'"Y*[((ZNT_-@'YW=B3`0\%U"NK!CI_;QF"`8_A/XA2$,@RL/KO)>8AY`>A>C+'^E[\0F>_).KXL$53K)`!5#)>13,++&R[X&SSDH MJG]V:/_SGV.8([(\'6[@,Z*NO`:O[@3NRNNK,!/7V%^!%L";(KUF&R:L3&^P M6PZ8L=MAF5VGLK*OX3SN6%,33TD7B`Z#>E,5>-0V"CG5?`\=,.QUNJ_*@@C0 M=\K>HE(H=\S(Q4&F'"G`"A`0\)U'O4@U]D7(;ZI-<=/P9L9>Z3<:=:^7_[33 M=CL+45.BI[M:;`7:CQ!SM_L9^GA$O@&.'_&LIK*]W:/3_%Y=.7 M-'LH8$X*]5"UA%!#6X0P#FAOUQYJ;2"AZG%UH>]Y84?-03?9H=?Y%,#?`MV/ MU4LC:O@7?-%BUKIQ=^O]5\K;7GM7-`@_X;=B=6Q2,M MOX16TC'W9U9)$Y(GVM5MMDUL]GU&BS1F.7'HH"7&(;S+,]PGD6?\CYS';J+% M"#PE-L]FV^9=X'>0=AZ`)@+U3*"9REEIQ;EP;LL--FD(."4A;G$F?LT:Y_VR M.&LE\.<[.T-^HQ3X7_,LVJ/5JUJAZT' M[C+F0H:53'D_'$#C'B.PH`'VIZVVR=Y)`C`T-\YFAE;\C(Z?NR0(B9PI'[)% M``[RM`0K9Q.=R$#0CE0\6D]>N7::UF@$V@,#[>HIWMH/'CW$RUF*38!2\],$ M\_XS/B&BX4QLJHN#D;1/&$G+&N-@Z80Q@LWG.H_Z$ MQ.1LX-AH/<$6MI)-9Y=K<,%@NYLJ6C%SS+=*N=EG/S2RE.*]#=<@M\UD3I(( M=Q?DI3IZF#?80;(F9\5LBOE=?;"`SQ0&G+J\GI\B4CKPC7#N:!?Q2GZ6QPD;9FD\V!/`E%N3,)J1T_M MT*4SFAHR=P_?U[,"[LH07:+-)+-^D#3'DYH(WQ:CH#,W+.9V#O6V[?#^9BNYM1<(VLRW- MU`0Q1=R[%XM1C-MW)(SGVJD"=Y^=0?KE+_LL/<_0V9@7:%./T4524=,!=R!D M6ECQQ>L^`V>P$3(,#8[@W5A#YY(U`<<>R\#GHA6?HCE9YV@X3=Q"J(L28*\ MP"<*K32W5."9EGR/0&O?H%7+[N"T]..D5,A(3WZU!,1JE\\0PJBX0AAAC8)- MY75Y0_1THB5ZZJDI>CK9%CUU>`1/1I(:HP(DA^@#`. M[RO^'BWP4^X1/DXNY[?!A8I#/-X+*YS'0F(S'+C4`N,Q>)66N$BX(6..$Q1< M2[%*+G0,[\6E=!W]9U64,#(4UB.8%S+;P<)`=!LH_R18'Y^,@\_KD6@=/)D[ M=M"@&540'^GH;_%)%"<5[MY`3O?FOD!.?4_5P%#P=+0!7^J6OP,3<1-O M!,QL7MX/6)RGW19`IYP[&>W_[4&7!-IWB2$)7MGE0DV/XU5#?ZN-=0T M+3#F\B%5`18[3B5!4;2KVN2?XL>GLM..1.)85(/:[TBEQH;)><8@'1$%60X( MV*K;E<6]8TUWHYC^2$:[-'\817@9Q$^V!T,*[/@S' MH=CBT=Q`VY>?.TF!`(MGVCBTCB$@+T($<2!(TY#;CV<(=$J9P%:VGFVV\.T($RQ3LA:R)F+_6X?"]&-47;U=[#0-%]JRV"1;YT\X(^![M=6X/@]#'C\8J,H MR3?]28Y=E`N9=A3+LZ#-"/0PV\$VGO.F7JJB_KX4RD%LN@P'-E`=C^Y$^#;C MG>>D&>P)&\2NN2'..4N9":.`\X6[A/DQ$O[R)E=&:V\T>2D)5;;2D7.,1(`RP7\)"MG3-%V;*=-DB?'VB2?XKQL,_C9!<<<'-1[>KVVI"6S0D=7!B[ M`@.=?`P.I+\JISC"PN7OM<)0E\&,0KJ..-7GP+X59JP*7!O]@Z&$ M*.$LRX<:#X:'"`@@)>]-1<,>!VGN3Y]_C#9G`O=LPC)#\YFSCP:@7?[1P63( M0#6,YQRDO4<]%C+#D>YV4:AV_:XD7ZX;/E$Y6[FW,[:."_*>F[5%9D=:?N6S%DK>U%& M@T`]RA>]+*;RX+HL)_'DCDA:&\T=ZJ+?D6JKZ_9&GNVUA-*`K02]!5%IM%@G/U`IL$ZF=L< M_AW@``<,5TMQN#PX_9P:BM]VBO.#L6;X15A.KRCP.<7`G7I).*A5OO(OD M*>ZZ.>E2];B:A_QA'BGI.0E1*KI/L.UOL[3AS(LXAR&"^P1W50ISHBCOLB0. M#W*CWV@*N[L-;8S>S=+4;OY-0(3JH/BQ]Q M012-^%S><`?1G-Q5\V,ZZZ&@'NO\HJ%#>C;`4T7W>=E`(Z"7#^"<%10!O@PS M.+?,];9`Q1`S.Y,;5:2(VV2&6:X:S*Q29,IZ$Y@I(&R_2JR,JM-CK0)EVV7. M0">Q5;V5"F*J`H\Z+0L)S`NA$E%WP@8WAH-B>YEA=C>77>5P:]L1OFRL@+"] M;952==Y;@F)_91#.[P#B7>>:_"H6F+S^$N:*0I*F2)P8(^'RDB)C:5U&FH>[ M];G:/3?K<;&/^ZZYWXXK#]W')4Y)O4ZC^#F.JB!1O',)QEMWD(G6S;R"XG$X MD_@XTOF]5(OV0P^9!N$=.)V*EG49"\MEN)[BN'V\BL,2;^3S78;AS!7O@Q(H>R7 MYY/BP-S@\&C0#@?U>`\.38,]88KWZ6Z(/8-^7'$SDVX.#:]/U)%6"0[SNZE MD;-.0;L)@,9XD=MGMF3'5UL1'_0NMG(FF,Z%]R^9%A=VQCGAPNXZ15N*QGB@ MD:34Y>VM@+06>]K7<6H*3T5_F/W^]/U5,CW:T;\`_MT;;P2/K$R'=2%-[6^_ MTK7@/`!6&;K:80)O?`%Z$:=38T5%K^$DEO<:+33%!@W^"DZQ5+R-RX$LOY0K M,!!$+[<`@/`$29GUY&S0VI/^L[K^AMA3&[=!6>6X%PXUDA6'!W>T=07"7S/S M$$)&D<9)S3W'DR-%0O.A0E$2W&9#F!+F\:Y3@/DV*VF1V(=$?>SH@3MH#Z.% M%=LEAH#5M;Q7=3%O!`I:6(\.+Y.M8]O&F.[;'"4]<:=M_#%%?JEHN*/RGLRJ MQ44^22MQTBG&D_-,07I^Q4\9W6TV$3IV`JZ+"'])XU\K>`&+,(_W&AW1]*=P MT')(&SL^NW6:9G=`O#D-37>/[58T9NL<W?I=V,G[EVWU. M8U>4C+;`3>\\*)YN8-$VAE7$R0I&6PZ6%:V9X0LT$."1;7]F+]S-RZW?7N"O ME&WZT;\:/#.E7@2"V&S;VHS2\DR\H98K1G!7RP1+X?(`2)-U2F?ZD,(C(76_ M:H2*SO-MMZ*4$W^PTRT7%W9B-]WYX:4FN6SCYSZJV$JLIUII'5P(Y[5S3\5J MGU,\]W3IDTO1QV@>+#1>?&WGKDC8254'F,M+\S*XPN4N@W#.X&)G.X\U5'YV M5PQNAH5/C\EJ=E(QN..G`F4Y%5$UE6ZF:'&=4E?BCWE6R#PRBWS-OV(_HVC& M^'D$32A!YT.X6UAW7/TQ6B!HU>0EKVAB<@'BM/5MDZ^ZO[$OR'[&A8.F\IX+ MH?TQRR+<>>PD"+,S?]-%M@"=+ZRHF!:@^0C89GG[9N"3',[$46+IFY6=ICQ+C2XD MUE,(]UD'D58]_`3CQR=<4@-91,$C;/PR=WG,%3K7"[+\M.:0\EQQYC5\[2X' MG!UZG6%[QVR_^@>2^JRK#0IPW1RZH%D:J-=V]#B2U3FTR?__CG!W!+Q!%E.4 M)4F0%V`/X`B+Y$QYWZD+8!0OY^]$`(DH[4`NUG;$]VK1<,NW7N&JF1L0&@DV=9!5?1-!HP$>[O3J MH8T!7FV%?FJN`3D,88R]7LBT+ZJ'(H[B(#\`))60YH3$E,<@D508H`L#O48, MKP8QZ4B/`8LLB;!#NWR"]6_ET7OD_&X@Y]"^Y:[#GA.DY2[/0@BCX@HML7&B M;;;#3FZWL-QLN]&_(FD:/9U=:1N/-Z?(*/1"$'V/?+$'?+L:_+L6_*DE#SMH!!]R[6^ MFJ@C>OIL%@4Q1=_!'"?C!8\D3.HQAX_HNYOMP(=!5&VQV9Z3TX5H7Z'&&S^A M99TW`7/."5[/A35=.QO^!^,TI3/BG^B+97XG;&YL3_2 M!@DR_LL+XPBE)!F8+\[%?*IH]`5]'KF8([,,1A=5'J>/]-Y!WP[K$@YM3#3/ ML3=J%D=Y:+HXBM/3$'_2*9IK&DPPP\Y/CS> MS+.9]2THHINYIYM9/Z:T*#=/*)%KK3-.2OFYB2-$=%)7U`32/CU(LY%'E,UV MLZ^;IQ0701GF\!T#=[+/"-'AG(O$")[[V/(>,KR=1J16L,PJFN(2-ZQ1`#6WYN$ M*V>$``\D897UT*;8BQNSU'C]=\$!S9NLD`6*"_423'(*Y/[E2:9 M<.[=H#LCKNUYEV=;6.`L[""Y@E!XR(G'VSW1).MFF!D/)2S0'0SP:(>WK%$( M[+L(;)=#0.N<-&V$Q6@J,(G="JB@Y"405Z!)'@Y MX*,0$R((0^P$QI<.]`.A3TAJ!:%CN(R?JQ?P^GIC\<$ M^4-6](UA/Q%TG2$G.6Q&`)VE*HHA;;MB% M)*IJ\O*E/9+,<<`>@AJ'L#/4_8$K9R"]+*5Y/:9(NAJ?">M3N<_J:!`D@,]Q MI*C393J5`]^I,;9\GQN:YN@HY7I3[[,VD*F9S;4?=3+NW9?>[N,..6Q:5R,Z MONI#%1\[2V*N[V6=C#J)*:O-=HQA]U6W%Y/2(06/$JY/WPDBS_I@I\B[O3-[ M@RRNO+ZKR-*1!^.LG]##=0Y9D/S>7'X=71>,UNK^M.5N_?"0E>S[A+/U+$A_ M.4?']Z/X_MH;8O(IB3X(U(=(O/@ M&S;X!M%_5D5)GX02!"Q2##8/H!%L.SR>1O.L90OK-DLS^CB2/JK?(<0@;NPN M_NKY)EAW[,*/$5IN$0,$KKMQIMW[3/?V1L/OL]J]J7>7LV[52=B-:^`I>6V" MK?<)XF.=V`F;;7TCND[1M1!*KAW:D'8M0RUUI+"Y9C:<5XT!1BY=!H%Z=S2$;/)P+91\8B#8A[X[4C9I9L[VEU9 MC-Z:Q;4KR!N@^W+$&B07EG\0T=MF'SI\$M\'7]=5^93E<7E0]'82`3CH-2=8 M.=M=CABX:"1HASKO.:%'?[9]G)KX+GE'HV^A",0#_I'T)^1QD/,&%KK[H.:B MF9M97,!GF&1[4NDNAX'5, M,*4-U`LN!MH8B1=Q#DDHO)PE%4"6VT(I,&"<7B^D4C!H2[E'#S+,@C1==B.9#EN&<% M!HR7KAT/&@!`('QA%:TMZ4>KZN^'ZUP2XR+-(YL,.%F%)UDO2]%X3-.>8GS7 MGE$=!-PGNRS*X<9]?I9B;YO=I]M:2G=!OLE)NGKT%QQHBA9-D)/(OQ:T@V[4 M.CBQ21K'G)05$J0<;'):*"("!)843B70;L/G)Z%74/3V"#T:3]EHUZXC%ZLZ&]0SH5#AT!>(6(*"4V'H MLY%2$'@\Y%`(-E59E`$IYV`B"3TP]^+0QT)/)CHPG@F&%C8]Z5B!3(6-4QGA M<)E24(0L9D]:[M!<$%=+&7N1T9W`N@1I8\:66:\!7\&-9@8D7\V]QHQ5A\(W MAD]=B:'!!4<%Z%CL-.X&C+AY=M.9@)"_]QT]?I/+D"^W'MZJE!W(NFH-07&J\N M1YI1#R>G,I(1P%MO+6+HAK;8>"GYO!WD2U"K>` M']2JH+\]!OH$GV%:28M@'8=89Y'.ZCB)V.0GMTIR]`)M`VP?^U^`O5BBT MFI'P,\E\@3DQ&JUI':"/+N-"JK:,"M"XK2DR&[-4"$/[J@/@A+1/QV>?P M9)]G445KX%1X_=AI)CPFOV1.='F,*<%`Y?1[LXC0M2%?U9HWJ&$M*Z M\*AQ&7);#5'+3A?&AVI5T_`)>C!+X:%3/\,<#UI%PQ0;FSI`4VZ&2L!(:"R6 MI1O4^Y(6_V7'VB]$QUDODXXT+#RW6(%6'1G063'E^F-I'RA=M]4Z]-;(F.[X5T!_]J#FGEH]TS* MV7K&ZA;MNT,+6^--2@+CWN*6O$NQEK?R9?GTSP;J9"F?UN&.\Z0J0LZII'.Y'%*FC56Y'1Z(**:PM([<1W%]$,QGL#Q M[@ZUBSBI2FDTJQ#"^<%V7+O.T5:/]D(&]3&I?_%.8A1\I#KBN$SD_)"K5V42 MRFH\DR\'G037B4==/;.7I]P8K(W/N:B66=V3SL[#SG2*7,`TV\4I%DK29UV, M)SBI6W>A7U_$=.QFEKI7:2.5@J89H*<1[*G`=13%)6F^?A?$T75Z'NQCQ$7* M&MX*..OJ387'D(F/XP$&.$&26X-X4`O-:'.&C&>P,S9C0\L@3F'4&`!*_A(! M.(@&%:R<#9RD`T%K=;JL)6F\_'485KN*=HV[@-LXC$N/)$'./VS0IYIY+%<# MU+0C?;`4=6P`>^4?]J0ZV^I)POTM?"&_%%?P(:^"_+!.HW^I4HAF^8XC M@A/GLUSY=3S>C"B3ZPN="]#)ZCJ4=1T*-!_]N0#-C`!-"?"<`$_JK%;RC%1H MVZ<.[W4XF+/MDXBDKR5!T"4!"$KP#Z?OWK\GEY\JC4O2-XVT8NPV9G59$GU& M:EW^6N&>%/%N'X0$R5X#]!0Q#"4>S;,&$>4J/NG>X6BOI(H0>_6RLS&Q@Q3] M+[)FD56^KQZ2.$33;R&9#%T\`U!`I*HB/.7@9]?]*J?JI7Z-XUF4TOQ:EJKU M&=6LSH1>Z%DMS`T4;>T_>W6:=A0=+*E:"R;>%+4[BG1'CZNACO53'>HK$!U] M:*H]+-X`)0J<_ODJRS_3ELNR5`;#>>S?'`WQU->0*VJ+-C4X`9H'-!.Y?6&8 MBC,)_\TA=;S@/MPB[8A^&W;E]N`*.(:SF>OA>+9V+L/="CR3A%@XD2]2+,;4 M1(S[M73]EV-]K*<(LF=^G5&LKBG56GP^X:[R$S4@V0]W/D8TR\>Z+,#'X""[ MJHR?S^Y-90+>S),WG8I_5>E*;.T@(C.2BPJ:<\E[BD*4YZ:#3*+;>PI/FI$P M?VQK:"Q,$ZT[R(Q$^4OCY:DIT/'6)#&LB+8+BB<2&<`2H:%5@51B6N;Q0U73 M%CN0<".G\N#ZKC)5@?2N*O-HCX75(5'),ZI#_GS^J4,!WN/5(9G0GCI4NVUF MI,*\RM`7Y\S\;%(,'#+T&9"HPU;W%1T^Z5+E-:@^F;(P5GUJ3;'TV^!ZG\>) M6NV-F\L+7[4*WRGO@60V7RR_F?#7=D]3Y'M:#;NF/[S[W:M_!513:=P+($NR M_[JO?P+-8_[R)U4[B[_Z35.@JLF\T*!*C">]]+T&'6I,@:E*%&AH45]LR+EH MIG[9IE?`@8JU:LQ7Z-4(W2F;S0C7)< MYPGS6E`[SF?W.560K\O<4Y#*()"+:$8_E9B&$I@0N&5#C1$%VGAN+[_"/(P+ M;AF$,9-XH;R$&!H;=:V#NYW%/X6EC6WS6_?YPD.M8KA[W*<':H2U^A31>>`8623Y;;/'C"'5/A/F\B5\3(KOB$!0.J2>:W&5I)5K.P?F M7;V4T>'>!H2I6=@DTE.#?YT++;549I):Z62^B*T<8VY:\,E#@&NAG&<[7,"1 MG'I@C97Q(^WZ]G``W7%WP8'\>8U.*"3>]5=6K4B3&P-=C(?";48?CG2_HM#/ M.41=F^F=RSI52G4A1AAUV7GL"2V8S!=9EV,\YHPF8G[&J(,5N$47_,T61T]M M85Q6^7+-+B8?W$;TJ'5:V!GJK5!K,+C1^:W!W?:$&C$8[5)PDQ6R;(S!..NB M.%PGXRA"@M)TP\!#WH)U2>-F@X<$@OL,G9^YL#V?'?'1P4%<>WW\&D>4B?=C MJ9-76>UPD>RZ_IJ_]52Y0CC4*1()G.3OJSOS;K9$:3UE281XF;Y249%Y@F4< M!HFDL/WHF6Q[_D;@RAY?35=F="YWIP'URUYO(B]:-T_+"N4X/*"B,GL\NP8S$6/CAM^D4D2315ZZZ^3NU64]#R]\Y& M`AR4OT?+A$WH.?<%3EA-P;43>!+S]R1X!LY?5(@U`R5'3.2;\!J$!ZH$UUIP MY$Q"JX&ZGL"JXR3]EUR=L+^)[&[EV)4%M9C.XINLZH9T:)^P"P:RS'RPBE`> M(:`M]DA2?8C7&,?;(X_3<7$:<_EN6[/]/"B>KI+L1:=3F1S,@3]6BH7TJH8! M`('PXDYFLC&L=U%W5ZSZ$?%:[F@V:W1V^%+`Z#IMNY2MPS)^CLL8%N=9BOY0 MH;_5/V:I#BO.]0$7GLMY*,/SP1&N;J;&+X9OOM#^"F_!LQ@GL>4CO,TU<-73/\I]VT`=B<6JRK23:3ZY`_5%`OHJ;3('V MPX!]RT$_]S7=6:/IK@6:SAN5YI;0R$3_M8IS6HHB;RG9ZJP4MZEYLR#-QEZLCE=T?%_/CT@72R*M'<`^$6WRY$W]$1SD MVS;0SN/:IZ+Y!$'P^)B3QW,0[+(J)>E!*55;*P#)*UU-`KC;)]D!0K3;NRJM MK;QWX/XI+L`NP"X:DF/8ST^D/IV,YA\UH7DK_*V\C/]&R8F&=1F(\0*Y=OJ, MUI-L3/UX)6G/;CXZJ(:NJ4Z!H4U^G@3Q3A8!9#B/=8O6%$]M%V[0=>$B2[2> MJS%&!=6%;=F7LZ$=#@J7=8N5Q>DSXN8LI\>#?^651_'XT-";P.#VI/D"N]S# M6!5>VQ]F718'JV0[8QY_=BL]DQ=JD\MY>S]D8O'&3WD"3,,CI0S[=P**CRTC$;%5KDW\3UE&^)KP%9ESD(&FKD[:2$&/N: MZ+-1XOP)9_B08(6>:!@HX^[:S`@^A3GO30!!I[@"Y#0P?C4^<$EL7CSRX/_"UV(LQ8_5Y MRZ6@-&)]%QRP3-_G0<2S&$PG\$!T!)CIR%#7,JC!5X!,X/B2.1E)?-KA,6!/ M`3S(UC;C2;68J1G2I;QML*4U6"(Z1]%?\@HIU#AXB!/R+F$DA`:S>B"9)C30 M%%7V3XED(PIKQ^PX5@IH*K=P;RX9:&8P4C%DOZ5=! MG).4T\VV\63IW\FYP*ZOX'R,M&[<&+0NT+39MOY<-V;J).P^07QE;)]:?"C* M-'FCLAQ$\*A.\,UVB_>+7(Z+7NN,5W#YE)WI"#6=<&"BR&?-L,QP_)-0#H0+AUFQGBE##?@8<@ M_04=Z/NLB$4HV11"'48;BI8^EUD4F#P+(8R**X3AYX#<)SX&);*'RL-F2RX< MFA)D-H]]D3+$DY&Q&A[@"0">H4X(I7-@^Y]>VQ<4/+-C;A#FU0BA8%+U^Q- MY4\RB7L)E&&H(X,-_`J0&5;D]&PG\4P.C9!%BWH*:%G1?0U'D(-RY)S*HY)? ME1*IR:ROQ;>TF$_IU?F2%O4AX:2\,DB6RG?1K$(X/W5ZN6X\MY%['3"/?,SK M+?),5US%:9"&"_JAC3_@B^XPIXRA#FD_\/K]T--I-?1#;UOBO`8_]$@ITM0L MDT1HPDMXURN@*L\C>A`WF\/NN[@A?G+WF%;:D\/\S[F0I:]$G2I5762+7H*B M?XTG)Q(!)X82LR=.L:JBM,`OZ$$4Q?B[08)^W\2')HV367V"(F_]B4NG]`4^3[+<89K!!_*MZZ?_\7-;`YW*E(#/\4+0J^%4J^BGP\MWN;"E<@OY'1>Z>I&7[3@"$2' M6C`HB@QGRB$-0Q0+48@T:9ZFX*`?"$V:`M\U;>KPHSAOLN$Y9/))*^G*MU`K MF0GW:[D:+G8E?'57P46O@/ZZD:91AVB2?8&5=/EEI,)X5*Z)^)[ MQ";JIC*G(?\#CQ.Y%>@P;#P5X/`_;%5=K9))^V$,:FS0DF M':=6-@F"-"YQ03RTO`FFB+2M#K"?()?CU7@NR0LS")H*?.!-EH-] MD)?-'][BI.BTP'H$>Q`ZN4TYW..2>FUW>M<.!0WAZ_D/M"7/HKN`TGR3WZ$= MJ/]!(F0*X@._BK_":%T4L"SJN)GH5.8C&#.;?0%^DRV?0FPES&I M,Z4/94;?CHC/573>Z\/;/?P-\&*,]!:4Y(0BT"9Y_'"?=5Z)')H$LV"'I:L% M$]6A['86HUEAP1Q.D`8!`4R)8CY0(OZ4M]$QX)P;228 MBF_/8A@GN_;,ATW^&*1UC6.TUB)+XHC\@U8C*QJ>V6SK:U&0M(UZ.M>B>_BU M/$OX.FRY3UDW/!:@UE"2NI\@CP_'CS2E%-O/8(EI/P2.7^IY,_#'`/F:8W_& MWR7Q;)I#2\GJT%9:5E`M]M:A-S1TW;Q#*(2:77$D0/;[V<@P8!JDM(-!,]JK MIG#J[6":E&CNA<6.@_%C&F_C$*><,(O3.01U)[#?A5`7,Z;[QA$0<%G0FP/( M(8I6FR\:\2C3AG$$@TZX&U_4%Q..0$\B(1I_\C`=5GJ/O7L5%&"1_A4%^F48702E2$.+A M5OE"LFKFO8(.!70LP(/1H1$!/-PM>ZA(W^40/;HOJS:NX@3FY^BCCUDN5QJ# MD0Y4QG"M`H5!AH%FG`_:@DMD5E=(*+P4$^#J^.BZ_/FP>\@8XMX.6=D[:GY'>`!;G>72\ON]DH(N;3D MTG03^15!,-:)+`_7*Q3J.E'*CXN!E-H\09>0>FF.H#<2NH`K]#>1-U$RW@EG M\-8MY([Z[E@S"1GN!X<(J<_C$@7I[7`*OKOJ\TEGM$,NZ:Y9Q2/$O^`=AS!4 M%_.'@.06(UM(I+(DS*`98#]BI5D98SZ0'URFU`J71E+Y<>$,X0*MALGT]I8) MB>%LK-5DDXPFO*>/UVF8[6#=JE:G(J$:UD4BB1(?3MI("P,H$'A3@[WU)GET M#&;':,BV*3/N:XU@WY+B81ZD@VHS("?_PX3[[(G499"G:$TX2YVX'#0D20QB M78`DJV><1_50;")2I]'RPA+!;9R2!)\?JSC"-X>8,[A;,5XNR%WPFG04%C,ZS';;4:*0HSB=\))DF9X?CD+HY MQ/HER*/;"@L]6G];!98^Y:RK\BG+X[]Q2W]:^:K]F/Y%:,A)P]X+M#] M'NA\$)>4ZXZK/PK(5U>`?I?HB&,-W_J!\?AM]X)F@3F9N'Q;G/F*1-RF8/\] MB+-M(?Y[E%QK\NJ-E.)HB&M2^>>"5/*AKR,DX_\6OI!?9*YH37C[TJ2)%R,A MI&H!!004LG[U6@$"C"0`OM`!B_F[8:Z1[C82P>M.L?M>I88RPS6AUP$/ZA;W7L@]28\S$BR.0-/\)HT=:C9#XK\ M)C((NYX3Z=J';-96F^>)DLLR*$98'`^[MJ)+727-X[)G:A[K.59T&>SU68[/ M09S@G+*K+/\1HVC!@&0_^6KM2`[UK)B3S7?!-LL!^;(')\S"'+F4>2EGQU<@ MT?PGQ[<__>F1U0)<%!)-\@?AJ\+]?L0CR6&@V>1/SCV7A>E`O M_F&X^,NO^YBV-Q":H`M\PXV0S42?!03M^!6I=6Q=UN;D**Z\S<].EF7N#G=^ M4PE-/<@-US M/1$,`0B(?T5%F+U0%!81;,2R:807V2Z(&2]$+XNM&>(@-;!=G2`)\& M\RC)IO7QR&CO)!`UG9.UHC2`M7YNZ.`C;\?8;SVIZ#9I\Z#1WJKA^6.X3VZ8 MK_;C-6N2/=K(P9RR'`<+.;?5`"V?>1"HH[,K,A:3;XG%9E:=,NZ=K&GJ*):% MN*D`[3>B4F$BK_'>SX6G4.[93&][F-9(!GMCL5`Y4:BD\`^,[C.RFKS`;=[* M`_U?09TVTPGL%Q77Q8RI=DW?6VM(_#Q+8?_Q-]]]_\<"4%CG9=_&;2!3DWK$ M[EF\[(=/,*H2N-D.H^K/@B(.UVET$2=5B5:.?>U:=8+'SFC?C3`:=\;G4,^$ M%2J;+;("9#Y2Q[V>L2YJ"?PJOSN-%QC/QAR,8+5[-4VOPA'%[>M2KZ=+W7B< M+E\C;W#LC"[Z58_$G9=?U*06TBCZXZ,G4O/=`CSUC(UT>)-_.!\MJAW.V\MR M'](/IW$WI^'T=-:V)]M$T<3/\#,,JYSTQ=007QF0=0F58L"X/>O!X#AZ!2ZW M6QB6.*F%RIN+K$9-$31"ML%K"Z(&[:*%\T#RU+PW%"Y=QG,I/Y3JFY3PTO!\ MWY1/W&3):=-Y('-:6,\DC2O0`M)[;1GC0_0XB6\R.HHX/PUB#Y&-<`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`LO MGLG,;X<",M:SVY9J'YB<>JU-6$#9B$N^Z4#YH7"$=R&9RG%^\3'8%BVUT]T3 MA`?%"S'2+^C?Z%_H/W!E4H+H_P-02P,$%`````@`38`.14!<^(5D/```)N\# M`!4`'`!DU3=7@+``$$ M)0X```0Y`0``[7UM<]LXMN;WK=K_D.W[.9W(EIRX:_K>\FNN=QW+ZS@S>VMK MBT6+L,W;-.DF*26:K?WO>T!*,D7AX(4$A4/.?)CI[@2`\)SG``0>G`/\Y=]^ MOD3O%BS-PB3^_9?1KQ]_>KG+'CWL'QW[N?^?>K/_LC6]=^-?AW]>O2._\OX_ MC7X;C7^;3/[/N_][\O7_O;OX=O_N_;L?/W[\&D`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`?;7I3Z42Q!Q/U7E(<.OQYJ\-5-D_2[<[[ MZ6S=//SK%I6[&N.JQ(?78MB_GSV'T<8+'M/DI9%E5[U)=('-,^AB\LK_E(^J M)(7YZ/=?8%4#,!]9FK+@NK03"J/`4!AS/[Q>LR<_*JUP\C/,$#IKI;S)X4>G M+"J)V"5."$',UP%AODH$Y\F+'\8(6=4B`'/DFBFAY7<)VNVVF)U#PNP(G!(^ M4>P*OO/8T))5`5\^=LV>Z3A3XQ'3.B9,:^F:=^PIY!^'.+_Q7[`/GZBH-_X\ M(4ACC19L1(JPB"F6P5A:`'_671"$8,8M'A%D\ MFZ?<1I=A!GNZ_V!^>A$'Y["+0HC$B@/\3WWD4HY'3.800QR?_'DHJ>N-CBAM"W8^C$AFRK_]( MF.VU.>ZA6<76@Q0'?:1/`@:AL0]B3;F<+C%=PI^IE)J=\F"!<9_I M1``AE%(6:K81\1V2/J&;TH#^L/]TUN`@9+:1;,`R'^J'<1TC]CG8'JURW/8/$?&6W4J#HH_!`]AP:V_+(.U@8Y3 MZ,8?$DRF37D'3E5M"17B(=,(GZ41M6#I0Y*QZ[T/+&$^BX.1M>G'.2PQH@2Z MPG0^9;)JWL&!JU$GZI;.$)/6\PZ76IH_?TXJ;.N'(RH_SGW4UC5 M1LO-`J*RXG\C06.0&;;D'7QV->ZD/=49@'H->`=.CQK:\"(>G`:P^SM*ZQF( M#L9DO0\:@P^KXM6BKQRBT%H\8G6\0Z=ZI9:9D?6B%%)_QXE6,JR#P;/;&XWA M@U?R)D?.1M`-^U'I6)K$\*^S81*_.G6)RMY+8LOTS2G9W]29KRE)]288NBU>TDT\>W M@O56LM/E;>270:M:'T$7_?$F)`1/@5,@GU5G1AJBEN-NNNA"T3D_0:1"VMNEJ!WL:H.AD'=F4P,\B/\N0G"2-6MZAVW!M#=YT M%>YM3'1REBQ,.Z=+!"Z:X63:A'?H--1;EU6%'JL#TFVZ%#*#7\4+ED'A[&\^ M7P3DV5?V\L!2;/I&BGN'3D.]&]$AF,=EZ-QF12'LP1JLW+B=/,'_Z5$HJ^,= MDM!DV_*HA.@V/THU%'GT0@-B=>M[8Q)[&6N#50,]>',&VP]^(*5:=JDK>V,2 MTJ6<1X1[/7!N$[6P3W4:+OR<;6:J]20%)4?POP/%1UNKMC`:UM&._NO@Y;TQ"(K3O8`I'MFU"QSF`R)II_:G?P%:>!.M4\\8DXN:[ M]AEM4W20+$@F,+C)\2SBC.H?4UT+J=^"-W$66O\6'C#-GUFZZE_\Q(_V^:V+ M/_EA/SOE-R^\)C&`,`O,,&W4F[A-Z&S`FRKLHI$)!G%0O&T"F,V2M16N8AC4 M;&6$!O$^)@UZ$[W;!/`%,Y@4)V'T1R,W,"? MC%H$B[I7S"U[5`,#V#_$WM,R0OP9-2&S^=.TN6)XWASV(]_!TKCS%)0 MPW,K>;:D$C_,Q*`.XNN]BT]]@HG5\28D@E-DG&FS7$%$YQ9M:SPK3S6$Y;TC M$G$IVU<` M6H-PA>9A"NMS7+TI?!L9'">KYQVY3X^SODQ6`AY$V%<-G7)Y+"SO'9&0/=64 MB:G&,0TBJ*KR(H%ROMXIZQV16!CC%(DI%>,@=*]X45'7IVNJS^C6J'JMV(]\GM:RJ=;&'-T"-NTZ^VVW5 M($R,;I^NLSFEVS`%XC#]$L6FV[&.UTDF^_X+2GN?^G?<6"-2/$=@6)&P$7U) M[;BD/69/?,:Z=LG^#M@G?F4!;,@[J>OX%EQ/RR[@XL7Y7O9##KR/8;.K9_/ MYCW>F.LR26_G#U$XNV.9CP!CH,K\C4R$NZSC&L?AH MW">G["K+YK`J?2V>BES`,K&PX3IW?B1=XVO4!X,[/5WJ#X5]KQ^!H=BW9\8.-*I[Q^X>E%AW#TL6%!?T M1A])G-5H6U<1!%4!-8@\OS6NXNI6S201K`Z8A<2QC8@L!:UB*$-(YJLB4YZU M[A8&0]!(\I`SA6Q`$3B#2-Y;&T1V.(<7!D/0N'74?*S6,`PA5V]USY3&FVY; M!<$`)(+_,6K$1(HP6,JVVWU_R!679_.46TZ;TEIYL`J)%`$15S)6A3`L9=%1 M()U#..G0O66?6!UZH/52%R#)Z$4^=[JH[.4 M?D?!)^X86";D%_RL\)>!0,56?64\:7B;LC98C$0(K+$_:&.SE+E'P1N^/2=I M?L_2EPI6J0"Z6QQL0B+7P)AO'(RE5+]V!&/1 M_7!]`2`>_:;;@#<^)K%!UB:V"3Q;V8'N8P*X%\?0]O*&R6;P:C$P`8GMLO'0 MW05A*ZN/PJ2\90[=M;@W/%MA8S:M%P(U]##=)L!T/10_ MS=#9RO:C,*`KR/7%4;P2&(B$0FI&J-(IA"AMY0)2<(/U1O+67Q875:=^P#06 MYG@M,!$)M51%(O(94`&SE4%(@?LM)6&%&`8-_$DZ9]4W5B2>H-T&F(^$:MK, M+PQAVDH;I.`ENP8S^D"`04BHI\UXQ_"T3A"TL$1$]--UE]=9[_?).KX0$TSQ M&@"6Q/TL9N1I@6J=8T=HB/+,CK#4]_EY7Y%6^,3BF7SJEM3R1@7+N3])J62"*2,D:D7!%"3D.@/> M\&EA%YBM%#CW'-^N^ZM%LZ`T&(2$E->::12;K?0P"A/_6RKQCR@"]56_A4%W]BUE'3Q5R\,YB0AYK7F'H.&<&TLY]$_ZFEQQ`.F MHB;=V=#V)5@1MS#6[^INL:_7GBNP5E/;ZLE&%XF8VIO/.HNUMT_V.6V^O>[Y M\AHE2\:^L701\G168=9W5/2E2.;E;\<_Q3RA^Y8!*0%_M1A]T;'3WP,#DA#O M1+0BLW1W9AA"=FAY2=W;`?<*O"(_5%++&]&XN;5#WL6.IK3)$%)-$9#*K%-I M/3`/">U/R:`1\55L0\A&Y:,`ELI^Q#*-IQ5J96$71&+1K\$5)NT)$0TA,_4. MF``K\N2=RF/*JXA_]3M5ZMI@5Q+Z;F/RM3$.XD5)%D7\2M$X^.JG?S!^LJ7K M"ZJJ8"02LD]C1]`#Z/9)23M>\(7%+/4C'H\2O(3QZJ[0!=-U!:WZ8"X2NG!C M?S!`.83'*.VLI*\U;K.P_$M``8E(TKUO2CJQXQ`>X5QA9H'8)*L!+#OJTFH` M#$9BW=N)'R!G9`:&H9PS7`B>#_7NKP.^8,I_2WTOKUW$0N&,&_(F-!)>]N`T M;0QD*PMYUWN<2^KWT-`<0/5)6?],0%DO+'JZ+"X%T]?'=VH!&)(J]V<-E1L! MXU:KEDVQY?VEB.`L*N:-CHDIS(C-L:FN#L6M,*SF!E5WQ04!E/NG?82&EA-2 M[;U;P1:AY#*9\Z<[LD)^B/WR2NA[YN-/D^M4`\#NK]-&:!`0IH7&K2R+T,<3 M>U@0YBQ8/R.'"^GR"@#2_3LU^I0I<+@53;'IC\WF:1'2<3M/9\^P.#UY2EGA M;'+2E!4!M%/1RY`\33QN-4]LP@SY5'')<+E25`P`.16+3"=$4>_=JHT('?PJ M]WE4O%>F-Y;0"@#2J:QB2)$"QQ#TM&_SARP,0C]=\C-2S5O&L3I@%A+!@88K M?$U9!& MU!J!M'4%G^5]Y_QIGN7PYP>&U"KJ`68287MMB-6":.NV/;NT3F=Y`ETTYU59 M$5"3B-=J0:PF1ENWZ5G>MK*'=`YK#OXW]=ZO3\44.UKM%L`.),X:6W!M"M;6 M57S[([TYV2OG;)Y3AA+YG)3KFJ9+[LE`9=360=$GL'8=1%$8N_,"+8N9*.1I\''Y[0`H]3ET3I@%QHR M7V>W213.EO(UI4$38`D:RN*>W**9?6Q=&M=!\&\YYV5? MN("J$:"]6QP0]E;%DD*R=9M;YZ1I1&Z+*@!*]S*7E`$]QJIH;-W*9I>S]62A M.,^I%0-$[F4OA;T%#`E1V+H6K9-01?5)VTY!0.5>^C+G!L&!Y$$XUL#6GU8% M-[5B@,B]^F7.C!`%PHOC?"[!ZD=!$5X#<#I5NQJRI0*$$.OXB!/%3S:;\]N)IH^/X8REZEO\\%I@&Q+B3B-*Q=ZA1(MX0K_N]3I-_#28/F[6 M)F?/?IB^^.KS`7E%L!`)J<>B/^@`1ES"M1`T"\%4(3CP2;`(LR1=%E@441RR M2MZ$QD.+%NC5!8M0V[^L//;G'+!>+'B:O#KB`*D!EJ010=H\(P]%A3#=LX2\ M783J4`*L#MB%Q*UE4MJTF:YB0BZ&Z%?.70VC^EI647FP!XDI74&8%LM51`C# M_8H/LW\K_\$!C83:9O.W$AG">K\BR;JY7/_@@$34H))"(^:KV!#N^Z78[>>^ MY8-#$G%^&J2*O<$`)>(5_=+X-B8J;P+D`2Q)S$-65*MX63VP3Y]U70UL"/?] MTNQJ\)1?`6%YL`<)K5:#-#';$E0(R_W2XRI/!FN\JE(K"W8@H<)*2$*T5C$2 MA-%^79*_2CE6LKE5#O"3T$^-F12@0%AT'&FUZN@T5F1-U82*A4C9BIH4#NP.R7+K6.D58L3JO%`#T-%:K96G07 M"D)DO^0G[62T>E3\(0F1:9<5.7O5WB/\.8[/*J<8V#;S4ZL%O_DBYE?;*(*& M994`+0E92,2!8-;4P((PY_B6II,XGOO1^A"9]UMQZ192WIO0N$5-DR\Y#(0J M8VVFW5UXEE+H>!J1XHNW*>,=C$FPV/!S5\.!T-@OF:7`I$Y\?"L%V$G(9S4R M)(Q5^XUPUB_1Y&L8AR]S_-D#83G`3T(*VZ%$S)R@[PAW_9)'OOH_];BKE@/\ M)(0N7>YV^XYPUZ]PHB+2BN?(IOFR/NX7!$B34-E/NU!Y0Q8<\EM$OM6?]EHMR)M\N"!8@H=IAW&!A M"+L8$!8=Y^!M;L4\>6+*[%5A84!'0I/38TB%`V&I7Y%!-WX^3_FKP66<@^(+ M*R@-MB`AS37\E**($';[%?MS%>)'GYKBK812/\2UT=K$5"[D.) MQ*9=76B((SB^R7OS1)`?SQCOOR('0US<.YB04(WTV1!,T5)L"'O]4I+.$E@D MI%G(7T)>S6[?X_#/.3MGV2P-7S4B>'6;`*N1T*`:3N=F,!'GZ)=DM0-9ZWQ- M4@ML0T+.,N-2TQ_J,!$7G9\]7[,LN_C)TEDH"=*5E`9\))0M)06"*5V& M"&',<1`0SRZ9/FX>X9->Q[];%)#U48^2PT&(9JG@VR9T:[U%)Z@%F$A^71E2)-O1:>!&.^Q485LRDJWGU.HS9%>"4GG.( MRH,]^OR=D&!"..Y79)?R'0WL&8WJM;S955P>'WY)DTRY_[3[:[`)('$&+G$4 MR8ZU"UN(_?)SO^+0WJ!_29*`+^AODIBM'V]BZ2*4STY>7]-DP8++ M)%T?2FMY8\O?\`Z.2!SEM_!!*Q9`/,]Q[%SSIX*V1MI]4K'-9MS]C85/S_P1 MDP5+_2>V/C2[34.AZ[GM$+!$(L!`VT\IF`MQZEZJQA?;0UMLV9NDD%%8^5(6 MV"WWH^K?\S"?FR3_#Y;?L5GR%(=_9X%DENWL-X$>$CL+XUFW8XL@#MLOI;LS M&Y7#_I*_X%;\$2\WCXM,1,B*-3B0YEP?D\#>.G$D&Y=(+O MRL+/V4:<5L:,ZC0"UB"1?&'X63>'B!#N^`'.`LA]`6X,S?_4Q$']I2R)T`$?KV];2^\ M'T*^HYRK6U49Z#5/ZQH6D&EBGGUJ0&I28\M''-BHP&.A#U4+0 MU3]6MOM+_<^W3,=^YBP.WL;HEO%>EH$/\]BOL^2E_,5-2N%7YF?SM(@6/&9C-H@1Z!-N0!YY),I/M`&75O$\35Z-HTZV3+&,YCQZ^#OV' M,`KSD&6EP5DPC>_8;)[R;TP97IRN_Q-6QV'&ZQ=$W[/9V6]#XYU;=P2RL8J?1>S(GCUV^J?57<0+!3TOOD5/*1V5K!2J7_R(M[ MO5H"V[]`YC,)667/TZFN89!G`'KE,ON\?>8SB40E%:N*99@.2.2F/B(WSQA> M-%.[9H5&YK<1':*/@`0=D@-.Z;$`/0JEU^70N+>C+8]*B$@@))&AV/4E4#2N MZ;`V6'7@(EIFKS[*F^M':@\6*U=RLGK>9Q(14:[6C>7O;#`C[_0J`-7_']C.)D*IM*B1T57J-$-8O6:W90ZC')*2S.B%B MVG9[CA#7+W&KV>O#QR1D*DWB=GJ.$->SX,/Y0Q8&H9\N*ZG*JLT/5L<[IB59 M[7GC(S4+XBT]"QA\`\;?PID^5FXW4^Z`U)6]R4<2#B1G$F%?$QWB!XYULGJR M\UKN@9(C^)_B'0R]VH"?A!*JRY1(!#4`BA#=+WVLHZGT6N,^W*Y_&E@BL?QP M]+7:CWF1J)A^27U54\U?RKC>NS#[XS)EK'C_DV7Y'4P+FLXL:\([)C%%[L74,7XU6]XR$??[5VK(V)$'8]5MA'B4L6*]ZU'N\YI&0TEL&AT< M4QBE0\EL&AV2.&124[[7W7[%-FZ3FRA'@XT.AZ\S%2[0)!ZL,([;W"E*\6`C M&C_.N_ARP% M:SXOK]F"18KI7J\!,-B0!3;EO&]BI4'E=ZUL6NPJ=I'K)WGIM`/FHR6V:9"M MI9RZC[^!'>TZV"=!!)*#5`2O7A>(*WH3&(]_-J-?! M-HAK8.OY0W;`?.0.&IPX7_"X:G=:SC;![OU,"M6IH#KJ$$\(X_.Y]+3I>G?L2O!T8BU1:%N>/<'<7O^'8NX8G[KI_FR,J=GI\OJWZ@N[M9N!"Q'(IZYK>1@ MBG@049!5:$K18;-&S*0( MPR`B^#JZ1>&(A%386C16@QS$3?Z6KD,XHJ$7JDD3LRU!-8AK_P'92Q(7^W/E MG+U3%NQ`0C:4D"1F%4$RB/<`&MYP<41"$C1F4H#"UCW]A&)!11^JRS"&/PO] M:#.WG?GE?6_7)ODB#9L&4_=:L[)K!YI/`A3S&W_"FP7GZE7 MJ*N#!6C=8]")/^C:P?%5^H@G;-T.JF8>*0X(B>ESEIF6XA[2)?:W:3)C+,@N MP;;F"^_ERK(#3N-S=C..3X#_G6?X6\*])];H:`"A4_/^72>9[D?!V!CF22MJ`K&(J%K=KG*U+,!XC".P^00/67M^INL3T-U M:J<^V("87+D?80HQ!.(,QGHEB=FC,F465BC%N-(6HM6H7D5O0NU>W@YF#@T+ M(*[B6KY\"RLN%EG@[=_C$!>QQ<6]R="WFS+<2%I3&SER3RG$WUA4O)2UL0A\ M_J:O+"VSJ,_]W%\E%)ME$J/)-ZI?DR0*&[;@'7QJD#/BR4R&O MD85%8\4$[B!2@C?S2;F`U$H)QNIX!Y^=3J7F%(H_B0J`0T@)KB)31G7M%@9# MD-#K%$Q)]TH[<(:0XGL5PP>2;(3Q$`SU,4O#R M52[+RKTEPU]<`0SB/O75F$#QT)?H@SJE'?F/LMA*H*Y' M%9^@=L`UZN$)U_%![TZXCIVJ8(TLW.:$ZQC/A>W55MCR"=>Q4P',G$+C$ZYC M/$ZL5[RW/N$Z)A'ZHV!*_X3K&%TG[>N$BXBF>=P'20L=PJPO,`5=)UEV MRAZAS+W_4S(7&[0"]NN9M+7K$XUAMSV@(O3J3;&EOTGBI#1;_*3>[&)5P#8] M$[MPEY!CM'1.U8'<><<6ZU=S-BD)Y9&M1+?2K.D=?NR9BH%\!G2AMCV;(C3, MJZZ\!54RSM$Z8!VG(6@V![H"9-LS+=0%J"E9!_U3LB:UIUI[H&1-W+Z[V3URUXI&G:5K(G;-_K,*315LB;X6WG_6$K69$SB_B4%4]I*5@'GGTH6 M-UL?SG31$=P,[Q#"M&_8:J7/=_4G"UCY1C->>## M-_YJQ;(DS]/P89Z7\^]M8?O"2L)[ M6$R;`-N1N/VKF;>8H;2KWMW7@M$V#:/H1C:7VH6AC`5LP[A>G'R`RV_`G,2"*CL84/6'"JT@I#BI(7 MPE]-RSLV*.]D+-[I:SA=Z;<,INZ#:M-\XC(UQ9!B]V%5D!;V]*/5CK6PPO82 MX5,EET7B<2U:!1.3>(O!BJ>(G;"U=6RE"5!P0&36QRQM_A7%6@)3 MDCADZ-#1&EG$UBMPKG)0Y@\9^W,.K5TL^&=B=4Y_#ZW,`8_1:;VE0]!:CS2^ MV%@5[_!C@[/[3F!@Y_JRXM!]$DM7N7F14UL4SR`.ZFOHX/=4Q_3B&M[AB(1, M@M.E1^\6G"$2LK@Z%(;+453"+T:\)S>RF:'3^H/[VEG-'%%<`@)':\NM2)B9=A(W%` MCJ:8P*;]*66E>HE2B)8%A"0"7IJQIX!EZ4S:Z2B]>'F-DB5C>J^2"TK#`H7$ MO?[MQB<*S-(]9W8#8&^2>-UAQ9C<+0FP2`20M!B1&"A;I[1VR;ID#^DS4@JPDQBA-3(DC%7[;>L,SREG7_V?XBP((PMB^)"&%LLY\Z>5*K>L+"L/6B ML1K29TJ"`V')LZ+%<1(3P[OH7VG"U8E+P6 M4T_*?/EL*RP,Z$@$=\FM+YAS)6@0KO8E["!<%7G7O*N*Y6:]'&`BL6HQ9D@, M!"&G7\K*)O?LXL\Y&(*_YY3$1?RXYHUFHGI@'Q(+'^/P.S4HA/1^O4M8@Z?\ M1`K+@SU(;/(U2!.S+4&%L-ROV)W*;3W*`Y&=LF`'$H+8 M8?0^S'G@Q%45Y>$2Q$XH2E$;%B']$!C+C$OI0M=13GIO?:T9RU&H"3A%YE@5@M MI`BCYF\.VG^5X?Y'8LZLM!)`)B%4V2)7`RS"KWD^?P>/#,]"L%7X&,Y.@D68 M)>FRF(+D_$HK`602PI8M?C7`(OSV*Z"IN(MB=4_J:AO#K]%6"2MX+;`-"?W, M6%9104+H[I>2=@D+B[_ZT9R=+A'`RH6[;A/>Y)#&%DY%K-@?S&`BSM$OQ:V\ M]0BF3O:37QY9/)F^1ES^OV):T&L`+$9"M3&=(4S0(?[0+VU.!ECK&@N]!KS) M$8FE@PF_YAY2QXMX2+^TOJV4PQ*]6?YEM0[8A<3*P81%1+270T1NPG`<\%79 MSNC0J:SC33Z1T&F:TZD)$:'3<618I;/9%QYSR`+DZRTK#F8AL6W7_5:KL2!L M.=;1!%U&OZ[R"H"2P-O',@;T&*NB03AS_(23IBQ6UX8F1P3>T9';6\"0$`7" MB^,HK8N?+)V%&;M-PQE3!"Z+R@(V`L\"&S.$0T%H3* M.M[D,XU0#Y-/E1H00MZ^9"=#\N0?+7DM;W+L_I5>-2$&+%9Q(3SV2R%:)X@I M-WG;!<$"3D_VM$D2;^=$8!`Z^R7PU*:J:\F+DZHJ8!42\1DMKY^MX4%8[I=( M4\C7IW[&`AZAQN)LQ4G*4_F+"\%6$G=1YM9?%D'>/WA(0F7]D5W%MPS&45"[ MVWQKV:$Z,MI/+[S#0XHK@9IO28ZA]FDFY+K.?H6E*:UF9+0OJ?PYS`Y^#;B@ M<5C6ARG*4G)+,X]6>&"@J$/\65)5MR;'%), M)Y+RI,:#,.98X5OW<7?6P$C#:P#.WBT6M2`AU+51_?;TDM`9+`J2*`SX?0"G M?L0WZ=^>&C$X@WA0:&T0+6EVIS`8@D1$58.Q6L,P MA,>#*DF_L)"9I@76K:8"H:6Q"$1&3\Z@*S]+`0A;=7*YA7 M3]"6EWS\G8EV,!JUP$(T=C%-J1<#LO2&$$G*RWV;"=UE#;`,C?#Y=E17P9!X M/:@CFO6>4)95`QO1.!MH1_@.(DM/#U%@_7;=XZ9?=[T&O,,)C4-V(T\PP6;I MJ2)Z/F'PF9=7!#O1..IIX0-B3+:>/J)*OO*#CU<"`]%2V!J37L5CZ]DCJH3K M??H5-<%4M/2VQM3O@++U>M(N_PX.*C;VR:://`XB9<\LSL(%N^;!)`[.*LH+ M)#?=TCB>0&H`61/G`ICIB<2$A!(BM:C>(<0$?[*J5^J7Y4.("2VYHT*6\2'$ M!+_+L5<,MSZ$F-#2-<1,Z1]"3/![`'K%:^M#B`DM^4)_K-8P#.$0XHXM6"R/ M.%P7\<;'M$X%:W2(R=ON_:#.#+)\^KB")Y42*^7`"K1.`+4X%$"P=!+0YBXU M.S06\O+`4* MXJ>+GSSFG64:&RRTCG=X1%;8Q3E6P!F0OG\';(`EGT_BH/(0Q@JV]%,JJ0=6 M(J'D*FC$/K-*9`/2\K_ZZ1^,FPC@G@30HSS,W@PF<0!Y1;`3"5FWD0?H0!N2 MI/^%Q6"EJ$#[$L8AMU`>+IC:"10UP50D%-Y&7J"%S9;0[W[UMF,CDZ\]+(1( M*!R-B$;0V-+P[1Z7L;H M!AF\/O#8OX#M3R2T%0/[BH><"-:@PK=%#]CKT"Q^^/X3"3U%1)J"7AS.$$*Y MA0_:RU96HO)@#EH:"LX9LKC"40TAKKN2H:V\SWVG+)B!A'8BX4A,*H)D"+'= M)T$0E@!N_3"XBL_\US#W(R6YTGK>X6<:RHDIT1JH+$6'.P[HS\$0+%CO#Y1L MBRN`06@((:8TR^`,)FB\=0K.9Q(*1X-U5@V#I9MB'"^EZQL+*9GUPF`($H($ M1A%&J!B'I2#QU^+B6^A2FKL=J`9"E$!_^4PV@$S"K!B&I>CO]L3*7EQ473M_ MR1[2N9\N3^+@O\]C!JT<"@AMU9XW_DCBPZM'N@6HMF+"VWR5S7RB]'"+3J%N M$$Q%ZXO=V"MTL0XG1EPV/,H_ODS2;RQ=A+/&+W_LM`-&[.NJP`QB=Y?&D/&4 MZDU)K5P%:0@,V<=U1@.,K6/8NPQ<7D?C[D"JP"A&PM=5HMU7?RG[V#1M#TQ% M(LC9X%O3#BKI<'8=:(7/6_0*47M@*EHG?BF M-1C^1%%0Z$ M5F/]L(Q\N8C=WI_1+J!I/.J15JB`@?!J+`6*>"66&=?BG75TRRK)J]KZ.4D2 M7,.6O/'!1WT)^-:QC< M)KPA:T,N@?`+IHIW\]8N>!(':XG^*C:(N&[4F#<^I'JF5=`F.-QH@=-25MR^ MG4`SJ,6X(3`*K;66#?*%&-TFS[4>_;((!K-6P!RT%F`VQ_L;0$NY=='>=0KA MNZJ`W,^>+Z/DAY/G5$7],+NP9Z<:L-2[>WK&A[3$=]2L>BK$X="NY['RNNKX MD)8>7R%+0:L8RA"4A[:OJXX/:4GQ8J:0K2D"9PAB0^N]Z2&M2%S]L5K#,`2A MX8;E_'-TFR:+$%8[I\OO&0NNXLT;*R>S/%R$><@R6.+`'\SASU9_"4L>G7=( MK/R`-QY3C=XM7`$]0K>&?4#OPC8,HAB34#QL#$>TK5`)\%_SK.\.-"] M2>(9&+(81/?)'9O!?X<1VT)_GVC:6F,BZOJG@2D2JDSW#KH?2UK2?KJ+9W^H M![NME8V3.+AC`"6<;>XLEH:TFS0$MB$A!.W'!P2R4D.+65*6W,^@;[):75"K MY`Q/4]B`A-*%N5$[8$,21X0NO*Z%P0;TGO`Y@S[/0E4D=+48V(#$(:1+I]FU M!XT'AK&CC7B6,IA;SUGYSZOX9#9+YF`YL!4+%WRGS.?8VY2]^F&`/TS6HC4P M$PG!UMD7KHW96M])57L\R_WG;L<85_$".$G24'J_D+2>-Z%QG9#3SYG:0*TO MKB+TJB(^J&[])1]1]ZD?R$Z5]!H`BY,XB*#E6;BE:%QWU96+%4^7UL#S=^=G MLW0.P$+_(8P*LQKYG7:K8&(2)RBTG-'0?*2OWMI%=^F':9&/MWD[&=4>M"J# M$4B3:2S%?RBK"P^(== MW)M8:%`/6K<2I#L[6O3&DW^<`Z76=K)UK5CN_#EFQ!I\]Y-U>>)M^`-@=A+' M259.O!MAMW61&86]`:PSBX_-?7(R^W,>IJRT2/%G$E>250,CD3@)LDFYV*G4 M5FA]XQFASR48=;AA-/P!,#L)I=;*AK$1=EO7S'4BU5?7G:K42$RQ M-VG#&Q^1B)BW2;!`GCKYUQ._MP@:%)*)S=^9Y-.]FZS,_]>HJ;`@8>_P??Q"S\B&]TRJMDZZ>M MLHQ1@V;`A"2T4K.UD3E"Q$G,P]R).LD)C*,T7<+P*`[@C;VC5A^,1D+UM.$6 M0FB(/SAXT[A?7D$B;KT;KT!#T`^-]6P:]_VN;]-8QW%L1(HX$'Q@S\-L%B79 M/&4:&_.V38.Y22C@YI[4'C7B9'M^EP399KT%TD_7P:G31WFFGJ0*`":A2MLA M3K!]4F)'R.[E$\18?<&[6;0M^3QA\]EA6@53KS,DUFA265,1I)![[7?T4F(V$P&;1!\1? MDVX,9^F6/6>SRK?P*0X?PQF/%R@7;?S%)K#-C&<<.9AK=GNA@T`1!)2A(H$\;`TP;COP?:7#[S+_!Z1PKC_'U!+`P04````"`!- M@`Y%2A*0T*\.``!PH@``$0`<`&1R:6\M,C`Q-#`V,S`N>'-D550)``/2%>U3 MTA7M4W5X"P`!!"4.```$.0$``.U=77/;N!5]WYG]#ZP[TTD?9)EVDEV[\>[( MMI2HE257DK,[T^GL0"0DH:$`+4#ZHYW^]P(@*5$D`8*4DR!3/<01A0^>@P-< M7%P"U+N?GU:!\P`I0P1?'KG')T<.Q![Q$5Y<'MU/>ZT?CYR??_K^NW=_:+6< M]Q!#"D+H.[-GYP:$8$J!]XFEY1WWV#U^ZX@/KUN=:-$Z/7%?._]PW0OW]<6; M-_]T_M.Y_:_3G4R=EO/X^'CL\QI"6<.Q1U9.JR7NP[PE7`$G!'0!PR%80;8& M'KP\6H;A^J+=7CW[@"(B"K1%]2=OSP3D`*X@#GN$KF[@'$1!>'GT>P0"-$?0 M/W(X1\PN?%ZNHAZ9<9-'8'P\.R9TP;.)FZR!IMY?![SB;*5(DQEA%@+L;4$40"<4W?/S M\[9,3;-&K+4`8+W)/`=L)K,F";+A6B=NZ\Q-BW@DPB%]WN7(H'>\(`_M)%$4 M.\L5BRCEW4Y5+DDMN9\/47D9GE"2'3YYR_+\(J6D`,(/D(7E1>*T$C88((^5 MEY%)HHB[6X0AK[P`3RC)S@4(G]>0E4HC4TJXL'!-%3?A*25W\>&:0D^,=V7_ M.F\#ZE$20([`"UOP:1T`#$)"GWO\>M,@!.-H55Z)']*V0-SFF5H\%Z3(VY2K M+I04X);#<=X!C`DW*=P4R6OQS7J-\)PDE_P+T;\O!.`I+^Z(#_?C?JE5D*QN MB!<)R]+!?A>'*'SN\]KH2M[CR$&\8;0Y-O=-[^S#.<)((G1/7&X'T^+9C[PJ M)Z[+R53VKIVOX?OO\M5'#/HC_)/\S+5CO#995AB,I'R215]V>Y.Z)3T0>%&@ MO&E2K+TC0Z;*NOI<$\Q(@'S12:]`(`S=9`EAR&)QU,EZ94ZY'!/>=#"1YGHT MG(P&_9O.M'OC7'4&G>%UUYE\Z':GDX,L=62Y`]R2ATL8(HZH0J/=O'K!SLP% M_WK_O2@ MY1Y:EAC99D7U*K_=6^6#*6YJBKF*@"U[`7G46>!L+KV6/Q@97JEK9_+!Z0U& MOQSL;9E:<8@D&77IA;[M?Q2^/V)>0%A$(;]XWQUVQYW!H7W+;"!:8,1-%>`K M+D\&%!!>W/&>[R&8#`5]%KT6YWDM)OWWPSXW5AW>^SO7UZ/[X;0_?._<\<%Q MW>\>QD"91O<81#[BAJB/0[XZ7_40YEX]`L%V%HJ5,LFHUMU/^SH/I]UQ_];I]8?<^^]W!ID)ZB!;J7NA]`IK.H"N6QA&!T>OAA(]@.A'$$3P M%@+>@)D14YJBU^(TKT6OTQ\['SN#^ZYSV^U,[L>'(:$<$C"`7FY-.UJ+9R`< M`!-/0)(14IU/+])98V<.]\TZ!]'*1(MF#/X><9[= MA^W(*7RK%^1U09#[JTGW[_?""^Y^/`R8)NY9#3?-S%USW]1TU_B",ZGXL-8T M=`&F8!9L)%,FZV5Z:^P..*_B"@_RF/H%67TTZ7J!?C#S$0[J[.DU*@05D@"/\RJIQDGJ.:AA."DE M[::"!9EI*:CPH5$^AG;%3G4VOEWE4X3"R&OL3.T-+ET&OE6'4 MX3"PF@KD5BKD5DA4B#E42.2X!Y%JBK1C_@SRZ04KQ"2J!#L8O[W<]5TOPSB[ M7L1BR,+083\8RI<0TZVI9I41+88VZLEY,*I["GI:4]#3"D$+H9"Z@IX>!#6) MRI!`;V,N(#H"ZCW)AY65[Q>,N>+>%7V;,G M\BM.B]#0P84S;+I#6O'QMP'Q9%6:(N*JE99KB:]:[FGKS#U^8OZV]>N`V'*L M!R(MUP!$^1$XP]NG!<1]WYC>47N&37%C>=/2@FT8A"S]IK6MJA9_S7DR':"2 M8LGGUK:*1D#*SNF9(,F62R_VQE)V]L\(3+;@YFI?C0K'!$V@;`K)3_M"*!XA M-,&P+15_;&TK:(0B?R[1!$-:1GS8^_[Y(XM&`-)"\E,#",7CCW*RP7`A]EV; M6:Z`TIU2PGR="[/IOMT;AJ'QS$`(7^3V^D.@II"RM72WE31`J#T*;-)3TC+B M0X,!JS^L:M0@^5+[ZE1^SK8>$H*'C<'H3R@WGWEE76J)DC<#2$"%$"S<[I`X M512"/AJLI-(/B1O$*6/B]O^E0*HCUY<1/ M*/L%4`IX]ENXFD&:LHH/8%_X9`40_JRTT`7:):-$IF!R%_!>(P]4+_@?Z^CH MX56IT\&^Y?S,H:KTH^B!3VN;LFDQ,=GR?Z?6,#4%JC(E<$8C0)^%Y5%590W7 M.F`5?--L&^,D#9((I%T%Q/N4(QFFWY?QG(.`?2:BE2@5[*K#QYT$_A>?*`H< MZV!5T!W1!<#HW[*$&.B9<-UH7G(*Q[HILB$!E?IB8\H8+A`+(87^/?8AC2]C MQ)MZ>H3>1;,`>6/(0*%%EH##^,(=OCETU5S%6"1"2KP?P=Q:\4X1S@3!QH,V5;@X*B$08(S%"` MPND+LO:X4:A#6P>Z:E$UFJ=YIR3K1TX@?4`>O*/D`?G;KKP' M>W5GWD_T^E1J+#1_0>'R'I,9XW4(R'V\CF37(GRR"I`DQ*\B*DSL%6"(;<3H M/O%9$#'HOV`/,F[#NEWH\W-7.G&\.C_OWUJW\#"#J>`HEV+,MHDYBTH+W)K) M>!>.42S"GN6<`I?.NQ63-_1O(M%+[B28B717\]W0%I?6'*^.]91_;Z9\%X/7FD+2:C8^V-W/ENF;/ MV:,$:355V]RL`C0#M6QQN$HPJ=9.?,DMCHCQY=8MP&`ATZ80K*SQORH1JGQ@ M+UY+B1<>)6M*:SAIL*F76WR`B>UQ=Q'UEH#!SH)"F<,:5@885;T0"8E[T)[X M6P&1`KEX%6`4B+=IV*>'!IMJS*PI"E9`/+HZRSO_UM`R`:GB%RVX"R)6_O:R MJX2H"@-[(>'I5I,SP*A@-^4.A;>$U@5C=G%5@+?&/\@#4IIERL(DKS5]J`R4 M-D9I&X%25*J>LT34.@)EH!3XAP1W5^N`/$-X@RCDPY^.X2K"R0-T^8*H9VN( MU4*K6PZ,UG)[P'NQ"K)T95,&T9R2-99,@TT5/TD4MF-7Y*Y2`P1\;$GC+3/RJNXQRFWV\*&'5B#XPH_K5,B4QTN(!Z'/ M>I2LTGEH-,]'[H8P',VSTY3-^^4:4U(U$>\18C/\0II3/F#%,=/1/-=Q9&O' M/]&V(O%/0>6&CJCD"X^+VS3F0YCR(TI#Q"6 M-_WROEN#0SP9L*H-YGQX!')#.IES5U9NX^C!%]E4_[DV6*LAZ\8O+Y#V_.+( MF))O9W]Y(S:*EKD"^-/U4OQ,NLV"[Z!4,!G#!Q!$R>&MI&GXDIFLX`L>$_EL MT[<)>B5QL84W\:CMB7N5PU+%4.$##,A:NK`4`FM(*'!I#RSQ?/:H4(2D6M`_ M$JO#P17X5(;?0R)F-D=>QW]`C-#G*\)72-:PJL!7SQV5QV6&\%&FL/2T-I\H M_AIA*#:5V&P`FW-JXK.;MY)][GNCUDBGE$*=/4(37X'%QZT`]99R2^*S[5VF M.:<]&DEJH&VDK])CFD/?Q\;('6O?1F=IQF8KM8W#/VX2];LB)6]NUTB3HG03:_HY[]Z9KXF>[.+]=;]'*8!I@K M7D*Q$VC-!B^PQ@7[BH]?&N)NW`J*R<+J%C"=*,S;,FL-K:9N;@EG^4=XFU-S MV!]#,;IE!%<:6HM#<`VX*-]CYXEX!+R!\?^\'Q5>D,(*;TBQ>:)HRLBX@4K> M*/)MM4;5%-0QGG3L?2*!U?W#VQ MW6YJ4:NW\21GK,G\$8CF"=+WV/#&DSV(91^UVV@#S#FH'@D0+Y)Q=^QW<2CW M/\X)7<6[8*SQE,U0JD[M81R!((UEBVV=U@2FU=`JWNQ97"]9L+K5@3-Y&X4] MFP++857OA\]876NXZ.$U>&.N-.IOV[;#GT]SIKDK-FS7P50\'K7CG_<05+\'U!+ M`0(>`Q0````(`$V`#D69R& M`Q0````(`$V`#D6[N'*\)@D``%AV```5`!@```````$```"D@>.)``!D`L``00E#@``!#D!``!02P$" M'@,4````"`!-@`Y%.&[LV",Y``!VH@,`%0`8```````!````I(%8DP``9')I M;RTR,#$T,#8S,%]D968N>&UL550%``/2%>U3=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`38`.14,SL+):2P``/NX#`!4`&````````0```*2!RLP``&1R M:6\M,C`Q-#`V,S!?;&%B+GAM;%54!0`#TA7M4W5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`$V`#D5`7/B%9#P``";O`P`5`!@```````$```"D@7,8`0!D M`L``00E#@``!#D!``!0 M2P$"'@,4````"`!-@`Y%2A*0T*\.``!PH@``$0`8```````!````I($F50$` M9')I;RTR,#$T,#8S,"YX`L``00E#@``!#D!``!02P4& 2``````8`!@`:`@``(&0!```` ` end XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2014
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES
 
The significant accounting policies applied in the annual financial statements of the Company as disclosed in the Company’s Annual Report on Form 10-K for the period ended December 31, 2013 are applied consistently in these financial statements except:
 
In June 2014 the FASB issued Update No. 2014-10 Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this Update remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of comprehensive loss, cash flows, and shareholder deficit, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments are effective prospectively for reporting periods beginning after December 15, 2014 early adoption is permitted. The Company chose to early adopt the update for June 30, 2014 consolidated financial statement.

EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V834S,V1F9%\U96)A7S1C,S%?.#4T,5\X838T M86,Q,V8V-C$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E1?3T9?0T%3 M2#PO>#I.86UE/@T*("`@(#QX.E=O#I7 M;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9!25)?5D%,545?345!4U52345.5%,\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-)1TY)1DE#04Y47T%#0T]53E1)3D=?4$], M24-)13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-% M3$5#5$5$7U-4051%345.5%-?3T9?3U!%4D%423$\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I7;W)K M#I7;W)K#I7 M;W)K#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-%3$5#5$5$7U-4051%345.5%-? M3T9?3U!%4D%423(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-50E-%455%3E1?159%3E137T1E=&%I;'-?5&5X=#PO>#I. M86UE/@T*("`@(#QX.E=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP M/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7S9A-3,S9&9D7S5E8F%?-&,S,5\X-30Q7SAA-C1A M8S$S9C8V,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\V834S,V1F M9%\U96)A7S1C,S%?.#4T,5\X838T86,Q,V8V-C$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"!+97D\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)RTM,3(M,S$\'0^)SQS<&%N/CPO6UB;VP\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^)S$P+5$\'0^)V9A;'-E/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)S(P,30\3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\V834S,V1F9%\U96)A7S1C,S%?.#4T,5\X838T86,Q,V8V M-C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U,S-D9F1?-65B M85\T8S,Q7S@U-#%?.&$V-&%C,3-F-C8Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPOF5D.B`X,"PP,#`L,#`P("AU M;F%U9&ET960I(&%N9"`T-2PP,#`L,#`P('-H87)E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,"PP,#`L,#`P M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'1087)T M7S9A-3,S9&9D7S5E8F%?-&,S,5\X-30Q7SAA-C1A8S$S9C8V,0T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\V834S,V1F9%\U96)A7S1C,S%?.#4T M,5\X838T86,Q,V8V-C$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-SQS<&%N/CPO'0^ M)SQS<&%N/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V834S,V1F9%\U96)A7S1C M,S%?.#4T,5\X838T86,Q,V8V-C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-F$U,S-D9F1?-65B85\T8S,Q7S@U-#%?.&$V-&%C,3-F-C8Q+U=O M'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO2`R,#$S(&%T("0R+C4P('!E2`R,#$S(&%T("0@,BXU,"!P97(@=6YI="P@;F5T(&]F(&ES'0^)SQS<&%N/CPO&5R8VES92!O9B!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG)FYB&5R8VES92!O9B!O<'1I;VYS("AI;B!S:&%R97,I/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO2`R,#$T(&%T M("0P+C4U('!E'0^)SQS<&%N/CPO M&5R8VES92!O9B!W87)R86YT'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2`R,#$S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'!E;G-E6%B;&4@86YD(&%C8W)U960@97AP M96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA&5D(&%S'0^)SQS<&%N/CPO M2!A;F0@97%U:7!M96YT/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-3`I/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAAF%T:6]N+"!#;VYS;VQI9&%T M:6]N(&%N9"!0'0^)SQS<&%N/CPOF%T:6]N+"!#;VYS;VQI9&%T:6]N(&%N9"!06QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)TU!4D=)3BU43U`Z(#!P>#L@1D]. M5#H@8F]L9"`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3L@5D52 M5$E#04PM04Q)1TXZ('1O<"<^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!724142#H@-38N-W!T)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H M.T-,14%2.B!B;W1H)SY.3U1%(#$Z+3PO9&EV/B`\+W1D/B`\=&0@2<^(#QD:78@6QE/3-$)TU!4D=)3BU43U`Z(#!P M=#L@5TE$5$@Z(#$P,"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)U9%4E1)0T%,+4%, M24=..B!T;W`G/B`\=&0@6QE/3-$)U=)1%1(.B`R."XW-7!T)SYA+CPO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!J=7-T:69Y)SY,86)3='EL92!);FYO=F%T:6]N M2!I"`P<'0@.3(N-W!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E3Y4:&4@0V]M M<&%N>2!H87,@82!W:&]L;'D@;W=N960@2P@3&%B4W1Y;&4@ M26YN;W9A=&EO;B!,=&0N("@F(S@R,C`[3'1D+B8C.#(R,3LI+"!I;F-O2!A;F0@=&\@<&5R9F]R;2!R M97-E87)C:"!A;F0@9&5V96QO<&UE;G0L(&UA;G5F86-T=7)I;F"`P<'0@,'!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`U-2XW<'0G/B`\9&EV('-T>6QE/3-$)T-,14%2 M.F)O=&@[0TQ%05(Z(&)O=&@G/CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/F(N/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!J=7-T:69Y)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2 M.B!B;W1H)SY$=7)I;F<@=&AE('-I>"!M;VYT:"!P97)I;V0@96YD960@2G5N M92`S,"P@,C`Q-"P@=&AE($-O;7!A;GD@:6YC=7)R960@;W!E2!N965D2!C;VYT:6YU:6YG('1O('-E96L@9F]R(&%D9&ET M:6]N86P@9G5N9&EN9R!F2!C;VUM96YC:6YG(&ETF%T:6]N(&]F(&ET6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\ M9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/D%C8V]R9&EN M9R!T;R!M86YA9V5M96YT(&5S=&EM871E28C,38P.V]N;'D@:6YT;R!/8W1O8F5R(#(P,30N M($9A:6QU2!A9'9E6QE/3-$)U=)1%1(.B`U-BXW<'0G/B`\9&EV('-T>6QE M/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/CPO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T-,14%2 M.F)O=&@[0TQ%05(Z(&)O=&@G/F,N/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!J=7-T:69Y)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.T-,14%2.B!B;W1H)SY/;B!-87)C:"`R,"P@,C`Q-"P@=&AE($-O;7!A M;GD@9FEL960@82!R96=I&-H86YG92!#;VUM:7-S:6]N("AT:&4@)B,X M,C(P.U-%0R8C.#(R,3LI(&-O=F5R:6YG('1H92!P=6)L:6,@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z M("TR."XS-7!T.R!-05)'24XZ(#!P="`P<'@@,'!T(#@U+C`U<'0[($9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3XF(S$V,#L\+V1I=CX@/'1A8FQE('-T>6QE/3-$)TU!4D=)3BU4 M3U`Z(#!P=#L@5TE$5$@Z(#$P,"4[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)U9%4E1) M0T%,+4%,24=..B!T;W`G/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU2`Q+"`R M,#$T('1H92!#;VUP86YY(&%N;F]U;F-E9"!T:&4@6QE/3-$)U=)1%1(.B`U-2XW<'0G/B`\9&EV('-T M>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/CPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)T-, M14%2.F)O=&@[0TQ%05(Z(&)O=&@G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG2!H96QD(&ET2!S=&]C:VAO;&1E28C.#(Q-SMS M($-EF5D M('-H87)E6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2`\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)U=)1%1(.B`U-2XW<'0G/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O M=&@[0TQ%05(Z(&)O=&@G/CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z M(&)O=&@G/F8N/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!J=7-T:69Y)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B M;W1H)SY/;B!!<')I;"`R."P@,C`Q-"!T:&4@0V]M<&%N>2!W87,@9W)A;G1E M9"!W:71H(&YA=&EO;F%L(&%P<')O=F%L(&%N9"!R96=I;VYA;"!R96EM8G5R M2X\+V1I M=CX@/"]T9#X@/"]T6QE/3-$ M)U=)1%1(.B`U-2XW<'0G/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G M/F6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U)3D1%3E0Z("TU-BXW<'0[($U!4D=)3CH@,'!T(#!P>"`P<'0@-38N M-W!T.R!&3TY4.B!B;VQD(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3XF(S$V,#L\+V1I=CX@/'1A8FQE('-T M>6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@5TE$5$@Z(#$P,"4[($9/3E0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/D]N M($IU;'D@,C`Q-"P@=&AE($-O;7!A;GD@2!O9B!(96%L=&@@=&\@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF M:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT M9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P M="!4:6UE"<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU2<^(#QD:78@6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X(#!P="`X-2XP-7!T M.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!A6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@ M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X(#!P M="`U-BXW<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"`P<'0@-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E2!O9B!T:&4@ M06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T:6]N+"!T:&5R96)Y(')E M;6]V:6YG('1H92!F:6YA;F-I86P@2!I2!F;W(@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^ M/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@"`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`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6QE/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE#L@9F]N="US:7IE M+6%D:G5S=#H@;F]N93L@9F]N="US=')E=&-H.B!N;W)M86PG(&-E;&QS<&%C M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^(#QT6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`U-BXW<'0G/B`\9&EV('-T M>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/DY/5$4@-#HM/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y)SX@/&1I M=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SY35$]#2TA/3$1% M4E,F(S@R,3<[($1%1DE#250\+V1I=CX@/"]T9#X@/"]T"`P<'0@ M.#4N,#5P=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`R."XW M-7!T)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SYA M+CPO9&EV/B`\+W1D/B`\=&0@2<^(#QD:78@2`R,#$T(%!R:79A=&4@4&QA8V5M96YT('=I=&@@:6YS=&ET M=71I;VYA;"!A;F0@;W1H97(@86-C6QE/3-$)T9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3XF(S$V,#L\ M+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4 M:6UE"`P<'0@.#0N-#5P=#L@1D].5#H@,3!P="!4 M:6UE2`R,#$T(%!R M:79A=&4@4&QA8V5M96YT(')E8V5I=F5D+"!I;B!A9&1I=&EO;B!T;R!A(&-A M6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z("TR."XS M-7!T.R!-05)'24XZ(#!P="`P<'@@,'!T(#@U+C`U<'0[($9/3E0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4 M+49!34E,63I4:6UE"`P<'0@.#0N-#5P=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG"`P<'0@.#4N,#5P=#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$)T-,14%2.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U) M3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X(#!P="`X-"XT-7!T.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!#;VUM;VX@4W1O8VL@*&EN8VQU9&EN9R!T:&4@061J=7-T;65N M="!3:&%R97,I+"!S96-U3XF M(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49! M34E,63I4:6UE"`P<'0@.#4N,#5P=#L@1D].5#H@,3!P="!4:6UE3XF M(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49! M34E,63I4:6UE"`P<'0@.#4N,#5P=#L@1D].5#H@,3!P="!4:6UE2!G2!I6EN9R!T:&4@5V%R3XF(S$V,#L\+V1I M=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE M"`P<'0@.#0N-#5P=#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG"`P<'0@.#0N-#5P M=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`R-RXW-7!T)SX@ M/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SYB+CPO9&EV M/B`\+W1D/B`\=&0@2<^(#QD M:78@6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%2 M1TE..B`P<'0@,'!X(#!P="`X-"XT-7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E3Y/;B!*=6YE(#$W+"`R,#$T+"!T:&4@0V]M<&%N>28C.#(Q-SMS(&UA:F]R M:71Y('-T;V-K:&]L9&5R6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1% M3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X(#!P="`X-"XT-7!T.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E28C M.#(Q-SMS($)O87)D(&]F($1I65E M(&1I65E(&1I6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG65E(&1I&5R M8VES92!F96%T=7)E(&%N9"!A('1E;B!Y96%R('1E3XF(S$V M,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E, M63I4:6UE"`P<'0@.#0N-#5P=#L@1D].5#H@,3!P M="!4:6UE28C.#(Q-SMS(%-C:65N=&EF:6,@061V:7-O&5R8VES92!P6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@ M,'!X(#!P="`X-"XT-7!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E65E(&1I6QE/3-$)U=)1%1( M.B`R."XW-7!T)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B M;W1H)SX\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU M6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G M/D%S(&]F($IU;F4L(#,P+"`R,#$T+"`\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)U=)1%1(.B`R."XW-7!T)SX@ M/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B2<^(#QD:78@6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$58 M5"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X(#!P="`Q,3,N-'!T.R!& M3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V M8V4@,'!X('-O;&ED.R!"3U)$15(M3$5&5#H@(SEE8C9C92`P<'@@6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#"!S;VQI9#L@ M1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$P)3X@/&1I=CXS-CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E, M13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+ M1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD M:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M,"4^(#QD:78^)B,Q-C`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXV.3`\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+#$Y.3PO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)U=)1%1(.B`U-2XW<'0G/B`\9&EV('-T>6QE/3-$)T-, M14%2.F)O=&@[0TQ%05(Z(&)O=&@G/CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/CPO9&EV/B`\+W1D/B`\=&0@2<^(#QD:78@3XF(S$V,#L\+V1I=CX@/'1A8FQE('-T>6QE/3-$ M)TU!4D=)3BU43U`Z(#!P=#L@5TE$5$@Z(#$P,"4[($9/3E0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/D1U6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG2X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T M86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO6QE/3-$)TU!4D=)3CH@,'!T M(#!P>#L@1D].5#H@,3!P="!4:6UE"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,#X@/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`P+C6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@ M,'!X(#!P="`U-BXW<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3Y!4T,@.#(P+"`F(S@R,C`[ M1F%I2!C;VYS:61E"`P<'0@-38N-W!T.R!&3TY4.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E&EM M:7IE('1H92!U2!I2!B92!U"`P<'0@-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@ M/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`P+C2<^(#QD:78^<75O=&5D('!R:6-E"`P M<'0@-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E"<@8V5L M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&IU6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`P+C2<^(#QD:78^:6YP=71S(&]T:&5R('1H86X@3&5V96PF(S$V,#LQ('1H870@ M87)E(&]B2!O6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@ M/'1R('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`P+C2<^(#QD:78^=6YO8G-E2!A;F0@=&AA="!A6QE/3-$)U=)1%1(.B`U M-BXW<'0G/CPO=&0^(#QT9"!S='EL93TS1"=724142#H@,C@N,S5P="<^(#QD M:78^82X\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU M2!C M;VYS=6UM871E9"!T:&4@,C`Q,2TR,#$R(%!R:79A=&4@4&QA8V5M96YT('!U M"`P<'0@-38N-W!T.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y4:&4@<&QA8V5M96YT(&%G96YT(&9O2`D,2XS,"!P97(@6QE/3-$)U=)1%1(.B`U M-BXW<'0G/CPO=&0^(#QT9"!S='EL93TS1"=724142#H@,C@N,S5P="<^(#QD M:78^8BX\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU M2!C;VYS=6UM871E9"!T:&4@1F5B2!I&EM871E;'D@)#,L-S4T(&YE="!O9B!I"`P<'0@-38N-W!T.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y);B!A9&1I=&EO;BP@=&AE($-O;7!A;GD@9W)A;G1E M9"!T;R!T:&4@<&QA8V5M96YT(&%G96YT(&9O6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1% M3E0Z("TU-BXW<'0[($U!4D=)3CH@,'!T(#!P>"`P<'0@.#4N,#5P=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M5T5)1TA4.B!N;W)M86PG M/B`F(S$V,#L\+V9O;G0^/"]D:78^(#QD:78@28C.#(R,3L@*"8C.#(R,#M!4T,@.#$U+30P)B,X,C(Q.RDN(%1H92!# M;VUP86YY(&UE87-U'!I"`P<'0@.#4N M,#5P=#L@1D].5#H@,3!P="!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X M(#!P="`U-BXW<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1% M3E0Z("TR."XS-7!T.R!-05)'24XZ(#!P="`P<'@@,'!T(#4V+C=P=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M5T5)1TA4.B!N;W)M86PG M/B`F(S$V,#L\+V9O;G0^/"]D:78^(#QD:78@"`P<'0@.#4N,#5P=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T M;VTG/B`\=&0@6QE/3-$)W=H:71E+7-P86-E.FYO=W)A<#L@4$%$1$E.1RU"3U143TTZ(#%P M=#L@1D].5"U714E'2%0Z(&)O;&0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE M/3-$)W=H:71E+7-P86-E.FYO=W)A<#L@0D]21$52+4)/5%1/33H@8FQA8VL@ M,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B M;VQD)R!C;VQS<&%N/3-$,CX@/&1I=CY$96-E;6)E6QE/3-$)U9%4E1) M0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=CXF M(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)R!C;VQS<&%N/3-$,CX@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@8V]L M6QE/3-$)T)!0TM'4D]5 M3D0M0T],3U(Z(')G8B@R,#0L,C,X+#(U-2D[(%9%4E1)0T%,+4%,24=..B!B M;W1T;VTG/B`\=&0@3L@5TE$ M5$@Z(#8T)2<^(#QD:78^4FES:RUF6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@,34E)SX@/&1I=CXP+C8Q M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!7 M24142#H@,24G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U=) M1%1(.B`Q)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^(#QD:78^)3PO9&EV/B`\ M+W1D/B`\+W1R/B`\='(@2<^(#QD:78^17AP96-T960@=F]L871I;&ET>2`H M,BD\+V1I=CX@/"]T9#X@/'1D/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/'1D/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C,X+#(U M-2D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@2<^(#QD:78^17AP96-T960@;&EF92`H:6X@>65A M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@/&1I=CXR+C,S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@'!E8W1E9"!D:79I9&5N9"!Y M:65L9"`H-"D\+V1I=CX@/"]T9#X@/'1D/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@/&1I=CXP/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@/&1I=CXE/"]D:78^(#PO=&0^(#PO='(^(#QT M6QE/3-$)U1%6%0M M04Q)1TXZ(&IU6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I=CXF(S$V,#L\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@/&1I=CXF(S$V,#L\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I M=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(@2<^ M(#QD:78^1F%I6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I=CXP+C6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U)3D1%3E0Z("TR."XS-7!T.R!-05)'24XZ(#!P="`P<'@@,'!T(#@U M+C`U<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS M1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE"`P<'0@-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E"`P<'0@ M.#4N,#5P=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\ M=&0@6QE/3-$ M)W=H:71E+7-P86-E.FYO=W)A<#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D]. M5"U714E'2%0Z(&)O;&0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)W=H M:71E+7-P86-E.FYO=W)A<#L@0D]21$52+4)/5%1/33H@8FQA8VL@,7!T('-O M;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5)1TA4.B!B;VQD)R!C M;VQS<&%N/3-$,CX@/&1I=CY$96-E;6)E6QE/3-$)U9%4E1)0T%,+4%, M24=..B!B;W1T;VTG/B`\=&0@2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=CXF(S$V,#L\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!C M;VQS<&%N/3-$,CX@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@8V]L6QE/3-$)T)!0TM'4D]53D0M0T], M3U(Z(')G8B@R,#0L,C,X+#(U-2D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG M/B`\=&0@3L@5TE$5$@Z(#8T M)2<^(#QD:78^4FES:RUF6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!724142#H@,34E)SX@/&1I=CXP+C,Y/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@ M,24G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q M)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!724142#H@,24G/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^(#QD:78^)3PO9&EV/B`\+W1D/B`\ M+W1R/B`\='(@2<^(#QD:78^17AP96-T960@=F]L871I;&ET>2`H,BD\+V1I M=CX@/"]T9#X@/'1D/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`\9&EV/B4\+V1I=CX@/"]T9#X@/'1D/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C,X+#(U-2D[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@2<^(#QD:78^17AP96-T960@;&EF92`H:6X@>65A6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I M=CXQ+C6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@/&1I=CXP/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@/&1I=CXE/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)U1%6%0M04Q)1TXZ M(&IU6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@/&1I=CXF(S$V,#L\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I=CXF(S$V M,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(@2<^(#QD:78^ M1F%I6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)W=H:71E+7-P86-E.FYO=W)A<#L@4$%$1$E.1RU"3U14 M3TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ M(&IU6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$U M)2<^(#QD:78^,2XU.3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!724142#H@,34E)SX@/&1I=CXQ+C8S/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B`\ M9&EV/B4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T)!0TM'4D]5 M3D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(@2<^(#QD:78^17AP96-T M960@9&EV:61E;F0@>6EE;&0@*#0I/"]D:78^(#PO=&0^(#QT9#X@/&1I=CXF M(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/'1D M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@/&1I=CXD/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^(#QD:78^ M,2XW.#PO9&EV/B`\+W1D/B`\=&0@"`P<'0@-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)U=)1%1(.B`U-BXW<'0G/CPO=&0^(#QT9"!S M='EL93TS1"=724142#H@,S4N,C5P="<^(#QD:78^*#$I/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!J=7-T:69Y)SX@/&1I=CY2:7-K M+69R964@:6YT97)E"!L:6YK960@52Y3+B!&961E"`P<'0@.3(N,35P=#L@1D].5#H@,3!P="!4:6UE2<^(#QD:78^17AP96-T960@ M=F]L871I;&ET>2`M('=A2!O=F5R(&$F(S$V,#MT97)M('1H M870@:7,@97%U:79A;&5N="!T;R!T:&4@97AP96-T960@=&5R;2!O9B!T:&4@ M;W!T:6]N+B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\9&EV M('-T>6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z("TS-2XT-7!T.R!- M05)'24XZ(#!P="`P<'@@,'!T(#DR+C$U<'0[($9/3E0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3XF(S$V M,#L\+V1I=CX@/'1A8FQE('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T M;W`G/B`\=&0@6QE/3-$)U=)1%1(.B`S-2XR-7!T)SX@/&1I=CXH,RD\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU"`P<'0@.3(N,35P M=#L@1D].5#H@,3!P="!4:6UE2<^(#QD:78^17AP96-T960@9&EV:61E;F0@>6EE;&0@+2!W87,@ M8F%S960@;VX@=&AE(&9A8W0@=&AA="!T:&4@0V]M<&%N>2!H87,@;F]T('!A M:60@9&EV:61E;F1S('1O(&ET3XF(S$V,#L\ M+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4 M:6UE"`P<'0@.#4N,#5P=#L@1D].5#H@,3!P="!4 M:6UE2`R,#$T(%!R:79A=&4@4&QA8V5M96YT('=A6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@ M,'!X(#!P="`U-BXW<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3XF(S$V,#L\+V1I=CX@/'1A M8FQE('-T>6QE/3-$)U=)1%1(.B`X,B4[($)/4D1%4BU#3TQ,05!313H@8V]L M;&%P6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L M,C,X+#(U-2D[(%9%4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@3L@5$585"U)3D1%3E0Z("TQ,2XS-7!T M.R!0041$24Y'+4Q%1E0Z(#$Q+C,U<'0[(%=)1%1(.B`X-R4G/B`\9&EV/D)A M;&%N8V4@870@1&5C96UB97(@,S$L(#(P,3,\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U=)1%1(.B`Q)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B`\9&EV M/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!724142#H@,3`E)SX@/&1I=CXR+#8Y-CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)!0TM'4D]53D0M M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@/&1I=CXS+#(S,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&IU6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I=CXH-3,X/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@/&1I=CXI/"]D:78^ M(#PO=&0^(#PO='(^(#QT6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^(#QD:78^)B,Q-C`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q<'0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-7!T(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)T-,14%2 M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X(#!P="`U M-BXW<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3XF(S$V,#L\+V1I=CX@/'1A8FQE('-T>6QE M/3-$)TU!4D=)3BU43U`Z(#!P=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0@"!M;VYT:"!P97)I M;V0@96YD960@2G5N92`S,"P@,C`Q-"P@=&AE('!L86-E;65N="!A9V5N="!E M>&5R8VES960@.2PQ,3@@=V%R2`H4V5E(&%L6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#!I M;CL@34%21TE..B`P<'0@,'!X(#!P="`X-2XP-7!T.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3Y!3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\V834S,V1F9%\U96)A7S1C,S%?.#4T,5\X838T86,Q,V8V-C$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U,S-D9F1?-65B85\T8S,Q M7S@U-#%?.&$V-&%C,3-F-C8Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!&:6YA;F-I86P@26YF;W)M871I;VX@6U1E>'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ M(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$ M)TU!4D=)3BU43U`Z(#!P=#L@5TE$5$@Z(#$P,"4[($9/3E0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/D=E;F5R86P@ M86YD(&%D;6EN:7-T6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[0TQ%05(Z(&)O=&@G/B`F(S$V M,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E, M63I4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C M96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M M4U193$4Z(&YO"!S;VQI M9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M M4U193$4Z(&YO"!S;VQI M9#L@1D].5"U714E'2%0Z(#"!S M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/C(P,3,\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C M96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C96YT M97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S M;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T-, M14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@1D].5"U714E'2%0Z(#

6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/E!A>7)O;&PL(&]F9FEC92!A;F0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G M/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F M9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-, M14%2.F)O=&@[0TQ%05(Z(&)O=&@G/C4V,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z M(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2 M.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2 M.F)O=&@[0TQ%05(Z(&)O=&@G/E-T;V-K+6)A6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV('-T>6QE M/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/C4S,3PO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O M=&@[0TQ%05(Z(&)O=&@G/C(X,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/C@W-SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\ M9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/C$L,S4X/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/DES6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/BT\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2 M.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\ M='(^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/C(U-CPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,24^(#QD:78@"!S;VQI9#L@5$585"U!3$E'3CH@"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5)) M1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Y M)3X@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SXF(S$V M,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I=B!S='EL M93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SXF(S$V,#L\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$ M)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.T-,14%2.B!B;W1H)SXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-, M14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Y)3X@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B M;W1H)SXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2 M.F)O=&@[0TQ%05(Z(&)O=&@G/C$L,CDR/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@ M5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-E969F.R!& M3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B0\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@ M5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/C,L-#(P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M3XF(S$V,#L\+V1I=CX@/&9O;G0@6QE/3-$)U=)1%1(.B`R."XW-7!T)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.T-,14%2.B!B;W1H)SYB+CPO9&EV/B`\+W1D/B`\=&0@2<^(#QD:78@6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5. M5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,&EN(#$N,3=I;CL@5TE$5$@Z(#@U)3L@0D]21$52+4-/3$Q! M4%-%.B!C;VQL87!S93L@3U9%4D9,3U6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([ M($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT M97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@ M1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E"!S;VQI9#L@1D].5"U714E'2%0Z(#

6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@ M1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV/C$P M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#DE/B`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`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#DE/B`\9&EV/C0Q/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#DE/B`\9&EV/C0X.3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV/BT\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`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`P M,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\ M9&EV/C$L-CDP/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58 M5"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4 M+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5) M1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@ M"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$ M)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[0TQ%05(Z(&)O=&@G/B`\+V1I=CX@/&1I=B!S='EL93TS M1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE6QE M/3-$)U=)1%1(.B`U-BXW<'0G/CPO=&0^(#QT9"!S='EL93TS1"=724142#H@ M,3AP="<^(#QD:78^8RX\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&IU#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U)3D1%3E0Z(#!I;CL@34%21TE..B`P:6X@,'!X(#!I;B`Q+C$U:6X[ M($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I M;65S($YE=R!2;VUA;B6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0G/B`F(S$V,#L\+V1I M=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI M9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@,3!P M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0T,"4^(#QD:78^3G5M97)A=&]R(&9O6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C965F9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE: M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Y)3X@/&1I=CXU+#(X-CPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R M:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`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`P M,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I=CXS+#4T-#PO9&EV M/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE: M13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Y)3X@/&1I=CXU+#(X-CPO9&EV/B`\+W1D/B`\=&0@ M"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Y)3X@/&1I=CXV+#4T,3PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T], M3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I=CXQ M,"PU,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T M,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C M8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$.24^(#QD:78^)B,Q M-C`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`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R M;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@;&5F M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/ M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I=CXQ."PS,C6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y' M+5))1TA4.B`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`P,#`@,W!X(&1O M=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-E M969F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@ M0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I M=CXR,BPR-C`L.34R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@ M5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-E969F.R!# M3TQ/4CH@(S`P,#`P,#L@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE M+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6QE/3-$)TU! M4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UEF4M861J=7-T.B!N;VYE.R!F;VYT+7-T M6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1% M6%0M04Q)1TXZ(&IU6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/E-50E-%455%3E0@159%3E13/"]D:78^(#PO=&0^(#PO M='(^(#PO=&%B;&4^(#QD:78@6QE/3-$)U=)1%1(.B`R."XW-7!T)SX@ M/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SYA+CPO9&EV M/B`\+W1D/B`\=&0@2<^(#QD M:78@2`R,#$T(%!R:79A=&4@4&QA8V5M96YT(&%G2!I6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z("TU-BXW<'0[ M($U!4D=)3CH@,'!T(#!P>"`P<'0@-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)TU!4D=)3BU43U`Z(#!P>#L@1D]. M5#H@,3!P="!4:6UE&5R8VES92!O9B!S=6-H('=A6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z("TR."XS-7!T.R!-05)'24XZ M(#!P="`P<'@@,'!T(#$Q,RXT<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3X\9F]N="!S='EL M93TS1"=&3TY4+5=%24=(5#H@;F]R;6%L)SX@)B,Q-C`[/"]F;VYT/CPO9&EV M/B`\=&%B;&4@6QE/3-$)U=) M1%1(.B`X-"XT-7!T)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2 M.B!B;W1H)SX\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`S,'!T M)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SX\9F]N M="!S='EL93TS1"=&3TY4+5=%24=(5#H@;F]R;6%L)SXR+CPO9F]N=#X\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/CQF;VYT('-T M>6QE/3-$)T9/3E0M5T5)1TA4.B!N;W)M86PG/E1H92!E>&5R8VES92!P6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG&EM871E;'D@)#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG"`P M<'0@,"XU:6X[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X\8CXF(S$V,#L\+V(^/"]D:78^(#QD M:78@3Y!;&P@=&AE(&%F;W)E;65N=&EO;F5D('=A M2!A8V-O"`P<'0@,"XU:6X[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3X\8CXF(S$V,#L\+V(^ M/"]D:78^(#QT86)L92!S='EL93TS1"=-05)'24XM5$]0.B`P<'0[(%=)1%1( M.B`Q,#`E.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)U=)1%1(.B`U-2XW<'0G/B`\9&EV('-T>6QE/3-$ M)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O M=&@[0TQ%05(Z(&)O=&@G/F(N/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!J=7-T:69Y)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H M.T-,14%2.B!B;W1H)SY/;B!*=6QY(#2!#;VUP96YS871I;VX@0V]M;6ET=&5E(&]F('1H M92!";V%R9"!O9B!$:7)E8W1O3Y);B!A9&1I=&EO;B!O;B!T:&4@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG28C.#(Q-SMS(#(P M,3(@17%U:71Y($EN8V5N=&EV92!0;&%N(&%N9"!S:&%L;"!B92!D965M960@ M=&\@:&%V92!B965N(&ES&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA2!497AT M($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD:78@ M65A2!T:&%T(&EN('!R:6]R('EE87)S(&ET(&AA9"!B965N(&EN('1H M92!D979E;&]P;65N="!S=&%G92X@5&AE(&%M96YD;65N=',@87)E(&5F9F5C M=&EV92!P2!C:&]S92!T;R!E87)L>2!A9&]P M="!T:&4@=7!D871E(&9O3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\V834S,V1F9%\U96)A7S1C,S%?.#4T,5\X838T86,Q,V8V M-C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U,S-D9F1?-65B M85\T8S,Q7S@U-#%?.&$V-&%C,3-F-C8Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!;06)S=')A8W1= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0@0FQO M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL M93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)U=)1%1(.B`U M-2XW<'0G/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G M/CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3XF(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=#3$5!4CIB M;W1H.R!&3TY4+49!34E,63I4:6UE"!S;VQI9#L@ M34%21TE..B`P:6X@,&EN(#!I;B`Q+C$W:6X[(%=)1%1(.B`X,B4[($)/4D1% M4BU#3TQ,05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B M-F-E(#!P>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!A;&EG;CTS1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`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`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P M)3X@/&1I=CXQ-#$\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@ M/&1I=CXV/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D]. M5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE'!E;G-E"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA M>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^ M/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$)TU!4D=)3CH@,'!T(#!P M>#L@1D].5#H@,3!P="!4:6UE"`P<'0@-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)W=H:71E+7-P86-E.FYO=W)A<#L@4$%$1$E.1RU"3U14 M3TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE M/3-$)W=H:71E+7-P86-E.FYO=W)A<#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@ M1D].5"U714E'2%0Z(&)O;&0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M+W1R/B`\='(@6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R M/B`\='(@3L@4$%$1$E.1RU"3U143TTZ(#%P=#L@ M5$585"U)3D1%3E0Z("TQ,2XS-7!T.R!0041$24Y'+4Q%1E0Z(#$Q+C,U<'0G M/B`\9&EV/D5X97)C:7-E(&]F('=A6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C,X+#(U-2D[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VTG/B`\=&0@3L@5$585"U)3D1%3E0Z("TQ,2XS-7!T.R!0041$24Y'+4Q% M1E0Z(#$Q+C,U<'0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD M:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\+W1R/B`\='(@3L@4$%$1$E.1RU"3U143TTZ(#(N-7!T M.R!415A4+4E.1$5.5#H@+3$Q+C,U<'0[(%!!1$1)3D"`P M<'0@-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$ M)U=)1%1(.B`X-2XP-7!T)SX\+W1D/B`\=&0@2<^(#QD:78^1'5R:6YG('1H92!S:7@@;6]N=&@@ M<&5R:6]D(&5N9&5D($IU;F4@,S`L(#(P,30L('1H92!P;&%C96UE;G0@86=E M;G0@97AE'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ(#!P M="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X\9F]N="!S='EL93TS1"=&3TY4+5=%24=(5#H@;F]R;6%L)SX@)B,Q M-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$58 M5"U)3D1%3E0Z(#!I;CL@34%21TE..B`P<'0@,'!X(#!P="`U-BXW<'0[($9/ M3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3Y);G9E6QE/3-$)T-,14%2.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[5$585"U)3D1%3E0Z("TR."XS-7!T.R!-05)'24XZ(#!P="`P<'@@,'!T M(#@U+C`U<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3XF(S$V,#L\+V1I=CX@/'1A8FQE('-T M>6QE/3-$)U=)1%1(.B`X."4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)W=H:71E+7-P86-E.FYO=W)A<#L@5$585"U!3$E'3CH@ M:G5S=&EF>2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=W:&ET92US<&%C93IN;W=R87`[(%!!1$1)3D6QE/3-$)W=H:71E+7-P86-E.FYO=W)A<#L@0D]21$52+4)/5%1/33H@ M8FQA8VL@,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M5T5) M1TA4.B!B;VQD)R!C;VQS<&%N/3-$,CX@/&1I=CY*=6YE(#,P+#QB6QE/3-$)W=H:71E+7-P86-E.FYO=W)A M<#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1( M.B`Q)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$U)2<^(#QD:78^,"XV,3PO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@ M,34E)SX@/&1I=CXP+C

6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\+W1R/B`\='(@2<^(#QD:78^17AP96-T960@9&EV:61E;F0@>6EE;&0@ M*#0I/"]D:78^(#PO=&0^(#QT9#X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/'1D/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$ M)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T M=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^(#QD:78^,"XW-#PO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D M/CPO='(^/"]T86)L93X\'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO6QE/3-$ M)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)W=H:71E+7-P86-E.FYO=W)A M<#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)W=H:71E+7-P86-E.FYO=W)A<#L@4$%$1$E.1RU"3U14 M3TTZ(#%P=#L@1D].5"U714E'2%0Z(&)O;&0G/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!C;VQS<&%N/3-$,CX@/&1I M=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\='(@6QE/3-$)U=)1%1(.B`Q)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!724142#H@,24G/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q)2<^(#QD M:78^)3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%=)1%1(.B`Q)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$U)2<^(#QD M:78^,"XU,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I=CXU,RXX-3PO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@/&1I M=CXU,"XY,3PO9&EV/B`\+W1D/B`\=&0@'!E8W1E9"!L:69E("AI;B!Y96%R6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78^)B,Q-C`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`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T)! M0TM'4D]53D0M0T],3U(Z(')G8B@R,#0L,C,X+#(U-2D[(%9%4E1)0T%,+4%, M24=..B!B;W1T;VTG/B`\=&0@2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=CXF(S$V,#L\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV M/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@/&1I=CXP+C0X+3`N-C,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^(#QD:78^)B,Q-C`[,"XV-RTP+C@S/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@/&1I=CXF M(S$V,#L\+V1I=CX@/"]T9#X@/"]T&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^ M/'1D/CPO=&0^/"]T'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/&1I=B!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=H:71E+7-P M86-E.FYO=W)A<#L@4$%$1$E.1RU"3U143TTZ(#%P=#L@1D].5"U714E'2%0Z M(&)O;&0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`Q M)2<^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H=#L@5TE$5$@Z(#$U)2<^(#QD:78^,2XU.3PO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!724142#H@,34E M)SX@/&1I=CXQ+C8S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!724142#H@,24G/B`\9&EV/B4\+V1I=CX@/"]T9#X@/"]T M6QE/3-$)T)!0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&IU6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(&IU6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M+W1R/B`\='(@2<^(#QD:78^17AP96-T960@9&EV:61E;F0@>6EE;&0@*#0I M/"]D:78^(#PO=&0^(#QT9#X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`\9&EV/B4\+V1I=CX@/"]T9#X@/'1D/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T)! M0TM'4D]53D0M0T],3U(Z('=H:71E.R!615)424-!3"U!3$E'3CH@8F]T=&]M M)SX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^(#QD:78^,2XW.#PO9&EV/B`\+W1D/B`\=&0@ M"`P<'0@ M-38N-W!T.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)U=) M1%1(.B`U-BXW<'0G/CPO=&0^(#QT9"!S='EL93TS1"=724142#H@,S4N,C5P M="<^(#QD:78^*#$I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!J=7-T:69Y)SX@/&1I=CY2:7-K+69R964@:6YT97)E"!L:6YK960@52Y3 M+B!&961E"`P<'0@.3(N,35P M=#L@1D].5#H@,3!P="!4:6UE2<^(#QD:78^17AP96-T960@=F]L871I;&ET>2`M('=A2!O=F5R(&$F(S$V,#MT97)M('1H870@:7,@97%U:79A;&5N="!T;R!T M:&4@97AP96-T960@=&5R;2!O9B!T:&4@;W!T:6]N+B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\+W1A8FQE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U)3D1%3E0Z("TS-2XT-7!T.R!-05)'24XZ(#!P="`P<'@@,'!T(#DR M+C$U<'0[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3XF(S$V,#L\+V1I=CX@/'1A8FQE('-T>6QE M/3-$)TU!4D=)3BU43U`Z(#!P=#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U9%4E1)0T%,+4%,24=..B!T;W`G/B`\=&0@6QE/3-$)U=)1%1(.B`S-2XR-7!T M)SX@/&1I=CXH,RD\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&IU"`P<'0@.3(N,35P=#L@1D].5#H@,3!P="!4:6UE2<^(#QD:78^17AP96-T M960@9&EV:61E;F0@>6EE;&0@+2!W87,@8F%S960@;VX@=&AE(&9A8W0@=&AA M="!T:&4@0V]M<&%N>2!H87,@;F]T('!A:60@9&EV:61E;F1S('1O(&ET&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^ M/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'!E;G-E+"!B>2!#;VUP;VYE;G0@6U1A8FQE(%1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=- M05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=)1%1(.B`R."XW-7!T M)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2.B!B;W1H)SYA+CPO M9&EV/B`\+W1D/B`\=&0@2<^ M(#QD:78@6QE/3-$)T-,14%2.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E' M3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L M92!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,&EN(#$N,3=I;CL@5TE$5$@Z M(#@U)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@1D].5"U325I%.B`Q M,'!T.R!/5D521DQ/5SH@=FES:6)L92<@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,#X@/'1R/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-, M14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B!4:')E928C,38P.VUO;G1H6QE/3-$ M)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/E-I>"8C,38P.VUO M;G1H6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!C M96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/C(P,30\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z M(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z M(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B0\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/C(V,SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B0\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z M(&)O=&@G/C4S-#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z M(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O M=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O M=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[ M0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C M,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#DE/B`\9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/C8Q M.#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV('-T M>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/BT\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E, M13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD M:78@"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D]. M5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%- M24Q9.B!4:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R M:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T-, M14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\ M9&EV('-T>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/C0X/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T-,14%2 M.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z M(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV('-T M>6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/C$L-3$V/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ%05(Z(&)O=&@G/B0\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T-,14%2.F)O=&@[0TQ% M05(Z(&)O=&@G/B8C,38P.R`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M)U1I;65S($YE=R!2;VUA;B&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,#X\='(^/'1D/CPO=&0^/"]T'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I M=B!S='EL93TS1"=-05)'24XZ(#!P="`P<'@[($9/3E0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE#L@1D].5#H@,3!P="!4:6UE6QE/3-$)U=) M1%1(.B`R."XW-7!T)SX@/&1I=B!S='EL93TS1"=#3$5!4CIB;W1H.T-,14%2 M.B!B;W1H)SYB+CPO9&EV/B`\+W1D/B`\=&0@2<^(#QD:78@6QE/3-$)T-, M14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!7 M24142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@ M,&EN(#$N,3=I;CL@5TE$5$@Z(#@U)3L@0D]21$52+4-/3$Q!4%-%.B!C;VQL M87!S93L@3U9%4D9,3U6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M M4U193$4Z(&YO"!S;VQI M9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV/C$P/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE M/B`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`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\ M9&EV/C0Q/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V-C965F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\ M9&EV/C0X.3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV/BT\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E, M13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+ M1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD M:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F M9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`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`P,#`@,W!X(&1O M=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F M9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#DE/B`\9&EV/C$L-CDP M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@ M;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G M('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^ M/'1D/CPO=&0^/"]T6QE M/3-$)TU!4D=)3CH@,'!T(#!P>#L@1D].5#H@,3!P="!4:6UE6QE/3-$)T-,14%2.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE M/3-$)T-,14%2.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0G/B`F(S$V,#L\+V1I=CX@/&1I=B!S='EL93TS1"=# M3$5!4CIB;W1H.R!&3TY4+49!34E,63I4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"!S;VQI M9#L@1D].5"U714E'2%0Z(#6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E"!S;VQI9#L@1D].5"U714E'2%0Z(#

6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0T,"4^(#QD:78^ M3G5M97)A=&]R(&9O6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C965F M9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@ M/&1I=CXU+#(X-CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!0041$24Y'+5))1TA4.B`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`P,#`[($9/3E0M4TE:13H@,3!P M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Y)3X@/&1I=CXS+#4T-#PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@ M/&1I=CXU+#(X-CPO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T],3U(Z(",P M,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I=CXV+#4T,3PO M9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I=CXQ,"PU,3,\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD M:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P M,#`P,#L@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4[($9/3E0M5T5)1TA4 M.B`T,#`G('=I9'1H/3-$.24^(#QD:78^)B,Q-C`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`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4 M.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$ M.B`C9F9F9F9F.R!#3TQ/4CH@(S`P,#`P,#L@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Y)3X@/&1I=CXQ."PS,C6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`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`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@ M;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P M,#L@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X M(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C965F9CL@0T],3U(Z(",P,#`P,#`[($9/ M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Y)3X@/&1I=CXR,BPR-C`L.34R/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C8V-E969F.R!#3TQ/4CH@(S`P,#`P,#L@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\V834S,V1F9%\U96)A7S1C,S%?.#4T,5\X838T M86,Q,V8V-C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U,S-D M9F1?-65B85\T8S,Q7S@U-#%?.&$V-&%C,3-F-C8Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!);F-E;G1I=F4@4&QA;B`R,#$R(%M-96UB97)=/&)R/CPO=&@^#0H@("`@ M("`@(#QT:"!C;&%S2`R,#$T M(%!R:79A=&4@4&QA8V5M96YT(%M-96UB97)=/&)R/DEN=F5S=&]R(%M-96UB M97)=/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO2!3 M:&%R92UB87-E9"!087EM96YT($%W87)D+"!.=6UB97(@;V8@061D:71I;VYA M;"!3:&%R97,@075T:&]R:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D(%!E'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPOF5D(%!E'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPOF5D(%!E'0^)SQS M<&%N/CPO'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4S,3QS<&%N/CPO'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA2!);F-E;G1I=F4@4&QA;B`R M,#$R(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S65E($1I65E(%-T;V-K($]P=&EO;B!;365M8F5R73QB2`R,#$T(%!R:79A=&4@4&QA8V5M96YT('=A2`R,#$T(%!R:79A=&4@4&QA8V5M96YT M('=A2`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`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@07=A M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES M960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA&EM=6T@6TUE;6)E&EM=6T@6TUE;6)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO65A7,\'0^)SQS<&%N/CPO M'0^)S0@>65A M'0^)S4@>65A'!E8W1E9"!D:79I9&5N9"!Y:65L9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6EE;&0@2!B;VYD2`M('=A'!E8W1E9"!T97)M(&]F('1H92!O<'1I;VXN/"]T9#X-"B`@("`@ M(#PO='(^#0H@("`@("`\='(@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2`R,#$T(%!R:79A=&4@4&QA8V5M96YT('=A'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA&-E<'0@4VAA'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2`R,#$T(%!R:79A=&4@4&QA8V5M96YT('=A2`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` end XML 18 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS (Details Textual) (USD $)
6 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended
Jun. 30, 2014
Private Placement warrants 2011-2012 [Member]
Jul. 31, 2014
Private Placement warrants 2011-2012 [Member]
Placement Agent Warrants [Member]
Jun. 30, 2014
February 2014 Private Placement warrants [Member]
Placement Agents [Member]
Jul. 31, 2014
Subsequent Event [Member]
Employee Stock Option [Member]
Jul. 31, 2014
Subsequent Event [Member]
Non Employee Stock Option [Member]
Jul. 31, 2014
Subsequent Event [Member]
Non-Employee Directors [Member]
Jul. 31, 2014
Subsequent Event [Member]
Private Placement warrants 2011-2012 [Member]
Investor [Member]
Jul. 31, 2014
Subsequent Event [Member]
Private Placement warrants 2011-2012 [Member]
Placement Agent 1 [Member]
Jul. 31, 2014
Subsequent Event [Member]
Private Placement warrants 2011-2012 [Member]
Placement Agent 2 [Member]
Jul. 31, 2014
Subsequent Event [Member]
February 2014 Private Placement warrants [Member]
Investor [Member]
Jul. 31, 2014
Subsequent Event [Member]
February 2014 Private Placement warrants [Member]
Placement Agents [Member]
Subsequent Event [Line Items]                      
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price       $ 0.98              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       1,100,000 395,000 150,000          
Stock Issued During Period, Value, New Issues                   $ 2,484,416  
Share Price                     $ 0.89
Exercise Price Of Warrants $ 1.30 $ 1.00 $ 2.35       $ 1.05 $ 1.05 $ 0.84 $ 0.89  
Warrants Issued During Period             645,054 122,838 83,561 2,746,688 238,265

XML 19 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
GENERAL
6 Months Ended
Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE 1:-
GENERAL
 
a. LabStyle Innovations Corp. (the “Company”) was incorporated in Delaware and commenced operations on August 11, 2011. The Company is a mobile health (mHealth) company developing and commercializing patent-pending technologies to provide consumers with laboratory-testing capabilities using smart phones and other mobile devices.  The Company’s initial product, Dario™, is a mobile, cloud-based, diabetes management solution which includes a pocket-sized blood glucose monitoring device that, utilizing proprietary software, integrates with smart phones and other mobile devices to offer users the ability to record, save, track, analyze, manage and share diabetes related information (the “Dario™ Smart Meter”)
 
The Company has a wholly owned subsidiary, LabStyle Innovation Ltd. (“Ltd.”), incorporated and located in Israel, which commenced operations on September 14, 2011. Its principal business activity is to hold the Company’s intellectual property and to perform research and development, manufacturing, marketing and other business activities.
 
b.
During the six month period ended June 30, 2014, the Company incurred operating losses and negative cash flows from operating activities amounting to $6,271 and $4,418, respectively. The Company will be required to obtain additional capital resources in the near term to extend its commercialization, ramp up its inventory and maintain its research and development activities. The Company is addressing its liquidity needs by continuing to seek for additional funding from public and/or private sources and by commencing its initial commercial sales. There are no assurances, however, that the Company will be able to obtain an adequate level of financing or commence an adequate level of initial commercial sales required for the short and long-term development and commercialization of its product.
 
According to management estimates, the Company has sufficient liquidity resources to continue its planned activity only into October 2014. Failure of the Company to obtain additional funding would have a materially adverse effect on the Company’s results of operations, future operations and overall viability. 
 
These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.
  
c.
On March 20, 2014, the Company filed a registration statement (the “Third Registration Statement”) with the Securities and Exchange Commission (the “SEC”) covering the public resale of up to 3,897,172 shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) (including 1,670,216 shares of Common Stock underlying warrants) previously issued to the investors from the private placement occurred on February 2014 (the “February 2014 Private Placement”) (see also Note 4a and 5b). The Third Registration Statement was declared effective on June 3, 2014.
 
d.
On May 1, 2014 the Company announced the receipt of a U.S. Notice of Allowance for a key patent relating to how the Dario™ blood glucose monitor draws power from and transmits data to a smart phone via the audio jack port. 
 
e.
On June 17, 2014, the Company held its 2014 Annual Meeting of Stockholders in which, among other matters, Company stockholders approved an amendment to the Company’s Certificate of Incorporation (the “COI”) to increase the number of authorized shares of Common Stock from 45,000,000 to 80,000,000; to amend the Company’s 2012 Equity Incentive Plan (the “2012 Plan”) to increase the number of Common Stock authorized for issuance under the 2012 Plan by 2,500,000 shares from 5,000,000 to 7,500,000 (see also Note 4b); and to approve the amendment to the COI to effect a reverse stock split of the Common Stock at a ratio of between one-for-two and one-for-five with such ratio to be determined at the sole discretion of the Board of Directors of the Company (the “Reverse Split”) and with such Reverse Split to be effected at such time and date, if at all, as determined by the Board of Directors of the Company in its sole discretion. No decision has been taken in connection to the Reverse Split as of the filing of this consolidated financial statement.
 
f.
On April 28, 2014 the Company was granted with national approval and regional reimbursement for the Dario™ in Italy.
 
g.
On June 25, 2014 the Company was granted with reimbursement status for strips and lancets to be utilized together with the Dario™, effective September 1, 2014 in England, Wales, Scotland and Northern Ireland.
 
h.
On July 2014, the Company received approval from Israel’s Ministry of Health to sell the Dario™ for diabetes in Israel as well as released the Dario™ App for Android smartphone users in select soft launch markets, including the United Kingdom and New Zealand.
XML 20 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2014
Dec. 31, 2013
CURRENT ASSETS:    
Cash and cash equivalents $ 1,819 $ 2,263
Restricted cash 0 38
Short-term bank deposits 166 154
Other accounts receivable and prepaid expenses 355 475
Inventory 22 0
Total current assets 2,362 2,930
LEASE DEPOSIT 49 41
PROPERTY AND EQUIPMENT, NET 991 1,145
Total assets 3,402 4,116
CURRENT LIABILITIES:    
Trade payables 681 586
Other accounts payable and accrued expenses 1,095 920
Total current liabilities 1,776 1,506
LIABILITY RELATED TO WARRANTS 5,379 2,696
COMMITMENTS AND CONTINGENT LIABILITIES      
STOCKHOLDERS' EQUITY DEFICIT:    
Common Stock of $0.0001 par value - Authorized: 80,000,000 (unaudited) and 45,000,000 shares at June 30, 2014 and December 31, 2013; Issued and Outstanding: 23,013,889 (unaudited) and 20,071,816 shares at June 30, 2014 and December 31, 2013, respectively 2 2
Preferred Stock of $0.0001 par value - Authorized: 5,000,000 shares at June 30, 2014 and December 31, 2013; Issued: None at June 30, 2014 and December 31, 2013; Outstanding: None at June 30, 2014 and December 31, 2013 0 0
Additional paid-in capital 22,486 19,915
Accumulated deficit (26,241) (20,003)
Total stockholders' deficit (3,753) (86)
Total liabilities and stockholders' deficit $ 3,402 $ 4,116
XML 21 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) (Common Stock [Member], USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Common Stock [Member]
   
Issuance Of Common Stock And Warrants In February And June 2013   $ 1.00
Issuance Of Common Stock And Warrants In April And May 2013   $ 2.50
Issuance Of Common Stock And Warrants In February 2014 $ 0.55  
XML 22 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASURMENTS (Details) (USD $)
6 Months Ended 12 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended 1 Months Ended
Jun. 30, 2014
Investors Warrants [Member]
Private Placement Warrants 2011-2012 [Member]
Dec. 31, 2013
Investors Warrants [Member]
Private Placement Warrants 2011-2012 [Member]
Jun. 30, 2014
Placement Agent Warrants [Member]
Private Placement Warrants 2011-2012 [Member]
Dec. 31, 2013
Placement Agent Warrants [Member]
Private Placement Warrants 2011-2012 [Member]
Jun. 30, 2014
Placement Agent Warrants [Member]
Maximum [Member]
Private Placement Warrants 2011-2012 [Member]
Dec. 31, 2013
Placement Agent Warrants [Member]
Maximum [Member]
Private Placement Warrants 2011-2012 [Member]
Jun. 30, 2014
Placement Agent Warrants [Member]
Minimum [Member]
Private Placement Warrants 2011-2012 [Member]
Dec. 31, 2013
Placement Agent Warrants [Member]
Minimum [Member]
Private Placement Warrants 2011-2012 [Member]
Jun. 30, 2014
Investors And Placement Agent Warrants [Member]
Feb. 28, 2014
Issuance Date [Member]
Investors And Placement Agent Warrants [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]                    
Risk-free interest rate 0.61% [1] 0.70% [1] 0.39% [1] 0.50% [1]         1.59% [1] 1.63% [1]
Expected volatility 52.04% [2] 52.09% [2] 53.85% [2] 50.91% [2]         52.84% [2] 61.49% [2]
Expected life (in years) 2 years 3 months 29 days [3] 2 years 9 months 25 days [3] 1 year 9 months 11 days [3] 2 years 3 months [3]         4 years 11 months 5 days [3] 5 years 2 months 12 days [3]
Expected dividend yield 0.00% [4] 0.00% [4] 0.00% [4] 0.00% [4]         0.00% [4] 0.00% [4]
Fair value Warrants $ 0.69 $ 0.74     $ 0.63 $ 0.83 $ 0.48 $ 0.67 $ 1.65 $ 1.78
[1] Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds.
[2] Expected volatility - was calculated based on actual historical stock price movements of companies in the same industry over a term that is equivalent to the expected term of the option.
[3] Expected life - the expected life was based on the expiration date of the warrants.
[4] Expected dividend yield - was based on the fact that the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future.
XML 23 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASURMENTS (Details Textual) (USD $)
12 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended
Dec. 31, 2012
Common Stock [Member]
Jun. 30, 2014
Placement Agents [Member]
Jun. 30, 2014
Placement Agents [Member]
Common Stock [Member]
Jun. 30, 2014
Private Placement [Member]
Jun. 30, 2014
Private Placement [Member]
Common Stock [Member]
Dec. 31, 2012
Private Placement [Member]
Investor [Member]
Dec. 31, 2012
Private Placement [Member]
Placement Agents [Member]
Feb. 18, 2014
February 2014 Private Placement warrants [Member]
Jun. 30, 2014
February 2014 Private Placement [Member]
Investor [Member]
Jun. 30, 2014
February 2014 Private Placement [Member]
Placement Agents [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                    
Stock Issued During Period Shares Private Placement 2,461,000       2,226,956          
Stock To Be Issued Upon Conversion Of Warrants             482,200      
Exercise Price of Warrants (in dollars per share)       $ 1.30   $ 1.50 $ 1.00      
Proceeds from Issuance of Private Placement (in dollars)       $ 3,754   $ 2,461        
Stock to be Issued Upon Conversion of Warrants (in shares)           2,461,000 482,200   1,670,216 144,885
Exercise Price of Warrants (in dollars per share)           $ 1.50 $ 1.50   $ 2.35  
Exercise Price of Warrants Adjusted (in dollars per share)           $ 1.30        
Stock to be Issued Upon Conversion of Warrants Additional Issue (in shares)           371,017 72,455      
Class of Warrant or Right, Outstanding       5,445,065            
Warrants exercised during Period   9,118                
Conversion of Stock, Shares Issued     9,118              
Sale Of Stock Price Per Unit               1.88    
XML 24 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 25 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:    
Net loss $ (6,238) $ (10,513)
Adjustments required to reconcile net loss to net cash used in operating activities:    
Stock-based compensation, warrants and restricted shares 1,199 2,862
Issuance cost related to warrants to investors and service provider 489 0
Depreciation 358 314
Decrease (increase) in other accounts receivable and prepaid expenses 120 (208)
Increase in inventory (22) 0
Increase in trade payables 39 371
Increase in other accounts payable and accrued expenses 175 350
Revaluation of warrants (538) 3,800
Loss from disposal of fixed assets 0 3
Net cash used in operating activities (4,418) (3,021)
Cash flows from investing activities:    
Investment in short-term bank deposits (130) (105)
Proceeds of maturities of short-term bank deposit 158 14
Investment in lease deposits (8) (92)
Purchase of property and equipment (150) (1,146)
Net cash used in investing activities (130) (1,329)
Cash flows from financing activities:    
Proceeds from issuance of Common Stocks and warrants, net of issuance cost 3,754 9,951
Proceeds from exercise of options and warrants 350 195
Net cash provided by financing activities 4,104 10,146
Increase (decrease) in cash and cash equivalents (444) 5,796
Cash and cash equivalents at beginning of period 2,263 1,230
Cash and cash equivalents at end of period 1,819 7,026
Non-cash investing and financing and activities:    
Receivable on account of shares 0 31
Purchase of property and equipment 56 39
Conversion of liability related to warrants to common stock $ 9 $ 385
XML 26 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Jun. 30, 2014
Dec. 31, 2013
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 80,000,000 45,000,000
Common stock, shares issued 23,013,889 20,071,816
Common stock, shares, outstanding 23,013,889 20,071,816
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
XML 27 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASURMENTS (Tables)
6 Months Ended
Jun. 30, 2014
Private Placement [Member]
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following tabular presentation reflects the components of the liability associated with such warrants as of June 30, 2014:
 
 
 
Fair value
of liability
related to
warrants
 
 
 
 
 
Balance at December 31, 2013
 
$
2,696
 
Fair value of warrants issue to investors and service provider
 
 
3,230
 
Change in fair value of warrants during the period
 
 
(538
)
Exercise of warrants (*)
 
 
(9
)
 
 
 
 
 
Balance at June 30, 2014 (unaudited)
 
$
5,379
 
 
(*)
During the six month period ended June 30, 2014, the placement agent exercised 9,118 warrants for a total amount of 9,118 shares of Common Stock of the Company, respectively (See also Note 4c).
Investors Warrants [Member] | Private Placement Warrants 2011-2012 [Member]
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrants Fair Value [Table Text Block]
In estimating the warrants’ fair value, the Company used the following assumptions:
 
Investors warrants in 2011-2012 Private Placement:
 
 
 
June 30,
2014
 
 
December 31,
2013
 
 
 
 
 
 
 
 
Risk-free interest rate (1)
 
 
0.61
%
 
 
0.70
%
Expected volatility (2)
 
 
52.04
%
 
 
52.09
%
Expected life (in years) (3)
 
 
2.33
 
 
 
2.82
 
Expected dividend yield (4)
 
 
0
%
 
 
0
%
 
 
 
 
 
 
 
 
 
Fair value Warrants
 
$
0.69
 
 
$
0.74
 
Placement Agent Warrants [Member] | Private Placement Warrants 2011-2012 [Member]
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrants Fair Value [Table Text Block]
Placement agent warrants 2011-2012 Private Placement:
 
 
 
June 30,
2014
 
 
December 31,
2013
 
 
 
 
 
 
 
 
Risk-free interest rate (1)
 
 
0.39
%
 
 
0.50
%
Expected volatility (2)
 
 
53.85
%
 
 
50.91
%
Expected life (in years) (3)
 
 
1.78
 
 
 
2.25
 
Expected dividend yield (4)
 
 
0
%
 
 
0
%
 
 
 
 
 
 
 
 
 
Fair value Warrants
 
$
0.48-0.63
 
 
$
 0.67-0.83
 
Investors And Placement Agent Warrants [Member] | Private Placement Warrants 2011-2012 [Member]
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrants Fair Value [Table Text Block]
Investors and placement agent warrants in February 2014 Private Placement:
 
 
 
June 30,
2014
 
 
Issuance
date
 
 
 
 
 
 
 
 
Risk-free interest rate (1)
 
 
1.59
%
 
 
1.63
%
Expected volatility (2)
 
 
52.84
%
 
 
61.49
%
Expected life (in years) (3)
 
 
4.93
 
 
 
5.20
 
Expected dividend yield (4)
 
 
0
%
 
 
0
%
 
 
 
 
 
 
 
 
 
Fair value Warrants
 
$
1.65
 
 
$
1.78
 
 
(1)
Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds.
 
(2)
Expected volatility - was calculated based on actual historical stock price movements of companies in the same industry over a term that is equivalent to the expected term of the option. 
 
(3)
Expected life - the expected life was based on the expiration date of the warrants.
 
(4)
Expected dividend yield - was based on the fact that the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future.
XML 28 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document And Entity Information
6 Months Ended
Jun. 30, 2014
Aug. 13, 2014
Document Information [Line Items]    
Entity Registrant Name LabStyle Innovations Corp.  
Entity Central Index Key 0001533998  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol DRIO  
Entity Common Stock, Shares Outstanding   25,498,305
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2014  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2014  
XML 29 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
SELECTED STATEMENTS OF OPERATIONS DATA (Tables)
6 Months Ended
Jun. 30, 2014
Selected Statements Of Operations Data [Abstract]  
Schedule of Other Operating Cost and Expense, by Component [Table Text Block]
a.
General and administrative:
 
 
 
Three months ended
June 30
 
Six months ended
June 30
 
 
 
2014
 
2013
 
2014
 
2013
 
 
 
Unaudited
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Payroll, office and related
 
$
263
 
$
276
 
$
560
 
$
534
 
Legal and professional fees
 
 
242
 
 
336
 
 
453
 
 
469
 
Stock-based compensation
 
 
531
 
 
280
 
 
877
 
 
1,358
 
Issuance of Common Stock and warrants to service provider
 
 
-
 
 
618
 
 
-
 
 
1,011
 
Other
 
 
256
 
 
6
 
 
256
 
 
48
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total General and administrative
 
$
1,292
 
$
1,516
 
$
2,146
 
$
3,420
 
Schedule of Other Nonoperating Income (Expense) [Table Text Block]
b.
Financial expenses (income), net:
 
 
 
Three months ended
June 30
 
Six months ended
June 30
 
 
 
2014
 
2013
 
2014
 
2013
 
 
 
Unaudited
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bank charges
 
$
2
 
$
10
 
$
7
 
$
14
 
Foreign currency adjustments losses
 
 
4
 
 
16
 
 
9
 
 
27
 
Issuance cost related to warrants to investors and service provider
 
 
41
 
 
-
 
 
489
 
 
-
 
Revaluation of warrants
 
 
(396)
 
 
1,664
 
 
(538)
 
 
3,800
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Financial expenses (income), net
 
$
(349)
 
$
1,690
 
$
(33)
 
$
3,841
 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table sets forth the computation of basic and diluted net loss per share:
 
 
 
Three months ended
June 30
 
Six months ended
June 30
 
 
 
2014
 
2013
 
2014
 
2013
 
 
 
Unaudited
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator for basic net loss per share
 
$
3,254
 
$
5,286
 
$
6,238
 
$
10,513
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants issued to investors and placement agent
 
 
(290)
 
 
-
 
 
(303)
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator for dilutive net loss per share
 
$
3,544
 
$
5,286
 
$
6,541
 
$
10,513
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator for dilutive net loss per share - weighted average number of Common Stock
 
 
22,985,523
 
 
18,327,387
 
 
22,152,675
 
 
16,590,423
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants issued to investors and placement agent
 
 
216,554
 
 
-
 
 
108,277
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator for diluted net loss per share - adjusted weighted average number of Common Stock
 
 
23,202,077
 
 
18,327,387
 
 
22,260,952
 
 
16,590,423
 
XML 30 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Revenues $ 0 $ 0 $ 0 $ 0
Ramp up of manufacturing costs 605 0 1,026 0
Gross loss 605 0 1,026 0
Operating expenses:        
Research and development 1,333 1,416 2,440 2,091
Marketing and pre-production costs 373 664 659 1,161
General and administrative 1,292 1,516 2,146 3,420
Total operating expenses 2,998 3,596 5,245 6,672
Operating loss 3,603 3,596 6,271 6,672
Financial expenses (income), net:        
Revaluation of warrants (396) 1,664 (538) 3,800
Other financial expense 47 26 505 41
Total financial expenses (income), net (349) 1,690 (33) 3,841
Net loss $ 3,254 $ 5,286 $ 6,238 $ 10,513
Net loss per share        
Basic loss per share $ (0.14) $ (0.29) $ (0.28) $ (0.63)
Weighted average number of common stock used in computing basic net loss per share 22,985,523 18,327,387 22,152,675 16,590,423
Diluted loss per share $ (0.15) $ (0.29) $ (0.29) $ (0.63)
Weighted average number of common stock used in computing diluted net loss per share 23,202,077 18,327,387 22,260,952 16,590,423
XML 31 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASURMENTS
6 Months Ended
Jun. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
NOTE 5:-
FAIR VALUE MEASURMENTS
 
ASC 820, “Fair Value Measurements and Disclosures” (“ASC 820”), defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions and risk of nonperformance.
 
ASC 820 also establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. ASC 820 establishes three levels of inputs that may be used to measure fair value:
 
Level 1 -
quoted prices in active markets for identical assets or liabilities;
 
Level 2 -
inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or
 
Level 3 -
unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
 
a.
On March 30, 2012, the Company consummated the 2011-2012 Private Placement pursuant to which the investors purchased an aggregate of 2,461,000 shares of Common Stock and warrants to purchase 2,461,000 shares of Common Stock at the exercise price of $1.50 for total consideration of $2,461.
 
The placement agent for the 2011-2012 Private Placement and its permitted designees were granted warrants to purchase an aggregate of (i) 482,200 shares of Common Stock at the exercise price of $1.00 per share and (ii) 482,200 shares of Common Stock at the exercise price of $1.50 per share. Subsequent to the issuance of the 2011-2012 Private Placement warrants, the $1.50 exercise price for both the warrants issued to the investors and placement agent were adjusted to approximately $1.30 per share due to a certain anti-dilutive issuance and, accordingly, additional warrants to purchase an aggregate of 371,017 and 72,455 shares of Common Stock were granted to such investors and the placement agent and its designees, respectively (see also Note 7a).
 
b.
On February 18, 2014, the Company consummated the February 2014 Private Placement with institutional and other accredited investors, pursuant to which the Company issued units comprised of an aggregate of (i) 2,226,956 shares of common stock and (ii) warrants initially exercisable to purchase an aggregate of 1,670,216 shares of Common Stock.  The price per unit issued in this offering was $1.88, yielding proceeds of approximately $3,754 net of issuance costs (See also Notes 4a, and 7a).
 
In addition, the Company granted to the placement agent for the February 2014 Private Placement the right to receive warrants to purchase an aggregate of 144,885 shares of Common Stock at an exercise price of $2.35.
 
All the aforementioned warrants contain anti-dilution protection provisions and therefore the Company accounts for such warrants as a liability according to the provisions of ASC 815-40, “Derivatives and Hedging - Contracts in Entity’s Own Equity” (“ASC 815-40”). The Company measures the warrants at fair value by using Binomial option-pricing model in each reporting period until the warrants are exercised or expired, with changes in the fair values being recognized in the Company’s statement of comprehensive loss as financial income or expense.
 
In estimating the warrants’ fair value, the Company used the following assumptions:
 
Investors warrants in 2011-2012 Private Placement:
 
 
 
June 30,
2014
 
 
December 31,
2013
 
 
 
 
 
 
 
 
Risk-free interest rate (1)
 
 
0.61
%
 
 
0.70
%
Expected volatility (2)
 
 
52.04
%
 
 
52.09
%
Expected life (in years) (3)
 
 
2.33
 
 
 
2.82
 
Expected dividend yield (4)
 
 
0
%
 
 
0
%
 
 
 
 
 
 
 
 
 
Fair value Warrants
 
$
0.69
 
 
$
0.74
 
 
Placement agent warrants 2011-2012 Private Placement:
 
 
 
June 30,
2014
 
 
December 31,
2013
 
 
 
 
 
 
 
 
Risk-free interest rate (1)
 
 
0.39
%
 
 
0.50
%
Expected volatility (2)
 
 
53.85
%
 
 
50.91
%
Expected life (in years) (3)
 
 
1.78
 
 
 
2.25
 
Expected dividend yield (4)
 
 
0
%
 
 
0
%
 
 
 
 
 
 
 
 
 
Fair value Warrants
 
$
0.48-0.63
 
 
$
 0.67-0.83
 
 
Investors and placement agent warrants in February 2014 Private Placement:
 
 
 
June 30,
2014
 
 
Issuance
date
 
 
 
 
 
 
 
 
Risk-free interest rate (1)
 
 
1.59
%
 
 
1.63
%
Expected volatility (2)
 
 
52.84
%
 
 
61.49
%
Expected life (in years) (3)
 
 
4.93
 
 
 
5.20
 
Expected dividend yield (4)
 
 
0
%
 
 
0
%
 
 
 
 
 
 
 
 
 
Fair value Warrants
 
$
1.65
 
 
$
1.78
 
 
(1)
Risk-free interest rate - based on yield rates of non-index linked U.S. Federal Reserve treasury bonds.
 
(2)
Expected volatility - was calculated based on actual historical stock price movements of companies in the same industry over a term that is equivalent to the expected term of the option. 
 
(3)
Expected life - the expected life was based on the expiration date of the warrants.
 
(4)
Expected dividend yield - was based on the fact that the Company has not paid dividends to its shareholders in the past and does not expect to pay dividends to its shareholders in the future.
 
The changes in Level 3 liabilities associated with the 2011-2012 Private Placement and the February 2014 Private Placement warrants are measured at fair value on a recurring basis. The following tabular presentation reflects the components of the liability associated with such warrants as of June 30, 2014:
 
 
 
Fair value
of liability
related to
warrants
 
 
 
 
 
Balance at December 31, 2013
 
$
2,696
 
Fair value of warrants issue to investors and service provider
 
 
3,230
 
Change in fair value of warrants during the period
 
 
(538
)
Exercise of warrants (*)
 
 
(9
)
 
 
 
 
 
Balance at June 30, 2014 (unaudited)
 
$
5,379
 
 
(*)
During the six month period ended June 30, 2014, the placement agent exercised 9,118 warrants for a total amount of 9,118 shares of Common Stock of the Company, respectively (See also Note 4c).
 
As of June 30, 2014, there were 5,445,065 outstanding warrants relating to the above issuances.
XML 32 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' DEFICIT
6 Months Ended
Jun. 30, 2014
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
NOTE 4:-
STOCKHOLDERS’ DEFICIT
 
a.
On February 18, 2014, the Company consummated the February 2014 Private Placement with institutional and other accredited investors, pursuant to which the Company issued units comprised of an aggregate of (i)  2,226,956 shares of common stock and (the “Shares”) (ii) warrants initially   exercisable to purchase an aggregate of 1,670,216 shares of Common Stock (the “Warrants”).  The price per unit issued in this offering was $1.88, yielding gross proceeds of approximately $3,754 net of issuance costs.
 
The placement agent for the February 2014 Private Placement received, in addition to a cash fee, 144,885 warrants to purchase Common Stock of the Company having the same terms and conditions as the investors warrants.  
 
Pursuant to the terms of the February 2014 Private Placement, the Company may be required to issue additional shares of Common Stock (the “Adjustment Shares”) to the investors in the February 2014 Private Placement at a specified time in the event that the price per share of Common Stock in the February 2014 Private Placement is greater than the price per share of the Common Stock, calculated as 90% of the average of the ten lowest weighted average prices of the Common Stock during the twenty trading day period starting immediately following the earlier of the date on which the shares, shares of Common Stock underlying warrants and Adjustment Shares have been registered for resale with the SEC or are able to be sold without restriction under Rule 144 under the Securities Act (the “Reset Price”); provided, that, subject to the terms and conditions of the February 2014 Private Placement, the Company may be required to issue further additional shares of Common Stock at one or more additional specified times if the shares of Common Stock issued in the February 2014 Private Placement are not freely tradable for certain specified minimum periods.
 
The warrants issued in the February 2014 Private Placement are immediately exercisable at an exercise price of $2.35 per share and expire five years after the date that the shares of Common Stock underlying such warrants have been registered for resale with the SEC or are able to be sold without restriction under Rule 144 under the Securities Act. The warrants are subject to adjustment under certain circumstances, including “full ratchet” anti-dilution protection upon the issuance of any Common Stock (including the Adjustment Shares), securities convertible into Common Stock, or certain other issuances at a price below the then-existing exercise price, with certain exceptions. In addition, upon certain changes in control events, as defined in the agreement, the holders of the warrants may elect to receive, subject to certain limitations and assumptions, cash equal to the Black-Scholes value of the outstanding warrants.
 
Based on the aforementioned terms the warrants are accounted as liability according to the provisions of ASC 815-40.
 
In connection with the February 2014 Private Placement, the Company also entered into a Registration Rights Agreement (the “RRA”) with the investors. Pursuant to the terms of the RRA, the Company granted to the investors certain registration rights related to the Shares, the Warrants and the Adjustment Shares issued and issuable in this private placement. The Company is required to file a registration statement for the resale of the Shares, Common Stock underlying the Warrants and Adjustment Shares within 30 days following the closing date of the Offering and to use its reasonable best efforts to cause such registration statement to be declared effective within 60 days following the closing date (or 120 days following the closing date if the SEC determines to review the registration statement). The Company may incur liquidated damages for each investor of up to nine percent of the pro-rata purchase price of the Shares if it does not meet its registration obligations under the RRA.
 
On June 3, 2014, the Company’s Third Registration Statement was declared effective and based on the Reset Price feature which occurred on July 2, 2014, subsequent to the balance sheet date, 2,484,416 Adjustment Shares have been issued and 2,984,953 warrants were issued in connection with the February 2014 Private Placement and additional 851,453 warrants were issued in connection with the 2011-2012 Private Placement (see also Notes 7a).
 
b.
Stock based compensation:
 
On June 17, 2014, the Company’s majority stockholders (with the prior recommendation and approval of the Company’s Board of Directors) approved an increase in the size of the 2012 Plan from 5,000,000 shares of Common Stock to 7,500,000 shares of Common Stock.
 
Following the approval of the Company’s Board of Directors of the non-employee directors option plan during March 2013 (the “Annual Directors Plan”), on May 7, 2014 our Board of Directors approved the 2014 grant of the Annual Directors Plan with 25,000 options granted to each of the Company’s then current non-employee directors. These options have an exercise price of $1.39 and shall vest in quarterly arrears over one year ended December 31, 2014. They also have a cashless exercise feature and a ten year term. On the same date, the Board of Directors also approved a one-time grant of fully-vested 150,000 options to each of the two newest non-employee directors. These options have an exercise price of $1.39, a cashless exercise feature and a ten year term.
 
In addition, on the same date, the Board of Directors approved the grant of 380,000 options to the Company’s Scientific Advisory Board (the “SAB”). These options have an exercise price of $1.39, shall vest in 4 quarterly arrears, have a cashless exercise feature and a ten year term.
 
The abovementioned options to non-employee directors and the SAB were not issued under the Company’s 2012 Equity Incentive Plan and shall be deemed to have been issued under an “employee benefit plan” as defined in Rule 405 promulgated under the Securities Act. 
 
As of June, 30, 2014, 3,139,750 options to purchase Common Stock are available for future grants under the 2012 Plan to employees, advisors, consultants and service providers of the Company or Ltd.
 
The total compensation cost related to all of the Company’s equity-based awards, recognized during the period of three and six months ended June 30, 2014 was comprised as follows:
 
 
 
Three months
ended June 30,
2014
 
Six months
ended June 30,
2014
 
 
 
 
 
 
 
 
 
 
 
Unaudited
 
 
 
 
 
 
 
 
 
Cost of revenues
 
$
18
 
$
36
 
Research and development
 
 
141
 
 
280
 
Sales and marketing
 
 
-
 
 
6
 
General and administrative
 
 
531
 
 
877
 
 
 
 
 
 
 
 
 
Total stock-based compensation expenses
 
$
690
 
$
1,199
 
 
As of June 30, 2014, the total amount of unrecognized stock-based compensation expenses was approximately $923 which will be recognized over a weighted average period of 0.56 years.
 
c.
During the six months ended June 30, 2014, proceeds from warrants and options exercise amounted to $343 and $7 following the issuance of 342,617 and 372,500 Common Stock, respectively.
XML 33 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
FAIR VALUE MEASURMENTS (Details 1) (Private Placement [Member], USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Private Placement [Member]
 
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]  
Balance at December 31, 2013 $ 2,696
Fair value of warrants to investors and service provider 3,230
Change in fair value of warrants during the period (538)
Exercise of warrants (9) [1]
Balance at June 30, 2014 (unaudited) $ 5,379
[1] During the six month period ended June 30, 2014, the placement agent exercised 9,118 warrants for a total amount of 9,118 shares of Common Stock of the Company, respectively (See also Note 4c).
XML 34 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
GENERAL (Details Textual) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Jun. 17, 2014
Dec. 31, 2013
Mar. 31, 2014
Common Stock [Member]
Jun. 30, 2014
Equity Incentive Plan 2012 [Member]
Dec. 31, 2013
Equity Incentive Plan 2012 [Member]
Jun. 30, 2014
February 2014 Private Placement [Member]
Investor [Member]
Organization And Presentation Of Financial Statements [Line Items]                    
Operating loss $ 3,603 $ 3,596 $ 6,271 $ 6,672            
Net Cash Used in (Provided by) Operating Activities     $ 4,418 $ 3,021            
Shares of Common Stock Underlying Warrants-Under Registration Statement For Public Resale             3,897,172      
Common Stock, Par Or Stated Value Per Share $ 0.0001   $ 0.0001     $ 0.0001 $ 0.0001      
Common Stock, Shares Authorized 80,000,000   80,000,000   45,000,000 45,000,000        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized               2,500,000    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized               7,500,000 5,000,000  
Stock To Be Issued Upon Conversion Of Warrants1                   1,670,216
XML 35 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2014
Accounting Policies [Abstract]  
New Accounting Pronouncements, Policy [Policy Text Block]
In June 2014 the FASB issued Update No. 2014-10 Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this Update remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of comprehensive loss, cash flows, and shareholder deficit, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments are effective prospectively for reporting periods beginning after December 15, 2014 early adoption is permitted. The Company chose to early adopt the update for June 30, 2014 consolidated financial statement.
XML 36 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
SELECTED STATEMENTS OF OPERATIONS DATA
6 Months Ended
Jun. 30, 2014
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Information [Text Block]
NOTE 6:-       SELECTED STATEMENTS OF OPERATIONS DATA
 
a.
General and administrative:
 
 
 
Three months ended
June 30
 
Six months ended
June 30
 
 
 
2014
 
2013
 
2014
 
2013
 
 
 
Unaudited
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Payroll, office and related
 
$
263
 
$
276
 
$
560
 
$
534
 
Legal and professional fees
 
 
242
 
 
336
 
 
453
 
 
469
 
Stock-based compensation
 
 
531
 
 
280
 
 
877
 
 
1,358
 
Issuance of Common Stock and warrants to service provider
 
 
-
 
 
618
 
 
-
 
 
1,011
 
Other
 
 
256
 
 
6
 
 
256
 
 
48
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total General and administrative
 
$
1,292
 
$
1,516
 
$
2,146
 
$
3,420
 
 
b.
Financial expenses (income), net:
 
 
 
Three months ended
June 30
 
Six months ended
June 30
 
 
 
2014
 
2013
 
2014
 
2013
 
 
 
Unaudited
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bank charges
 
$
2
 
$
10
 
$
7
 
$
14
 
Foreign currency adjustments losses
 
 
4
 
 
16
 
 
9
 
 
27
 
Issuance cost related to warrants to investors and service provider
 
 
41
 
 
-
 
 
489
 
 
-
 
Revaluation of warrants
 
 
(396)
 
 
1,664
 
 
(538)
 
 
3,800
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Financial expenses (income), net
 
$
(349)
 
$
1,690
 
$
(33)
 
$
3,841
 
 
c.
   Net loss per share:
 
The following table sets forth the computation of basic and diluted net loss per share:
 
 
 
Three months ended
June 30
 
Six months ended
June 30
 
 
 
2014
 
2013
 
2014
 
2013
 
 
 
Unaudited
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator for basic net loss per share
 
$
3,254
 
$
5,286
 
$
6,238
 
$
10,513
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants issued to investors and placement agent
 
 
(290)
 
 
-
 
 
(303)
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator for dilutive net loss per share
 
$
3,544
 
$
5,286
 
$
6,541
 
$
10,513
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator for dilutive net loss per share - weighted average number of Common Stock
 
 
22,985,523
 
 
18,327,387
 
 
22,152,675
 
 
16,590,423
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of dilutive securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants issued to investors and placement agent
 
 
216,554
 
 
-
 
 
108,277
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denominator for diluted net loss per share - adjusted weighted average number of Common Stock
 
 
23,202,077
 
 
18,327,387
 
 
22,260,952
 
 
16,590,423
 
XML 37 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2014
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
NOTE 7:-
SUBSEQUENT EVENTS
 
a.
Following the effectiveness of the Company’s Third Registration Statement on June 3, 2014 (see also Note 1c), and in accordance with the February 2014 Private Placement agreements, on July 2, 2014 the Company issued a total of 2,484,416 shares based on a Reset Price of approximately $0.89 to the investors from the February 2014 Private Placement. In addition, the abovementioned issuance triggered the following anti-dilution adjustments:
 
1.
The exercise price for the investors and placement agent warrants of the February 2014 Private Placement was adjusted to approximately $0.89 and additional 2,746,688 and 238,265 warrants became eligible for issuance upon exercise of such warrants, respectively.
 
2.
The exercise price for the investors and placement agent warrants of the 2011-2012 Private Placement, with a current exercise price of $1.30 was adjusted to approximately $1.05 and additional 645,054 and 122,838 warrants were issued, respectively. The exercise price for the placement agent warrants of the 2011-2012 Private Placement, with a current exercise price of $1.00 was adjusted to approximately $0.84 and additional 83,561 warrants were issued.
 
All the aforementioned warrants contain anti-dilution protection provisions and therefore will be accounted as a liability according to the provisions of ASC 815-40.
 
b.
On July 7, 2014, the Company’s Board of Directors approved the grant of 1,100,000 and 395,000 options to employees and non-employees, respectively, at an exercise price of $0.98 per share. Such options shall vest in 8 quarterly instalments over a period of 2 years commencing the above date. The options have a cashless exercise feature and a ten years term, unless otherwise approved by Compensation Committee of the Board of Directors, and shall be issued under the 2012 Plan.
 
In addition on the same date, the Board of Directors approved a one-time grant of fully-vested 150,000 options to a new non-employee director. These options have an exercise price of $0.98, have a cashless exercise feature and a ten years term. The non-employee director options were not issued under the Company’s 2012 Equity Incentive Plan and shall be deemed to have been issued under an “employee benefit plan” as defined in Rule 405 promulgated under the Securities Act.
XML 38 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' DEFICIT (Tables)
6 Months Ended
Jun. 30, 2014
Equity [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The total compensation cost related to all of the Company’s equity-based awards, recognized during the period of three and six months ended June 30, 2014 was comprised as follows:
 
 
 
Three months
ended June 30,
2014
 
Six months
ended June 30,
2014
 
 
 
 
 
 
 
 
 
 
 
Unaudited
 
 
 
 
 
 
 
 
 
Cost of revenues
 
$
18
 
$
36
 
Research and development
 
 
141
 
 
280
 
Sales and marketing
 
 
-
 
 
6
 
General and administrative
 
 
531
 
 
877
 
 
 
 
 
 
 
 
 
Total stock-based compensation expenses
 
$
690
 
$
1,199
 
XML 39 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' DEFICIT (Details Textual) (USD $)
6 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2014
Equity Incentive Plan 2012 [Member]
Dec. 31, 2013
Equity Incentive Plan 2012 [Member]
Jun. 30, 2014
Annual Directors Plan [Member]
Jun. 30, 2014
Common Stock [Member]
Dec. 31, 2013
Common Stock [Member]
Dec. 31, 2012
Common Stock [Member]
Jun. 30, 2014
Scientific Advisory Board [Member]
Jun. 30, 2014
Non Employee Directors [Member]
Jul. 31, 2014
Non Employee Directors [Member]
Subsequent Event [Member]
Jun. 30, 2014
Employee Stock Option [Member]
Scientific Advisory Board [Member]
Jun. 30, 2014
Private Placement warrants 2011-2012 [Member]
Dec. 31, 2012
Private Placement warrants 2011-2012 [Member]
Investor [Member]
Jun. 30, 2014
Private Placement warrants 2011-2012 [Member]
Common Stock [Member]
Jul. 31, 2014
Private Placement warrants 2011-2012 [Member]
Subsequent Event [Member]
Third Registration Statement [Member]
Jun. 30, 2014
February 2014 Private Placement warrants [Member]
Feb. 18, 2014
February 2014 Private Placement warrants [Member]
Jun. 30, 2014
February 2014 Private Placement warrants [Member]
Placement Agents [Member]
Jul. 31, 2014
February 2014 Private Placement warrants [Member]
Subsequent Event [Member]
Investors And Placement Agent Warrants [Member]
Third Registration Statement [Member]
Jul. 31, 2014
February 2014 Private Placement warrants [Member]
Subsequent Event [Member]
Investor [Member]
Third Registration Statement [Member]
Jul. 31, 2014
February 2014 Private Placement warrants [Member]
Subsequent Event [Member]
Placement Agents [Member]
Jun. 30, 2014
February 2014 Private Placement [Member]
Investor [Member]
Jun. 30, 2014
February 2014 Private Placement [Member]
Placement Agents [Member]
Class of Stock [Line Items]                                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                     380,000                        
Share-based Goods and Nonemployee Services Transaction, Shares Approved for Issuance       25,000           150,000                          
Share Based Compensation Arrangements By Share Based Payment Award Options Grants To Nonemployees In Period Weighted Average Exercise Price (in dollars per shares)       $ 1.39       $ 1.39 $ 1.39                            
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total $ 923                                            
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 6 months 22 days                                            
Stock Issued During Period Shares Private Placement             2,461,000             2,226,956                  
Stock To Be Issued Upon Conversion Of Warrants1                         2,461,000                 1,670,216 144,885
Sale Of Stock Price Per Unit                                 1.88            
Exercise Price of Warrants (in dollars per share)                       $ 1.30 $ 1.50         $ 2.35          
Proceeds from Issuance of Private Placement Net of Issuance Cost                               3,754              
Percentage Of Aggregate Of Weighted Average Prices Of Common Stock 90.00%                                            
Stock Issued During Period Shares Warrants Exercised         342,617 300,771                                  
Stock Issued During Period, Value, New Issues                                       2,484,416      
Warrants Issued During Period                             851,453       2,984,953   238,265    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   7,500,000 5,000,000                                        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   3,139,750                                          
Share-based Compensation Arrangement by Share-based Payment Award, Terms of Award       vest in quarterly arrears over one year ended December 31, 2014                                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period       10 years                                      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period         372,500 15,000                                  
Proceeds from Stock Options Exercised 7,000                                            
Proceeds from Warrant Exercises $ 343,000                                            
XML 40 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
SELECTED STATEMENTS OF OPERATIONS DATA (Details 1) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Selected Statements Of Operations Data [Line Items]        
Bank charges $ 2 $ 10 $ 7 $ 14
Foreign currency adjustments losses 4 16 9 27
Issuance cost related to warrants to investors and service provider 41 0 489 0
Revaluation of warrants (396) 1,664 (538) 3,800
Total Financial expenses (income), net $ (349) $ 1,690 $ (33) $ 3,841
XML 41 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (USD $)
In Thousands, except Share data
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2012 $ (1,070) $ 1 $ 5,001 $ (6,072)
Balance (in shares) at Dec. 31, 2012   14,547,689    
Issuance of common stock and warrants in February and June 2013 at $1.00 per unit, net of issuance cost 996    [1] 996 0
Issuance of common stock and warrants in February and June 2013 at $1.00 per unit, net of issuance cost (in shares)   1,000,022    
Cost related to issuance of common stock to service provider 488    [1] 488 0
Cost related to issuance of common stock to service provider (in shares)   208,334    
Cost related to issuance of warrants to service provider in March and May 2013 523 0 523 0
Cost related to issuance of warrants to service provider in March and May 2013 (in shares)   0    
Issuance of common stock and warrants in April and May 2013 at $2.50 per unit, net of issuance cost 8,987    [1] 8,986 0
Issuance of common stock and warrants in April and May 2013 at $ 2.50 per unit, net of issuance cost (in shares)   4,000,000    
Exercise of warrants 708    [1] 708 0
Exercise of warrants (in shares)   300,771    
Exercise of options    [1]    [1]    [1] 0
Exercise of options (in shares)   15,000    
Stock-based compensation 3,213 0 3,213 0
Net loss (13,931) 0 0 (13,931)
Balance at Dec. 31, 2013 (86) 2 19,915 (20,003)
Balance (in shares) at Dec. 31, 2013   20,071,816    
Issuance of common stock and warrants in February 2014 at $0.55 per unit, net of issuance cost 1,013    [1] 1,013 0
Issuance of common stock and warrants in February 2014 at $0.55 per unit, net of issuance cost (in shares)   2,226,956    
Exercise of warrants 352    [1] 352 0
Exercise of warrants (in shares)   342,617    
Exercise of options 7    [1] 7 0
Exercise of options (in shares)   372,500    
Stock-based compensation 1,199 0 1,199 0
Net loss (6,238) 0 0 (6,238)
Balance at Jun. 30, 2014 $ (3,753) $ 2 $ 22,486 $ (26,241)
Balance (in shares) at Jun. 30, 2014   23,013,889    
[1] Represent an amount lower than $1.
XML 42 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
UNAUDITED INTERIM FINANCIAL STATEMENTS
6 Months Ended
Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Accounting [Text Block]
NOTE 3:-       UNAUDITED INTERIM FINANCIAL STATEMENTS
 
The accompanying unaudited interim consolidated financial statements as of June 30, 2014, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company’s consolidated financial position as of June 30, 2014, the Company’s consolidated results of operations and the Company’s consolidated cash flows for the six and three months ended June 30, 2014. Results for the six and three months periods ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.
XML 43 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
SELECTED STATEMENTS OF OPERATIONS DATA (Details 2) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Numerator:          
Numerator for basic net loss per share $ 3,254 $ 5,286 $ 6,238 $ 10,513 $ 13,931
Effect of dilutive securities:          
Warrants issued to investors and placement agent (290) 0 (303) 0  
Numerator for dilutive net loss per share $ 3,544 $ 5,286 $ 6,541 $ 10,513  
Denominator:          
Weighted average number of common stock used in computing basic net loss per share 22,985,523 18,327,387 22,152,675 16,590,423  
Effect of dilutive securities:          
Warrants issued to investors and placement agent 216,554 0 108,277 0  
Denominator for diluted net loss per share - adjusted weighted average number of Common Stock 23,202,077 18,327,387 22,260,952 16,590,423  
XML 44 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 90 162 1 true 35 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://mydario.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://mydario.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://mydario.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://mydario.com/role/ConsolidatedStatementsOfComprehensiveLoss CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS false false R5.htm 105 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT Sheet http://mydario.com/role/StatementsOfChangesInStockholdersDeficit STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT false false R6.htm 106 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) Sheet http://mydario.com/role/StatementsOfChangesInStockholdersDeficitParenthetical STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) false false R7.htm 107 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS Sheet http://mydario.com/role/ConsolidatedStatementOfCashFlows CONSOLIDATED STATEMENT OF CASH FLOWS false false R8.htm 108 - Disclosure - GENERAL Sheet http://mydario.com/role/General GENERAL false false R9.htm 109 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://mydario.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES false false R10.htm 110 - Disclosure - UNAUDITED INTERIM FINANCIAL STATEMENTS Sheet http://mydario.com/role/UnauditedInterimFinancialStatements UNAUDITED INTERIM FINANCIAL STATEMENTS false false R11.htm 111 - Disclosure - STOCKHOLDERS' DEFICIT Sheet http://mydario.com/role/StockholdersDeficit STOCKHOLDERS' DEFICIT false false R12.htm 112 - Disclosure - FAIR VALUE MEASURMENTS Sheet http://mydario.com/role/FairValueMeasurments FAIR VALUE MEASURMENTS false false R13.htm 113 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA Sheet http://mydario.com/role/SelectedStatementsOfOperationsData SELECTED STATEMENTS OF OPERATIONS DATA false false R14.htm 114 - Disclosure - SUBSEQUENT EVENTS Sheet http://mydario.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R15.htm 115 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://mydario.com/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R16.htm 116 - Disclosure - STOCKHOLDERS' DEFICIT (Tables) Sheet http://mydario.com/role/StockholdersDeficitTables STOCKHOLDERS' DEFICIT (Tables) false false R17.htm 117 - Disclosure - FAIR VALUE MEASURMENTS (Tables) Sheet http://mydario.com/role/FairValueMeasurmentsTables FAIR VALUE MEASURMENTS (Tables) false false R18.htm 118 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA (Tables) Sheet http://mydario.com/role/SelectedStatementsOfOperationsDataTables SELECTED STATEMENTS OF OPERATIONS DATA (Tables) false false R19.htm 119 - Disclosure - GENERAL (Details Textual) Sheet http://mydario.com/role/GeneralDetailsTextual GENERAL (Details Textual) false false R20.htm 120 - Disclosure - STOCKHOLDERS' DEFICIT (Details) Sheet http://mydario.com/role/StockholdersDeficitDetails STOCKHOLDERS' DEFICIT (Details) false false R21.htm 121 - Disclosure - STOCKHOLDERS' DEFICIT (Details Textual) Sheet http://mydario.com/role/StockholdersDeficitDetailsTextual STOCKHOLDERS' DEFICIT (Details Textual) false false R22.htm 122 - Disclosure - FAIR VALUE MEASURMENTS (Details) Sheet http://mydario.com/role/FairValueMeasurmentsDetails FAIR VALUE MEASURMENTS (Details) false false R23.htm 123 - Disclosure - FAIR VALUE MEASURMENTS (Details 1) Sheet http://mydario.com/role/FairValueMeasurmentsDetails1 FAIR VALUE MEASURMENTS (Details 1) false false R24.htm 124 - Disclosure - FAIR VALUE MEASURMENTS (Details Textual) Sheet http://mydario.com/role/FairValueMeasurmentsDetailsTextual FAIR VALUE MEASURMENTS (Details Textual) false false R25.htm 125 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA (Details) Sheet http://mydario.com/role/SelectedStatementsOfOperationsDataDetails SELECTED STATEMENTS OF OPERATIONS DATA (Details) false false R26.htm 126 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA (Details 1) Sheet http://mydario.com/role/SelectedStatementsOfOperationsDataDetails1 SELECTED STATEMENTS OF OPERATIONS DATA (Details 1) false false R27.htm 127 - Disclosure - SELECTED STATEMENTS OF OPERATIONS DATA (Details 2) Sheet http://mydario.com/role/SelectedStatementsOfOperationsDataDetails2 SELECTED STATEMENTS OF OPERATIONS DATA (Details 2) false false R28.htm 128 - Disclosure - SUBSEQUENT EVENTS (Details Textual) Sheet http://mydario.com/role/SubsequentEventsDetailsTextual SUBSEQUENT EVENTS (Details Textual) false false All Reports Book All Reports Process Flow-Through: 102 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: Removing column 'Jun. 17, 2014' Process Flow-Through: 104 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013' Process Flow-Through: 106 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) Process Flow-Through: 107 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013' drio-20140630.xml drio-20140630.xsd drio-20140630_cal.xml drio-20140630_def.xml drio-20140630_lab.xml drio-20140630_pre.xml true true XML 45 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' DEFICIT (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Mar. 31, 2014
Jun. 30, 2014
Jun. 30, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Total stock-based compensation expenses $ 690 $ 1,199 $ 2,862
Cost of Sales [Member]
     
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated Share Based Compensation Expense 18 36  
Research and Development Expense [Member]
     
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated Share Based Compensation Expense 141 280  
Selling and Marketing Expense [Member]
     
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated Share Based Compensation Expense 0 6  
General and Administrative Expense [Member]
     
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]      
Allocated Share Based Compensation Expense $ 531 $ 877